1	Pediatr	NNP	O	Pediatr	nn	3	SENT_1	[p1l1441t81r1565b109],
2	Blood	NNP	O	Blood	nn	3	SENT_1	[p1l1576t81r1674b109],
3	Cancer	NNP	O	Cancer	_	0	SENT_1	[p1l1687t81r1807b109],
4	2013	CD	DATE	2013	num	3	SENT_1	[p1l1819t81r2100b115],
5	;	:	O	;	_	0	SENT_1	[p1l1819t81r2100b115],
6	60:593	CD	NUMBER	60:593	num	7	SENT_1	[p1l1819t81r2100b115],
7	—	NN	O	—	dep	3	SENT_1	[p1l1819t81r2100b115],
8	598	CD	NUMBER	598	dep	7	SENT_1	[p1l1819t81r2100b115],

1	Glutathione	NN	O	glutathione	nn	3	SENT_2	[p1l218t130r507b174],
2	S-Transferase	NN	O	s-transferase	nn	3	SENT_2	[p1l525t130r846b174],
3	P1	NN	O	p1	nsubj	7	SENT_2	[p1l865t134r912b173],
4	Single	JJ	O	single	amod	6	SENT_2	[p1l939t130r1082b188],
5	Nucleotide	NN	O	nucleotide	nn	6	SENT_2	[p1l1102t130r1367b174],
6	Polymorphism	NN	O	polymorphism	dep	3	SENT_2	[p1l1386t130r1730b188],
7	Predicts	VBZ	O	predict	_	0	SENT_2	[p1l1751t130r1942b174],

1	Permanent	JJ	O	permanent	amod	2	SENT_3	[p1l375t198r634b238],
2	Ototoxicity	NN	O	ototoxicity	_	0	SENT_3	[p1l651t195r929b251],
3	in	IN	O	in	dep	2	SENT_3	[p1l947t195r987b237],
4	Children	NNP	O	Children	pobj	3	SENT_3	[p1l1005t194r1213b238],
5	With	IN	O	with	dep	2	SENT_3	[p1l1230t194r1348b238],
6	Medulloblastoma	NN	O	medulloblastoma	pobj	5	SENT_3	[p1l1367t194r1787b238],

1	Surya	NNP	PERSON	Surya	nn	2	SENT_4	[p1l140t272r239b313],
2	Rednam	NNP	PERSON	Rednam	_	0	SENT_4	[p1l253t270r407b310],
3	,	,	O	,	_	0	SENT_4	[p1l253t270r407b310],
4	MD	NNP	O	MD	nn	9	SENT_4	[p1l421t264r514b310],
5	,1	CD	NUMBER	,1	num	9	SENT_4	[p1l421t264r514b310],
6	*	CD	NUMBER	*	num	9	SENT_4	[p1l421t264r514b310],
7	Michael	NNP	PERSON	Michael	nn	9	SENT_4	[p1l528t270r669b302],
8	E.	NNP	PERSON	E.	nn	9	SENT_4	[p1l686t273r713b302],
9	Scheurer	NNP	PERSON	Scheurer	appos	2	SENT_4	[p1l727t270r896b310],
10	,	,	O	,	_	0	SENT_4	[p1l727t270r896b310],
11	PhD	NNP	O	PhD	appos	2	SENT_4	[p1l911t279r973b310],
12	,	,	O	,	_	0	SENT_4	[p1l911t279r973b310],
13	MPH	NNP	O	MPH	nn	16	SENT_4	[p1l991t264r1078b310],
14	,1	CD	NUMBER	,1	num	16	SENT_4	[p1l991t264r1078b310],
15	Adekunle	NNP	PERSON	Adekunle	nn	16	SENT_4	[p1l1094t270r1263b302],
16	Adesina	NNP	PERSON	Adesina	appos	2	SENT_4	[p1l1275t270r1427b310],
17	,	,	O	,	_	0	SENT_4	[p1l1275t270r1427b310],
18	MD	NNP	O	MD	appos	2	SENT_4	[p1l1441t281r1498b310],
19	,	,	O	,	_	0	SENT_4	[p1l1441t281r1498b310],
20	PhD	NNP	O	PhD	nn	24	SENT_4	[p1l1517t264r1597b310],
21	,2	CD	NUMBER	,2	num	24	SENT_4	[p1l1517t264r1597b310],
22	Ching	NNP	PERSON	Ching	nn	24	SENT_4	[p1l1610t270r1715b313],
23	C.	NNP	PERSON	C.	nn	24	SENT_4	[p1l1726t272r1762b303],
24	Lau	NNP	PERSON	Lau	appos	2	SENT_4	[p1l1778t273r1849b310],
25	,	,	O	,	_	0	SENT_4	[p1l1778t273r1849b310],
26	MD	NNP	O	MD	appos	2	SENT_4	[p1l1863t281r1920b310],
27	,	,	O	,	_	0	SENT_4	[p1l1863t281r1920b310],
28	PhD	NNP	O	PhD	appos	2	SENT_4	[p1l1939t264r2015b310],
29	,1	CD	NUMBER	,1	num	28	SENT_4	[p1l1939t264r2015b310],

1	and	CC	O	and	dep	4	SENT_5	[p1l772t320r836b352],
2	Mehmet	NNP	PERSON	Mehmet	nn	4	SENT_5	[p1l850t320r998b352],
3	Fatih	NNP	PERSON	Fatih	nn	4	SENT_5	[p1l1012t320r1097b352],
4	Okcu	NNP	PERSON	Okcu	_	0	SENT_5	[p1l1111t320r1218b359],
5	,	,	O	,	_	0	SENT_5	[p1l1111t320r1218b359],
6	MD	NNP	O	MD	appos	4	SENT_5	[p1l1232t331r1289b359],
7	,	,	O	,	_	0	SENT_5	[p1l1232t331r1289b359],
8	MPH1	NN	O	mph1	appos	4	SENT_5	[p1l1306t314r1382b351],

1	Background	NN	O	background	_	0	SENT_6	[p1l143t428r322b462],
2	.	.	O	.	_	0	SENT_6	[p1l143t428r322b462],

1	Glutathione	NN	O	glutathione	nn	2	SENT_7	[p1l341t428r508b454],
2	S-transferase	NN	O	s-transferase	nsubjpass	8	SENT_7	[p1l526t428r702b454],
3	(	CD	NUMBER	(	num	6	SENT_7	[p1l721t428r797b456],
4	GST	NN	O	gst	nn	6	SENT_7	[p1l721t428r797b456],
5	)	NN	O	)	nn	6	SENT_7	[p1l721t428r797b456],
6	enzymes	NNS	O	enzyme	dep	2	SENT_7	[p1l816t437r939b462],
7	are	VBP	O	be	auxpass	8	SENT_7	[p1l957t437r999b453],
8	involved	VBN	O	involve	_	0	SENT_7	[p1l1019t430r1054b453, p1l92t465r185b491],
9	in	IN	O	in	_	0	SENT_7	[p1l203t467r226b491],
10	detoxifying	VBG	O	detoxify	prepc_in	8	SENT_7	[p1l243t465r400b499],
11	chemotherapy	NN	O	chemotherapy	nn	16	SENT_7	[p1l415t465r617b499],
12	and	CC	O	and	_	0	SENT_7	[p1l632t465r682b491],
13	clearing	NN	O	clearing	nn	16	SENT_7	[p1l699t465r812b499],
14	reactive	JJ	O	reactive	amod	16	SENT_7	[p1l828t467r938b491],
15	oxygen	NN	O	oxygen	nn	16	SENT_7	[p1l953t474r1053b499],
16	species	NNS	O	species	nsubj	17	SENT_7	[p1l93t504r194b536],
17	formed	VBN	O	form	dep	10	SENT_7	[p1l204t503r304b528],
18	by	IN	O	by	_	0	SENT_7	[p1l317t503r350b536],
19	radiation	NN	O	radiation	prep_by	17	SENT_7	[p1l363t503r494b528],
20	.	.	O	.	_	0	SENT_7	[p1l363t503r494b528],

1	We	PRP	O	we	nsubj	2	SENT_8	[p1l507t505r556b528],
2	explored	VBD	O	explore	_	0	SENT_8	[p1l567t503r690b536],
3	the	DT	O	the	det	4	SENT_8	[p1l701t503r745b528],
4	relationship	NN	O	relationship	dep	13	SENT_8	[p1l758t503r922b536],
5	between	IN	O	between	_	0	SENT_8	[p1l935t503r1053b528],
6	the	DT	O	the	det	7	SENT_8	[p1l92t540r135b565],
7	host	NN	O	host	prep_between	4	SENT_8	[p1l151t540r208b565],
8	GSTP1	NN	O	gstp1	dep	13	SENT_8	[p1l225t542r316b566],
9	105	CD	NUMBER	105	num	8	SENT_8	[p1l336t542r385b565],
10	A	DT	O	a	det	13	SENT_8	[p1l401t542r423b565],
11	>	JJR	O	>	amod	13	SENT_8	[p1l437t547r457b566],
12	G	NN	O	g	nn	13	SENT_8	[p1l472t542r494b566],
13	polymorphism	NN	O	polymorphism	dep	2	SENT_8	[p1l512t540r714b574],
14	(	CD	NUMBER	(	num	15	SENT_8	[p1l731t540r852b570],
15	rs1695	NN	O	rs1695	dep	13	SENT_8	[p1l731t540r852b570],
16	)	NN	O	)	dobj	2	SENT_8	[p1l731t540r852b570],
17	,	,	O	,	_	0	SENT_8	[p1l731t540r852b570],
18	tumor	NN	O	tumor	nn	21	SENT_8	[p1l868t545r953b565],
19	GSTpi	NN	O	gstpus	nn	21	SENT_8	[p1l968t542r1052b574],
20	protein	NN	O	protein	nn	21	SENT_8	[p1l93t579r191b611],
21	expression	NN	O	expression	dobj	2	SENT_8	[p1l203t579r359b611],
22	,	,	O	,	_	0	SENT_8	[p1l203t579r359b611],
23	and	CC	O	and	_	0	SENT_8	[p1l373t577r423b603],
24	clinical	JJ	O	clinical	amod	25	SENT_8	[p1l436t577r537b603],
25	outcomes	NNS	O	outcome	dobj	2	SENT_8	[p1l550t582r686b603],
26	in	IN	O	in	_	0	SENT_8	[p1l700t579r722b603],
27	pediatric	JJ	O	pediatric	amod	28	SENT_8	[p1l736t577r858b611],
28	medulloblastoma	NN	O	medulloblastoma	prep_in	25	SENT_8	[p1l871t577r1054b603, p1l91t620r170b640],
29	.	.	O	.	_	0	SENT_8	[p1l871t577r1054b603, p1l91t620r170b640],

1	We	PRP	O	we	nsubj	2	SENT_9	[p1l183t617r231b640],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_9	[p1l244t615r429b649],
3	that	IN	O	that	complm	15	SENT_9	[p1l441t615r495b640],
4	the	DT	O	the	det	7	SENT_9	[p1l505t615r548b640],
5	GSTPI	NN	O	gstpus	nn	7	SENT_9	[p1l562t616r653b640],
6	105	CD	NUMBER	105	num	7	SENT_9	[p1l669t617r718b640],
7	G-allele	NN	O	g-allele	nsubjpass	15	SENT_9	[p1l733t615r845b641],
8	and	CC	O	and	_	0	SENT_9	[p1l857t615r907b640],
9	increased	VBD	O	increase	amod	10	SENT_9	[p1l921t615r1053b640],
10	tumor	NN	O	tumor	nsubjpass	15	SENT_9	[p1l92t657r176b678],
11	GSTpi	NN	MISC	gstpus	nn	12	SENT_9	[p1l191t654r275b686],
12	expression	NN	O	expression	dep	7	SENT_9	[p1l292t654r440b686],
13	would	MD	O	would	aux	15	SENT_9	[p1l456t652r544b678],
14	be	VB	O	be	auxpass	15	SENT_9	[p1l561t652r593b678],
15	associated	VBN	O	associate	ccomp	2	SENT_9	[p1l609t652r753b678],
16	with	IN	O	with	_	0	SENT_9	[p1l768t652r829b678],
17	lower	JJR	O	lower	amod	18	SENT_9	[p1l847t652r925b678],
18	progression	NN	O	progression	prep_with	15	SENT_9	[p1l941t661r1054b686, p1l93t689r214b715],
19	—	CD	NUMBER	—	num	21	SENT_9	[p1l941t661r1054b686, p1l93t689r214b715],
20	free	JJ	O	free	amod	21	SENT_9	[p1l941t661r1054b686, p1l93t689r214b715],
21	survival	NN	O	survival	dep	18	SENT_9	[p1l229t689r335b715],
22	and	CC	O	and	_	0	SENT_9	[p1l352t689r402b715],
23	fewer	JJR	O	fewer	amod	25	SENT_9	[p1l417t689r496b715],
24	adverse	JJ	O	adverse	amod	25	SENT_9	[p1l510t689r617b715],
25	events	NNS	O	event	prep_with	15	SENT_9	[p1l631t694r727b715],
26	.	.	O	.	_	0	SENT_9	[p1l631t694r727b715],

1	Procedure	NN	O	procedure	_	0	SENT_10	[p1l745t689r899b715],
2	.	.	O	.	_	0	SENT_10	[p1l745t689r899b715],

1	The	DT	O	the	det	2	SENT_11	[p1l914t689r966b715],
2	study	NN	O	study	nsubj	3	SENT_11	[p1l981t689r1054b723],
3	included	VBD	O	include	_	0	SENT_11	[p1l94t727r215b752],
4	106	CD	NUMBER	106	num	9	SENT_11	[p1l238t729r288b752],
5	meduIloblastoma/primitive	JJ	O	meduiloblastoma/primitive	amod	9	SENT_11	[p1l310t727r690b761],
6	neuroectodermal	JJ	O	neuroectodermal	amod	9	SENT_11	[p1l711t727r949b752],
7	tumor	NN	O	tumor	nn	9	SENT_11	[p1l970t732r1055b752],
8	(	NN	O	(	nn	9	SENT_11	[p1l93t764r142b792],
9	PN	NN	O	pn	dobj	3	SENT_11	[p1l93t764r142b792],
10	ET	NNP	O	ET	nn	12	SENT_11	[p1l148t764r187b792],
11	)	CD	NUMBER	)	num	12	SENT_11	[p1l148t764r187b792],
12	patients	NNS	O	patient	nsubj	13	SENT_11	[p1l199t766r307b798],
13	seen	VBN	O	see	rcmod	9	SENT_11	[p1l318t773r379b790],
14	at	IN	O	at	_	0	SENT_11	[p1l390t769r415b790],
15	Texas	NNP	LOCATION	Texas	nn	16	SENT_11	[p1l423t766r503b790],
16	Children	NNP	O	Children	poss	19	SENT_11	[p1l513t764r657b790],
17	's	POS	O	's	_	0	SENT_11	[p1l513t764r657b790],
18	Cancer	NNP	O	Cancer	nn	19	SENT_11	[p1l667t766r767b790],
19	Center	NNP	O	Center	prep_at	13	SENT_11	[p1l777t766r876b790],
20	.	.	O	.	_	0	SENT_11	[p1l777t766r876b790],

1	Genotyping	VBG	O	genotype	nsubjpass	3	SENT_12	[p1l889t766r1054b798],
2	was	VBD	O	be	auxpass	3	SENT_12	[p1l92t810r146b827],
3	performed	VBN	O	perform	_	0	SENT_12	[p1l164t802r308b835],
4	using	VBG	O	use	xcomp	3	SENT_12	[p1l327t803r400b836],
5	an	DT	O	a	det	8	SENT_12	[p1l417t810r448b827],
6	Illumina	NNP	O	Illumina	nn	8	SENT_12	[p1l469t802r584b827],
7	HumanOmni1-Quad	NN	O	humanomni1-quad	nn	8	SENT_12	[p1l602t802r897b833],
8	BeadChip	NN	O	beadchip	dobj	4	SENT_12	[p1l918t802r1054b835],
9	and	CC	O	and	_	0	SENT_12	[p1l93t839r143b865],
10	GSTpi	NN	O	gstpus	nn	11	SENT_12	[p1l161t841r245b873],
11	expression	NN	O	expression	nsubjpass	13	SENT_12	[p1l263t841r410b873],
12	was	VBD	O	be	auxpass	13	SENT_12	[p1l427t848r481b865],
13	assessed	VBN	O	assess	conj_and	3	SENT_12	[p1l498t839r614b865],
14	using	VBG	O	use	xcomp	13	SENT_12	[p1l632t841r705b873],
15	immunohistochemistry	NN	O	immunohistochemistry	dobj	14	SENT_12	[p1l723t839r1052b873],
16	.	.	O	.	_	0	SENT_12	[p1l723t839r1052b873],

1	We	PRP	O	we	nsubj	2	SENT_13	[p1l92t878r140b902],
2	used	VBD	O	use	_	0	SENT_13	[p1l154t876r216b902],
3	the	DT	O	the	det	4	SENT_13	[p1l229t876r272b902],
4	KapIan	NNP	O	KapIan	dobj	2	SENT_13	[p1l286t876r482b910],
5	.	.	O	.	_	0	SENT_13	[p1l286t876r482b910],

1	—	NN	O	—	_	0	SENT_14	[p1l286t876r482b910],
2	.	.	O	.	_	0	SENT_14	[p1l286t876r482b910],

1	I\/Ieier	NN	O	i\/ieier	nn	2	SENT_15	[p1l286t876r482b910],
2	method	NN	O	method	_	0	SENT_15	[p1l495t876r600b902],
3	for	IN	O	for	_	0	SENT_15	[p1l613t876r651b902],
4	survival	NN	O	survival	nn	5	SENT_15	[p1l663t876r769b902],
5	analyses	NNS	O	analysis	prep_for	2	SENT_15	[p1l785t876r902b910],
6	and	CC	O	and	_	0	SENT_15	[p1l915t876r965b902],
7	logistic	JJ	O	logistic	amod	8	SENT_15	[p1l981t876r1054b910, p1l91t915r125b939],
8	regression	NN	O	regression	conj_and	5	SENT_15	[p1l148t915r286b948],
9	for	IN	O	for	_	0	SENT_15	[p1l308t914r346b939],
10	toxicity	NN	O	toxicity	nn	11	SENT_15	[p1l365t915r470b947],
11	comparisons	NNS	O	comparison	prep_for	2	SENT_15	[p1l491t915r676b947],
12	.	.	O	.	_	0	SENT_15	[p1l491t915r676b947],

1	Results	NNS	O	result	_	0	SENT_16	[p1l700t913r807b939],
2	.	.	O	.	_	0	SENT_16	[p1l700t913r807b939],

1	Patients	NNS	O	patient	nsubj	28	SENT_17	[p1l829t915r937b939],
2	with	IN	O	with	_	0	SENT_17	[p1l957t914r1017b939],
3	a	DT	O	a	det	7	SENT_17	[p1l1039t922r1054b939],
4	GSTP1	NN	O	gstp1	nn	7	SENT_17	[p1l95t953r186b977],
5	105	CD	NUMBER	105	num	7	SENT_17	[p1l206t953r255b976],
6	AG/CG	NN	O	ag/cg	nn	7	SENT_17	[p1l272t951r379b979],
7	genotype	NN	O	genotype	prep_with	1	SENT_17	[p1l396t956r525b985],
8	(	CD	NUMBER	(	dep	7	SENT_17	[p1l541t951r585b979],
9	vs.	CC	O	vs.	prep	8	SENT_17	[p1l541t951r585b979],
10	AA	NNP	O	AA	dep	9	SENT_17	[p1l602t951r653b979],
11	)	CD	NUMBER	)	num	10	SENT_17	[p1l602t951r653b979],
12	or	CC	O	or	_	0	SENT_17	[p1l670t960r698b976],
13	who	WP	O	who	nsubj	15	SENT_17	[p1l713t951r774b976],
14	had	VBD	O	have	aux	15	SENT_17	[p1l792t951r841b976],
15	received	VBN	O	receive	prep_with	1	SENT_17	[p1l859t951r976b976],
16	high	JJ	O	high	amod	20	SENT_17	[p1l994t951r1053b985],
17	dose	NN	O	dose	nn	20	SENT_17	[p1l1105t428r1170b453],
18	craniospinal	NN	O	craniospinal	nn	20	SENT_17	[p1l1182t428r1352b462],
19	radiation	NN	O	radiation	nn	20	SENT_17	[p1l1367t428r1490b453],
20	(	NN	O	(	dobj	15	SENT_17	[p1l1504t428r1572b458],
21	234	CD	NUMBER	234	num	22	SENT_17	[p1l1504t428r1572b458],
22	Gy	NN	O	gy	dep	20	SENT_17	[p1l1586t430r1627b462],
23	vs.	CC	O	vs.	_	0	SENT_17	[p1l1638t437r1673b453],
24	<	JJR	O	<	conj_vs.	20	SENT_17	[p1l1688t430r1746b454],
25	26	CD	NUMBER	26	num	26	SENT_17	[p1l1688t430r1746b454],
26	Cy	NNP	O	Cy	dep	24	SENT_17	[p1l1761t428r1809b462],
27	)	CD	NUMBER	)	num	26	SENT_17	[p1l1761t428r1809b462],
28	had	VBD	O	have	_	0	SENT_17	[p1l1823t428r1872b453],
29	a	DT	O	a	det	31	SENT_17	[p1l1885t437r1900b453],
30	greater	JJR	O	greater	amod	31	SENT_17	[p1l1911t433r2008b462],
31	risk	NN	O	risk	dobj	28	SENT_17	[p1l2020t428r2067b453],
32	of	IN	O	of	_	0	SENT_17	[p1l1105t465r1133b491],
33	requiring	VBG	O	require	prepc_of	31	SENT_17	[p1l1147t467r1273b499],
34	hearing	NN	O	hearing	nn	35	SENT_17	[p1l1289t465r1393b499],
35	aids	NNS	O	aid	dobj	33	SENT_17	[p1l1408t465r1463b491],
36	than	IN	O	than	mark	39	SENT_17	[p1l1477t465r1537b491],
37	their	PRP$	O	they	poss	38	SENT_17	[p1l1552t465r1616b491],
38	counterparts	NNS	O	counterpart	nsubj	39	SENT_17	[p1l1631t470r1805b499],
39	(	VBP	O	(	advcl	33	SENT_17	[p1l1821t465r1875b494],
40	OR	NN	O	or	dobj	39	SENT_17	[p1l1821t465r1875b494],
41	4.0	CD	NUMBER	4.0	num	40	SENT_17	[p1l1890t468r1942b496],
42	,	,	O	,	_	0	SENT_17	[p1l1890t468r1942b496],
43	95	CD	PERCENT	95	number	44	SENT_17	[p1l1959t467r2022b492],
44	%	NN	PERCENT	%	amod	45	SENT_17	[p1l1959t467r2022b492],
45	CI	NN	O	ci	dobj	39	SENT_17	[p1l2038t467r2065b491],
46	1.2	CD	NUMBER	1.2	num	47	SENT_17	[p1l1107t505r1238b533],
47	—	NN	O	—	dep	45	SENT_17	[p1l1107t505r1238b533],
48	13.6	CD	NUMBER	13.6	dep	45	SENT_17	[p1l1107t505r1238b533],
49	,	,	O	,	_	0	SENT_17	[p1l1107t505r1238b533],
50	and	CC	O	and	_	0	SENT_17	[p1l1253t503r1303b528],
51	OR	NN	O	or	dobj	39	SENT_17	[p1l1318t504r1364b528],
52	3.1	CD	NUMBER	3.1	num	51	SENT_17	[p1l1378t505r1429b533],
53	,	,	O	,	_	0	SENT_17	[p1l1378t505r1429b533],
54	95	CD	PERCENT	95	num	56	SENT_17	[p1l1445t504r1508b529],
55	%	NN	PERCENT	%	nn	56	SENT_17	[p1l1445t504r1508b529],
56	CI	NN	O	ci	appos	51	SENT_17	[p1l1522t504r1549b528],
57	1.1-8	CD	NUMBER	1.1-8	num	58	SENT_17	[p1l1567t505r1679b533],
58	.8	CD	NUMBER	.8	dep	56	SENT_17	[p1l1567t505r1679b533],
59	,	,	O	,	_	0	SENT_17	[p1l1567t505r1679b533],
60	respectively	RB	O	respectively	advmod	56	SENT_17	[p1l1695t503r1869b536],
61	,	,	O	,	_	0	SENT_17	[p1l1695t503r1869b536],
62	n	NN	O	n	appos	51	SENT_17	[p1l1886t511r1900b528],
63	:	:	O	:	_	0	SENT_17	[p1l1915t515r1937b523],
64	69	CD	NUMBER	69	num	65	SENT_17	[p1l1951t503r2002b531],
65	)	NN	O	)	dep	28	SENT_17	[p1l1951t503r2002b531],
66	.	.	O	.	_	0	SENT_17	[p1l1951t503r2002b531],

1	Additionally	RB	O	additionally	advmod	4	SENT_18	[p1l2017t503r2067b528, p1l1105t540r1246b574],
2	,	,	O	,	_	0	SENT_18	[p1l2017t503r2067b528, p1l1105t540r1246b574],
3	there	EX	O	there	expl	4	SENT_18	[p1l1262t540r1334b565],
4	was	VBD	O	be	_	0	SENT_18	[p1l1349t549r1403b565],
5	a	DT	O	a	det	8	SENT_18	[p1l1419t549r1434b565],
6	statistically	RB	O	statistically	advmod	7	SENT_18	[p1l1450t540r1605b574],
7	significant	JJ	O	significant	amod	8	SENT_18	[p1l1621t540r1765b574],
8	interaction	NN	O	interaction	nsubj	4	SENT_18	[p1l1782t542r1930b565],
9	between	IN	O	between	_	0	SENT_18	[p1l1948t540r2066b565],
10	these	DT	O	these	det	11	SENT_18	[p1l1104t577r1177b603],
11	variables	NNS	O	variable	prep_between	8	SENT_18	[p1l1191t577r1324b603],
12	.	.	O	.	_	0	SENT_18	[p1l1191t577r1324b603],

1	Compared	VBN	O	compare	_	0	SENT_19	[p1l1340t578r1486b611],
2	with	IN	O	with	prepc_compared_with	39	SENT_19	[p1l1501t578r1561b603],
3	the	DT	O	the	det	6	SENT_19	[p1l1576t577r1619b603],
4	lowest	JJS	O	lowest	amod	6	SENT_19	[p1l1635t578r1724b603],
5	risk	NN	O	risk	nn	6	SENT_19	[p1l1739t577r1786b603],
6	group	NN	O	group	pobj	39	SENT_19	[p1l1800t586r1881b611],
7	(	CD	NUMBER	(	num	8	SENT_19	[p1l1896t578r1998b606],
8	G$	NN	O	g$	dep	6	SENT_19	[p1l1896t578r1998b606],
9	TP7	NN	O	tp7	nn	12	SENT_19	[p1l1896t578r1998b606],
10	105	CD	NUMBER	105	num	12	SENT_19	[p1l2016t580r2065b603],
11	AA	NN	O	aa	nn	12	SENT_19	[p1l1105t615r1218b640],
12	—	NN	O	—	dep	8	SENT_19	[p1l1105t615r1218b640],
13	low	JJ	O	low	amod	16	SENT_19	[p1l1105t615r1218b640],
14	dose	NN	O	dose	nn	16	SENT_19	[p1l1231t615r1296b640],
15	radiation	NN	O	radiation	nn	16	SENT_19	[p1l1310t615r1452b645],
16	)	NN	O	)	dep	8	SENT_19	[p1l1310t615r1452b645],
17	,	,	O	,	_	0	SENT_19	[p1l1310t615r1452b645],
18	patients	NNS	O	patient	nsubj	39	SENT_19	[p1l1467t617r1575b649],
19	with	IN	O	with	_	0	SENT_19	[p1l1588t615r1648b640],
20	a	DT	O	a	det	24	SENT_19	[p1l1664t624r1678b640],
21	GSTP1	NN	O	gstp1	nn	24	SENT_19	[p1l1694t616r1785b641],
22	105	CD	NUMBER	105	num	24	SENT_19	[p1l1803t617r1852b640],
23	AG/CG	NN	O	ag/cg	nn	24	SENT_19	[p1l1867t615r1973b643],
24	genotype	NN	O	genotype	prep_with	18	SENT_19	[p1l1988t624r2067b649, p1l1105t657r1164b686],
25	who	WP	O	who	nsubj	26	SENT_19	[p1l1174t652r1235b678],
26	received	VBD	O	receive	rcmod	24	SENT_19	[p1l1247t652r1364b678],
27	high	JJ	O	high	amod	29	SENT_19	[p1l1377t652r1435b686],
28	dose	NN	O	dose	nn	29	SENT_19	[p1l1446t652r1511b678],
29	radiation	NN	O	radiation	nsubj	34	SENT_19	[p1l1522t652r1645b678],
30	were	VBD	O	be	cop	34	SENT_19	[p1l1656t661r1725b678],
31	8.4	CD	NUMBER	8.4	num	32	SENT_19	[p1l1736t655r1778b678],
32	times	NNS	O	time	npadvmod	33	SENT_19	[p1l1788t654r1863b678],
33	more	RBR	O	more	advmod	34	SENT_19	[p1l1874t661r1945b678],
34	likely	JJ	O	likely	ccomp	26	SENT_19	[p1l1957t652r2031b686],
35	to	TO	O	to	aux	36	SENT_19	[p1l2040t657r2067b678],
36	require	VB	O	require	xcomp	34	SENT_19	[p1l1107t691r1205b723],
37	hearing	NN	O	hearing	nn	38	SENT_19	[p1l1221t689r1325b723],
38	aids	NNS	O	aid	dobj	36	SENT_19	[p1l1340t689r1395b715],
39	(	VBP	O	(	_	0	SENT_19	[p1l1411t690r1483b718],
40	95	CD	PERCENT	95	num	41	SENT_19	[p1l1411t690r1483b718],
41	%	NN	PERCENT	%	dobj	39	SENT_19	[p1l1411t690r1483b718],
42	CI	NN	O	ci	dep	41	SENT_19	[p1l1498t691r1526b715],
43	1.4	CD	NUMBER	1.4	num	42	SENT_19	[p1l1545t692r1676b720],
44	—	CD	NUMBER	—	number	45	SENT_19	[p1l1545t692r1676b720],
45	49.9	CD	NUMBER	49.9	dep	42	SENT_19	[p1l1545t692r1676b720],
46	,	,	O	,	_	0	SENT_19	[p1l1545t692r1676b720],
47	p	NN	O	p	nn	49	SENT_19	[p1l1693t689r1792b723],
48	—	NN	O	—	nn	49	SENT_19	[p1l1693t689r1792b723],
49	trend	NN	O	trend	appos	41	SENT_19	[p1l1693t689r1792b723],
50	=	JJ	O	=	amod	49	SENT_19	[p1l1807t702r1829b710],
51	0.005	CD	NUMBER	0.005	tmod	50	SENT_19	[p1l1843t692r1931b720],
52	,	,	O	,	_	0	SENT_19	[p1l1843t692r1931b720],
53	n	NN	O	n	appos	41	SENT_19	[p1l1949t698r1963b715],
54	=	JJ	O	=	amod	56	SENT_19	[p1l1978t702r2000b710],
55	69	CD	NUMBER	69	tmod	54	SENT_19	[p1l2014t690r2065b718],
56	)	NN	O	)	dep	53	SENT_19	[p1l2014t690r2065b718],
57	.	.	O	.	_	0	SENT_19	[p1l2014t690r2065b718],

1	When	WRB	O	when	advmod	2	SENT_20	[p1l1105t727r1189b752],
2	adjusted	VBN	O	adjust	advcl	16	SENT_20	[p1l1205t727r1322b761],
3	for	IN	O	for	_	0	SENT_20	[p1l1337t727r1375b752],
4	age	NN	O	age	prep_for	2	SENT_20	[p1l1390t736r1445b761],
5	,	,	O	,	_	0	SENT_20	[p1l1390t736r1445b761],
6	cumulative	JJ	O	cumulative	amod	8	SENT_20	[p1l1462t727r1618b752],
7	cisplatin	NN	O	cisplatin	nn	8	SENT_20	[p1l1634t727r1750b761],
8	dose	NN	O	dose	conj_and	4	SENT_20	[p1l1766t727r1838b757],
9	,	,	O	,	_	0	SENT_20	[p1l1766t727r1838b757],
10	and	CC	O	and	_	0	SENT_20	[p1l1855t727r1905b752],
11	amifostine	NN	O	amifostine	nn	12	SENT_20	[p1l1922t727r2067b752],
12	use	NN	O	use	prep_for	2	SENT_20	[p1l1106t773r1159b794],
13	,	,	O	,	_	0	SENT_20	[p1l1106t773r1159b794],
14	the	DT	O	the	det	15	SENT_20	[p1l1178t764r1222b790],
15	association	NN	O	association	nsubj	16	SENT_20	[p1l1241t766r1395b790],
16	remained	VBD	O	remain	_	0	SENT_20	[p1l1416t764r1555b790],
17	.	.	O	.	_	0	SENT_20	[p1l1416t764r1555b790],

1	Conclusions	NNS	O	conclusion	_	0	SENT_21	[p1l1577t764r1757b790],
2	.	.	O	.	_	0	SENT_21	[p1l1577t764r1757b790],

1	The	DT	O	the	det	2	SENT_22	[p1l1775t764r1827b790],
2	GSTPY	NN	MISC	gstpy	nsubj	15	SENT_22	[p1l1849t766r1939b790],
3	105	CD	NUMBER	105	num	4	SENT_22	[p1l1962t766r2011b790],
4	Gallele	NNP	MISC	Gallele	dep	2	SENT_22	[p1l2033t766r2067b790, p1l1106t802r1181b827],
5	is	VBZ	O	be	auxpass	6	SENT_22	[p1l1197t803r1215b827],
6	associated	VBN	O	associate	_	0	SENT_22	[p1l1230t802r1374b827],
7	with	IN	O	with	_	0	SENT_22	[p1l1388t802r1448b827],
8	permanent	JJ	O	permanent	amod	9	SENT_22	[p1l1464t807r1615b835],
9	ototoxicity	NN	O	ototoxicity	prep_with	6	SENT_22	[p1l1627t803r1778b835],
10	in	IN	O	in	_	0	SENT_22	[p1l1793t803r1815b827],
11	pediatric	JJ	O	pediatric	amod	12	SENT_22	[p1l1831t802r1954b835],
12	medulloblastoma/PNET	NN	O	medulloblastoma/pnet	prep_in	9	SENT_22	[p1l1969t802r2067b827, p1l1107t839r1349b868],
13	and	CC	O	and	_	0	SENT_22	[p1l1359t839r1409b865],
14	strongly	RB	O	strongly	advmod	15	SENT_22	[p1l1420t839r1531b873],
15	interacts	VBZ	O	interact	conj_and	6	SENT_22	[p1l1542t841r1658b865],
16	with	IN	O	with	_	0	SENT_22	[p1l1668t839r1728b864],
17	radiation	NN	O	radiation	nn	18	SENT_22	[p1l1741t839r1864b865],
18	dose	NN	O	dose	prep_with	15	SENT_22	[p1l1875t839r1947b865],
19	.	.	O	.	_	0	SENT_22	[p1l1875t839r1947b865],

1	Patients	NNS	O	patient	nsubjpass	7	SENT_23	[p1l1960t841r2067b865],
2	with	IN	O	with	_	0	SENT_23	[p1l1105t876r1165b902],
3	this	DT	O	this	det	4	SENT_23	[p1l1181t876r1230b902],
4	allele	NN	O	allele	prep_with	1	SENT_23	[p1l1246t876r1322b902],
5	should	MD	O	should	aux	7	SENT_23	[p1l1337t876r1430b902],
6	be	VB	O	be	auxpass	7	SENT_23	[p1l1447t876r1479b902],
7	considered	VBN	O	consider	_	0	SENT_23	[p1l1495t876r1648b902],
8	for	IN	O	for	_	0	SENT_23	[p1l1664t876r1702b902],
9	clinical	JJ	O	clinical	amod	10	SENT_23	[p1l1717t876r1818b902],
10	trials	NNS	O	trial	prep_for	7	SENT_23	[p1l1835t876r1902b902],
11	employing	VBG	O	employ	partmod	10	SENT_23	[p1l1918t876r2067b910],
12	radiation	NN	O	radiation	nn	14	SENT_23	[p1l1107t914r1229b939],
13	dose	NN	O	dose	nn	14	SENT_23	[p1l1245t914r1309b939],
14	modifications	NNS	O	modification	dobj	11	SENT_23	[p1l1324t913r1514b939],
15	and	CC	O	and	_	0	SENT_23	[p1l1529t914r1579b939],
16	cytoprotectant	JJ	O	cytoprotectant	amod	17	SENT_23	[p1l1594t918r1797b947],
17	strategies	NNS	O	strategy	dobj	11	SENT_23	[p1l1811t915r1947b948],
18	.	.	O	.	_	0	SENT_23	[p1l1811t915r1947b948],

1	Pediatr	NNP	O	Pediatr	nn	3	SENT_24	[p1l1971t914r2068b939],
2	Blood	NNP	O	Blood	nn	3	SENT_24	[p1l1107t951r1187b976],
3	Cancer	NNP	O	Cancer	_	0	SENT_24	[p1l1202t953r1302b977],
4	2013	CD	DATE	2013	num	3	SENT_24	[p1l1326t953r1587b981],
5	;	:	O	;	_	0	SENT_24	[p1l1326t953r1587b981],
6	60:593	CD	NUMBER	60:593	number	7	SENT_24	[p1l1326t953r1587b981],
7	-598	CD	NUMBER	-598	dep	3	SENT_24	[p1l1326t953r1587b981],
8	.	.	O	.	_	0	SENT_24	[p1l1326t953r1587b981],

1	©	RB	O	©	advmod	2	SENT_25	[p1l1624t956r1644b976],
2	2012	CD	DATE	2012	_	0	SENT_25	[p1l1658t956r1719b976],
3	Wiley	NNP	ORGANIZATION	Wiley	nn	4	SENT_25	[p1l1731t954r1805b984],
4	Periodicals	NNPS	ORGANIZATION	Periodicals	dep	2	SENT_25	[p1l1818t954r1959b981],
5	,	,	ORGANIZATION	,	_	0	SENT_25	[p1l1818t954r1959b981],
6	Inc.	NNP	ORGANIZATION	Inc.	appos	4	SENT_25	[p1l1974t956r2016b976],
7	.	.	O	.	_	0	SENT_25	[p1l1974t956r2016b976],

1	Key	NN	O	key	_	0	SENT_26	[p1l366t1022r420b1056],
2	words	NNS	O	word	dep	1	SENT_26	[p1l431t1020r532b1047],
3	:	:	O	:	_	0	SENT_26	[p1l431t1020r532b1047],
4	glutathione	NN	O	glutathione	nn	5	SENT_26	[p1l570t1020r739b1056],
5	S-transferase	NN	O	s-transferase	dep	1	SENT_26	[p1l751t1020r947b1053],
6	;	:	O	;	_	0	SENT_26	[p1l751t1020r947b1053],
7	medulloblastoma	NN	O	medulloblastoma	dep	5	SENT_26	[p1l961t1020r1229b1053],
8	;	:	O	;	_	0	SENT_26	[p1l961t1020r1229b1053],
9	ototoxicity	NN	O	ototoxicity	dep	7	SENT_26	[p1l1242t1022r1410b1056],
10	;	:	O	;	_	0	SENT_26	[p1l1242t1022r1410b1056],
11	polymorphism	NN	O	polymorphism	dep	9	SENT_26	[p1l1423t1020r1648b1056],
12	;	:	O	;	_	0	SENT_26	[p1l1423t1020r1648b1056],
13	radiation	NN	O	radiation	dep	5	SENT_26	[p1l1663t1020r1793b1047],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_27	[p1l14t1241r700b1304],

1	Medulloblastoma	NN	O	medulloblastoma	nsubj	8	SENT_28	[p1l114t1401r677b1457],
2	is	VBZ	O	be	cop	8	SENT_28	[p1l707t1401r757b1457],
3	the	DT	O	the	det	8	SENT_28	[p1l789t1401r885b1457],
4	most	RBS	O	most	advmod	5	SENT_28	[p1l916t1409r1071b1457],
5	common	JJ	O	common	amod	8	SENT_28	[p1l1101t1419r1381b1457],
6	malignant	JJ	O	malignant	amod	8	SENT_28	[p1l1411t1401r1733b1473],
7	brain	NN	O	brain	nn	8	SENT_28	[p1l1762t1401r1926b1457],
8	tumor	NN	O	tumor	_	0	SENT_28	[p1l1957t1409r2149b1457],
9	in	IN	O	in	_	0	SENT_28	[p1l7t1498r68b1553],
10	pediatrics	NNS	O	pediatrics	prep_in	8	SENT_28	[p1l98t1498r428b1571],
11	,	,	O	,	_	0	SENT_28	[p1l98t1498r428b1571],
12	accounting	VBG	O	account	partmod	8	SENT_28	[p1l464t1498r812b1571],
13	for	IN	O	for	_	0	SENT_28	[p1l845t1498r938b1554],
14	20	CD	PERCENT	20	num	15	SENT_28	[p1l969t1498r1109b1554],
15	%	NN	PERCENT	%	prep_for	12	SENT_28	[p1l969t1498r1109b1554],
16	of	IN	O	of	_	0	SENT_28	[p1l1145t1498r1214b1554],
17	central	JJ	O	central	amod	20	SENT_28	[p1l1241t1498r1457b1554],
18	nervous	JJ	O	nervous	amod	20	SENT_28	[p1l1489t1516r1739b1554],
19	system	NN	O	system	nn	20	SENT_28	[p1l1774t1506r1994b1571],
20	malignancies	NNS	O	malignancy	prep_of	15	SENT_28	[p1l2024t1516r2145b1554, p1l7t1594r330b1667],
21	in	IN	O	in	_	0	SENT_28	[p1l355t1594r416b1650],
22	the	DT	O	the	det	24	SENT_28	[p1l438t1594r534b1650],
23	United	NNP	LOCATION	United	nn	24	SENT_28	[p1l557t1594r775b1651],
24	States	NNPS	LOCATION	States	prep_in	12	SENT_28	[p1l799t1595r986b1650],
25	[	CD	NUMBER	[	number	26	SENT_28	[p1l1015t1595r1178b1662],
26	1,2	CD	NUMBER	1,2	num	27	SENT_28	[p1l1015t1595r1178b1662],
27	]	NN	O	]	dep	12	SENT_28	[p1l1015t1595r1178b1662],
28	.	.	O	.	_	0	SENT_28	[p1l1015t1595r1178b1662],

1	Treatment	NN	O	treatment	nsubj	10	SENT_29	[p1l1205t1596r1533b1650],
2	in	IN	O	in	_	0	SENT_29	[p1l1554t1594r1615b1650],
3	children	NNS	O	child	prep_in	1	SENT_29	[p1l1639t1594r1900b1650],
4	at	IN	DURATION	at	quantmod	6	SENT_29	[p1l1924t1602r1979b1650],
5	least	JJS	DURATION	least	mwe	4	SENT_29	[p1l2001t1594r2148b1650],
6	3	CD	DURATION	3	num	7	SENT_29	[p1l9t1692r41b1748],
7	years	NNS	NUMBER	year	npadvmod	3	SENT_29	[p1l68t1710r234b1764],
8	of	IN	O	of	_	0	SENT_29	[p1l260t1692r329b1748],
9	age	NN	O	age	prep_of	3	SENT_29	[p1l348t1709r455b1764],
10	consists	VBZ	O	consist	_	0	SENT_29	[p1l479t1692r729b1748],
11	of	IN	O	of	_	0	SENT_29	[p1l754t1692r823b1748],
12	surgical	JJ	O	surgical	amod	13	SENT_29	[p1l844t1692r1092b1764],
13	resection	NN	O	resection	prep_of	10	SENT_29	[p1l1115t1692r1422b1758],
14	,	,	O	,	_	0	SENT_29	[p1l1115t1692r1422b1758],
15	craniospinal	JJ	O	craniospinal	amod	19	SENT_29	[p1l1449t1692r1839b1764],
16	radiation	NN	O	radiation	nn	19	SENT_29	[p1l1862t1692r2148b1748],
17	(	NN	O	(	nn	19	SENT_29	[p1l10t1789r200b1858],
18	CS1	NN	O	cs1	nn	19	SENT_29	[p1l10t1789r200b1858],
19	)	NN	O	)	conj_and	13	SENT_29	[p1l10t1789r200b1858],
20	,	,	O	,	_	0	SENT_29	[p1l10t1789r200b1858],
21	and	CC	O	and	_	0	SENT_29	[p1l239t1789r352b1845],
22	chemotherapy	NN	O	chemotherapy	conj_and	13	SENT_29	[p1l386t1789r839b1862],
23	[	CD	NUMBER	[	number	24	SENT_29	[p1l880t1789r1042b1857],
24	3,4	CD	NUMBER	3,4	num	25	SENT_29	[p1l880t1789r1042b1857],
25	]	NN	O	]	dep	22	SENT_29	[p1l880t1789r1042b1857],
26	.	.	O	.	_	0	SENT_29	[p1l880t1789r1042b1857],

1	This	DT	O	this	nsubj	2	SENT_30	[p1l1080t1789r1219b1845],
2	produces	VBZ	O	produce	_	0	SENT_30	[p1l1254t1789r1541b1862],
3	long-term	JJ	O	long-term	amod	5	SENT_30	[p1l1578t1789r1894b1862],
4	overall	JJ	O	overall	amod	5	SENT_30	[p1l1928t1789r2147b1845],
5	survival	NN	O	survival	dobj	2	SENT_30	[p1l10t1885r261b1941],
6	of	IN	O	of	_	0	SENT_30	[p1l296t1885r365b1941],
7	60-80	JJ	PERCENT	60-80	quantmod	8	SENT_30	[p1l394t1885r655b1942],
8	%	NN	PERCENT	%	prep_of	5	SENT_30	[p1l394t1885r655b1942],
9	[	CD	NUMBER	[	number	10	SENT_30	[p1l697t1885r800b1953],
10	5	CD	NUMBER	5	dep	11	SENT_30	[p1l697t1885r800b1953],
11	]	NN	O	]	dep	5	SENT_30	[p1l697t1885r800b1953],
12	.	.	O	.	_	0	SENT_30	[p1l697t1885r800b1953],

1	Despite	IN	O	despite	_	0	SENT_31	[p1l837t1885r1080b1958],
2	improving	VBG	O	improve	prepc_despite	7	SENT_31	[p1l1114t1885r1446b1958],
3	survival	NN	O	survival	dobj	2	SENT_31	[p1l1483t1885r1751b1951],
4	,	,	O	,	_	0	SENT_31	[p1l1483t1885r1751b1951],
5	many	JJ	O	many	amod	6	SENT_31	[p1l1787t1903r1964b1958],
6	individuals	NNS	O	individual	nsubj	7	SENT_31	[p1l1997t1885r2145b1941, p1l8t1983r236b2039],
7	experience	VBP	O	experience	_	0	SENT_31	[p1l275t1983r620b2055],
8	therapy-related	JJ	O	therapy-related	amod	9	SENT_31	[p1l657t1983r1144b2055],
9	morbidities	NNS	O	morbidity	dobj	7	SENT_31	[p1l1180t1983r1562b2049],
10	,	,	O	,	_	0	SENT_31	[p1l1180t1983r1562b2049],
11	including	VBG	O	include	_	0	SENT_31	[p1l1601t1983r1903b2055],
12	neurocognitive	JJ	O	neurocognitive	amod	13	SENT_31	[p1l1939t2001r2145b2039, p1l8t2080r303b2153],
13	impairment	NN	O	impairment	prep_including	9	SENT_31	[p1l342t2080r730b2153],
14	,	,	O	,	_	0	SENT_31	[p1l342t2080r730b2153],
15	endocrinopathies	NNS	O	endocrinopathy	conj_and	13	SENT_31	[p1l773t2080r1337b2153],
16	,	,	O	,	_	0	SENT_31	[p1l773t2080r1337b2153],
17	and	CC	O	and	_	0	SENT_31	[p1l1382t2080r1495b2136],
18	hearing	NN	O	hearing	nn	19	SENT_31	[p1l1534t2080r1773b2153],
19	loss	NN	O	loss	prep_including	9	SENT_31	[p1l1814t2080r1934b2136],
20	[	CD	NUMBER	[	number	21	SENT_31	[p1l1981t2080r2143b2148],
21	5,6	CD	NUMBER	5,6	num	22	SENT_31	[p1l1981t2080r2143b2148],
22	]	NN	O	]	dep	19	SENT_31	[p1l1981t2080r2143b2148],
23	.	.	O	.	_	0	SENT_31	[p1l1981t2080r2143b2148],

1	Well	RB	O	well	advmod	2	SENT_32	[p1l6t2176r156b2232],
2	established	VBN	O	establish	_	0	SENT_32	[p1l190t2176r546b2232],
3	prognostic	JJ	O	prognostic	amod	4	SENT_32	[p1l578t2176r915b2249],
4	criteria	NNS	O	criterion	dobj	2	SENT_32	[p1l950t2176r1177b2232],
5	for	IN	O	for	_	0	SENT_32	[p1l1210t2176r1303b2232],
6	survival	NN	O	survival	prep_for	4	SENT_32	[p1l1337t2176r1588b2232],
7	include	VBP	O	include	dep	2	SENT_32	[p1l1622t2176r1856b2232],
8	age	NN	O	age	dobj	7	SENT_32	[p1l1892t2194r1999b2249],
9	and	CC	O	and	_	0	SENT_32	[p1l2035t2176r2148b2232],
10	risk	NN	O	risk	dobj	7	SENT_32	[p1l6t2273r127b2329],
11	grouping-based	JJ	O	grouping-based	nsubj	2	SENT_32	[p1l151t2273r649b2346],
12	on	IN	O	on	_	0	SENT_32	[p1l675t2291r752b2329],
13	the	DT	O	the	det	16	SENT_32	[p1l777t2273r873b2329],
14	initial	JJ	O	initial	amod	16	SENT_32	[p1l898t2273r1084b2329],
15	disease	NN	O	disease	nn	16	SENT_32	[p1l1111t2273r1339b2329],
16	extent	NN	O	extent	prep_on	11	SENT_32	[p1l1366t2282r1562b2329],
17	and	CC	O	and	_	0	SENT_32	[p1l1586t2273r1700b2329],
18	the	DT	O	the	det	19	SENT_32	[p1l1724t2274r1820b2329],
19	degree	NN	O	degree	conj_and	11	SENT_32	[p1l1846t2273r2058b2346],
20	of	IN	O	of	_	0	SENT_32	[p1l2084t2273r2153b2329],
21	surgical	JJ	O	surgical	amod	25	SENT_32	[p1l10t2371r259b2444],
22	resection	NN	O	resection	nn	25	SENT_32	[p1l284t2371r575b2427],
23	[	NN	O	[	nn	25	SENT_32	[p1l606t2371r768b2439],
24	1,5	CD	NUMBER	1,5	num	25	SENT_32	[p1l606t2371r768b2439],
25	]	NN	O	]	prep_of	19	SENT_32	[p1l606t2371r768b2439],
26	.	.	O	.	_	0	SENT_32	[p1l606t2371r768b2439],

1	More	RBR	O	more	advmod	2	SENT_33	[p1l798t2373r970b2427],
2	recently	RB	DATE	recently	advmod	17	SENT_33	[p1l996t2371r1267b2444],
3	,	,	O	,	_	0	SENT_33	[p1l996t2371r1267b2444],
4	the	DT	O	the	det	5	SENT_33	[p1l1296t2371r1392b2427],
5	presence	NN	O	presence	nsubjpass	17	SENT_33	[p1l1417t2389r1697b2444],
6	of	IN	O	of	_	0	SENT_33	[p1l1725t2371r1795b2427],
7	distinctive	JJ	O	distinctive	amod	9	SENT_33	[p1l1816t2371r2147b2427],
8	disease	NN	O	disease	nn	9	SENT_33	[p1l8t2467r236b2523],
9	subtypes	NNS	O	subtype	prep_of	5	SENT_33	[p1l317t2467r592b2540],
10	characterized	VBN	O	characterize	partmod	9	SENT_33	[p1l671t2467r1100b2523],
11	by	IN	O	by	_	0	SENT_33	[p1l1176t2467r1254b2540],
12	molecular	JJ	O	molecular	amod	14	SENT_33	[p1l1331t2467r1653b2523],
13	classiﬁcation	NN	O	classiﬁcation	nn	14	SENT_33	[p1l1730t2467r2147b2523],
14	schemes	NNS	O	scheme	agent	10	SENT_33	[p1l10t2565r276b2620],
15	has	VBZ	O	have	aux	17	SENT_33	[p1l315t2565r419b2620],
16	been	VBN	O	be	auxpass	17	SENT_33	[p1l458t2565r609b2620],
17	proposed	VBN	O	propose	_	0	SENT_33	[p1l647t2564r940b2637],
18	[	CD	NUMBER	[	number	19	SENT_33	[p1l984t2565r1146b2632],
19	7,8	CD	NUMBER	7,8	num	20	SENT_33	[p1l984t2565r1146b2632],
20	]	NN	O	]	dobj	17	SENT_33	[p1l984t2565r1146b2632],
21	.	.	O	.	_	0	SENT_33	[p1l984t2565r1146b2632],

1	However	RB	O	however	advmod	9	SENT_34	[p1l1189t2566r1491b2631],
2	,	,	O	,	_	0	SENT_34	[p1l1189t2566r1491b2631],
3	for	IN	O	for	_	0	SENT_34	[p1l1533t2564r1625b2620],
4	toxicities	NNS	O	toxicity	prep_for	9	SENT_34	[p1l1662t2564r1973b2631],
5	,	,	O	,	_	0	SENT_34	[p1l1662t2564r1973b2631],
6	it	PRP	O	it	nsubj	9	SENT_34	[p1l2014t2564r2058b2620],
7	is	VBZ	O	be	cop	9	SENT_34	[p1l2096t2564r2146b2620],
8	largely	RB	O	largely	advmod	9	SENT_34	[p1l8t2662r228b2735],
9	uncertain	JJ	O	uncertain	_	0	SENT_34	[p1l262t2662r561b2718],
10	which	WDT	O	which	dobj	13	SENT_34	[p1l595t2662r789b2718],
11	patients	NNS	O	patient	nsubj	13	SENT_34	[p1l822t2662r1069b2735],
12	will	MD	O	will	aux	13	SENT_34	[p1l1106t2662r1228b2718],
13	develop	VB	O	develop	dep	9	SENT_34	[p1l1263t2662r1512b2735],
14	them	PRP	O	they	dobj	13	SENT_34	[p1l1547t2662r1707b2718],
15	and	CC	O	and	_	0	SENT_34	[p1l1741t2662r1854b2718],
16	how	WRB	O	how	advmod	20	SENT_34	[p1l1887t2662r2021b2718],
17	severe	JJ	O	severe	dep	16	SENT_34	[p1l2058t2680r2145b2718, p1l7t2776r142b2814],
18	they	PRP	O	they	nsubj	20	SENT_34	[p1l173t2758r309b2831],
19	will	MD	O	will	aux	20	SENT_34	[p1l340t2758r462b2815],
20	be	VB	O	be	conj_and	13	SENT_34	[p1l492t2758r583b2814],
21	.	.	O	.	_	0	SENT_34	[p1l492t2758r583b2814],

1	One	CD	NUMBER	one	num	2	SENT_35	[p1l116t2856r245b2912],
2	group	NN	O	group	nsubj	18	SENT_35	[p1l274t2873r457b2928],
3	of	IN	O	of	_	0	SENT_35	[p1l487t2855r556b2911],
4	enzymes	NNS	O	enzyme	prep_of	2	SENT_35	[p1l579t2873r856b2928],
5	that	WDT	O	that	nsubj	6	SENT_35	[p1l885t2856r1005b2911],
6	deserves	VBZ	O	deserve	rcmod	4	SENT_35	[p1l1033t2855r1304b2912],
7	more	JJR	O	more	amod	8	SENT_35	[p1l1334t2873r1496b2911],
8	attention	NN	O	attention	dobj	6	SENT_35	[p1l1526t2855r1806b2911],
9	in	IN	O	in	_	0	SENT_35	[p1l1833t2855r1893b2911],
10	medulloblastoma	NN	O	medulloblastoma	prep_in	6	SENT_35	[p1l1921t2855r2145b2911, p1l8t2953r360b3009],
11	is	VBZ	O	be	cop	18	SENT_35	[p1l395t2953r445b3009],
12	the	DT	O	the	det	18	SENT_35	[p1l483t2953r579b3009],
13	glutathione	NN	O	glutathione	nn	18	SENT_35	[p1l617t2953r976b3026],
14	S-transferase	NN	O	s-transferase	nn	18	SENT_35	[p1l1015t2953r1430b3009],
15	(	CD	NUMBER	(	num	18	SENT_35	[p1l1470t2953r1668b3022],
16	GST	NN	O	gst	nn	18	SENT_35	[p1l1470t2953r1668b3022],
17	)	NN	O	)	nn	18	SENT_35	[p1l1470t2953r1668b3022],
18	family	NN	O	family	_	0	SENT_35	[p1l1707t2953r1926b3026],
19	.	.	O	.	_	0	SENT_35	[p1l1707t2953r1926b3026],

1	GSTS	NNS	O	gst	nsubj	2	SENT_36	[p1l1969t2953r2146b3009],
2	detoxify	VBP	O	detoxify	_	0	SENT_36	[p1l8t3049r273b3122],
3	electrophilic	JJ	O	electrophilic	amod	4	SENT_36	[p1l300t3049r700b3122],
4	compounds	NNS	O	compound	dobj	2	SENT_36	[p1l729t3049r1095b3122],
5	via	IN	O	via	_	0	SENT_36	[p1l1123t3049r1220b3105],
6	conjugation	NN	O	conjugation	prep_via	4	SENT_36	[p1l1246t3049r1624b3122],
7	of	IN	O	of	_	0	SENT_36	[p1l1651t3049r1720b3105],
8	reduced	VBN	O	reduce	amod	9	SENT_36	[p1l1740t3049r1994b3105],
9	glutathione	NN	O	glutathione	prep_of	6	SENT_36	[p1l2021t3049r2145b3122, p1l7t3146r281b3202],
10	.	.	O	.	_	0	SENT_36	[p1l2021t3049r2145b3122, p1l7t3146r281b3202],

1	These	DT	O	these	det	2	SENT_37	[p1l320t3147r509b3202],
2	compounds	NNS	O	compound	nsubj	3	SENT_37	[p1l546t3146r912b3219],
3	include	VBP	O	include	_	0	SENT_37	[p1l949t3146r1183b3202],
4	mutagenic	JJ	O	mutagenic	amod	7	SENT_37	[p1l1219t3146r1551b3219],
5	and	CC	O	and	_	0	SENT_37	[p1l1589t3146r1703b3202],
6	carcinogenic	JJ	O	carcinogenic	amod	7	SENT_37	[p1l1738t3146r2146b3219],
7	materials	NNS	O	material	dobj	3	SENT_37	[p1l7t3244r318b3310],
8	,	,	O	,	_	0	SENT_37	[p1l7t3244r318b3310],
9	chemotherapy	NN	O	chemotherapy	nn	10	SENT_37	[p1l362t3244r815b3317],
10	agents	NNS	O	agent	dobj	3	SENT_37	[p1l857t3252r1058b3317],
11	and	CC	O	and	_	0	SENT_37	[p1l1101t3244r1215b3300],
12	their	PRP$	O	they	poss	13	SENT_37	[p1l1254t3244r1401b3300],
13	metabolites	NNS	O	metabolite	dobj	3	SENT_37	[p1l1439t3244r1826b3310],
14	,	,	O	,	_	0	SENT_37	[p1l1439t3244r1826b3310],
15	and	CC	O	and	_	0	SENT_37	[p1l1871t3244r1984b3300],
16	free	JJ	O	free	amod	17	SENT_37	[p1l2024t3244r2146b3300],
17	radicals	NNS	O	radical	nsubj	18	SENT_37	[p1l6t3340r254b3396],
18	[	VBP	O	[	conj_and	3	SENT_37	[p1l322t3341r423b3408],
19	9	CD	NUMBER	9	num	20	SENT_37	[p1l322t3341r423b3408],
20	]	NN	O	]	dobj	18	SENT_37	[p1l322t3341r423b3408],
21	.	.	O	.	_	0	SENT_37	[p1l322t3341r423b3408],

1	Genetic	JJ	O	genetic	amod	2	SENT_38	[p1l490t3340r735b3397],
2	variation	NN	O	variation	nsubjpass	28	SENT_38	[p1l797t3340r1080b3396],
3	in	IN	O	in	_	0	SENT_38	[p1l1140t3340r1201b3396],
4	these	DT	O	these	det	5	SENT_38	[p1l1261t3340r1424b3396],
5	enzymes	NNS	O	enzyme	prep_in	2	SENT_38	[p1l1485t3358r1781b3413],
6	,	,	O	,	_	0	SENT_38	[p1l1485t3358r1781b3413],
7	including	VBG	O	include	_	0	SENT_38	[p1l1845t3340r2147b3413],
8	GSTPI	NN	O	gstpus	prep_including	2	SENT_38	[p1l10t3438r231b3494],
9	105	CD	NUMBER	105	num	8	SENT_38	[p1l283t3437r389b3494],
10	A	DT	O	a	det	16	SENT_38	[p1l432t3438r488b3493],
11	>	JJR	O	>	dep	12	SENT_38	[p1l522t3449r571b3496],
12	G	NN	O	g	amod	16	SENT_38	[p1l604t3438r659b3494],
13	SNP	NN	O	snp	nn	16	SENT_38	[p1l698t3438r841b3494],
14	(	CD	NUMBER	(	num	16	SENT_38	[p1l881t3437r1146b3507],
15	rsl695	NN	O	rsl695	nn	16	SENT_38	[p1l881t3437r1146b3507],
16	)	NN	O	)	dep	8	SENT_38	[p1l881t3437r1146b3507],
17	and	CC	O	and	_	0	SENT_38	[p1l1188t3437r1302b3493],
18	Whole	JJ	O	whole	amod	20	SENT_38	[p1l1339t3437r1533b3494],
19	gene	NN	O	gene	nn	20	SENT_38	[p1l1572t3455r1721b3510],
20	deletions	NNS	O	deletion	conj_and	8	SENT_38	[p1l1760t3437r2047b3493],
21	in	IN	O	in	_	0	SENT_38	[p1l2087t3437r2147b3493],
22	GSTMI	NNP	O	GSTMI	prep_in	20	SENT_38	[p1l10t3535r248b3591],
23	and	CC	O	and	_	0	SENT_38	[p1l286t3535r399b3591],
24	GSTTI	NNP	O	GSTTI	prep_in	20	SENT_38	[p1l431t3535r670b3601],
25	,	,	O	,	_	0	SENT_38	[p1l431t3535r670b3601],
26	have	VBP	O	have	aux	28	SENT_38	[p1l702t3535r851b3591],
27	been	VBN	O	be	auxpass	28	SENT_38	[p1l880t3535r1032b3591],
28	associated	VBN	O	associate	_	0	SENT_38	[p1l1064t3535r1391b3591],
29	with	IN	O	with	_	0	SENT_38	[p1l1421t3535r1562b3591],
30	survival	NN	O	survival	prep_with	28	SENT_38	[p1l1595t3535r1845b3591],
31	and	CC	O	and	_	0	SENT_38	[p1l1878t3535r1991b3591],
32	toxicities	NNS	O	toxicity	prep_with	28	SENT_38	[p1l2020t3543r2145b3591, p1l7t3631r196b3687],

1	in	IN	O	in	dep	7	SENT_39	[p1l228t3631r288b3687],
2	other	JJ	O	other	amod	4	SENT_39	[p1l319t3631r483b3687],
3	brain	NN	O	brain	nn	4	SENT_39	[p1l510t3631r675b3687],
4	tumors	NNS	O	tumor	pobj	1	SENT_39	[p1l704t3640r924b3687],
5	and	CC	O	and	_	0	SENT_39	[p1l957t3631r1070b3687],
6	other	JJ	O	other	conj_and	1	SENT_39	[p1l1100t3631r1264b3687],
7	cancers	NNS	O	cancer	nsubj	8	SENT_39	[p1l1293t3649r1530b3687],
8	treated	VBN	O	treat	_	0	SENT_39	[p1l1561t3631r1779b3687],
9	with	IN	O	with	_	0	SENT_39	[p1l1809t3631r1950b3687],
10	platinum	NN	O	platinum	nn	11	SENT_39	[p1l1978t3631r2145b3704, p1l7t3746r149b3784],
11	agents	NNS	O	agent	prep_with	8	SENT_39	[p1l194t3737r394b3801],
12	and	CC	O	and	_	0	SENT_39	[p1l442t3728r555b3784],
13	radiation	NN	O	radiation	nn	18	SENT_39	[p1l598t3728r884b3784],
14	[	NN	O	[	nn	18	SENT_39	[p1l933t3728r1196b3796],
15	l0	NN	O	l0	nn	18	SENT_39	[p1l933t3728r1196b3796],
16	—	CD	NUMBER	—	num	18	SENT_39	[p1l933t3728r1196b3796],
17	l5	NN	O	l5	nn	18	SENT_39	[p1l933t3728r1196b3796],
18	]	NN	O	]	conj_and	11	SENT_39	[p1l933t3728r1196b3796],
19	.	.	O	.	_	0	SENT_39	[p1l933t3728r1196b3796],

1	Additionally	RB	O	additionally	dep	4	SENT_40	[p1l1244t3728r1662b3801],
2	,	,	O	,	_	0	SENT_40	[p1l1244t3728r1662b3801],
3	higher	JJR	O	higher	dep	4	SENT_40	[p1l1708t3728r1914b3801],
4	tumor	NN	O	tumor	_	0	SENT_40	[p1l1957t3737r2149b3784],

1	GSTpi	NN	O	gstpus	nn	2	SENT_41	[p2l8t19r218b91],
2	expression	NN	O	expression	nsubjpass	5	SENT_41	[p2l259t19r599b91],
3	has	VBZ	O	have	aux	5	SENT_41	[p2l637t19r741b75],
4	been	VBN	O	be	auxpass	5	SENT_41	[p2l780t19r932b75],
5	correlated	VBN	O	correlate	dep	19	SENT_41	[p2l971t19r1291b75],
6	with	IN	O	with	_	0	SENT_41	[p2l1330t19r1471b75],
7	worse	JJR	O	worse	amod	8	SENT_41	[p2l1510t36r1698b75],
8	prognosis	NN	O	prognosis	prep_with	5	SENT_41	[p2l1737t19r2046b91],
9	in	IN	O	in	_	0	SENT_41	[p2l2087t19r2148b74],
10	adults	NNS	O	adult	prep_in	8	SENT_41	[p2l9t115r196b171],
11	with	IN	O	with	_	0	SENT_41	[p2l246t115r387b171],
12	high	JJ	O	high	amod	14	SENT_41	[p2l435t115r577b188],
13	grade	NN	O	grade	nn	14	SENT_41	[p2l626t115r801b188],
14	glioma	NN	O	glioma	prep_with	5	SENT_41	[p2l850t115r1073b188],
15	and	CC	O	and	_	0	SENT_41	[p2l1121t115r1234b171],
16	other	JJ	O	other	amod	18	SENT_41	[p2l1283t115r1447b171],
17	platinum-responsive	JJ	O	platinum-responsive	amod	18	SENT_41	[p2l1494t115r2146b188],
18	malignancies	NNS	O	malignancy	prep_with	5	SENT_41	[p2l7t212r429b285],
19	[	VBP	O	[	_	0	SENT_41	[p2l471t212r734b280],
20	l6	NN	O	l6	dobj	19	SENT_41	[p2l471t212r734b280],
21	—	CD	NUMBER	—	num	20	SENT_41	[p2l471t212r734b280],
22	18	CD	NUMBER	18	num	23	SENT_41	[p2l471t212r734b280],
23	]	NN	O	]	nsubj	19	SENT_41	[p2l471t212r734b280],
24	.	.	O	.	_	0	SENT_41	[p2l471t212r734b280],

1	Little	JJ	O	little	nsubjpass	3	SENT_42	[p2l772t212r946b268],
2	is	VBZ	O	be	auxpass	3	SENT_42	[p2l982t212r1031b268],
3	known	VBN	O	know	_	0	SENT_42	[p2l1067t212r1282b269],
4	about	IN	O	about	_	0	SENT_42	[p2l1318t212r1494b268],
5	the	DT	O	the	det	6	SENT_42	[p2l1528t212r1624b268],
6	role	NN	O	role	prep_about	3	SENT_42	[p2l1659t213r1783b268],
7	of	IN	O	of	_	0	SENT_42	[p2l1819t212r1888b268],
8	GSTP1	NN	O	gstp1	nn	9	SENT_42	[p2l1921t213r2141b269],
9	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_42	[p2l6t310r504b382],
10	and	CC	O	and	_	0	SENT_42	[p2l536t310r649b366],
11	tumor	NN	O	tumor	nn	13	SENT_42	[p2l676t318r868b366],
12	GSTpi	NN	O	gstpus	nn	13	SENT_42	[p2l896t310r1106b382],
13	expression	NN	O	expression	conj_and	6	SENT_42	[p2l1137t310r1476b382],
14	in	IN	O	in	_	0	SENT_42	[p2l1505t310r1566b365],
15	medulloblastoma	NN	O	medulloblastoma	nn	16	SENT_42	[p2l1594t310r2148b366],
16	outcomes	NNS	O	outcome	prep_in	13	SENT_42	[p2l8t394r330b441],
17	.	.	O	.	_	0	SENT_42	[p2l8t394r330b441],

1	In	IN	O	in	_	0	SENT_43	[p2l114t484r179b538],
2	this	DT	O	this	det	3	SENT_43	[p2l210t482r322b538],
3	study	NN	O	study	prep_in	6	SENT_43	[p2l358t482r539b555],
4	,	,	O	,	_	0	SENT_43	[p2l358t482r539b555],
5	we	PRP	O	we	nsubj	6	SENT_43	[p2l573t500r664b539],
6	assessed	VBD	O	assess	_	0	SENT_43	[p2l697t483r965b538],
7	the	DT	O	the	det	8	SENT_43	[p2l996t483r1092b538],
8	relationship	NN	O	relationship	iobj	6	SENT_43	[p2l1123t482r1501b555],
9	between	IN	O	between	_	0	SENT_43	[p2l1532t483r1799b539],
10	the	DT	O	the	det	12	SENT_43	[p2l1830t483r1926b538],
11	germline	NN	O	germline	nn	12	SENT_43	[p2l1958t500r2145b555, p2l7t580r126b636],
12	GSTP1	NN	O	gstp1	prep_between	8	SENT_43	[p2l157t580r378b636],
13	105	CD	NUMBER	105	dobj	6	SENT_43	[p2l420t579r527b636],
14	A	DT	O	a	det	17	SENT_43	[p2l558t580r614b635],
15	>	JJR	O	>	amod	17	SENT_43	[p2l649t591r698b638],
16	G	NN	O	g	nn	17	SENT_43	[p2l730t580r785b636],
17	polymorphism	NN	O	polymorphism	dep	13	SENT_43	[p2l812t580r1297b652],
18	,	,	O	,	_	0	SENT_43	[p2l812t580r1297b652],
19	tumor	NN	O	tumor	nn	22	SENT_43	[p2l1328t588r1520b636],
20	GST	NN	O	gst	nn	22	SENT_43	[p2l1548t580r1695b636],
21	pi	NN	O	pi	nn	22	SENT_43	[p2l1697t580r1757b652],
22	expression	NN	O	expression	dobj	6	SENT_43	[p2l1787t580r2144b652],
23	,	,	O	,	_	0	SENT_43	[p2l1787t580r2144b652],
24	and	CC	O	and	_	0	SENT_43	[p2l9t676r122b732],
25	survival	NN	O	survival	dobj	6	SENT_43	[p2l168t676r419b732],
26	and	CC	O	and	_	0	SENT_43	[p2l466t676r579b732],
27	the	DT	O	the	det	28	SENT_43	[p2l623t676r719b732],
28	occurrence	NN	O	occurrence	conj_and	25	SENT_43	[p2l765t694r1115b732],
29	of	IN	O	of	_	0	SENT_43	[p2l1161t676r1231b732],
30	toxicities	NNS	O	toxicity	prep_of	28	SENT_43	[p2l1269t676r1562b732],
31	in	IN	O	in	_	0	SENT_43	[p2l1608t676r1668b732],
32	patients	NNS	O	patient	prep_in	30	SENT_43	[p2l1712t676r1960b749],
33	with	IN	O	with	_	0	SENT_43	[p2l2007t676r2148b732],
34	medulloblastoma/PNET	NN	O	medulloblastoma/pnet	prep_with	32	SENT_43	[p2l7t773r783b830],
35	seen	VBN	O	see	partmod	34	SENT_43	[p2l818t791r956b829],
36	at	IN	O	at	_	0	SENT_43	[p2l990t782r1045b829],
37	our	PRP$	O	we	poss	38	SENT_43	[p2l1077t791r1182b829],
38	institution	NN	O	institution	prep_at	35	SENT_43	[p2l1212t773r1553b829],
39	.	.	O	.	_	0	SENT_43	[p2l1212t773r1553b829],

1	We	PRP	O	we	nsubj	2	SENT_44	[p2l1588t775r1692b830],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_44	[p2l1724t773r2148b846],
3	©	CD	NUMBER	©	num	4	SENT_44	[p2l12t893r71b951],
4	2012	CD	DATE	2012	dobj	2	SENT_44	[p2l102t892r269b951],
5	Wiley	NNP	ORGANIZATION	Wiley	nn	6	SENT_44	[p2l294t892r503b967],
6	Periodicals	NNPS	ORGANIZATION	Periodicals	tmod	2	SENT_44	[p2l529t892r947b965],
7	,	,	ORGANIZATION	,	_	0	SENT_44	[p2l529t892r947b965],
8	Inc.	NNP	ORGANIZATION	Inc.	appos	6	SENT_44	[p2l974t893r1108b951],
9	.	.	O	.	_	0	SENT_44	[p2l974t893r1108b951],

1	DOI	NNP	O	DOI	nsubj	6	SENT_45	[p2l7t994r165b1055],
2	10.1002	CD	NUMBER	10.1002	num	1	SENT_45	[p2l194t994r851b1070],
3	/	:	O	/	punct	4	SENT_45	[p2l194t994r851b1070],
4	pbc	NN	O	pbc	dep	1	SENT_45	[p2l194t994r851b1070],
5	.24366	CD	NUMBER	.24366	num	4	SENT_45	[p2l194t994r851b1070],
6	Published	VBN	O	publish	_	0	SENT_45	[p2l7t1078r362b1138],
7	online	NN	O	online	prep	6	SENT_45	[p2l389t1078r606b1138],
8	12	CD	DATE	12	dep	7	SENT_45	[p2l636t1079r714b1137],
9	October	NNP	DATE	October	dep	6	SENT_45	[p2l741t1078r1035b1139],
10	2012	CD	DATE	2012	num	9	SENT_45	[p2l1060t1079r1227b1138],
11	in	IN	O	in	dep	9	SENT_45	[p2l1253t1078r1322b1137],
12	Wiley	NNP	ORGANIZATION	Wiley	nn	14	SENT_45	[p2l1346t1078r1556b1154],
13	Online	NNP	ORGANIZATION	Online	nn	14	SENT_45	[p2l1582t1078r1823b1139],
14	Library	NNP	ORGANIZATION	Library	pobj	11	SENT_45	[p2l1849t1078r2134b1154],
15	(	CD	NUMBER	(	num	16	SENT_45	[p2l10t1162r911b1238],
16	wileyonlinelibrary.com	NNP	O	wileyonlinelibrary.com	dep	14	SENT_45	[p2l10t1162r911b1238],
17	)	CD	NUMBER	)	num	16	SENT_45	[p2l10t1162r911b1238],
18	.	.	O	.	_	0	SENT_45	[p2l10t1162r911b1238],

1	that	IN	O	that	dep	8	SENT_46	[p2l8t1264r129b1320],
2	the	DT	O	the	det	3	SENT_46	[p2l167t1264r263b1320],
3	presence	NN	O	presence	nsubj	8	SENT_46	[p2l303t1282r583b1337],
4	of	IN	O	of	_	0	SENT_46	[p2l625t1264r694b1320],
5	a	DT	O	a	det	6	SENT_46	[p2l730t1282r763b1320],
6	G	NN	O	g	prep_of	3	SENT_46	[p2l803t1264r1059b1320],
7	—	CD	NUMBER	—	num	8	SENT_46	[p2l803t1264r1059b1320],
8	allele	NN	O	allele	ccomp	22	SENT_46	[p2l803t1264r1059b1320],
9	at	IN	O	at	_	0	SENT_46	[p2l1102t1272r1157b1320],
10	the	DT	O	the	det	14	SENT_46	[p2l1196t1264r1292b1320],
11	GSTP	NN	O	gstp	nn	14	SENT_46	[p2l1336t1265r1557b1321],
12	]	NN	O	]	nn	14	SENT_46	[p2l1336t1265r1557b1321],
13	105	CD	NUMBER	105	num	14	SENT_46	[p2l1610t1264r1717b1320],
14	site	NN	O	site	prep_at	8	SENT_46	[p2l1764t1264r1870b1320],
15	and	CC	O	and	_	0	SENT_46	[p2l1912t1264r2025b1320],
16	increased	VBD	O	increase	ccomp	22	SENT_46	[p2l2064t1264r2150b1319, p2l9t1362r248b1418],
17	tumor	NN	O	tumor	nn	19	SENT_46	[p2l278t1370r470b1418],
18	GSTpi	NN	MISC	gstpus	nn	19	SENT_46	[p2l499t1362r709b1434],
19	expression	NN	O	expression	nsubjpass	22	SENT_46	[p2l740t1362r1081b1434],
20	would	MD	O	would	aux	22	SENT_46	[p2l1111t1362r1310b1418],
21	be	VB	O	be	auxpass	22	SENT_46	[p2l1338t1362r1412b1418],
22	associated	VBN	O	associate	_	0	SENT_46	[p2l1444t1362r1772b1418],
23	with	IN	O	with	_	0	SENT_46	[p2l1802t1362r1943b1418],
24	lower	JJR	O	lower	amod	26	SENT_46	[p2l1972t1362r2153b1418],
25	progression-free	JJ	O	progression-free	amod	26	SENT_46	[p2l7t1460r533b1532],
26	survival	NN	O	survival	prep_with	22	SENT_46	[p2l568t1460r818b1516],
27	and	CC	O	and	_	0	SENT_46	[p2l851t1460r964b1516],
28	reduced	VBD	O	reduce	conj_and	22	SENT_46	[p2l992t1460r1247b1516],
29	therapy-related	JJ	O	therapy-related	amod	30	SENT_46	[p2l1277t1460r1765b1532],
30	toxicities	NNS	O	toxicity	dobj	28	SENT_46	[p2l1795t1460r2105b1516],
31	.	.	O	.	_	0	SENT_46	[p2l1795t1460r2105b1516],

1	METHODS	NNS	O	method	_	0	SENT_47	[p2l10t1664r438b1729],

1	Study	NNP	O	Study	nn	2	SENT_48	[p2l11t1820r225b1910],
2	Population	NNP	O	Population	_	0	SENT_48	[p2l256t1820r667b1910],

1	There	EX	O	there	expl	2	SENT_49	[p2l116t1986r300b2042],
2	were	VBD	O	be	_	0	SENT_49	[p2l320t2003r472b2042],
3	106	CD	NUMBER	106	num	4	SENT_49	[p2l502t1986r611b2042],
4	patients	NNS	O	patient	nsubj	2	SENT_49	[p2l633t1986r878b2058],
5	with	IN	O	with	_	0	SENT_49	[p2l902t1986r1042b2042],
6	medulloblastoma	NN	O	medulloblastoma	prep_with	4	SENT_49	[p2l1062t1986r1610b2042],
7	or	CC	O	or	_	0	SENT_49	[p2l1632t2004r1698b2042],
8	supratentorial	JJ	O	supratentorial	amod	13	SENT_49	[p2l1720t1986r2152b2058],
9	primitive	JJ	O	primitive	amod	10	SENT_49	[p2l7t2083r295b2156],
10	neuroectodermal	JJ	O	neuroectodermal	amod	13	SENT_49	[p2l321t2083r855b2139],
11	tumor	NN	O	tumor	nn	13	SENT_49	[p2l880t2092r1071b2139],
12	(	NN	O	(	nn	13	SENT_49	[p2l1096t2084r1341b2152],
13	PNET	NN	O	pnet	nsubj	2	SENT_49	[p2l1096t2084r1341b2152],
14	)	CD	NUMBER	)	nsubj	22	SENT_49	[p2l1096t2084r1341b2152],
15	seen	VBN	O	see	partmod	14	SENT_49	[p2l1372t2101r1509b2139],
16	at	IN	O	at	_	0	SENT_49	[p2l1536t2091r1591b2139],
17	Texas	NNP	LOCATION	Texas	nn	18	SENT_49	[p2l1615t2085r1797b2139],
18	Children	NNP	O	Children	poss	21	SENT_49	[p2l1824t2083r2150b2139],
19	’s	POS	O	’s	_	0	SENT_49	[p2l1824t2083r2150b2139],
20	Cancer	NNP	O	Cancer	nn	21	SENT_49	[p2l9t2180r234b2236],
21	Center	NNP	O	Center	prep_at	15	SENT_49	[p2l251t2180r463b2236],
22	included	VBD	O	include	rcmod	13	SENT_49	[p2l480t2179r753b2235],
23	in	IN	O	in	_	0	SENT_49	[p2l771t2179r832b2235],
24	this	DT	O	this	det	25	SENT_49	[p2l850t2179r961b2235],
25	study	NN	O	study	prep_in	22	SENT_49	[p2l984t2179r1161b2252],
26	.	.	O	.	_	0	SENT_49	[p2l984t2179r1161b2252],

1	Peripheral	JJ	O	peripheral	amod	3	SENT_50	[p2l1184t2179r1509b2252],
2	blood	NN	O	blood	nn	3	SENT_50	[p2l1527t2179r1708b2235],
3	samples	NNS	O	sample	nsubjpass	5	SENT_50	[p2l1729t2179r1979b2252],
4	were	VBD	O	be	auxpass	5	SENT_50	[p2l1999t2197r2151b2235],
5	obtained	VBN	O	obtain	_	0	SENT_50	[p2l9t2277r282b2333],
6	for	IN	O	for	_	0	SENT_50	[p2l320t2277r413b2333],
7	genotyping	VBG	O	genotype	prepc_for	5	SENT_50	[p2l449t2277r804b2349],
8	from	IN	O	from	_	0	SENT_50	[p2l843t2277r997b2333],
9	86	CD	NUMBER	86	num	10	SENT_50	[p2l1038t2277r1112b2333],
10	patients	NNS	O	patient	prep_from	7	SENT_50	[p2l1150t2277r1412b2349],
11	.	.	O	.	_	0	SENT_50	[p2l1150t2277r1412b2349],

1	Tumor	NN	O	tumor	nn	2	SENT_51	[p2l1455t2278r1669b2333],
2	samples	NNS	O	sample	nsubjpass	4	SENT_51	[p2l1709t2277r1959b2349],
3	were	VBD	O	be	auxpass	4	SENT_51	[p2l1999t2294r2151b2333],
4	obtained	VBN	O	obtain	_	0	SENT_51	[p2l9t2374r282b2430],
5	for	IN	O	for	_	0	SENT_51	[p2l301t2374r394b2430],
6	immunohistochemical	JJ	O	immunohistochemical	amod	10	SENT_51	[p2l412t2374r1117b2430],
7	(	NN	O	(	nn	10	SENT_51	[p2l1141t2374r1324b2443],
8	IHC	NN	ORGANIZATION	ihc	nn	10	SENT_51	[p2l1141t2374r1324b2443],
9	)	CD	NUMBER	)	num	10	SENT_51	[p2l1141t2374r1324b2443],
10	staining	NN	O	staining	prep_for	4	SENT_51	[p2l1349t2374r1595b2447],
11	from	IN	O	from	_	0	SENT_51	[p2l1616t2374r1770b2430],
12	51	CD	NUMBER	51	num	13	SENT_51	[p2l1790t2374r1860b2430],
13	patients	NNS	O	patient	prep_from	4	SENT_51	[p2l1886t2374r2148b2447],
14	.	.	O	.	_	0	SENT_51	[p2l1886t2374r2148b2447],

1	Paired	JJ	O	paired	amod	3	SENT_52	[p2l8t2470r211b2526],
2	peripheral	JJ	O	peripheral	amod	3	SENT_52	[p2l241t2470r562b2543],
3	blood	NN	O	blood	nsubj	8	SENT_52	[p2l594t2470r775b2526],
4	and	CC	O	and	_	0	SENT_52	[p2l808t2470r922b2526],
5	tumor	NN	O	tumor	nn	6	SENT_52	[p2l953t2479r1143b2526],
6	samples	NNS	O	sample	conj_and	3	SENT_52	[p2l1177t2470r1427b2543],
7	were	VBD	O	be	cop	8	SENT_52	[p2l1462t2488r1614b2526],
8	available	JJ	O	available	_	0	SENT_52	[p2l1649t2470r1931b2526],
9	on	IN	O	on	_	0	SENT_52	[p2l1965t2488r2042b2526],
10	32	CD	NUMBER	32	num	11	SENT_52	[p2l2076t2471r2152b2527],
11	patients	NNS	O	patient	prep_on	8	SENT_52	[p2l7t2568r270b2640],
12	.	.	O	.	_	0	SENT_52	[p2l7t2568r270b2640],

1	The	DT	O	the	det	3	SENT_53	[p2l309t2568r431b2624],
2	parents/legal	JJ	O	parents/legal	amod	3	SENT_53	[p2l465t2568r870b2640],
3	guardians	NNS	O	guardian	nsubj	7	SENT_53	[p2l907t2568r1212b2640],
4	of	IN	O	of	_	0	SENT_53	[p2l1249t2568r1318b2624],
5	all	DT	O	all	det	6	SENT_53	[p2l1350t2568r1425b2624],
6	subjects	NNS	O	subject	prep_of	3	SENT_53	[p2l1464t2568r1713b2640],
7	provided	VBD	O	provide	_	0	SENT_53	[p2l1749t2568r2031b2640],
8	informed	VBN	O	inform	amod	9	SENT_53	[p2l2066t2568r2149b2623, p2l8t2665r237b2721],
9	consent	NN	O	consent	dobj	7	SENT_53	[p2l257t2674r499b2721],
10	for	IN	O	for	_	0	SENT_53	[p2l517t2665r610b2721],
11	an	DT	O	a	det	14	SENT_53	[p2l629t2683r702b2721],
12	IRB-approved	JJ	O	irb-approved	amod	14	SENT_53	[p2l721t2665r1173b2738],
13	institutional	JJ	O	institutional	amod	14	SENT_53	[p2l1191t2665r1570b2721],
14	protocol	NN	O	protocol	prep_for	9	SENT_53	[p2l1588t2665r1852b2738],
15	for	IN	O	for	_	0	SENT_53	[p2l1872t2665r1965b2721],
16	SNPcancer	NN	O	snpcancer	nn	18	SENT_53	[p2l1984t2665r2149b2721, p2l9t2779r217b2817],
17	outcome	NN	O	outcome	nn	18	SENT_53	[p2l262t2770r534b2817],
18	associations	NNS	O	association	prep_for	14	SENT_53	[p2l582t2761r977b2817],
19	.	.	O	.	_	0	SENT_53	[p2l582t2761r977b2817],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_54	[p2l1027t2761r1276b2817],
2	were	VBD	O	be	auxpass	3	SENT_54	[p2l1323t2779r1474b2817],
3	diagnosed	VBN	O	diagnose	_	0	SENT_54	[p2l1522t2761r1843b2834],
4	between	IN	O	between	_	0	SENT_54	[p2l1887t2761r2152b2817],
5	March	NNP	DATE	March	prep_between	3	SENT_54	[p2l8t2859r215b2915],
6	1987	CD	DATE	1987	num	5	SENT_54	[p2l261t2859r408b2916],
7	and	CC	O	and	_	0	SENT_54	[p2l450t2859r562b2915],
8	July	NNP	DATE	July	prep_between	3	SENT_54	[p2l599t2859r730b2931],
9	2009	CD	DATE	2009	num	8	SENT_54	[p2l769t2859r924b2916],
10	and	CC	O	and	_	0	SENT_54	[p2l965t2859r1078b2915],
11	were	VBD	O	be	cop	12	SENT_54	[p2l1116t2877r1268b2915],
12	younger	JJR	O	younger	conj_and	3	SENT_54	[p2l1305t2876r1566b2931],
13	than	IN	O	than	_	0	SENT_54	[p2l1602t2859r1738b2915],
14	19	CD	DURATION	19	num	15	SENT_54	[p2l1784t2859r1852b2916],
15	years	NNS	NUMBER	year	prep_than	12	SENT_54	[p2l1892t2876r2057b2931],
16	at	IN	O	at	_	0	SENT_54	[p2l2098t2867r2153b2915],
17	diagnosis	NN	O	diagnosis	prep_at	12	SENT_54	[p2l9t2956r322b3029],
18	.	.	O	.	_	0	SENT_54	[p2l9t2956r322b3029],

1	Seventy	CD	NUMBER	seventy	num	2	SENT_55	[p2l355t2956r604b3029],
2	patients	NNS	O	patient	nsubj	3	SENT_55	[p2l630t2956r876b3029],
3	(	VBD	O	(	_	0	SENT_55	[p2l906t2956r1098b3025],
4	66	CD	PERCENT	66	num	5	SENT_55	[p2l906t2956r1098b3025],
5	%	NN	PERCENT	%	dobj	3	SENT_55	[p2l906t2956r1098b3025],
6	)	CD	NUMBER	)	nsubjpass	8	SENT_55	[p2l906t2956r1098b3025],
7	were	VBD	O	be	auxpass	8	SENT_55	[p2l1127t2974r1279b3012],
8	treated	VBN	O	treat	dep	3	SENT_55	[p2l1306t2956r1522b3012],
9	on	IN	O	on	_	0	SENT_55	[p2l1549t2974r1626b3012],
10	the	DT	O	the	det	14	SENT_55	[p2l1652t2956r1747b3012],
11	SJMB96/03	NN	O	sjmb96/03	nn	14	SENT_55	[p2l1776t2956r2148b3013],
12	or	CC	O	or	_	0	SENT_55	[p2l9t3070r75b3108],
13	CCG-A9961	NN	O	ccg-a9961	conj_or	11	SENT_55	[p2l106t3052r502b3109],
14	protocols	NNS	O	protocol	prep_on	8	SENT_55	[p2l540t3052r833b3125],
15	with	IN	O	with	_	0	SENT_55	[p2l867t3052r1007b3108],
16	the	DT	O	the	det	17	SENT_55	[p2l1038t3052r1134b3108],
17	remainder	NN	O	remainder	prep_with	8	SENT_55	[p2l1165t3052r1489b3108],
18	mostly	RB	O	mostly	advmod	19	SENT_55	[p2l1519t3052r1732b3125],
19	treated	VBN	O	treat	partmod	17	SENT_55	[p2l1765t3052r1982b3108],
20	with	IN	O	with	_	0	SENT_55	[p2l2013t3052r2153b3108],
21	vincristine	NN	O	vincristine	prep_with	19	SENT_55	[p2l9t3150r358b3216],
22	,	,	O	,	_	0	SENT_55	[p2l9t3150r358b3216],
23	cisplatin	NN	O	cisplatin	appos	21	SENT_55	[p2l388t3150r672b3222],
24	,	,	O	,	_	0	SENT_55	[p2l388t3150r672b3222],
25	and	CC	O	and	_	0	SENT_55	[p2l703t3150r815b3206],
26	cyclophosphamide-based	JJ	O	cyclophosphamide-based	amod	27	SENT_55	[p2l840t3150r1642b3222],
27	regimens	NNS	O	regimen	nsubj	28	SENT_55	[p2l1666t3150r1956b3222],
28	[	VBP	O	[	conj_and	3	SENT_55	[p2l1988t3150r2148b3218],
29	3,4	CD	NUMBER	3,4	number	30	SENT_55	[p2l1988t3150r2148b3218],
30	]	CD	NUMBER	]	dobj	28	SENT_55	[p2l1988t3150r2148b3218],
31	.	.	O	.	_	0	SENT_55	[p2l1988t3150r2148b3218],

1	1Section	NN	O	1section	_	0	SENT_56	[p2l13t3405r264b3475],
2	of	IN	O	of	_	0	SENT_56	[p2l293t3422r358b3475],
3	Hematology-Oncology	NNP	O	Hematology-Oncology	nn	5	SENT_56	[p2l382t3422r1093b3491],
4	,	,	O	,	_	0	SENT_56	[p2l382t3422r1093b3491],
5	Department	NNP	ORGANIZATION	Department	prep_of	1	SENT_56	[p2l1124t3423r1483b3491],
6	of	IN	ORGANIZATION	of	_	0	SENT_56	[p2l1512t3422r1577b3475],
7	Pediatrics	NNPS	ORGANIZATION	Pediatrics	prep_of	5	SENT_56	[p2l1600t3422r1915b3485],
8	,	,	O	,	_	0	SENT_56	[p2l1600t3422r1915b3485],
9	Baylor	NNP	ORGANIZATION	Baylor	nn	10	SENT_56	[p2l1946t3422r2153b3491],
10	College	NNP	ORGANIZATION	College	appos	5	SENT_56	[p2l9t3509r243b3578],
11	of	IN	ORGANIZATION	of	_	0	SENT_56	[p2l270t3509r336b3563],
12	Medicine	NNP	ORGANIZATION	Medicine	prep_of	10	SENT_56	[p2l357t3510r659b3572],
13	,	,	O	,	_	0	SENT_56	[p2l357t3510r659b3572],
14	Houston	NNP	LOCATION	Houston	appos	5	SENT_56	[p2l688t3511r960b3572],
15	,	,	O	,	_	0	SENT_56	[p2l688t3511r960b3572],
16	Texas	NNP	LOCATION	Texas	appos	14	SENT_56	[p2l989t3511r1182b3572],
17	;	:	O	;	_	0	SENT_56	[p2l989t3511r1182b3572],
18	2Department	NN	O	2department	dep	5	SENT_56	[p2l1212t3494r1598b3578],
19	of	IN	O	of	_	0	SENT_56	[p2l1625t3509r1691b3563],
20	Pathology	NN	O	pathology	prep_of	18	SENT_56	[p2l1712t3510r2017b3578],
21	and	CC	O	and	_	0	SENT_56	[p2l2045t3510r2152b3563],
22	Immunology	NN	O	immunology	prep_of	18	SENT_56	[p2l8t3598r411b3666],
23	,	,	O	,	_	0	SENT_56	[p2l8t3598r411b3666],
24	Baylor	NNP	ORGANIZATION	Baylor	nn	25	SENT_56	[p2l443t3598r649b3666],
25	College	NNP	ORGANIZATION	College	appos	5	SENT_56	[p2l678t3598r911b3666],
26	of	IN	ORGANIZATION	of	_	0	SENT_56	[p2l941t3598r1006b3651],
27	Medicine	NNP	ORGANIZATION	Medicine	nn	29	SENT_56	[p2l1030t3598r1332b3661],
28	,	,	O	,	_	0	SENT_56	[p2l1030t3598r1332b3661],
29	Houston	NNP	LOCATION	Houston	prep_of	25	SENT_56	[p2l1364t3599r1635b3660],
30	,	,	O	,	_	0	SENT_56	[p2l1364t3599r1635b3660],
31	Texas	NNP	LOCATION	Texas	dep	1	SENT_56	[p2l1666t3599r1839b3651],

1	Grant	NNP	PERSON	Grant	nn	2	SENT_57	[p3l9t19r180b72],
2	sponsor	NN	O	sponsor	_	0	SENT_57	[p3l250t36r497b88],
3	:	:	O	:	_	0	SENT_57	[p3l250t36r497b88],
4	National	NNP	O	National	nn	5	SENT_57	[p3l569t19r830b72],
5	Institutes	NNPS	O	Institutes	dep	2	SENT_57	[p3l898t19r1173b72],
6	of	IN	O	of	_	0	SENT_57	[p3l1243t19r1309b72],
7	Health	NNP	O	Health	prep_of	5	SENT_57	[p3l1371t19r1590b82],
8	;	:	O	;	_	0	SENT_57	[p3l1371t19r1590b82],
9	Grant	NNP	O	Grant	nn	10	SENT_57	[p3l1662t19r1833b72],
10	number	NN	O	number	dep	2	SENT_57	[p3l1900t19r2146b72],
11	:	:	O	:	_	0	SENT_57	[p3l1900t19r2146b72],
12	P50CA127001	NN	O	p50ca127001	nn	14	SENT_57	[p3l8t108r577b171],
13	—	CD	NUMBER	—	num	14	SENT_57	[p3l8t108r577b171],
14	04	NN	NUMBER	04	dep	2	SENT_57	[p3l8t108r577b171],
15	;	:	O	;	_	0	SENT_57	[p3l8t108r577b171],
16	Grant	NNP	PERSON	Grant	nn	17	SENT_57	[p3l610t108r780b161],
17	sponsor	NN	O	sponsor	dep	2	SENT_57	[p3l810t125r1057b177],
18	:	:	O	:	_	0	SENT_57	[p3l810t125r1057b177],
19	Gillson	NNP	ORGANIZATION	Gillson	nn	21	SENT_57	[p3l1093t108r1313b161],
20	Longenbaugh	NNP	ORGANIZATION	Longenbaugh	nn	21	SENT_57	[p3l1341t108r1758b177],
21	Foundation	NNP	ORGANIZATION	Foundation	conj_and	5	SENT_57	[p3l1786t108r2149b171],
22	;	:	O	;	_	0	SENT_57	[p3l1786t108r2149b171],
23	Grant	NNP	PERSON	Grant	nn	24	SENT_57	[p3l9t197r180b250],
24	sponsor	NN	O	sponsor	conj_and	5	SENT_57	[p3l217t213r464b265],
25	:	:	O	:	_	0	SENT_57	[p3l217t213r464b265],
26	John	NNP	ORGANIZATION	John	nn	30	SENT_57	[p3l505t196r646b250],
27	S.	NNP	ORGANIZATION	S.	nn	30	SENT_57	[p3l684t197r736b250],
28	Dunn	NNP	ORGANIZATION	Dunn	nn	30	SENT_57	[p3l776t198r942b249],
29	Research	NNP	ORGANIZATION	Research	nn	30	SENT_57	[p3l977t196r1254b249],
30	Foundation	NNP	ORGANIZATION	Foundation	conj_and	5	SENT_57	[p3l1289t196r1652b259],
31	;	:	O	;	_	0	SENT_57	[p3l1289t196r1652b259],
32	Grant	NNP	PERSON	Grant	nn	33	SENT_57	[p3l1691t197r1862b250],
33	sponsor	NN	O	sponsor	conj_and	5	SENT_57	[p3l1899t213r2146b265],
34	:	:	O	:	_	0	SENT_57	[p3l1899t213r2146b265],
35	Robert	NNP	PERSON	Robert	nn	39	SENT_57	[p3l8t284r214b337],
36	J.	NNP	PERSON	J.	nn	39	SENT_57	[p3l240t285r283b337],
37	Kleberg	NNP	PERSON	Kleberg	nn	39	SENT_57	[p3l314t284r572b353],
38	,	,	O	,	_	0	SENT_57	[p3l314t284r572b353],
39	Jr.	NNP	O	Jr.	dep	2	SENT_57	[p3l599t285r664b337],
40	and	CC	O	and	_	0	SENT_57	[p3l695t284r802b337],
41	Helen	NNP	ORGANIZATION	Helen	nn	44	SENT_57	[p3l828t284r1008b337],
42	C.	NNP	ORGANIZATION	C.	nn	44	SENT_57	[p3l1035t284r1098b337],
43	Kleberg	NNP	ORGANIZATION	Kleberg	nn	44	SENT_57	[p3l1129t284r1370b353],
44	Foundation	NNP	ORGANIZATION	Foundation	conj_and	5	SENT_57	[p3l1396t284r1759b347],
45	;	:	O	;	_	0	SENT_57	[p3l1396t284r1759b347],
46	Grant	NNP	PERSON	Grant	dep	2	SENT_57	[p3l1789t284r1960b337],
47	sponsor	NN	O	sponsor	dep	46	SENT_57	[p3l1988t301r2150b353, p3l11t390r115b426],
48	:	:	O	:	_	0	SENT_57	[p3l1988t301r2150b353, p3l11t390r115b426],
49	American	NNP	ORGANIZATION	American	dep	2	SENT_57	[p3l149t373r448b426],
50	Brain	NNP	ORGANIZATION	Brain	nn	52	SENT_57	[p3l476t373r644b426],
51	Tumor	NN	ORGANIZATION	tumor	nn	52	SENT_57	[p3l672t374r876b426],
52	Association	NNP	ORGANIZATION	Association	dep	49	SENT_57	[p3l903t373r1276b426],
53	.	.	O	.	_	0	SENT_57	[p3l903t373r1276b426],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_58	[p3l9t467r252b521],
2	of	IN	O	of	_	0	SENT_58	[p3l281t467r346b520],
3	interest	NN	O	interest	prep_of	1	SENT_58	[p3l370t467r608b520],
4	:	:	O	:	_	0	SENT_58	[p3l370t467r608b520],
5	Nothing	NN	O	nothing	dep	1	SENT_58	[p3l642t467r889b536],
6	to	TO	O	to	aux	7	SENT_58	[p3l918t475r975b520],
7	declare	VB	O	declare	infmod	5	SENT_58	[p3l1005t467r1238b520],
8	.	.	O	.	_	0	SENT_58	[p3l1005t467r1238b520],

1	*	NN	O	*	nn	2	SENT_59	[p3l12t562r538b630],
2	Correspondence	NN	O	correspondence	_	0	SENT_59	[p3l12t562r538b630],
3	to	TO	O	to	_	0	SENT_59	[p3l565t570r638b615],
4	:	:	O	:	_	0	SENT_59	[p3l565t570r638b615],
5	Surya	NNP	O	Surya	nn	6	SENT_59	[p3l672t562r847b630],
6	Rednam	NNP	O	Rednam	prep_to	2	SENT_59	[p3l872t562r1140b625],
7	,	,	O	,	_	0	SENT_59	[p3l872t562r1140b625],
8	MD	NNP	O	MD	appos	6	SENT_59	[p3l1169t563r1305b625],
9	,	,	O	,	_	0	SENT_59	[p3l1169t563r1305b625],
10	Texas	NNP	LOCATION	Texas	nn	11	SENT_59	[p3l1334t563r1508b615],
11	Children	NNP	O	Children	poss	13	SENT_59	[p3l1536t561r1849b615],
12	’s	POS	O	’s	_	0	SENT_59	[p3l1536t561r1849b615],
13	Hospital	NNP	O	Hospital	appos	6	SENT_59	[p3l1877t561r2149b630],
14	,	,	O	,	_	0	SENT_59	[p3l1877t561r2149b630],
15	6701	CD	NUMBER	6701	num	17	SENT_59	[p3l9t651r152b704],
16	Fannin	NNP	LOCATION	Fannin	nn	17	SENT_59	[p3l187t651r396b704],
17	St.	NNP	LOCATION	St.	appos	6	SENT_59	[p3l426t651r521b714],
18	,	,	O	,	_	0	SENT_59	[p3l426t651r521b714],
19	CCl5l0	NNP	O	CCl5l0	appos	17	SENT_59	[p3l553t650r914b714],
20	.06	CD	NUMBER	.06	num	19	SENT_59	[p3l553t650r914b714],
21	,	,	O	,	_	0	SENT_59	[p3l553t650r914b714],
22	Houston	NNP	LOCATION	Houston	appos	17	SENT_59	[p3l946t652r1217b714],
23	,	,	O	,	_	0	SENT_59	[p3l946t652r1217b714],
24	TX	NNP	LOCATION	TX	appos	17	SENT_59	[p3l1249t652r1349b703],
25	77030	CD	NUMBER	77030	num	24	SENT_59	[p3l1377t651r1579b704],
26	.	.	O	.	_	0	SENT_59	[p3l1377t651r1579b704],

1	E-mail	NN	O	e-mail	_	0	SENT_60	[p3l8t739r230b792],
2	:	:	O	:	_	0	SENT_60	[p3l8t739r230b792],
3	sprednam@txch.org	NN	O	sprednam@txch.org	dep	1	SENT_60	[p3l267t739r878b808],
4	Received	VBN	O	receive	partmod	3	SENT_60	[p3l8t832r289b885],
5	6	CD	DATE	6	dobj	4	SENT_60	[p3l318t832r352b885],
6	June	NNP	DATE	June	tmod	4	SENT_60	[p3l381t833r518b885],
7	2012	CD	DATE	2012	num	6	SENT_60	[p3l548t832r715b895],
8	;	:	O	;	_	0	SENT_60	[p3l548t832r715b895],
9	Accepted	JJ	O	accepted	amod	10	SENT_60	[p3l747t832r1033b901],
10	17	CD	DATE	17	dep	1	SENT_60	[p3l1070t833r1134b885],
11	September	NNP	DATE	September	tmod	10	SENT_60	[p3l1167t832r1490b901],
12	2012	CD	DATE	2012	num	11	SENT_60	[p3l1519t833r1667b885],
13	594	CD	NUMBER	594	num	14	SENT_60	[p3l9t935r133b994],
14	Rednam	NNP	O	Rednam	dep	10	SENT_60	[p3l350t936r652b995],
15	et	FW	O	et	nn	16	SENT_60	[p3l679t940r743b995],
16	al.	FW	O	al.	dep	14	SENT_60	[p3l767t936r850b995],
17	.	.	O	.	_	0	SENT_60	[p3l767t936r850b995],

1	Medical	JJ	O	medical	amod	3	SENT_61	[p3l7t1117r266b1173],
2	record	NN	O	record	nn	3	SENT_61	[p3l287t1117r489b1173],
3	abstractions	NNS	O	abstraction	nsubjpass	5	SENT_61	[p3l511t1117r885b1173],
4	were	VBD	O	be	auxpass	5	SENT_61	[p3l908t1134r1060b1173],
5	performed	VBN	O	perform	_	0	SENT_61	[p3l1080t1117r1410b1189],
6	for	IN	O	for	_	0	SENT_61	[p3l1431t1117r1523b1173],
7	patient	NN	O	patient	nn	10	SENT_61	[p3l1541t1117r1758b1189],
8	and	CC	O	and	_	0	SENT_61	[p3l1780t1117r1891b1173],
9	therapy	NN	O	therapy	nn	10	SENT_61	[p3l1911t1117r2148b1189],
10	characteristics	NNS	O	characteristic	prep_for	5	SENT_61	[p3l8t1214r459b1270],
11	and	CC	O	and	_	0	SENT_61	[p3l489t1214r602b1270],
12	outcomes	NNS	O	outcome	nsubj	23	SENT_61	[p3l628t1222r929b1270],
13	including	VBG	O	include	_	0	SENT_61	[p3l957t1214r1255b1286],
14	survival	NN	O	survival	nn	15	SENT_61	[p3l1285t1214r1533b1270],
15	events	NNS	O	event	prep_including	12	SENT_61	[p3l1560t1222r1757b1270],
16	and	CC	O	and	_	0	SENT_61	[p3l1787t1214r1900b1270],
17	the	DT	O	the	det	18	SENT_61	[p3l1926t1214r2022b1270],
18	occurrence	NN	O	occurrence	prep_including	12	SENT_61	[p3l2050t1232r2146b1270, p3l8t1329r280b1367],
19	of	IN	O	of	_	0	SENT_61	[p3l322t1311r391b1367],
20	acute	JJ	O	acute	amod	22	SENT_61	[p3l427t1319r592b1367],
21	toxicities/late	JJ	O	toxicities/late	amod	22	SENT_61	[p3l632t1311r1058b1367],
22	effects	NNS	O	effect	prep_of	18	SENT_61	[p3l1099t1311r1305b1367],
23	(	VBP	O	(	conj_and	5	SENT_61	[p3l1350t1311r1485b1380],
24	i.e.	FW	O	i.e.	dobj	23	SENT_61	[p3l1350t1311r1485b1380],
25	,	,	O	,	_	0	SENT_61	[p3l1350t1311r1485b1380],
26	present	JJ	DATE	present	amod	29	SENT_61	[p3l1527t1319r1757b1383],
27	or	CC	O	or	_	0	SENT_61	[p3l1797t1329r1863b1367],
28	absent	JJ	O	absent	conj_or	26	SENT_61	[p3l1903t1311r2145b1380],
29	)	NN	O	)	appos	24	SENT_61	[p3l1903t1311r2145b1380],
30	.	.	O	.	_	0	SENT_61	[p3l1903t1311r2145b1380],

1	Acute	JJ	O	acute	amod	2	SENT_62	[p3l8t1408r196b1464],
2	toxicities	NNS	O	toxicity	nsubj	5	SENT_62	[p3l219t1408r507b1464],
3	included	VBN	O	include	partmod	2	SENT_62	[p3l530t1408r803b1464],
4	were	VBD	O	be	cop	5	SENT_62	[p3l825t1425r977b1464],
5	myelosuppression	NN	O	myelosuppression	_	0	SENT_62	[p3l1000t1408r1587b1480],
6	,	,	O	,	_	0	SENT_62	[p3l1000t1408r1587b1480],
7	renal	JJ	O	renal	amod	8	SENT_62	[p3l1611t1408r1769b1464],
8	insufﬁcien	NN	O	insufﬁcien	conj_and	5	SENT_62	[p3l1792t1408r2146b1464],
9	—	CD	NUMBER	—	num	10	SENT_62	[p3l1792t1408r2146b1464],
10	cy	NN	O	cy	dep	8	SENT_62	[p3l8t1523r92b1577],
11	,	,	O	,	_	0	SENT_62	[p3l8t1523r92b1577],
12	and	CC	O	and	_	0	SENT_62	[p3l126t1505r239b1561],
13	neurotoxicity	NN	O	neurotoxicity	conj_and	5	SENT_62	[p3l267t1505r699b1577],
14	.	.	O	.	_	0	SENT_62	[p3l267t1505r699b1577],

1	They	PRP	O	they	nsubjpass	3	SENT_63	[p3l732t1505r893b1577],
2	were	VBD	O	be	auxpass	3	SENT_63	[p3l923t1523r1075b1561],
3	deemed	VBN	O	deem	_	0	SENT_63	[p3l1106t1505r1353b1561],
4	present	JJ	DATE	present	acomp	3	SENT_63	[p3l1380t1514r1610b1577],
5	if	IN	O	if	mark	7	SENT_63	[p3l1638t1505r1690b1560],
6	they	PRP	O	they	nsubj	7	SENT_63	[p3l1714t1505r1849b1577],
7	led	VBD	O	lead	advcl	3	SENT_63	[p3l1878t1505r1975b1561],
8	to	TO	O	to	_	0	SENT_63	[p3l2002t1514r2062b1561],
9	at	IN	O	at	quantmod	11	SENT_63	[p3l2094t1513r2150b1561],
10	least	JJS	O	least	mwe	9	SENT_63	[p3l8t1602r153b1658],
11	one	CD	NUMBER	one	num	12	SENT_63	[p3l178t1620r289b1658],
12	instance	NN	O	instance	prep_to	7	SENT_63	[p3l314t1602r573b1658],
13	of	IN	O	of	_	0	SENT_63	[p3l598t1602r667b1658],
14	chemotherapy	NN	O	chemotherapy	nn	16	SENT_63	[p3l687t1602r1135b1675],
15	dose	NN	O	dose	nn	16	SENT_63	[p3l1161t1602r1303b1658],
16	reduction	NN	O	reduction	prep_of	12	SENT_63	[p3l1327t1602r1643b1668],
17	,	,	O	,	_	0	SENT_63	[p3l1327t1602r1643b1668],
18	delay	NN	O	delay	prep_of	12	SENT_63	[p3l1671t1602r1852b1675],
19	,	,	O	,	_	0	SENT_63	[p3l1671t1602r1852b1675],
20	or	CC	O	or	_	0	SENT_63	[p3l1881t1620r1946b1658],
21	omission	NN	O	omission	prep_of	12	SENT_63	[p3l1970t1602r2146b1658, p3l10t1699r154b1755],
22	.	.	O	.	_	0	SENT_63	[p3l1970t1602r2146b1658, p3l10t1699r154b1755],

1	Late	JJ	O	late	amod	2	SENT_64	[p3l185t1700r325b1755],
2	effects	NNS	O	effect	nsubj	5	SENT_64	[p3l354t1699r561b1755],
3	included	VBN	O	include	partmod	2	SENT_64	[p3l590t1699r863b1755],
4	were	VBD	O	be	cop	5	SENT_64	[p3l890t1716r1042b1755],
5	hypothyroidism	NN	O	hypothyroidism	_	0	SENT_64	[p3l1070t1699r1587b1771],
6	,	,	O	,	_	0	SENT_64	[p3l1070t1699r1587b1771],
7	growth	NN	O	growth	nn	9	SENT_64	[p3l1619t1699r1839b1771],
8	hormone	NN	O	hormone	nn	9	SENT_64	[p3l1867t1699r2148b1755],
9	deﬁciency	NN	O	deﬁciency	conj_and	5	SENT_64	[p3l8t1796r343b1868],
10	,	,	O	,	_	0	SENT_64	[p3l8t1796r343b1868],
11	chronic	JJ	O	chronic	amod	13	SENT_64	[p3l372t1796r607b1852],
12	renal	JJ	O	renal	amod	13	SENT_64	[p3l633t1796r792b1852],
13	insufﬁciency	NN	O	insufﬁciency	conj_and	5	SENT_64	[p3l817t1796r1233b1868],
14	,	,	O	,	_	0	SENT_64	[p3l817t1796r1233b1868],
15	and	CC	O	and	_	0	SENT_64	[p3l1264t1796r1375b1852],
16	ototoxicity	NN	O	ototoxicity	conj_and	5	SENT_64	[p3l1401t1796r1753b1868],
17	.	.	O	.	_	0	SENT_64	[p3l1401t1796r1753b1868],

1	These	DT	O	these	nsubjpass	3	SENT_65	[p3l1783t1796r1971b1852],
2	were	VBD	O	be	auxpass	3	SENT_65	[p3l1996t1813r2148b1852],
3	deﬁned	VBN	O	deﬁned	_	0	SENT_65	[p3l8t1893r240b1949],
4	as	IN	O	as	_	0	SENT_65	[p3l266t1911r328b1949],
5	present	JJ	DATE	present	prep_as	3	SENT_65	[p3l354t1902r583b1966],
6	if	IN	O	if	mark	9	SENT_65	[p3l608t1893r660b1948],
7	they	PRP	O	they	nsubjpass	9	SENT_65	[p3l680t1893r813b1966],
8	were	VBD	O	be	auxpass	9	SENT_65	[p3l841t1911r992b1949],
9	noted	VBN	O	note	advcl	3	SENT_65	[p3l1019t1893r1194b1949],
10	in	IN	O	in	_	0	SENT_65	[p3l1219t1893r1280b1948],
11	the	DT	O	the	det	13	SENT_65	[p3l1305t1893r1400b1949],
12	medical	JJ	O	medical	amod	13	SENT_65	[p3l1426t1893r1677b1949],
13	record	NN	O	record	prep_in	9	SENT_65	[p3l1702t1893r1904b1949],
14	greater	JJR	O	greater	mwe	15	SENT_65	[p3l1930t1901r2149b1966],
15	than	IN	O	than	quantmod	16	SENT_65	[p3l8t1989r144b2045],
16	1	CD	DURATION	1	num	13	SENT_65	[p3l172t1990r195b2045],
17	year	NN	NUMBER	year	tmod	9	SENT_65	[p3l224t2007r361b2062],
18	after	IN	O	after	_	0	SENT_65	[p3l382t1989r525b2045],
19	the	DT	O	the	det	20	SENT_65	[p3l546t1989r640b2045],
20	end	NN	O	end	prep_after	9	SENT_65	[p3l663t1989r777b2045],
21	of	IN	O	of	_	0	SENT_65	[p3l798t1989r867b2045],
22	the	DT	O	the	det	25	SENT_65	[p3l882t1989r978b2045],
23	initial	JJ	O	initial	amod	25	SENT_65	[p3l999t1989r1182b2045],
24	therapy	NN	O	therapy	nn	25	SENT_65	[p3l1204t1989r1440b2062],
25	regimen	NN	O	regimen	prep_of	20	SENT_65	[p3l1462t1989r1721b2062],
26	and	CC	O	and	_	0	SENT_65	[p3l1743t1989r1856b2045],
27	led	VBD	O	lead	advcl	3	SENT_65	[p3l1877t1989r1972b2045],
28	to	TO	O	to	_	0	SENT_65	[p3l1993t1998r2053b2045],
29	an	DT	O	a	det	30	SENT_65	[p3l2076t2007r2149b2045],
30	intervention	NN	O	intervention	prep_to	27	SENT_65	[p3l8t2087r404b2143],
31	.	.	O	.	_	0	SENT_65	[p3l8t2087r404b2143],

1	These	DT	O	these	det	2	SENT_66	[p3l436t2087r624b2143],
2	interventions	NNS	O	intervention	nsubjpass	4	SENT_66	[p3l652t2087r1062b2143],
3	were	VBD	O	be	auxpass	4	SENT_66	[p3l1091t2104r1243b2143],
4	deﬁned	VBN	O	deﬁned	conj_and	4	SENT_66	[p3l1272t2087r1504b2143],
5	for	IN	O	for	_	0	SENT_66	[p3l1530t2087r1623b2143],
6	hypothyroidism	NN	O	hypothyroidism	nn	10	SENT_66	[p3l1647t2087r2150b2159],
7	and	CC	O	and	_	0	SENT_66	[p3l9t2184r122b2240],
8	growth	NN	O	growth	nn	10	SENT_66	[p3l154t2184r374b2257],
9	hormone	NN	O	hormone	nn	10	SENT_66	[p3l405t2184r686b2240],
10	deﬁciency	NN	O	deﬁciency	prep_for	4	SENT_66	[p3l720t2184r1041b2257],
11	as	IN	O	as	_	0	SENT_66	[p3l1076t2202r1137b2240],
12	hormone	NN	O	hormone	nn	13	SENT_66	[p3l1169t2184r1451b2240],
13	supplementation	NN	O	supplementation	prep_as	4	SENT_66	[p3l1485t2184r2023b2257],
14	,	,	O	,	_	0	SENT_66	[p3l1485t2184r2023b2257],
15	for	IN	O	for	_	0	SENT_66	[p3l2058t2184r2150b2240],
16	chronic	JJ	O	chronic	amod	18	SENT_66	[p3l8t2280r243b2336],
17	renal	JJ	O	renal	amod	18	SENT_66	[p3l281t2280r440b2336],
18	insufﬁciency	NN	O	insufﬁciency	prep_for	4	SENT_66	[p3l478t2280r882b2353],
19	as	IN	O	as	_	0	SENT_66	[p3l923t2298r984b2336],
20	ongoing	JJ	O	ongoing	amod	22	SENT_66	[p3l1024t2280r1281b2353],
21	nephrology	NN	O	nephrology	nn	22	SENT_66	[p3l1320t2280r1679b2353],
22	care	NN	O	care	prep_as	18	SENT_66	[p3l1718t2298r1865b2346],
23	,	,	O	,	_	0	SENT_66	[p3l1718t2298r1865b2346],
24	and	CC	O	and	_	0	SENT_66	[p3l1908t2280r2020b2336],
25	for	IN	O	for	_	0	SENT_66	[p3l2057t2280r2150b2336],
26	ototoxicity	NN	O	ototoxicity	prep_for	4	SENT_66	[p3l9t2378r349b2450],
27	as	IN	O	as	_	0	SENT_66	[p3l378t2395r439b2434],
28	the	DT	O	the	det	29	SENT_66	[p3l466t2378r561b2434],
29	need	NN	O	need	prep_as	4	SENT_66	[p3l587t2378r736b2434],
30	for	IN	O	for	_	0	SENT_66	[p3l762t2378r853b2434],
31	hearing	NN	O	hearing	nn	32	SENT_66	[p3l877t2378r1114b2450],
32	aids	NNS	O	aid	prep_for	29	SENT_66	[p3l1141t2378r1281b2434],
33	.	.	O	.	_	0	SENT_66	[p3l1141t2378r1281b2434],

1	Laboratory	NNP	O	Laboratory	nn	2	SENT_67	[p3l13t2603r432b2694],
2	Methods	NNS	O	method	_	0	SENT_67	[p3l459t2603r791b2672],

1	Peripheral	JJ	O	peripheral	amod	3	SENT_68	[p3l115t2769r443b2842],
2	blood	NN	O	blood	nn	3	SENT_68	[p3l471t2769r654b2825],
3	samples	NNS	O	sample	nsubjpass	5	SENT_68	[p3l684t2769r937b2842],
4	were	VBD	O	be	auxpass	5	SENT_68	[p3l968t2787r1121b2825],
5	collected	VBN	O	collect	dep	13	SENT_68	[p3l1151t2769r1440b2825],
6	in	IN	O	in	_	0	SENT_68	[p3l1468t2769r1529b2824],
7	EDTA	NN	O	edta	nn	8	SENT_68	[p3l1556t2770r1763b2824],
8	vacutainers	NNS	O	vacutainer	prep_in	5	SENT_68	[p3l1785t2769r2146b2825],
9	and	CC	O	and	_	0	SENT_68	[p3l9t2865r122b2921],
10	genomic	JJ	O	genomic	amod	11	SENT_68	[p3l158t2865r432b2938],
11	DNA	NN	MISC	dna	prep_in	5	SENT_68	[p3l468t2866r637b2921],
12	was	VBD	O	be	auxpass	13	SENT_68	[p3l666t2883r786b2921],
13	extracted	VBN	O	extract	_	0	SENT_68	[p3l824t2865r1117b2921],
14	from	IN	O	from	_	0	SENT_68	[p3l1152t2865r1307b2921],
15	mononuclear	JJ	O	mononuclear	amod	16	SENT_68	[p3l1341t2865r1761b2921],
16	cells	NNS	O	cell	prep_from	13	SENT_68	[p3l1796t2865r1939b2921],
17	using	VBG	O	use	xcomp	13	SENT_68	[p3l1975t2865r2147b2938],
18	the	DT	O	the	det	22	SENT_68	[p3l8t2963r104b3018],
19	QIAamp	NN	O	qiaamp	nn	22	SENT_68	[p3l132t2963r408b3035],
20	DNA	NN	O	dna	nn	22	SENT_68	[p3l436t2963r605b3018],
21	blood	NN	O	blood	nn	22	SENT_68	[p3l630t2962r812b3018],
22	mini	NNS	O	minus	dobj	17	SENT_68	[p3l838t2962r983b3018],
23	kit	NN	O	kit	nn	25	SENT_68	[p3l1009t2962r1094b3018],
24	(	CD	NUMBER	(	num	25	SENT_68	[p3l1123t2962r1394b3035],
25	Qiagen	NNP	ORGANIZATION	Qiagen	nsubjpass	13	SENT_68	[p3l1123t2962r1394b3035],
26	,	,	O	,	_	0	SENT_68	[p3l1123t2962r1394b3035],
27	Valencia	NNP	LOCATION	Valencia	nn	30	SENT_68	[p3l1423t2962r1717b3029],
28	,	,	O	,	_	0	SENT_68	[p3l1423t2962r1717b3029],
29	CA	NNP	LOCATION	CA	appos	30	SENT_68	[p3l1747t2963r1880b3031],
30	)	NNP	O	)	appos	25	SENT_68	[p3l1747t2963r1880b3031],
31	according	VBG	O	accord	_	0	SENT_68	[p3l1910t2963r2146b3018, p3l8t3060r107b3133],
32	to	TO	O	to	prepc_according_to	30	SENT_68	[p3l155t3068r215b3116],
33	the	DT	O	the	det	34	SENT_68	[p3l262t3060r358b3116],
34	manufacturer	NN	O	manufacturer	poss	36	SENT_68	[p3l404t3060r884b3116],
35	’s	POS	O	’s	_	0	SENT_68	[p3l404t3060r884b3116],
36	protocol	NN	O	protocol	pobj	30	SENT_68	[p3l931t3060r1214b3133],
37	.	.	O	.	_	0	SENT_68	[p3l931t3060r1214b3133],

1	DNA	NN	O	dna	nn	2	SENT_69	[p3l1265t3061r1434b3116],
2	concentrations	NNS	O	concentration	nsubjpass	4	SENT_69	[p3l1481t3060r1946b3116],
3	were	VBD	O	be	auxpass	4	SENT_69	[p3l1994t3078r2147b3116],
4	determined	VBN	O	determine	_	0	SENT_69	[p3l8t3156r369b3212],
5	using	VBG	O	use	xcomp	4	SENT_69	[p3l404t3156r575b3229],
6	the	DT	O	the	det	8	SENT_69	[p3l612t3156r708b3212],
7	PICOgreen	NN	O	picogreen	nn	8	SENT_69	[p3l744t3157r1103b3229],
8	method	NN	O	method	nsubjpass	13	SENT_69	[p3l1139t3156r1379b3212],
9	and	CC	O	and	_	0	SENT_69	[p3l1416t3156r1529b3212],
10	DNA	NN	MISC	dna	nn	11	SENT_69	[p3l1564t3157r1733b3212],
11	quality	NN	O	quality	nsubjpass	13	SENT_69	[p3l1768t3156r1989b3229],
12	was	VBD	O	be	auxpass	13	SENT_69	[p3l2026t3174r2147b3212],
13	determined	VBN	O	determine	ccomp	5	SENT_69	[p3l8t3253r369b3309],
14	by	IN	O	by	_	0	SENT_69	[p3l402t3254r480b3326],
15	gel	NN	O	gel	nn	16	SENT_69	[p3l515t3254r610b3326],
16	electrophoresis	NN	O	electrophoresis	agent	13	SENT_69	[p3l646t3253r1129b3326],
17	of	IN	O	of	_	0	SENT_69	[p3l1165t3253r1234b3309],
18	extracted	VBN	O	extract	amod	19	SENT_69	[p3l1264t3253r1556b3309],
19	products	NNS	O	product	prep_of	16	SENT_69	[p3l1589t3254r1880b3326],
20	.	.	O	.	_	0	SENT_69	[p3l1589t3254r1880b3326],

1	GSTPI	NN	O	gstpus	nsubjpass	8	SENT_70	[p3l1922t3254r2142b3310],
2	105	CD	NUMBER	105	num	1	SENT_70	[p3l15t3351r122b3407],
3	A	DT	O	a	det	6	SENT_70	[p3l161t3352r217b3406],
4	>	JJR	O	>	amod	6	SENT_70	[p3l251t3363r301b3409],
5	G	NN	O	g	nn	6	SENT_70	[p3l333t3351r388b3407],
6	genotyping	NN	O	genotyping	dep	1	SENT_70	[p3l424t3351r782b3424],
7	was	VBD	O	be	auxpass	8	SENT_70	[p3l818t3369r938b3407],
8	performed	VBN	O	perform	_	0	SENT_70	[p3l974t3351r1309b3424],
9	as	IN	O	as	_	0	SENT_70	[p3l1345t3369r1407b3407],
10	part	NN	O	part	prep_as	8	SENT_70	[p3l1442t3359r1567b3424],
11	of	IN	O	of	_	0	SENT_70	[p3l1602t3351r1672b3407],
12	another	DT	O	another	det	13	SENT_70	[p3l1703t3351r1943b3407],
13	study	NN	O	study	prep_of	10	SENT_70	[p3l1979t3351r2147b3424],
14	involving	VBG	O	involve	partmod	13	SENT_70	[p3l8t3447r310b3520],
15	these	DT	O	these	det	16	SENT_70	[p3l355t3447r518b3503],
16	subjects	NNS	O	subject	dobj	14	SENT_70	[p3l566t3447r836b3520],
17	.	.	O	.	_	0	SENT_70	[p3l566t3447r836b3520],

1	For	IN	O	for	_	0	SENT_71	[p3l883t3449r994b3503],
2	that	DT	O	that	det	3	SENT_71	[p3l1036t3447r1156b3503],
3	study	NN	O	study	prep_for	18	SENT_71	[p3l1202t3447r1383b3520],
4	,	,	O	,	_	0	SENT_71	[p3l1202t3447r1383b3520],
5	the	DT	O	the	det	10	SENT_71	[p3l1430t3447r1526b3503],
6	Illumina	NNP	PERSON	Illumina	nn	10	SENT_71	[p3l1571t3447r1844b3503],
7	HumanOmnil-Quad	NNP	PERSON	HumanOmnil-Quad	nn	10	SENT_71	[p3l1886t3449r2146b3503, p3l9t3544r430b3614],
8	BeadChip	NNP	PERSON	BeadChip	nn	10	SENT_71	[p3l479t3544r798b3617],
9	(	NNP	O	(	nn	10	SENT_71	[p3l851t3544r1163b3614],
10	Illumina	NNP	ORGANIZATION	Illumina	appos	3	SENT_71	[p3l851t3544r1163b3614],
11	,	,	O	,	_	0	SENT_71	[p3l851t3544r1163b3614],
12	San	NNP	LOCATION	San	nn	13	SENT_71	[p3l1218t3545r1334b3601],
13	Diego	NNP	LOCATION	Diego	appos	10	SENT_71	[p3l1383t3544r1594b3617],
14	,	,	O	,	_	0	SENT_71	[p3l1383t3544r1594b3617],
15	CA	NNP	LOCATION	CA	nn	16	SENT_71	[p3l1647t3545r1780b3613],
16	)	NNP	O	)	nsubjpass	18	SENT_71	[p3l1647t3545r1780b3613],
17	was	VBD	O	be	auxpass	18	SENT_71	[p3l1832t3562r1952b3601],
18	used	VBN	O	use	_	0	SENT_71	[p3l2002t3545r2149b3600],
19	according	VBG	O	accord	_	0	SENT_71	[p3l9t3642r322b3715],
20	to	TO	O	to	prepc_according_to	18	SENT_71	[p3l354t3650r414b3698],
21	the	DT	O	the	det	22	SENT_71	[p3l445t3642r541b3698],
22	manufacturer	NN	O	manufacturer	poss	24	SENT_71	[p3l571t3642r1051b3698],
23	’s	POS	O	’s	_	0	SENT_71	[p3l571t3642r1051b3698],
24	protocol	NN	O	protocol	pobj	18	SENT_71	[p3l1082t3642r1366b3715],
25	.	.	O	.	_	0	SENT_71	[p3l1082t3642r1366b3715],

1	Immunohistochemical	JJ	O	immunohistochemical	amod	2	SENT_72	[p3l115t3738r833b3794],
2	staining	NN	O	staining	_	0	SENT_72	[p3l866t3738r1116b3811],
3	of	IN	O	of	_	0	SENT_72	[p3l1148t3738r1217b3794],
4	formalin-ﬁxed	JJ	O	formalin-ﬁxed	prep_of	2	SENT_72	[p3l1240t3738r1718b3805],
5	,	,	O	,	_	0	SENT_72	[p3l1240t3738r1718b3805],
6	parafﬁnembedded	JJ	O	parafﬁnembedded	appos	4	SENT_72	[p3l1750t3738r2146b3811, p4l7t19r239b75],

1	tumor	NN	O	tumor	nn	2	SENT_73	[p4l261t28r452b75],
2	samples	NNS	O	sample	nsubjpass	4	SENT_73	[p4l476t20r729b92],
3	was	VBD	O	be	auxpass	4	SENT_73	[p4l753t37r874b76],
4	performed	VBN	O	perform	_	0	SENT_73	[p4l897t19r1232b92],
5	to	TO	O	to	aux	6	SENT_73	[p4l1254t28r1313b75],
6	assess	VB	O	assess	xcomp	4	SENT_73	[p4l1338t37r1528b75],
7	GSTpi	NN	O	gstpus	nn	8	SENT_73	[p4l1554t19r1764b92],
8	expression	NN	O	expression	dobj	6	SENT_73	[p4l1788t19r2144b92],
9	.	.	O	.	_	0	SENT_73	[p4l1788t19r2144b92],

1	Sections	NNS	O	section	nsubjpass	8	SENT_74	[p4l10t117r277b173],
2	were	VBD	O	be	auxpass	3	SENT_74	[p4l306t135r459b173],
3	rehydrated	VBN	O	rehydrate	_	0	SENT_74	[p4l485t117r829b190],
4	in	IN	O	in	_	0	SENT_74	[p4l855t117r916b172],
5	PBS	NNP	O	PBS	prep_in	3	SENT_74	[p4l942t117r1079b173],
6	and	CC	O	and	_	0	SENT_74	[p4l1111t117r1224b173],
7	then	RB	O	then	advmod	8	SENT_74	[p4l1251t117r1388b173],
8	incubated	VBN	O	incubate	conj_and	3	SENT_74	[p4l1413t117r1725b173],
9	with	IN	O	with	_	0	SENT_74	[p4l1752t117r1893b173],
10	a	DT	O	a	det	12	SENT_74	[p4l1922t135r1955b173],
11	polyclonal	JJ	O	polyclonal	amod	12	SENT_74	[p4l1980t117r2146b190, p4l8t213r202b269],
12	rabbit	NN	O	rabbit	prep_with	8	SENT_74	[p4l229t213r417b269],
13	anti-human	JJ	O	anti-human	amod	15	SENT_74	[p4l444t213r808b269],
14	GSTpi	NN	MISC	gstpus	nn	15	SENT_74	[p4l836t213r1045b286],
15	antibody	NN	O	antibody	dobj	3	SENT_74	[p4l1074t213r1351b286],
16	at	IN	O	at	_	0	SENT_74	[p4l1380t222r1436b269],
17	a	DT	O	a	det	19	SENT_74	[p4l1463t231r1496b269],
18	1:500	CD	NUMBER	1:500	num	19	SENT_74	[p4l1530t213r1703b270],
19	dilution	NN	O	dilution	prep_at	3	SENT_74	[p4l1730t213r1994b269],
20	.	.	O	.	_	0	SENT_74	[p4l1730t213r1994b269],

1	The	DT	O	the	det	2	SENT_75	[p4l2025t213r2147b269],
2	slides	NNS	O	slide	nsubjpass	9	SENT_75	[p4l10t310r187b366],
3	were	VBD	O	be	auxpass	5	SENT_75	[p4l222t328r375b367],
4	then	RB	O	then	advmod	5	SENT_75	[p4l408t311r545b366],
5	rinsed	VBN	O	rinse	_	0	SENT_75	[p4l577t310r773b366],
6	with	IN	O	with	_	0	SENT_75	[p4l806t310r946b367],
7	PBS	NNP	ORGANIZATION	PBS	prep_with	5	SENT_75	[p4l979t311r1116b367],
8	and	CC	O	and	_	0	SENT_75	[p4l1153t311r1266b366],
9	incubated	VBN	O	incubate	conj_and	5	SENT_75	[p4l1298t310r1610b366],
10	with	IN	O	with	_	0	SENT_75	[p4l1643t310r1783b367],
11	an	DT	O	a	det	15	SENT_75	[p4l1818t328r1890b366],
12	avidinconjugated	JJ	O	avidinconjugated	amod	15	SENT_75	[p4l1924t310r2146b367, p4l8t408r360b480],
13	mouse	NN	O	mouse	nn	15	SENT_75	[p4l386t425r593b464],
14	anti-rabbit	JJ	O	anti-rabbit	amod	15	SENT_75	[p4l622t408r955b464],
15	antibody	NN	O	antibody	prep_with	9	SENT_75	[p4l982t408r1272b480],
16	.	.	O	.	_	0	SENT_75	[p4l982t408r1272b480],

1	After	IN	O	after	_	0	SENT_76	[p4l1302t408r1471b464],
2	further	JJ	O	further	amod	4	SENT_76	[p4l1497t408r1715b464],
3	PBS	NNP	O	PBS	nn	4	SENT_76	[p4l1740t408r1877b464],
4	rinsing	NN	O	rinsing	prep_after	9	SENT_76	[p4l1906t408r2145b480],
5	,	,	O	,	_	0	SENT_76	[p4l1906t408r2145b480],
6	the	DT	O	the	det	7	SENT_76	[p4l8t504r104b560],
7	slides	NNS	O	slide	nsubjpass	9	SENT_76	[p4l149t504r325b560],
8	were	VBD	O	be	auxpass	9	SENT_76	[p4l368t522r521b560],
9	treated	VBN	O	treat	_	0	SENT_76	[p4l564t504r781b560],
10	with	IN	O	with	_	0	SENT_76	[p4l823t504r964b560],
11	a	DT	O	a	det	32	SENT_76	[p4l1006t522r1039b560],
12	biotinylated	VBN	O	biotinylate	dep	32	SENT_76	[p4l1078t504r1463b577],
13	peroxidase	NN	O	peroxidase	nn	14	SENT_76	[p4l1502t504r1849b577],
14	solution	NN	O	solution	dobj	12	SENT_76	[p4l1894t504r2148b560],
15	(	CD	NUMBER	(	num	14	SENT_76	[p4l10t602r245b671],
16	Vector	NNP	O	Vector	nn	17	SENT_76	[p4l10t602r245b671],
17	Laboratories	NNPS	O	Laboratories	tmod	12	SENT_76	[p4l303t601r726b668],
18	,	,	O	,	_	0	SENT_76	[p4l303t601r726b668],
19	Burlingame	NNP	LOCATION	Burlingame	nn	22	SENT_76	[p4l790t601r1185b674],
20	,	,	O	,	_	0	SENT_76	[p4l790t601r1185b674],
21	CA	NNP	LOCATION	CA	appos	22	SENT_76	[p4l1250t602r1382b671],
22	)	NNP	O	)	appos	17	SENT_76	[p4l1250t602r1382b671],
23	and	CC	O	and	_	0	SENT_76	[p4l1447t601r1560b657],
24	developed	VBN	O	develop	conj_and	12	SENT_76	[p4l1621t601r1947b674],
25	with	IN	O	with	_	0	SENT_76	[p4l2007t601r2148b658],
26	0.05	CD	PERCENT	0.05	num	28	SENT_76	[p4l8t699r209b755],
27	%	NN	PERCENT	%	nn	28	SENT_76	[p4l8t699r209b755],
28	diaminobenzidine	NN	O	diaminobenzidine	prep_with	24	SENT_76	[p4l248t699r823b755],
29	and	CC	O	and	_	0	SENT_76	[p4l860t699r973b755],
30	0.01	CD	PERCENT	0.01	num	31	SENT_76	[p4l1007t699r1208b755],
31	%	NN	PERCENT	%	conj_and	28	SENT_76	[p4l1007t699r1208b755],
32	H202	NN	O	h202	prep_with	9	SENT_76	[p4l1246t699r1419b768],
33	in	IN	O	in	_	0	SENT_76	[p4l1454t699r1515b754],
34	50	CD	NUMBER	50	num	36	SENT_76	[p4l1551t698r1627b755],
35	mM	NN	O	mm	nn	36	SENT_76	[p4l1656t700r1787b754],
36	Tris	NNP	O	Tris	prep_in	9	SENT_76	[p4l1822t699r2148b755],
37	.	.	O	.	_	0	SENT_76	[p4l1822t699r2148b755],

1	—	NN	O	—	_	0	SENT_77	[p4l1822t699r2148b755],
2	.	.	O	.	_	0	SENT_77	[p4l1822t699r2148b755],

1	HCL	NNP	ORGANIZATION	HCL	nn	4	SENT_78	[p4l1822t699r2148b755],
2	buffer	NN	O	buffer	nn	4	SENT_78	[p4l7t795r201b851],
3	(	NN	O	(	nn	4	SENT_78	[p4l245t796r365b868],
4	pH	NN	O	ph	_	0	SENT_78	[p4l245t796r365b868],
5	7.5	CD	NUMBER	7.5	num	6	SENT_78	[p4l408t795r549b864],
6	)	NN	O	)	dep	4	SENT_78	[p4l408t795r549b864],
7	.	.	O	.	_	0	SENT_78	[p4l408t795r549b864],

1	GSTpi	NN	MISC	gstpus	nn	2	SENT_79	[p4l596t795r806b868],
2	expression	NN	O	expression	nsubjpass	4	SENT_79	[p4l851t795r1191b868],
3	was	VBD	O	be	auxpass	4	SENT_79	[p4l1234t813r1354b851],
4	quantiﬁed	VBN	O	quantiﬁed	_	0	SENT_79	[p4l1399t795r1719b868],
5	for	IN	O	for	_	0	SENT_79	[p4l1761t795r1854b851],
6	staining	VBG	O	stain	prepc_for	4	SENT_79	[p4l1898t795r2147b868],
7	intensity	NN	O	intensity	dobj	6	SENT_79	[p4l8t892r282b965],
8	and	CC	O	and	_	0	SENT_79	[p4l318t892r431b948],
9	proportion	NN	O	proportion	dobj	6	SENT_79	[p4l461t892r800b965],
10	of	IN	O	of	_	0	SENT_79	[p4l834t892r903b948],
11	positive	JJ	O	positive	amod	12	SENT_79	[p4l929t892r1180b965],
12	cells	NNS	O	cell	prep_of	7	SENT_79	[p4l1213t893r1374b948],
13	.	.	O	.	_	0	SENT_79	[p4l1213t893r1374b948],

1	Intensity	NN	O	intensity	nsubjpass	3	SENT_80	[p4l1411t892r1690b965],
2	was	VBD	O	be	auxpass	3	SENT_80	[p4l1724t910r1844b948],
3	assessed	VBN	O	assess	_	0	SENT_80	[p4l1880t893r2149b948],
4	in	IN	O	in	_	0	SENT_80	[p4l8t990r68b1045],
5	600	CD	NUMBER	600	num	6	SENT_80	[p4l105t990r221b1046],
6	cells	NNS	O	cell	prep_in	3	SENT_80	[p4l251t990r394b1046],
7	(	VBP	O	(	dep	6	SENT_80	[p4l433t990r733b1059],
8	200-fold	JJ	O	200-fold	amod	10	SENT_80	[p4l433t990r733b1059],
9	magniﬁcation	NN	O	magniﬁcation	nn	10	SENT_80	[p4l766t990r1250b1062],
10	)	NN	O	)	dobj	7	SENT_80	[p4l766t990r1250b1062],
11	.	.	O	.	_	0	SENT_80	[p4l766t990r1250b1062],

1	Based	VBN	O	base	_	0	SENT_81	[p4l1289t990r1483b1046],
2	on	IN	O	on	prepc_based_on	18	SENT_81	[p4l1518t1007r1596b1046],
3	the	DT	O	the	det	6	SENT_81	[p4l1630t990r1726b1046],
4	cytoplasmic	JJ	O	cytoplasmic	amod	6	SENT_81	[p4l1762t990r2146b1062],
5	staining	NN	O	staining	nn	6	SENT_81	[p4l10t1086r260b1159],
6	intensity	NN	O	intensity	pobj	18	SENT_81	[p4l308t1086r583b1159],
7	of	IN	O	of	_	0	SENT_81	[p4l633t1086r702b1142],
8	at	IN	O	at	quantmod	10	SENT_81	[p4l745t1095r801b1142],
9	least	JJS	O	least	mwe	8	SENT_81	[p4l848t1086r994b1142],
10	70	CD	PERCENT	70	num	11	SENT_81	[p4l1041t1087r1182b1143],
11	%	NN	PERCENT	%	prep_of	6	SENT_81	[p4l1041t1087r1182b1143],
12	of	IN	O	of	_	0	SENT_81	[p4l1234t1086r1303b1142],
13	cells	NNS	O	cell	prep_of	11	SENT_81	[p4l1346t1086r1508b1153],
14	,	,	O	,	_	0	SENT_81	[p4l1346t1086r1508b1153],
15	the	DT	O	the	det	16	SENT_81	[p4l1558t1086r1654b1142],
16	intensity	NN	O	intensity	nsubjpass	18	SENT_81	[p4l1703t1086r1978b1159],
17	was	VBD	O	be	auxpass	18	SENT_81	[p4l2026t1104r2147b1142],
18	categorized	VBN	O	categorize	_	0	SENT_81	[p4l8t1183r378b1256],
19	in	IN	O	in	_	0	SENT_81	[p4l408t1183r469b1239],
20	quartiles	NNS	O	quartile	prep_in	18	SENT_81	[p4l500t1183r791b1256],
21	.	.	O	.	_	0	SENT_81	[p4l500t1183r791b1256],

1	In	IN	O	in	_	0	SENT_82	[p4l826t1185r891b1239],
2	the	DT	O	the	det	5	SENT_82	[p4l922t1184r1018b1239],
3	same	JJ	O	same	amod	5	SENT_82	[p4l1052t1201r1212b1239],
4	microscopic	JJ	O	microscopic	amod	5	SENT_82	[p4l1244t1183r1634b1256],
5	ﬁelds	NNS	O	ﬁelds	prep_in	14	SENT_82	[p4l1668t1183r1855b1250],
6	,	,	O	,	_	0	SENT_82	[p4l1668t1183r1855b1250],
7	the	DT	O	the	det	8	SENT_82	[p4l1889t1183r1984b1239],
8	proportion	NN	O	proportion	nsubjpass	14	SENT_82	[p4l2015t1201r2146b1256, p4l7t1281r238b1353],
9	of	IN	O	of	_	0	SENT_82	[p4l266t1281r335b1337],
10	cells	NNS	O	cell	prep_of	8	SENT_82	[p4l358t1281r501b1337],
11	expressing	VBG	O	express	partmod	10	SENT_82	[p4l531t1281r870b1353],
12	GSTpi	NN	O	gstpus	dobj	11	SENT_82	[p4l899t1281r1109b1353],
13	was	VBD	O	be	auxpass	14	SENT_82	[p4l1138t1298r1258b1337],
14	evaluated	VBN	O	evaluate	_	0	SENT_82	[p4l1287t1281r1591b1337],
15	and	CC	O	and	_	0	SENT_82	[p4l1620t1281r1733b1337],
16	also	RB	O	also	advmod	17	SENT_82	[p4l1761t1281r1885b1337],
17	categorized	VBN	O	categorize	conj_and	14	SENT_82	[p4l1914t1289r2146b1353, p4l7t1377r167b1433],
18	into	IN	O	into	_	0	SENT_82	[p4l198t1377r320b1433],
19	quartiles	NNS	O	quartile	prep_into	17	SENT_82	[p4l353t1377r644b1450],
20	.	.	O	.	_	0	SENT_82	[p4l353t1377r644b1450],

1	An	DT	O	a	det	3	SENT_83	[p4l679t1378r775b1433],
2	IHC	NN	ORGANIZATION	ihc	nn	3	SENT_83	[p4l805t1378r939b1433],
3	score	NN	NUMBER	score	nsubjpass	5	SENT_83	[p4l974t1395r1138b1433],
4	was	VBD	O	be	auxpass	5	SENT_83	[p4l1169t1395r1289b1433],
5	deﬁned	VBN	O	deﬁned	_	0	SENT_83	[p4l1322t1377r1556b1433],
6	as	IN	O	as	_	0	SENT_83	[p4l1587t1395r1649b1433],
7	the	DT	O	the	det	8	SENT_83	[p4l1681t1377r1777b1433],
8	product	NN	O	product	prep_as	5	SENT_83	[p4l1808t1377r2053b1450],
9	of	IN	O	of	_	0	SENT_83	[p4l2084t1377r2153b1433],
10	the	DT	O	the	det	12	SENT_83	[p4l8t1475r104b1530],
11	category	NN	O	category	nn	12	SENT_83	[p4l135t1483r408b1547],
12	values	NNS	O	value	prep_of	8	SENT_83	[p4l440t1475r640b1531],
13	for	IN	O	for	_	0	SENT_83	[p4l672t1474r765b1530],
14	the	DT	O	the	det	16	SENT_83	[p4l794t1475r890b1530],
15	staining	NN	O	staining	nn	16	SENT_83	[p4l924t1474r1173b1547],
16	intensity	NN	O	intensity	prep_for	5	SENT_83	[p4l1204t1474r1479b1547],
17	and	CC	O	and	_	0	SENT_83	[p4l1511t1475r1624b1530],
18	proportion	NN	O	proportion	prep_for	5	SENT_83	[p4l1654t1474r2008b1547],
19	.	.	O	.	_	0	SENT_83	[p4l1654t1474r2008b1547],

1	Statistical	JJ	O	statistical	amod	2	SENT_84	[p4l10t1700r379b1769],
2	Analyses	NNS	O	analysis	_	0	SENT_84	[p4l411t1700r745b1790],

1	Descriptive	JJ	O	descriptive	amod	2	SENT_85	[p4l115t1866r482b1938],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_85	[p4l514t1866r781b1938],
3	were	VBD	O	be	auxpass	4	SENT_85	[p4l814t1883r967b1922],
4	performed	VBN	O	perform	_	0	SENT_85	[p4l997t1866r1332b1938],
5	for	IN	O	for	_	0	SENT_85	[p4l1363t1866r1455b1922],
6	patient	NN	O	patient	prep_for	4	SENT_85	[p4l1483t1866r1719b1938],
7	,	,	O	,	_	0	SENT_85	[p4l1483t1866r1719b1938],
8	disease	NN	O	disease	prep_for	4	SENT_85	[p4l1754t1866r2000b1932],
9	,	,	O	,	_	0	SENT_85	[p4l1754t1866r2000b1932],
10	and	CC	O	and	_	0	SENT_85	[p4l2036t1866r2149b1922],
11	therapy	NN	O	therapy	nn	12	SENT_85	[p4l8t1963r246b2035],
12	characteristics	NNS	O	characteristic	prep_for	4	SENT_85	[p4l277t1963r752b2029],
13	,	,	O	,	_	0	SENT_85	[p4l277t1963r752b2029],
14	the	DT	O	the	det	15	SENT_85	[p4l784t1963r880b2019],
15	GSTP1	NN	O	gstp1	conj_and	6	SENT_85	[p4l912t1963r1133b2019],
16	105	CD	NUMBER	105	num	15	SENT_85	[p4l1174t1963r1281b2019],
17	A	DT	O	a	det	20	SENT_85	[p4l1313t1963r1369b2018],
18	>	JJR	O	>	amod	20	SENT_85	[p4l1403t1974r1452b2021],
19	G	NN	O	g	nn	20	SENT_85	[p4l1485t1963r1540b2019],
20	genotype	NN	O	genotype	dep	15	SENT_85	[p4l1569t1971r1878b2035],
21	,	,	O	,	_	0	SENT_85	[p4l1569t1971r1878b2035],
22	and	CC	O	and	_	0	SENT_85	[p4l1911t1963r2024b2019],
23	the	DT	O	the	det	25	SENT_85	[p4l2052t1963r2148b2019],
24	GSTpi	NNP	O	GSTpi	nn	25	SENT_85	[p4l9t2059r219b2132],
25	IHC	NNP	ORGANIZATION	IHC	prep_for	4	SENT_85	[p4l252t2060r386b2116],
26	staining	VBG	O	stain	partmod	25	SENT_85	[p4l421t2059r671b2132],
27	variables	NNS	O	variable	dobj	26	SENT_85	[p4l703t2059r1006b2116],
28	.	.	O	.	_	0	SENT_85	[p4l703t2059r1006b2116],

1	The	DT	O	the	det	2	SENT_86	[p4l1042t2060r1164b2115],
2	consistency	NN	O	consistency	_	0	SENT_86	[p4l1197t2059r1568b2132],
3	of	IN	O	of	_	0	SENT_86	[p4l1601t2059r1671b2115],
4	the	DT	O	the	det	5	SENT_86	[p4l1697t2060r1792b2115],
5	genotypes	NNS	O	genotype	prep_of	2	SENT_86	[p4l1825t2068r2147b2132],
6	with	IN	O	with	_	0	SENT_86	[p4l8t2157r149b2213],
7	Hardy	NNP	PERSON	Hardy	prep_with	2	SENT_86	[p4l202t2157r752b2229],
8	.	.	O	.	_	0	SENT_86	[p4l202t2157r752b2229],

1	—	NN	O	—	_	0	SENT_87	[p4l202t2157r752b2229],
2	.	.	O	.	_	0	SENT_87	[p4l202t2157r752b2229],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_88	[p4l202t2157r752b2229],
2	equilibrium	NN	O	equilibrium	nsubjpass	7	SENT_88	[p4l806t2157r1180b2229],
3	and	CC	O	and	_	0	SENT_88	[p4l1235t2157r1348b2213],
4	published	VBN	O	publish	amod	5	SENT_88	[p4l1399t2157r1711b2229],
5	results	NNS	O	result	conj_and	2	SENT_88	[p4l1763t2157r1970b2213],
6	was	VBD	O	be	auxpass	7	SENT_88	[p4l2026t2174r2146b2213],
7	assessed	VBN	O	assess	_	0	SENT_88	[p4l9t2254r293b2310],
8	.	.	O	.	_	0	SENT_88	[p4l9t2254r293b2310],

1	All	DT	O	all	det	3	SENT_89	[p4l336t2254r436b2309],
2	SNP	NN	O	snp	nn	3	SENT_89	[p4l478t2254r621b2310],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_89	[p4l659t2254r926b2326],
4	were	VBD	O	be	auxpass	5	SENT_89	[p4l968t2272r1121b2310],
5	performed	VBN	O	perform	_	0	SENT_89	[p4l1159t2254r1494b2326],
6	using	VBG	O	use	xcomp	5	SENT_89	[p4l1532t2254r1703b2326],
7	co-dominant	JJ	O	co-dominant	amod	10	SENT_89	[p4l1743t2254r2149b2310],
8	and	CC	O	and	_	0	SENT_89	[p4l9t2351r122b2406],
9	dominant	JJ	O	dominant	amod	10	SENT_89	[p4l147t2350r449b2406],
10	modeling	NN	O	modeling	dobj	6	SENT_89	[p4l473t2350r791b2423],
11	.	.	O	.	_	0	SENT_89	[p4l473t2350r791b2423],

1	Spearman	NNP	PERSON	Spearman	nn	4	SENT_90	[p4l821t2351r1139b2423],
2	rank	NN	O	rank	nn	4	SENT_90	[p4l1162t2350r1305b2406],
3	correlation	NN	O	correlation	nn	4	SENT_90	[p4l1328t2350r1675b2406],
4	methods	NNS	O	method	nsubjpass	6	SENT_90	[p4l1699t2350r1968b2406],
5	were	VBD	O	be	auxpass	6	SENT_90	[p4l1994t2368r2147b2407],
6	used	VBN	O	use	_	0	SENT_90	[p4l7t2448r153b2504],
7	to	TO	O	to	aux	8	SENT_90	[p4l177t2456r236b2504],
8	assess	VB	O	assess	xcomp	6	SENT_90	[p4l263t2465r452b2504],
9	the	DT	O	the	det	10	SENT_90	[p4l478t2448r574b2504],
10	correlation	NN	O	correlation	dobj	8	SENT_90	[p4l599t2448r963b2514],
11	,	,	O	,	_	0	SENT_90	[p4l599t2448r963b2514],
12	rs	NNS	O	r	appos	10	SENT_90	[p4l989t2465r1054b2517],
13	,	,	O	,	_	0	SENT_90	[p4l989t2465r1054b2517],
14	between	IN	O	between	_	0	SENT_90	[p4l1080t2448r1348b2504],
15	the	DT	O	the	det	19	SENT_90	[p4l1371t2448r1467b2504],
16	genotyping	NN	O	genotyping	nn	19	SENT_90	[p4l1492t2448r1850b2520],
17	and	CC	O	and	_	0	SENT_90	[p4l1876t2448r1989b2504],
18	IHC	NN	ORGANIZATION	ihc	nn	19	SENT_90	[p4l2012t2448r2146b2504],
19	staining	NN	O	staining	prep_between	10	SENT_90	[p4l10t2545r276b2617],
20	.	.	O	.	_	0	SENT_90	[p4l10t2545r276b2617],

1	Since	IN	O	since	mark	6	SENT_91	[p4l311t2545r486b2601],
2	radiation	NN	O	radiation	nn	3	SENT_91	[p4l513t2545r800b2601],
3	therapy	NN	O	therapy	nsubjpass	11	SENT_91	[p4l828t2545r1067b2617],
4	is	VBZ	O	be	auxpass	6	SENT_91	[p4l1096t2545r1146b2601],
5	typically	RB	O	typically	advmod	6	SENT_91	[p4l1175t2545r1455b2617],
6	delayed	VBN	O	delay	advcl	23	SENT_91	[p4l1486t2545r1751b2617],
7	,	,	O	,	_	0	SENT_91	[p4l1486t2545r1751b2617],
8	reduced	VBN	O	reduce	dep	6	SENT_91	[p4l1781t2545r2052b2611],
9	,	,	O	,	_	0	SENT_91	[p4l1781t2545r2052b2611],
10	or	CC	O	or	_	0	SENT_91	[p4l2084t2563r2149b2601],
11	omitted	VBN	O	omit	advcl	23	SENT_91	[p4l9t2642r253b2698],
12	for	IN	O	for	_	0	SENT_91	[p4l281t2642r374b2698],
13	patients	NNS	O	patient	prep_for	11	SENT_91	[p4l400t2642r648b2715],
14	younger	JJR	O	younger	dobj	6	SENT_91	[p4l678t2660r941b2715],
15	than	IN	O	than	_	0	SENT_91	[p4l968t2642r1105b2698],
16	3	CD	DURATION	3	num	17	SENT_91	[p4l1136t2642r1167b2698],
17	years	NNS	NUMBER	year	prep_than	6	SENT_91	[p4l1199t2660r1384b2715],
18	,	,	O	,	_	0	SENT_91	[p4l1199t2660r1384b2715],
19	separate	JJ	O	separate	amod	21	SENT_91	[p4l1418t2651r1677b2715],
20	survival	NN	O	survival	nn	21	SENT_91	[p4l1709t2642r1960b2698],
21	analyses	NNS	O	analysis	nsubjpass	23	SENT_91	[p4l1990t2642r2146b2698, p4l7t2756r142b2811],
22	were	VBD	O	be	auxpass	23	SENT_91	[p4l169t2756r322b2795],
23	performed	VBN	O	perform	_	0	SENT_91	[p4l347t2739r681b2811],
24	for	IN	O	for	mark	26	SENT_91	[p4l706t2739r799b2795],
25	patients	NNS	O	patient	nsubj	26	SENT_91	[p4l821t2739r1069b2811],
26	diagnosed	VBD	O	diagnose	advcl	23	SENT_91	[p4l1096t2739r1420b2811],
27	before	IN	O	before	_	0	SENT_91	[p4l1443t2739r1648b2795],
28	3	CD	DURATION	3	num	29	SENT_91	[p4l1675t2739r1707b2795],
29	years	NNS	NUMBER	year	prep_before	26	SENT_91	[p4l1736t2756r1902b2811],
30	of	IN	O	of	_	0	SENT_91	[p4l1929t2739r1998b2795],
31	age	NN	O	age	prep_of	29	SENT_91	[p4l2020t2756r2144b2811],
32	.	.	O	.	_	0	SENT_91	[p4l2020t2756r2144b2811],

1	Survival	NN	O	survival	nn	2	SENT_92	[p4l10t2836r275b2892],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_92	[p4l305t2836r572b2908],
3	were	VBD	O	be	auxpass	4	SENT_92	[p4l602t2854r756b2892],
4	performed	VBN	O	perform	_	0	SENT_92	[p4l783t2836r1118b2908],
5	using	VBG	O	use	xcomp	4	SENT_92	[p4l1146t2836r1317b2908],
6	the	DT	O	the	det	7	SENT_92	[p4l1346t2836r1442b2892],
7	Kaplan	NNP	PERSON	Kaplan	dobj	5	SENT_92	[p4l1472t2836r1935b2908],
8	.	.	O	.	_	0	SENT_92	[p4l1472t2836r1935b2908],

1	—	NN	O	—	_	0	SENT_93	[p4l1472t2836r1935b2908],
2	.	.	O	.	_	0	SENT_93	[p4l1472t2836r1935b2908],

1	Meier	JJR	PERSON	meier	amod	2	SENT_94	[p4l1472t2836r1935b2908],
2	method	NN	O	method	_	0	SENT_94	[p4l1962t2836r2145b2892, p4l9t2933r87b2989],
3	with	IN	O	with	_	0	SENT_94	[p4l129t2933r270b2989],
4	log-rank	JJ	O	log-rank	amod	5	SENT_94	[p4l313t2933r585b3006],
5	comparisons	NNS	O	comparison	prep_with	2	SENT_94	[p4l627t2933r1047b3006],
6	.	.	O	.	_	0	SENT_94	[p4l627t2933r1047b3006],

1	Progression-free	JJ	O	progression-free	amod	2	SENT_95	[p4l1095t2933r1623b3006],
2	survival	NN	O	survival	nsubjpass	13	SENT_95	[p4l1669t2933r1920b2989],
3	(	CD	NUMBER	(	num	5	SENT_95	[p4l1966t2933r2146b3002],
4	PFS	NN	O	pf	nn	5	SENT_95	[p4l1966t2933r2146b3002],
5	)	NN	O	)	dep	2	SENT_95	[p4l1966t2933r2146b3002],
6	and	CC	O	and	_	0	SENT_95	[p4l9t3030r122b3086],
7	overall	JJ	O	overall	amod	8	SENT_95	[p4l175t3030r394b3086],
8	survival	NN	O	survival	conj_and	2	SENT_95	[p4l450t3030r700b3086],
9	(	CD	NUMBER	(	num	11	SENT_95	[p4l755t3030r904b3099],
10	OS	NN	O	os	nn	11	SENT_95	[p4l755t3030r904b3099],
11	)	NN	O	)	dep	8	SENT_95	[p4l755t3030r904b3099],
12	were	VBD	O	be	auxpass	13	SENT_95	[p4l959t3047r1112b3086],
13	calculated	VBN	O	calculate	conj_or	13	SENT_95	[p4l1166t3030r1491b3086],
14	from	IN	O	from	_	0	SENT_95	[p4l1543t3030r1698b3086],
15	the	DT	O	the	det	16	SENT_95	[p4l1750t3030r1846b3086],
16	date	NN	O	date	prep_from	13	SENT_95	[p4l1899t3030r2030b3086],
17	of	IN	O	of	_	0	SENT_95	[p4l2084t3030r2153b3086],
18	Pediatr	NNP	O	Pediatr	nn	21	SENT_95	[p4l7t3135r218b3185],
19	Blood	NNP	O	Blood	nn	21	SENT_95	[p4l235t3135r408b3186],
20	Cancer	NNP	O	Cancer	nn	21	SENT_95	[p4l429t3136r638b3186],
21	DOI	NNP	O	DOI	prep_of	16	SENT_95	[p4l655t3136r780b3186],
22	10.1002	CD	NUMBER	10.1002	num	21	SENT_95	[p4l808t3135r1152b3200],
23	/	:	O	/	punct	25	SENT_95	[p4l808t3135r1152b3200],
24	pbc	NN	O	pbc	nn	25	SENT_95	[p4l808t3135r1152b3200],
25	diagnosis	NN	O	diagnosis	dep	21	SENT_95	[p4l8t3226r307b3299],
26	to	TO	O	to	_	0	SENT_95	[p4l341t3235r401b3282],
27	progressiorﬂrecurrence	NN	O	progressiorﬂrecurrence	prep_to	25	SENT_95	[p4l433t3226r1169b3299],
28	or	CC	O	or	_	0	SENT_95	[p4l1204t3244r1269b3282],
29	death	NN	O	death	prep_to	25	SENT_95	[p4l1300t3226r1490b3293],
30	,	,	O	,	_	0	SENT_95	[p4l1300t3226r1490b3293],
31	respectively	RB	O	respectively	dep	25	SENT_95	[p4l1525t3226r1923b3299],
32	,	,	O	,	_	0	SENT_95	[p4l1525t3226r1923b3299],
33	or	CC	O	or	_	0	SENT_95	[p4l1959t3244r2024b3282],
34	for	IN	O	for	_	0	SENT_95	[p4l2056t3226r2149b3282],
35	survivors	NNS	O	survivor	prep_for	13	SENT_95	[p4l10t3324r318b3390],
36	,	,	O	,	_	0	SENT_95	[p4l10t3324r318b3390],
37	the	DT	O	the	det	38	SENT_95	[p4l351t3324r447b3380],
38	date	NN	O	date	appos	35	SENT_95	[p4l479t3324r610b3380],
39	of	IN	O	of	_	0	SENT_95	[p4l642t3324r711b3380],
40	the	DT	O	the	det	42	SENT_95	[p4l736t3324r832b3380],
41	last	JJ	O	last	amod	42	SENT_95	[p4l863t3324r974b3380],
42	contact	NN	O	contact	prep_of	38	SENT_95	[p4l1004t3332r1250b3380],
43	.	.	O	.	_	0	SENT_95	[p4l1004t3332r1250b3380],

1	Patients	NNS	O	patient	nsubjpass	6	SENT_96	[p4l114t3421r364b3477],
2	of	IN	O	of	_	0	SENT_96	[p4l393t3421r462b3477],
3	all	DT	O	all	det	4	SENT_96	[p4l483t3421r560b3477],
4	ages	NNS	O	age	prep_of	1	SENT_96	[p4l588t3438r725b3493],
5	were	VBD	O	be	auxpass	6	SENT_96	[p4l753t3439r906b3477],
6	included	VBN	O	include	_	0	SENT_96	[p4l931t3421r1208b3477],
7	in	IN	O	in	_	0	SENT_96	[p4l1233t3421r1294b3476],
8	the	DT	O	the	det	10	SENT_96	[p4l1319t3421r1415b3477],
9	toxicity	NN	O	toxicity	nn	10	SENT_96	[p4l1440t3421r1684b3493],
10	analyses	NNS	O	analysis	prep_in	6	SENT_96	[p4l1712t3421r1979b3493],
11	with	IN	O	with	_	0	SENT_96	[p4l2007t3421r2148b3477],
12	some	DT	O	some	det	13	SENT_96	[p4l10t3535r174b3573],
13	exceptions	NNS	O	exception	prep_with	6	SENT_96	[p4l211t3517r570b3590],
14	:	:	O	:	_	0	SENT_96	[p4l211t3517r570b3590],
15	(	CD	NUMBER	(	number	16	SENT_96	[p4l614t3518r701b3587],
16	1	CD	NUMBER	1	num	17	SENT_96	[p4l614t3518r701b3587],
17	)	CD	NUMBER	)	nsubj	44	SENT_96	[p4l614t3518r701b3587],
18	those	DT	O	those	dep	17	SENT_96	[p4l739t3518r906b3573],
19	having	VBG	O	have	partmod	17	SENT_96	[p4l943t3517r1160b3590],
20	the	DT	O	the	det	21	SENT_96	[p4l1196t3518r1292b3573],
21	outcome	NN	O	outcome	dobj	19	SENT_96	[p4l1330t3526r1604b3573],
22	of	IN	O	of	_	0	SENT_96	[p4l1641t3517r1711b3573],
23	interest	NN	O	interest	prep_of	21	SENT_96	[p4l1741t3517r1977b3573],
24	as	IN	O	as	_	0	SENT_96	[p4l2014t3535r2076b3573],
25	a	DT	O	a	det	27	SENT_96	[p4l2115t3535r2149b3573],
26	pre-existing	JJ	O	pre-existing	amod	27	SENT_96	[p4l6t3615r388b3687],
27	condition	NN	O	condition	nsubj	41	SENT_96	[p4l426t3615r728b3671],
28	(	CD	NUMBER	(	dep	27	SENT_96	[p4l766t3615r922b3687],
29	e.g.	FW	O	e.g.	dep	27	SENT_96	[p4l766t3615r922b3687],
30	,	,	O	,	_	0	SENT_96	[p4l766t3615r922b3687],
31	pre-therapy	JJ	O	pre-therapy	amod	34	SENT_96	[p4l960t3615r1330b3687],
32	hearing	NN	O	hearing	nn	34	SENT_96	[p4l1367t3615r1606b3687],
33	loss	NN	O	loss	nn	34	SENT_96	[p4l1643t3615r1811b3684],
34	)	NN	O	)	appos	29	SENT_96	[p4l1643t3615r1811b3684],
35	;	:	O	;	_	0	SENT_96	[p4l1643t3615r1811b3684],
36	(	NN	O	(	dep	29	SENT_96	[p4l1854t3615r1940b3684],
37	2	CD	NUMBER	2	number	38	SENT_96	[p4l1854t3615r1940b3684],
38	)	CD	NUMBER	)	num	39	SENT_96	[p4l1854t3615r1940b3684],
39	those	DT	O	those	dep	36	SENT_96	[p4l1980t3615r2147b3671],
40	not	RB	O	not	neg	41	SENT_96	[p4l7t3721r109b3768],
41	receiving	VBG	O	receive	prepc_as	23	SENT_96	[p4l153t3712r449b3784],
42	toxicity-inducing	JJ	O	toxicity-inducing	amod	43	SENT_96	[p4l496t3712r1048b3784],
43	therapies	NNS	O	therapy	dobj	41	SENT_96	[p4l1096t3712r1383b3784],
44	(	VBP	O	(	parataxis	6	SENT_96	[p4l1434t3713r1589b3784],
45	e.g.	FW	O	e.g.	dobj	44	SENT_96	[p4l1434t3713r1589b3784],
46	,	,	O	,	_	0	SENT_96	[p4l1434t3713r1589b3784],
47	CSI	NNP	O	CSI	nn	49	SENT_96	[p4l1639t3712r1760b3768],
48	unexposed	JJ	O	unexposed	amod	49	SENT_96	[p4l1806t3712r2148b3784],
49	subjects	NNS	O	subject	nsubjpass	51	SENT_96	[p5l10t19r263b91],
50	were	VBD	O	be	auxpass	51	SENT_96	[p5l302t36r455b75],
51	excluded	VBN	O	exclude	parataxis	6	SENT_96	[p5l494t19r783b75],
52	from	IN	O	from	_	0	SENT_96	[p5l819t19r974b75],
53	endocrinopathy	NN	O	endocrinopathy	nn	54	SENT_96	[p5l1011t19r1508b91],
54	analyses	NNS	O	analysis	prep_from	51	SENT_96	[p5l1548t19r1863b91],
55	)	CD	NUMBER	)	tmod	51	SENT_96	[p5l1548t19r1863b91],
56	;	:	O	;	_	0	SENT_96	[p5l1548t19r1863b91],
57	and	CC	O	and	_	0	SENT_96	[p5l1906t19r2019b75],
58	(	NN	O	(	nn	60	SENT_96	[p5l2058t19r2145b88],
59	3	CD	NUMBER	3	num	60	SENT_96	[p5l2058t19r2145b88],
60	)	NN	O	)	nsubj	63	SENT_96	[p5l2058t19r2145b88],
61	and	CC	O	and	_	0	SENT_96	[p5l9t116r122b172],
62	those	DT	O	those	conj_and	60	SENT_96	[p5l148t116r315b172],
63	lacking	VBG	O	lack	parataxis	6	SENT_96	[p5l342t116r576b188],
64	adequate	JJ	O	adequate	amod	66	SENT_96	[p5l605t116r888b188],
65	medical	JJ	O	medical	amod	66	SENT_96	[p5l915t116r1168b172],
66	documentation	NN	O	documentation	dobj	63	SENT_96	[p5l1195t116r1672b172],
67	for	IN	O	for	_	0	SENT_96	[p5l1699t116r1792b172],
68	evaluation	NN	O	evaluation	prep_for	63	SENT_96	[p5l1817t116r2147b172],
69	of	IN	O	of	_	0	SENT_96	[p5l8t213r77b269],
70	the	DT	O	the	det	71	SENT_96	[p5l98t213r194b269],
71	toxicity	NN	O	toxicity	prep_of	68	SENT_96	[p5l221t213r476b285],
72	.	.	O	.	_	0	SENT_96	[p5l221t213r476b285],

1	Toxicity	NN	O	toxicity	nn	2	SENT_97	[p5l506t213r771b285],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_97	[p5l799t213r1066b285],
3	were	VBD	O	be	auxpass	4	SENT_97	[p5l1095t231r1248b269],
4	performed	VBN	O	perform	_	0	SENT_97	[p5l1273t213r1608b285],
5	with	IN	O	with	_	0	SENT_97	[p5l1634t213r1775b269],
6	chi-Square	NN	O	chi-square	prep_with	4	SENT_97	[p5l1801t213r2147b285],
7	and	CC	O	and	_	0	SENT_97	[p5l9t310r122b366],
8	Fisher	NNP	PERSON	Fisher	poss	11	SENT_97	[p5l160t310r411b366],
9	’s	POS	O	’s	_	0	SENT_97	[p5l160t310r411b366],
10	Exact	JJ	O	exact	amod	11	SENT_97	[p5l451t311r634b366],
11	tests	NNS	O	test	prep_with	4	SENT_97	[p5l672t319r831b377],
12	,	,	O	,	_	0	SENT_97	[p5l672t319r831b377],
13	as	IN	O	as	_	0	SENT_97	[p5l874t328r935b366],
14	appropriate	JJ	O	appropriate	prep_as	4	SENT_97	[p5l978t310r1357b383],
15	.	.	O	.	_	0	SENT_97	[p5l978t310r1357b383],

1	Odds	NNS	O	odds	nn	2	SENT_98	[p5l1402t310r1566b366],
2	ratios	NNS	O	ratio	nsubjpass	9	SENT_98	[p5l1605t310r1781b366],
3	with	IN	O	with	_	0	SENT_98	[p5l1823t310r1963b366],
4	95	CD	PERCENT	95	number	5	SENT_98	[p5l2003t310r2144b367],
5	%	NN	PERCENT	%	amod	7	SENT_98	[p5l2003t310r2144b367],
6	conﬁdence	NN	O	conﬁdence	nn	7	SENT_98	[p5l8t407r352b463],
7	intervals	NNS	O	interval	prep_with	2	SENT_98	[p5l385t407r658b463],
8	were	VBD	O	be	auxpass	9	SENT_98	[p5l692t424r845b463],
9	calculated	VBN	O	calculate	_	0	SENT_98	[p5l879t407r1205b463],
10	using	VBG	O	use	xcomp	9	SENT_98	[p5l1237t407r1408b479],
11	univariate	JJ	O	univariate	amod	13	SENT_98	[p5l1441t407r1759b463],
12	logistic	JJ	O	logistic	amod	13	SENT_98	[p5l1792t407r2026b479],
13	regression	NN	O	regression	dobj	10	SENT_98	[p5l2059t424r2145b463, p5l8t504r292b576],
14	;	:	O	;	_	0	SENT_98	[p5l2059t424r2145b463, p5l8t504r292b576],
15	multivariable	JJ	O	multivariable	amod	18	SENT_98	[p5l351t504r776b560],
16	logistic	JJ	O	logistic	amod	18	SENT_98	[p5l833t504r1067b576],
17	regression	NN	O	regression	nn	18	SENT_98	[p5l1124t504r1452b576],
18	models	NNS	O	model	nsubjpass	20	SENT_98	[p5l1509t504r1737b560],
19	were	VBD	O	be	auxpass	20	SENT_98	[p5l1796t521r1949b560],
20	constructed	VBN	O	construct	parataxis	9	SENT_98	[p5l2007t522r2145b560, p5l10t601r261b657],
21	in	IN	O	in	_	0	SENT_98	[p5l316t601r377b656],
22	a	DT	O	a	det	25	SENT_98	[p5l435t619r467b657],
23	forward	RB	O	forward	advmod	25	SENT_98	[p5l522t601r775b657],
24	selection	NN	O	selection	nn	25	SENT_98	[p5l833t601r1115b657],
25	manner	NN	O	manner	prep_in	20	SENT_98	[p5l1171t619r1423b657],
26	.	.	O	.	_	0	SENT_98	[p5l1171t619r1423b657],

1	For	IN	O	for	_	0	SENT_99	[p5l1482t603r1593b657],
2	the	DT	O	the	det	4	SENT_99	[p5l1647t601r1743b657],
3	ototoxicity	NN	O	ototoxicity	nn	4	SENT_99	[p5l1801t601r2147b674],
4	outcome	NN	O	outcome	prep_for	10	SENT_99	[p5l8t706r300b764],
5	,	,	O	,	_	0	SENT_99	[p5l8t706r300b764],
6	exploratory	JJ	O	exploratory	amod	8	SENT_99	[p5l329t698r696b770],
7	interaction	NN	O	interaction	nn	8	SENT_99	[p5l722t698r1065b754],
8	analyses	NNS	O	analysis	nsubjpass	10	SENT_99	[p5l1092t698r1360b770],
9	were	VBD	O	be	auxpass	10	SENT_99	[p5l1387t715r1540b754],
10	conducted	VBN	O	conduct	_	0	SENT_99	[p5l1567t698r1895b754],
11	by	IN	O	by	_	0	SENT_99	[p5l1919t698r1998b770],
12	creating	VBG	O	create	agent	10	SENT_99	[p5l2024t715r2145b754, p5l9t795r165b867],
13	combined	JJ	O	combined	amod	14	SENT_99	[p5l200t795r516b851],
14	genotype	NN	O	genotype	dobj	12	SENT_99	[p5l549t795r1006b867],
15	.	.	O	.	_	0	SENT_99	[p5l549t795r1006b867],

1	—	NN	O	—	_	0	SENT_100	[p5l549t795r1006b867],
2	.	.	O	.	_	0	SENT_100	[p5l549t795r1006b867],

1	CSI	NNP	O	CSI	nn	3	SENT_101	[p5l549t795r1006b867],
2	dose	NN	O	dose	nn	3	SENT_101	[p5l1039t795r1183b851],
3	groups	NNS	O	group	_	0	SENT_101	[p5l1217t813r1431b867],
4	and	CC	O	and	_	0	SENT_101	[p5l1467t795r1580b851],
5	comparing	VBG	O	compare	conj_and	3	SENT_101	[p5l1613t795r1954b867],
6	them	PRP	O	they	dobj	5	SENT_101	[p5l1988t795r2148b851],
7	with	IN	O	with	_	0	SENT_101	[p5l8t892r148b948],
8	the	DT	O	the	det	10	SENT_101	[p5l179t892r275b948],
9	chi-square	JJ	O	chi-square	amod	10	SENT_101	[p5l307t892r639b965],
10	test	NN	O	test	prep_with	3	SENT_101	[p5l670t900r781b948],
11	of	IN	O	of	_	0	SENT_101	[p5l812t892r881b948],
12	homogeneity	NN	O	homogeneity	nn	15	SENT_101	[p5l907t892r1325b965],
13	and	CC	O	and	_	0	SENT_101	[p5l1358t892r1471b948],
14	score	NN	NUMBER	score	nn	15	SENT_101	[p5l1504t910r1668b948],
15	test	NN	O	test	prep_of	3	SENT_101	[p5l1700t900r1811b948],
16	for	IN	O	for	_	0	SENT_101	[p5l1842t892r1934b948],
17	trend	NN	O	trend	prep_for	15	SENT_101	[p5l1964t892r2143b948],
18	.	.	O	.	_	0	SENT_101	[p5l1964t892r2143b948],

1	These	DT	O	these	det	2	SENT_102	[p5l7t989r197b1045],
2	analyses	NNS	O	analysis	nsubjpass	7	SENT_102	[p5l232t989r499b1061],
3	were	VBD	O	be	auxpass	4	SENT_102	[p5l534t1006r688b1045],
4	performed	VBN	O	perform	_	0	SENT_102	[p5l720t989r1054b1061],
5	unadjusted	JJ	O	unadjusted	dobj	4	SENT_102	[p5l1086t989r1434b1061],
6	and	CC	O	and	_	0	SENT_102	[p5l1468t989r1581b1045],
7	adjusted	VBN	O	adjust	conj_and	4	SENT_102	[p5l1615t989r1881b1061],
8	for	IN	O	for	_	0	SENT_102	[p5l1913t989r2006b1045],
9	age	NN	O	age	nn	10	SENT_102	[p5l2039t1006r2147b1061],
10	group	NN	O	group	prep_for	7	SENT_102	[p5l8t1103r191b1158],
11	(	CD	NUMBER	(	dep	12	SENT_102	[p5l230t1086r493b1155],
12	divided	VBN	O	divide	amod	10	SENT_102	[p5l230t1086r493b1155],
13	at	IN	O	at	_	0	SENT_102	[p5l529t1094r585b1142],
14	median	JJ	O	median	amod	15	SENT_102	[p5l619t1086r898b1155],
15	)	NN	O	)	prep_at	12	SENT_102	[p5l619t1086r898b1155],
16	,	,	O	,	_	0	SENT_102	[p5l619t1086r898b1155],
17	cumulative	JJ	O	cumulative	amod	19	SENT_102	[p5l937t1086r1290b1142],
18	cisplatin	NN	O	cisplatin	nn	19	SENT_102	[p5l1327t1086r1598b1158],
19	dose	NN	O	dose	prep_for	7	SENT_102	[p5l1634t1086r1778b1142],
20	group	NN	O	group	nsubj	32	SENT_102	[p5l1813t1104r1996b1158],
21	(	CD	NUMBER	(	num	20	SENT_102	[p5l2036t1086r2145b1155, p5l8t1182r185b1238],
22	divided	VBN	O	divide	partmod	20	SENT_102	[p5l2036t1086r2145b1155, p5l8t1182r185b1238],
23	at	IN	O	at	_	0	SENT_102	[p5l219t1190r274b1238],
24	median	NN	O	median	prep_at	22	SENT_102	[p5l306t1182r542b1238],
25	:	:	O	:	_	0	SENT_102	[p5l574t1207r628b1227],
26	300	CD	NUMBER	300	num	28	SENT_102	[p5l662t1183r777b1238],
27	mg/m2	NN	O	mg/m2	nn	28	SENT_102	[p5l807t1165r1067b1255],
28	)	NN	O	)	conj_and	20	SENT_102	[p5l807t1165r1067b1255],
29	,	,	O	,	_	0	SENT_102	[p5l807t1165r1067b1255],
30	and	CC	O	and	_	0	SENT_102	[p5l1105t1182r1218b1238],
31	amifostine	NN	O	amifostine	conj_and	20	SENT_102	[p5l1252t1182r1588b1238],
32	use	VBP	O	use	rcmod	19	SENT_102	[p5l1621t1200r1725b1238],
33	(	CD	NUMBER	(	dobj	32	SENT_102	[p5l1762t1183r1890b1255],
34	yes	UH	O	yes	dep	33	SENT_102	[p5l1762t1183r1890b1255],
35	or	CC	O	or	_	0	SENT_102	[p5l1926t1200r1991b1238],
36	no	DT	O	no	det	37	SENT_102	[p5l2022t1183r2143b1251],
37	)	NN	O	)	prep_for	7	SENT_102	[p5l2022t1183r2143b1251],
38	.	.	O	.	_	0	SENT_102	[p5l2022t1183r2143b1251],

1	Cumulative	JJ	O	cumulative	amod	3	SENT_103	[p5l8t1280r378b1336],
2	cisplatin	NN	O	cisplatin	nn	3	SENT_103	[p5l432t1280r703b1352],
3	doses	NNS	O	dose	nsubj	5	SENT_103	[p5l756t1280r929b1336],
4	were	VBD	O	be	cop	5	SENT_103	[p5l983t1298r1136b1336],
5	standardized	JJ	O	standardized	_	0	SENT_103	[p5l1192t1280r1595b1336],
6	using	VBG	O	use	partmod	5	SENT_103	[p5l1646t1280r1818b1352],
7	a	DT	O	a	det	15	SENT_103	[p5l1872t1298r1906b1336],
8	1	CD	NUMBER	1	num	9	SENT_103	[p5l1964t1280r1988b1335],
9	mg	NN	O	mg	nn	15	SENT_103	[p5l2024t1280r2149b1352],
10	/	:	O	/	punct	12	SENT_103	[p5l2024t1280r2149b1352],
11	kg	NN	O	kg	dep	12	SENT_103	[p5l6t1377r84b1450],
12	=	JJ	O	=	dep	9	SENT_103	[p5l118t1402r172b1422],
13	30	CD	NUMBER	30	tmod	12	SENT_103	[p5l205t1378r280b1433],
14	mg/m2	NN	O	mg/m2	nn	15	SENT_103	[p5l310t1360r526b1450],
15	conversion	NN	O	conversion	dobj	6	SENT_103	[p5l567t1377r930b1433],
16	.	.	O	.	_	0	SENT_103	[p5l567t1377r930b1433],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_104	[p5l976t1377r1290b1433],
2	signiﬁcance	NN	O	signiﬁcance	nsubjpass	4	SENT_104	[p5l1333t1377r1712b1450],
3	was	VBD	O	be	auxpass	4	SENT_104	[p5l1751t1395r1872b1433],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_104	[p5l1914t1377r2148b1433],
5	as	IN	O	as	_	0	SENT_104	[p5l9t1491r70b1529],
6	a	DT	O	a	det	10	SENT_104	[p5l99t1491r133b1529],
7	P-value	JJ	MISC	p-value	amod	10	SENT_104	[p5l156t1473r404b1529],
8	less	JJR	O	less	mwe	9	SENT_104	[p5l432t1473r548b1529],
9	than	IN	O	than	quantmod	10	SENT_104	[p5l576t1473r712b1529],
10	0.05	CD	NUMBER	0.05	prep_as	4	SENT_104	[p5l739t1473r873b1530],
11	and	CC	O	and	_	0	SENT_104	[p5l904t1473r1017b1529],
12	all	DT	O	all	det	13	SENT_104	[p5l1044t1473r1121b1529],
13	tests	NNS	O	test	nsubj	18	SENT_104	[p5l1148t1481r1287b1529],
14	of	IN	O	of	_	0	SENT_104	[p5l1316t1473r1385b1529],
15	signiﬁcance	NN	O	signiﬁcance	prep_of	13	SENT_104	[p5l1409t1473r1787b1546],
16	performed	VBN	O	perform	partmod	15	SENT_104	[p5l1813t1473r2148b1546],
17	were	VBD	O	be	cop	18	SENT_104	[p5l8t1588r161b1627],
18	two-sided	JJ	O	two-sided	conj_and	4	SENT_104	[p5l191t1570r522b1627],
19	.	.	O	.	_	0	SENT_104	[p5l191t1570r522b1627],

1	No	DT	O	no	det	2	SENT_105	[p5l555t1572r650b1627],
2	adjustments	NNS	O	adjustment	nsubjpass	7	SENT_105	[p5l683t1570r1062b1643],
3	for	IN	O	for	_	0	SENT_105	[p5l1094t1570r1187b1626],
4	multiple	JJ	O	multiple	amod	5	SENT_105	[p5l1215t1570r1481b1643],
5	testing	NN	O	testing	prep_for	2	SENT_105	[p5l1512t1570r1724b1643],
6	were	VBD	O	be	auxpass	7	SENT_105	[p5l1755t1588r1908b1627],
7	implemented	VBN	O	implement	_	0	SENT_105	[p5l1939t1570r2144b1643, p5l7t1668r243b1724],
8	since	IN	O	since	mark	14	SENT_105	[p5l284t1668r444b1724],
9	only	RB	O	only	advmod	12	SENT_105	[p5l484t1668r624b1741],
10	a	DT	O	a	det	12	SENT_105	[p5l665t1686r698b1724],
11	single	JJ	O	single	amod	12	SENT_105	[p5l738t1668r925b1741],
12	polymorphism	NN	O	polymorphism	nsubjpass	14	SENT_105	[p5l964t1668r1433b1741],
13	was	VBD	O	be	auxpass	14	SENT_105	[p5l1471t1686r1591b1724],
14	studied	VBN	O	study	advcl	7	SENT_105	[p5l1635t1668r1878b1724],
15	.	.	O	.	_	0	SENT_105	[p5l1635t1668r1878b1724],

1	For	IN	O	for	_	0	SENT_106	[p5l1921t1670r2032b1724],
2	all	DT	O	all	det	3	SENT_106	[p5l2070t1668r2147b1724],
3	analyses	NNS	O	analysis	prep_for	11	SENT_106	[p5l9t1764r294b1837],
4	,	,	O	,	_	0	SENT_106	[p5l9t1764r294b1837],
5	the	DT	O	the	det	9	SENT_106	[p5l327t1764r423b1820],
6	Stata	NNP	ORGANIZATION	Stata	nn	9	SENT_106	[p5l455t1765r613b1820],
7	11	CD	NUMBER	11	num	9	SENT_106	[p5l649t1765r712b1820],
8	software	NN	O	software	nn	9	SENT_106	[p5l751t1764r1022b1820],
9	package	NN	O	package	appos	3	SENT_106	[p5l1052t1764r1314b1837],
10	was	VBD	O	be	auxpass	11	SENT_106	[p5l1342t1782r1463b1820],
11	used	VBN	O	use	_	0	SENT_106	[p5l1494t1764r1639b1820],
12	(	CD	NUMBER	(	num	14	SENT_106	[p5l1671t1765r2014b1837],
13	StataCorp	NNP	O	StataCorp	nn	14	SENT_106	[p5l1671t1765r2014b1837],
14	LP	NN	O	lp	nsubjpass	11	SENT_106	[p5l2043t1766r2144b1831],
15	,	,	O	,	_	0	SENT_106	[p5l2043t1766r2144b1831],
16	College	NNP	O	College	nn	17	SENT_106	[p5l8t1861r255b1934],
17	Station	NNP	O	Station	appos	14	SENT_106	[p5l288t1861r529b1928],
18	,	,	O	,	_	0	SENT_106	[p5l288t1861r529b1928],
19	TX	NNP	LOCATION	TX	nn	20	SENT_106	[p5l562t1862r709b1930],
20	)	NNP	O	)	appos	17	SENT_106	[p5l562t1862r709b1930],
21	.	.	O	.	_	0	SENT_106	[p5l562t1862r709b1930],

1	RESU	NNP	O	RESU	nn	2	SENT_107	[p5l12t2092r212b2157],
2	LTS	NNP	O	LTS	_	0	SENT_107	[p5l227t2092r357b2157],

1	Patient	NN	O	patient	_	0	SENT_108	[p5l12t2250r300b2333],
2	,	,	O	,	_	0	SENT_108	[p5l12t2250r300b2333],
3	Disease	NN	O	disease	conj_and	1	SENT_108	[p5l335t2250r647b2333],
4	,	,	O	,	_	0	SENT_108	[p5l335t2250r647b2333],
5	and	CC	O	and	_	0	SENT_108	[p5l678t2248r815b2317],
6	Therapy	NN	O	therapy	nn	7	SENT_108	[p5l844t2249r1159b2339],
7	Characteristics	NNS	O	characteristic	conj_and	1	SENT_108	[p5l1186t2248r1763b2318],

1	The	DT	O	the	det	2	SENT_109	[p5l114t2414r237b2470],
2	patient	NN	O	patient	nsubj	21	SENT_109	[p5l273t2414r508b2487],
3	,	,	O	,	_	0	SENT_109	[p5l273t2414r508b2487],
4	disease	NN	O	disease	conj_and	2	SENT_109	[p5l549t2414r795b2481],
5	,	,	O	,	_	0	SENT_109	[p5l549t2414r795b2481],
6	and	CC	O	and	_	0	SENT_109	[p5l837t2415r950b2470],
7	therapy	NN	O	therapy	conj_and	2	SENT_109	[p5l985t2415r1224b2487],
8	characteristics	NNS	O	characteristic	nsubjpass	10	SENT_109	[p5l1262t2414r1719b2470],
9	are	VBP	O	be	auxpass	10	SENT_109	[p5l1758t2432r1853b2470],
10	summarized	VBN	O	summarize	rcmod	2	SENT_109	[p5l1893t2432r2145b2470, p5l6t2511r167b2567],
11	in	IN	O	in	_	0	SENT_109	[p5l192t2511r252b2567],
12	Table	NNP	O	Table	nn	16	SENT_109	[p5l279t2512r454b2567],
13	I.	NNP	O	I.	nn	16	SENT_109	[p5l481t2513r521b2567],
14	The	NNP	O	The	nn	16	SENT_109	[p5l551t2512r674b2567],
15	median	JJ	O	median	amod	16	SENT_109	[p5l701t2511r936b2567],
16	follow-up	NN	O	follow-up	prep_in	10	SENT_109	[p5l962t2511r1274b2584],
17	in	IN	O	in	_	0	SENT_109	[p5l1301t2511r1362b2567],
18	survivors	NNS	O	survivor	prep_in	10	SENT_109	[p5l1390t2511r1679b2568],
19	was	VBD	O	be	cop	21	SENT_109	[p5l1708t2529r1828b2568],
20	7.3	CD	DURATION	7.3	num	21	SENT_109	[p5l1856t2512r1950b2568],
21	years	NNS	NUMBER	year	_	0	SENT_109	[p5l1979t2529r2145b2584],
22	(	JJ	O	(	amod	23	SENT_109	[p5l10t2610r210b2681],
23	range	NN	O	range	attr	21	SENT_109	[p5l10t2610r210b2681],
24	1.7	CD	NUMBER	1.7	num	23	SENT_109	[p5l257t2608r525b2665],
25	—	CD	NUMBER	—	number	26	SENT_109	[p5l257t2608r525b2665],
26	23.5	CD	DURATION	23.5	num	27	SENT_109	[p5l257t2608r525b2665],
27	years	NNS	NUMBER	year	tmod	23	SENT_109	[p5l567t2626r751b2681],
28	,	,	O	,	_	0	SENT_109	[p5l567t2626r751b2681],
29	n	NN	O	n	appos	23	SENT_109	[p5l793t2626r831b2664],
30	=	JJ	O	=	amod	32	SENT_109	[p5l863t2634r917b2653],
31	78	CD	NUMBER	78	tmod	30	SENT_109	[p5l949t2609r1069b2678],
32	)	NN	O	)	dep	29	SENT_109	[p5l949t2609r1069b2678],
33	.	.	O	.	_	0	SENT_109	[p5l949t2609r1069b2678],

1	The	DT	O	the	det	2	SENT_110	[p5l1112t2609r1235b2665],
2	mean	NN	O	mean	nsubj	25	SENT_110	[p5l1274t2626r1447b2665],
3	and	CC	O	and	_	0	SENT_110	[p5l1486t2609r1599b2665],
4	median	JJ	O	median	amod	5	SENT_110	[p5l1638t2609r1873b2665],
5	ages	NNS	O	age	conj_and	2	SENT_110	[p5l1913t2626r2051b2681],
6	at	IN	O	at	_	0	SENT_110	[p5l2092t2617r2148b2665],
7	diagnosis	NN	O	diagnosis	prep_at	5	SENT_110	[p5l8t2705r307b2778],
8	were	VBD	O	be	cop	25	SENT_110	[p5l356t2723r509b2762],
9	7.0	CD	NUMBER	7.0	nn	12	SENT_110	[p5l558t2706r655b2762],
10	and	CC	O	and	_	0	SENT_110	[p5l705t2705r818b2761],
11	6.0	CD	DURATION	6.0	nn	12	SENT_110	[p5l866t2705r962b2762],
12	years	NNS	NUMBER	year	nn	25	SENT_110	[p5l1010t2723r1194b2778],
13	,	,	O	,	_	0	SENT_110	[p5l1010t2723r1194b2778],
14	respectively	RB	O	respectively	advmod	16	SENT_110	[p5l1244t2705r1629b2778],
15	(	CD	NUMBER	(	num	16	SENT_110	[p5l1680t2706r1880b2778],
16	range	NN	O	range	appos	12	SENT_110	[p5l1680t2706r1880b2778],
17	0.5	CD	NUMBER	0.5	number	18	SENT_110	[p5l1929t2705r2144b2762],
18	—	CD	NUMBER	—	amod	16	SENT_110	[p5l1929t2705r2144b2762],
19	l8	CD	NUMBER	l8	num	20	SENT_110	[p5l1929t2705r2144b2762],
20	years	NNS	NUMBER	year	tmod	18	SENT_110	[p5l7t2820r192b2875],
21	,	,	O	,	_	0	SENT_110	[p5l7t2820r192b2875],
22	n	NN	O	n	appos	12	SENT_110	[p5l227t2820r265b2858],
23	=	JJ	O	=	amod	25	SENT_110	[p5l297t2828r351b2847],
24	106	CD	NUMBER	106	tmod	23	SENT_110	[p5l390t2803r544b2872],
25	)	NN	O	)	_	0	SENT_110	[p5l390t2803r544b2872],
26	.	.	O	.	_	0	SENT_110	[p5l390t2803r544b2872],

1	Eighty	CD	NUMBER	eighty	num	4	SENT_111	[p5l579t2803r912b2875],
2	—	CD	NUMBER	—	num	4	SENT_111	[p5l579t2803r912b2875],
3	six	CD	NUMBER	six	num	4	SENT_111	[p5l579t2803r912b2875],
4	patients	NNS	O	patient	nsubj	13	SENT_111	[p5l944t2803r1192b2875],
5	(	IN	O	(	_	0	SENT_111	[p5l1229t2803r1422b2872],
6	81	CD	PERCENT	81	num	7	SENT_111	[p5l1229t2803r1422b2872],
7	%	NN	PERCENT	%	prep_(	4	SENT_111	[p5l1229t2803r1422b2872],
8	)	CD	NUMBER	)	dep	7	SENT_111	[p5l1229t2803r1422b2872],
9	were	VBD	O	be	cop	13	SENT_111	[p5l1457t2820r1610b2859],
10	at	IN	DURATION	at	quantmod	12	SENT_111	[p5l1645t2811r1700b2859],
11	least	JJS	DURATION	least	mwe	10	SENT_111	[p5l1732t2803r1878b2859],
12	3	CD	DURATION	3	num	13	SENT_111	[p5l1912t2803r1943b2859],
13	years	NNS	NUMBER	year	_	0	SENT_111	[p5l1979t2820r2145b2875],
14	of	IN	O	of	_	0	SENT_111	[p5l8t2900r77b2956],
15	age	NN	O	age	prep_of	13	SENT_111	[p5l95t2917r203b2972],
16	at	IN	O	at	_	0	SENT_111	[p5l228t2908r284b2956],
17	diagnosis	NN	O	diagnosis	prep_at	15	SENT_111	[p5l306t2900r622b2972],
18	.	.	O	.	_	0	SENT_111	[p5l306t2900r622b2972],

1	Seventy-four	CD	NUMBER	seventy-four	num	2	SENT_112	[p5l651t2900r1066b2972],
2	patients	NNS	O	patient	nsubj	17	SENT_112	[p5l1085t2900r1334b2972],
3	(	IN	O	(	_	0	SENT_112	[p5l1360t2900r1554b2969],
4	70	CD	PERCENT	70	num	5	SENT_112	[p5l1360t2900r1554b2969],
5	%	NN	PERCENT	%	prep_(	2	SENT_112	[p5l1360t2900r1554b2969],
6	)	CD	NUMBER	)	nsubj	8	SENT_112	[p5l1360t2900r1554b2969],
7	were	VBD	O	be	cop	8	SENT_112	[p5l1579t2917r1732b2956],
8	male	JJ	O	male	rcmod	5	SENT_112	[p5l1755t2900r1910b2956],
9	and	CC	O	and	_	0	SENT_112	[p5l1935t2900r2048b2956],
10	47	CD	PERCENT	47	number	11	SENT_112	[p5l2068t2900r2144b2956],
11	(	CD	PERCENT	(	conj_and	5	SENT_112	[p5l10t2996r203b3066],
12	45	CD	PERCENT	45	num	13	SENT_112	[p5l10t2996r203b3066],
13	%	NN	PERCENT	%	dep	11	SENT_112	[p5l10t2996r203b3066],
14	)	CD	NUMBER	)	dep	11	SENT_112	[p5l10t2996r203b3066],
15	were	VBD	O	be	cop	17	SENT_112	[p5l240t3014r393b3053],
16	non-Hispanic	JJ	MISC	non-hispanic	amod	17	SENT_112	[p5l428t2996r857b3069],
17	white	JJ	O	white	_	0	SENT_112	[p5l893t2996r1085b3052],
18	.	.	O	.	_	0	SENT_112	[p5l893t2996r1085b3052],

1	In	IN	O	in	_	0	SENT_113	[p5l1123t2998r1188b3052],
2	addition	NN	O	addition	_	0	SENT_113	[p5l1223t2996r1484b3052],
3	to	TO	O	to	_	0	SENT_113	[p5l1518t3005r1577b3052],
4	97	CD	NUMBER	97	num	5	SENT_113	[p5l1613t2997r1687b3053],
5	patients	NNS	O	patient	prep_in_addition_to	15	SENT_113	[p5l1723t2996r1971b3069],
6	with	IN	O	with	_	0	SENT_113	[p5l2007t2996r2148b3052],
7	medulloblastoma	NN	O	medulloblastoma	prep_with	5	SENT_113	[p5l7t3094r577b3160],
8	,	,	O	,	_	0	SENT_113	[p5l7t3094r577b3160],
9	nine	CD	NUMBER	nine	num	10	SENT_113	[p5l623t3094r759b3150],
10	patients	NNS	O	patient	nsubjpass	15	SENT_113	[p5l800t3094r1048b3166],
11	with	IN	O	with	_	0	SENT_113	[p5l1093t3094r1233b3150],
12	supratentorial	JJ	O	supratentorial	amod	13	SENT_113	[p5l1278t3094r1715b3166],
13	PNET	NN	ORGANIZATION	pnet	prep_with	10	SENT_113	[p5l1758t3095r1956b3150],
14	were	VBD	O	be	auxpass	15	SENT_113	[p5l1993t3111r2146b3150],
15	included	VBN	O	include	_	0	SENT_113	[p5l7t3191r299b3247],
16	.	.	O	.	_	0	SENT_113	[p5l7t3191r299b3247],

1	Fifty-two	CD	NUMBER	fifty-two	num	2	SENT_114	[p5l346t3191r647b3263],
2	patients	NNS	O	patient	nsubjpass	8	SENT_114	[p5l691t3191r939b3263],
3	(	IN	O	(	_	0	SENT_114	[p5l987t3191r1180b3260],
4	61	CD	PERCENT	61	num	5	SENT_114	[p5l987t3191r1180b3260],
5	%	NN	PERCENT	%	prep_(	2	SENT_114	[p5l987t3191r1180b3260],
6	)	CD	NUMBER	)	dep	5	SENT_114	[p5l987t3191r1180b3260],
7	were	VBD	O	be	auxpass	8	SENT_114	[p5l1227t3209r1380b3247],
8	classiﬁed	VBN	O	classiﬁed	_	0	SENT_114	[p5l1425t3191r1722b3247],
9	as	IN	O	as	_	0	SENT_114	[p5l1766t3209r1828b3247],
10	averagerisk	NN	O	averagerisk	prep_as	8	SENT_114	[p5l1875t3209r2144b3263, p5l6t3287r127b3343],
11	and	CC	O	and	_	0	SENT_114	[p5l172t3287r286b3343],
12	33	CD	NUMBER	33	num	13	SENT_114	[p5l332t3288r404b3344],
13	patients	NNS	O	patient	conj_and	10	SENT_114	[p5l452t3287r700b3360],
14	(	IN	O	(	_	0	SENT_114	[p5l749t3288r943b3357],
15	38	CD	PERCENT	38	num	16	SENT_114	[p5l749t3288r943b3357],
16	%	NN	PERCENT	%	prep_(	8	SENT_114	[p5l749t3288r943b3357],
17	)	CD	NUMBER	)	nsubj	19	SENT_114	[p5l749t3288r943b3357],
18	were	VBD	O	be	cop	19	SENT_114	[p5l991t3305r1144b3344],
19	high-risk	JJ	O	high-risk	rcmod	16	SENT_114	[p5l1189t3287r1495b3360],
20	,	,	O	,	_	0	SENT_114	[p5l1189t3287r1495b3360],
21	including	VBG	O	include	_	0	SENT_114	[p5l1543t3287r1845b3360],
22	the	DT	O	the	det	24	SENT_114	[p5l1891t3287r1987b3343],
23	ﬁve	NN	O	ﬁve	nn	24	SENT_114	[p5l2033t3287r2147b3344],
24	patients	NNS	O	patient	prep_including	19	SENT_114	[p5l6t3385r254b3457],
25	with	IN	O	with	_	0	SENT_114	[p5l292t3385r433b3441],
26	supratentorial	JJ	O	supratentorial	amod	27	SENT_114	[p5l470t3385r908b3457],
27	PNET	NN	ORGANIZATION	pnet	prep_with	24	SENT_114	[p5l945t3386r1143b3441],
28	who	WP	O	who	nsubj	33	SENT_114	[p5l1173t3385r1308b3441],
29	were	VBD	O	be	cop	33	SENT_114	[p5l1343t3402r1496b3441],
30	at	IN	DURATION	at	quantmod	32	SENT_114	[p5l1534t3393r1590b3441],
31	least	JJS	DURATION	least	mwe	30	SENT_114	[p5l1625t3385r1771b3441],
32	3	CD	DURATION	3	num	33	SENT_114	[p5l1808t3385r1839b3441],
33	years	NNS	NUMBER	year	rcmod	24	SENT_114	[p5l1879t3402r2045b3457],
34	of	IN	O	of	_	0	SENT_114	[p5l2084t3385r2153b3441],
35	age	NN	O	age	prep_of	33	SENT_114	[p5l9t3499r133b3554],
36	.	.	O	.	_	0	SENT_114	[p5l9t3499r133b3554],

1	All	DT	O	all	det	3	SENT_115	[p5l161t3482r261b3537],
2	high-risk	JJ	O	high-risk	amod	3	SENT_115	[p5l285t3482r576b3554],
3	patients	NNS	O	patient	nsubj	4	SENT_115	[p5l597t3482r845b3554],
4	received	VBD	O	receive	_	0	SENT_115	[p5l869t3482r1140b3538],
5	high	JJ	O	high	amod	6	SENT_115	[p5l1163t3482r1305b3554],
6	dose	NN	O	dose	iobj	4	SENT_115	[p5l1328t3482r1472b3538],
7	CSI	NNP	O	CSI	dobj	4	SENT_115	[p5l1498t3482r1620b3538],
8	(	CD	NUMBER	(	num	7	SENT_115	[p5l1646t3482r1906b3551],
9	median	JJ	O	median	amod	7	SENT_115	[p5l1646t3482r1906b3551],
10	36	CD	NUMBER	36	num	11	SENT_115	[p5l1931t3482r2006b3538],
11	Gy	NN	O	gy	dobj	4	SENT_115	[p5l2038t3482r2144b3554],
12	,	,	O	,	_	0	SENT_115	[p5l2038t3482r2144b3554],
13	range	NN	O	range	appos	11	SENT_115	[p5l6t3596r184b3651],
14	34.2-39	CD	NUMBER	34.2-39	num	13	SENT_115	[p5l237t3578r553b3635],
15	.6	CD	NUMBER	.6	num	17	SENT_115	[p5l237t3578r553b3635],
16	Gy	NN	O	gy	nn	17	SENT_115	[p5l585t3579r723b3651],
17	)	NN	O	)	dep	13	SENT_115	[p5l585t3579r723b3651],
18	,	,	O	,	_	0	SENT_115	[p5l585t3579r723b3651],
19	while	IN	O	while	mark	29	SENT_115	[p5l778t3578r954b3635],
20	50/52	CD	PERCENT	50/52	nsubj	29	SENT_115	[p5l1007t3578r1186b3635],
21	(	CD	PERCENT	(	num	23	SENT_115	[p5l1241t3578r1435b3648],
22	96	CD	PERCENT	96	num	23	SENT_115	[p5l1241t3578r1435b3648],
23	%	NN	PERCENT	%	dep	20	SENT_115	[p5l1241t3578r1435b3648],
24	)	CD	NUMBER	)	dep	20	SENT_115	[p5l1241t3578r1435b3648],
25	of	IN	O	of	_	0	SENT_115	[p5l1489t3578r1559b3634],
26	the	DT	O	the	det	28	SENT_115	[p5l1605t3578r1701b3634],
27	average-risk	JJ	O	average-risk	amod	28	SENT_115	[p5l1755t3578r2148b3651],
28	patients	NNS	O	patient	prep_of	24	SENT_115	[p5l6t3676r254b3748],
29	received	VBD	O	receive	advcl	4	SENT_115	[p5l306t3676r577b3732],
30	low	JJ	O	low	amod	31	SENT_115	[p5l625t3676r742b3732],
31	dose	NN	O	dose	iobj	29	SENT_115	[p5l793t3676r937b3732],
32	CSI	NNP	O	CSI	dobj	29	SENT_115	[p5l989t3676r1110b3732],
33	(	CD	NUMBER	(	num	32	SENT_115	[p5l1163t3676r1423b3745],
34	median	JJ	O	median	amod	32	SENT_115	[p5l1163t3676r1423b3745],
35	23.4	CD	NUMBER	23.4	num	36	SENT_115	[p5l1474t3676r1611b3732],
36	Gy	NN	O	gy	tmod	34	SENT_115	[p5l1642t3676r1749b3748],
37	,	,	O	,	_	0	SENT_115	[p5l1642t3676r1749b3748],
38	range	NN	O	range	appos	36	SENT_115	[p5l1801t3693r1978b3748],
39	1825.2	CD	NUMBER	1825.2	num	38	SENT_115	[p5l2037t3676r2149b3732, p6l8t19r145b75],

1	Gy	NN	O	gy	_	0	SENT_116	[p6l176t19r313b91],
2	)	NN	O	)	dep	1	SENT_116	[p6l176t19r313b91],
3	.	.	O	.	_	0	SENT_116	[p6l176t19r313b91],

1	Genotyping	NN	O	genotyping	_	0	SENT_117	[p6l10t253r462b343],
2	and	CC	O	and	_	0	SENT_117	[p6l488t252r625b321],
3	lmmunohistochemical	JJ	O	lmmunohistochemical	amod	4	SENT_117	[p6l662t252r1516b321],
4	Staining	NN	O	staining	conj_and	1	SENT_117	[p6l1550t253r1858b343],

1	The	DT	O	the	det	2	SENT_118	[p6l114t363r237b419],
2	frequencies	NNS	O	frequency	nsubj	11	SENT_118	[p6l267t363r635b436],
3	of	IN	O	of	_	0	SENT_118	[p6l667t363r736b419],
4	AA	NN	O	aa	prep_of	2	SENT_118	[p6l761t364r891b430],
5	,	,	O	,	_	0	SENT_118	[p6l761t364r891b430],
6	AG	NNP	O	AG	prep_of	2	SENT_118	[p6l924t364r1052b430],
7	,	,	O	,	_	0	SENT_118	[p6l924t364r1052b430],
8	and	CC	O	and	_	0	SENT_118	[p6l1086t363r1200b419],
9	GG	NNS	O	gg	conj_and	4	SENT_118	[p6l1230t364r1343b420],
10	were	VBD	O	be	cop	11	SENT_118	[p6l1372t381r1525b420],
11	0.37	CD	NUMBER	0.37	_	0	SENT_118	[p6l1557t364r1692b420],
12	(	CD	NUMBER	(	number	13	SENT_118	[p6l1727t363r1976b433],
13	32/86	CD	NUMBER	32/86	num	14	SENT_118	[p6l1727t363r1976b433],
14	)	NN	O	)	dep	11	SENT_118	[p6l1727t363r1976b433],
15	,	,	O	,	_	0	SENT_118	[p6l1727t363r1976b433],
16	0.41	CD	NUMBER	0.41	number	17	SENT_118	[p6l2010t364r2140b420],
17	(	CD	NUMBER	(	conj_and	11	SENT_118	[p6l10t460r259b530],
18	35/86	CD	NUMBER	35/86	num	19	SENT_118	[p6l10t460r259b530],
19	)	NN	O	)	dep	17	SENT_118	[p6l10t460r259b530],
20	,	,	O	,	_	0	SENT_118	[p6l10t460r259b530],
21	and	CC	O	and	_	0	SENT_118	[p6l304t461r416b517],
22	0.22	CD	NUMBER	0.22	number	23	SENT_118	[p6l456t461r593b517],
23	(	CD	NUMBER	(	conj_and	11	SENT_118	[p6l636t460r885b530],
24	19/86	CD	NUMBER	19/86	num	25	SENT_118	[p6l636t460r885b530],
25	)	NN	O	)	dep	23	SENT_118	[p6l636t460r885b530],
26	,	,	O	,	_	0	SENT_118	[p6l636t460r885b530],
27	respectively	RB	O	respectively	amod	23	SENT_118	[p6l927t461r1325b533],
28	,	,	O	,	_	0	SENT_118	[p6l927t461r1325b533],
29	yielding	VBG	O	yield	partmod	23	SENT_118	[p6l1368t461r1629b533],
30	a	DT	O	a	det	36	SENT_118	[p6l1672t478r1705b517],
31	minor	JJ	O	minor	amod	36	SENT_118	[p6l1744t461r1935b517],
32	allele	NN	O	allele	nn	36	SENT_118	[p6l1975t461r2147b517],
33	frequency	NN	O	frequency	nn	36	SENT_118	[p6l7t558r325b630],
34	(	CD	NUMBER	(	num	36	SENT_118	[p6l357t558r577b627],
35	MAF	NN	O	maf	nn	36	SENT_118	[p6l357t558r577b627],
36	)	NN	O	)	dobj	29	SENT_118	[p6l357t558r577b627],
37	for	IN	O	for	_	0	SENT_118	[p6l607t558r700b614],
38	the	DT	O	the	det	39	SENT_118	[p6l727t558r823b614],
39	G-allele	NN	O	g-allele	prep_for	36	SENT_118	[p6l853t558r1109b614],
40	of	IN	O	of	_	0	SENT_118	[p6l1139t558r1208b614],
41	0.42	CD	NUMBER	0.42	prep_of	39	SENT_118	[p6l1232t558r1386b614],
42	.	.	O	.	_	0	SENT_118	[p6l1232t558r1386b614],

1	These	DT	O	these	det	2	SENT_119	[p6l1417t558r1607b614],
2	data	NNS	O	datum	nsubj	4	SENT_119	[p6l1637t558r1769b614],
3	are	VBP	O	be	cop	4	SENT_119	[p6l1799t576r1893b614],
4	consistent	JJ	O	consistent	_	0	SENT_119	[p6l1922t558r2145b614, p6l7t663r127b710],
5	with	IN	O	with	_	0	SENT_119	[p6l160t654r301b711],
6	Hardy	NNP	PERSON	Hardy	prep_with	4	SENT_119	[p6l334t654r884b727],
7	.	.	O	.	_	0	SENT_119	[p6l334t654r884b727],

1	—	NN	O	—	_	0	SENT_120	[p6l334t654r884b727],
2	.	.	O	.	_	0	SENT_120	[p6l334t654r884b727],

1	Weinberg	NNP	PERSON	Weinberg	nsubj	11	SENT_121	[p6l334t654r884b727],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_121	[p6l918t654r1292b727],
3	and	CC	O	and	_	0	SENT_121	[p6l1327t655r1440b710],
4	with	IN	O	with	dep	1	SENT_121	[p6l1473t654r1614b711],
5	allelic	JJ	O	allelic	amod	6	SENT_121	[p6l1649t654r1841b710],
6	frequencies	NNS	O	frequency	pobj	4	SENT_121	[p6l1877t654r2145b727, p6l8t752r129b808],
7	reported	VBN	O	report	partmod	6	SENT_121	[p6l171t752r439b824],
8	in	IN	O	in	_	0	SENT_121	[p6l480t752r541b807],
9	public	JJ	O	public	amod	10	SENT_121	[p6l581t752r780b824],
10	databases	NNS	O	database	prep_in	7	SENT_121	[p6l824t752r1128b808],
11	(	VBP	O	(	_	0	SENT_121	[p6l1174t752r2150b824],
12	http://www.ncbi.nlm.nih.gov/	JJ	O	http://www.ncbi.nlm.nih.gov/	amod	15	SENT_121	[p6l1174t752r2150b824],
13	projects/SNP/snp	NN	O	projects/snp/snp	nn	15	SENT_121	[p6l6t849r1170b921],
14	_	NN	O	_	nn	15	SENT_121	[p6l6t849r1170b921],
15	ref	NN	O	ref	dobj	11	SENT_121	[p6l6t849r1170b921],
16	.	.	O	.	_	0	SENT_121	[p6l6t849r1170b921],

1	cgi	NN	O	cgus	_	0	SENT_122	[p6l6t849r1170b921],
2	?	.	O	?	_	0	SENT_122	[p6l6t849r1170b921],

1	rs	NN	O	r	_	0	SENT_123	[p6l6t849r1170b921],
2	=	JJ	O	=	amod	1	SENT_123	[p6l6t849r1170b921],
3	1695	CD	DATE	1695	number	4	SENT_123	[p6l6t849r1170b921],
4	)	CD	NUMBER	)	num	1	SENT_123	[p6l6t849r1170b921],
5	.	.	O	.	_	0	SENT_123	[p6l6t849r1170b921],

1	For	IN	O	for	_	0	SENT_124	[p6l1215t850r1326b905],
2	the	DT	O	the	det	4	SENT_124	[p6l1365t849r1461b905],
3	IHC	NNP	ORGANIZATION	IHC	nn	4	SENT_124	[p6l1502t849r1636b905],
4	staining	NN	O	staining	prep_for	9	SENT_124	[p6l1682t849r1949b921],
5	,	,	O	,	_	0	SENT_124	[p6l1682t849r1949b921],
6	samples	NNS	O	sample	nsubj	9	SENT_124	[p6l1995t866r2144b905, p6l6t946r133b1019],
7	were	VBD	O	be	cop	9	SENT_124	[p6l185t964r338b1002],
8	more	RBR	O	more	advmod	9	SENT_124	[p6l389t964r552b1002],
9	likely	JJ	O	likely	_	0	SENT_124	[p6l603t946r784b1019],
10	to	TO	O	to	aux	11	SENT_124	[p6l835t955r894b1002],
11	have	VB	O	have	xcomp	9	SENT_124	[p6l945t946r1093b1002],
12	absent/mild	JJ	O	absent/mild	amod	14	SENT_124	[p6l1145t946r1519b1002],
13	staining	NN	O	staining	nn	14	SENT_124	[p6l1571t946r1820b1019],
14	intensity	NN	O	intensity	dobj	11	SENT_124	[p6l1871t946r2146b1019],
15	(	CD	PERCENT	(	number	16	SENT_124	[p6l10t1042r203b1112],
16	59	CD	PERCENT	59	num	17	SENT_124	[p6l10t1042r203b1112],
17	%	NN	PERCENT	%	dep	14	SENT_124	[p6l10t1042r203b1112],
18	)	CD	NUMBER	)	dep	14	SENT_124	[p6l10t1042r203b1112],
19	and	CC	O	and	_	0	SENT_124	[p6l267t1043r380b1099],
20	over	IN	O	over	quantmod	21	SENT_124	[p6l440t1060r580b1099],
21	50	CD	PERCENT	50	num	22	SENT_124	[p6l640t1042r780b1099],
22	%	NN	PERCENT	%	conj_and	14	SENT_124	[p6l640t1042r780b1099],
23	of	IN	O	of	_	0	SENT_124	[p6l844t1043r914b1099],
24	the	DT	O	the	det	25	SENT_124	[p6l967t1043r1064b1099],
25	cells	NNS	O	cell	prep_of	22	SENT_124	[p6l1125t1043r1268b1099],
26	staining	VBG	O	stain	partmod	25	SENT_124	[p6l1333t1043r1582b1115],
27	positive	JJ	O	positive	amod	28	SENT_124	[p6l1641t1043r1892b1115],
28	(	NN	O	(	dobj	26	SENT_124	[p6l1955t1042r2143b1112],
29	55	CD	PERCENT	55	number	30	SENT_124	[p6l1955t1042r2143b1112],
30	%	NN	PERCENT	%	amod	28	SENT_124	[p6l1955t1042r2143b1112],
31	;	:	O	;	_	0	SENT_124	[p6l1955t1042r2143b1112],
32	n	NN	O	n	dep	22	SENT_124	[p6l7t1158r46b1195],
33	=	JJ	O	=	amod	35	SENT_124	[p6l77t1165r131b1184],
34	51	CD	NUMBER	51	tmod	33	SENT_124	[p6l164t1140r283b1209],
35	)	NN	O	)	dep	32	SENT_124	[p6l164t1140r283b1209],
36	.	.	O	.	_	0	SENT_124	[p6l164t1140r283b1209],

1	The	DT	O	the	det	2	SENT_125	[p6l336t1140r459b1196],
2	GSTPI	NN	O	gstpus	nsubj	10	SENT_125	[p6l511t1140r732b1196],
3	105	CD	NUMBER	105	num	2	SENT_125	[p6l794t1140r901b1196],
4	A	DT	O	a	det	7	SENT_125	[p6l952t1140r1008b1195],
5	>	JJR	O	>	amod	7	SENT_125	[p6l1042t1151r1091b1198],
6	G	NN	O	g	nn	7	SENT_125	[p6l1124t1140r1179b1196],
7	genotype	NN	O	genotype	dep	2	SENT_125	[p6l1227t1148r1519b1212],
8	did	VBD	O	do	aux	10	SENT_125	[p6l1569t1140r1670b1196],
9	not	RB	O	not	neg	10	SENT_125	[p6l1717t1148r1819b1196],
10	correlate	VB	O	correlate	dep	16	SENT_125	[p6l1868t1140r2147b1196],
11	with	IN	O	with	_	0	SENT_125	[p6l8t1237r148b1293],
12	the	DT	O	the	det	15	SENT_125	[p6l235t1237r331b1293],
13	GSTpi	NN	MISC	gstpus	nn	15	SENT_125	[p6l420t1237r629b1310],
14	expression	NN	O	expression	nn	15	SENT_125	[p6l718t1237r1059b1310],
15	variables	NNS	O	variable	prep_with	10	SENT_125	[p6l1142t1237r1427b1293],
16	(	VBP	O	(	_	0	SENT_125	[p6l1519t1237r1696b1306],
17	-0.1	CD	NUMBER	-0.1	num	19	SENT_125	[p6l1519t1237r1696b1306],
18	<	JJR	O	<	amod	19	SENT_125	[p6l1738t1249r1787b1295],
19	rs	NNS	O	r	nsubj	20	SENT_125	[p6l1820t1255r1867b1307],
20	<	JJR	O	<	xcomp	16	SENT_125	[p6l1902t1249r1952b1295],
21	0.05	CD	NUMBER	0.05	nsubj	16	SENT_125	[p6l1987t1237r2143b1303],
22	;	:	O	;	_	0	SENT_125	[p6l1987t1237r2143b1303],
23	P	NN	O	p	dep	21	SENT_125	[p6l6t1338r55b1391],
24	2	CD	NUMBER	2	number	25	SENT_125	[p6l89t1339r138b1403],
25	0.48	CD	NUMBER	0.48	num	26	SENT_125	[p6l172t1336r353b1405],
26	)	NN	O	)	dep	23	SENT_125	[p6l172t1336r353b1405],
27	.	.	O	.	_	0	SENT_125	[p6l172t1336r353b1405],

1	GSTP1	NN	O	gstp1	_	0	SENT_126	[p6l1199t1480r1319b1509],
2	and	CC	O	and	_	0	SENT_126	[p6l1332t1480r1394b1508],
3	Ototoxicity	NN	O	ototoxicity	conj_and	1	SENT_126	[p6l1407t1480r1594b1516],
4	in	IN	O	in	_	0	SENT_126	[p6l1605t1480r1637b1508],
5	Medulloblastoma	NN	O	medulloblastoma	prep_in	1	SENT_126	[p6l1649t1480r1942b1508],
6	595	CD	NUMBER	595	num	5	SENT_126	[p6l2043t1480r2100b1508],

1	TABLE	NN	O	table	nn	2	SENT_127	[p6l59t1566r174b1591],
2	I.	NN	O	i.	_	0	SENT_127	[p6l187t1566r208b1591],
3	Clinical	JJ	O	clinical	amod	4	SENT_127	[p6l228t1566r344b1592],
4	Data	NNS	O	datum	dep	2	SENT_127	[p6l357t1566r429b1591],
5	for	IN	O	for	_	0	SENT_127	[p6l442t1566r486b1591],
6	Study	NN	O	study	nn	7	SENT_127	[p6l499t1566r586b1598],
7	Patients	NNS	O	patient	prep_for	4	SENT_127	[p6l599t1566r720b1591],

1	Study	NNP	O	Study	_	0	SENT_128	[p6l10t1836r265b1936],
2	subset	NN	O	subset	dep	1	SENT_128	[p6l303t1836r577b1914],

1	Genotyping	VBG	O	genotype	_	0	SENT_129	[p6l121t1968r644b2070],
2	86	CD	NUMBER	86	num	4	SENT_129	[p6l2026t1968r2129b2046],
3	IHC	NNP	ORGANIZATION	IHC	nn	4	SENT_129	[p6l119t2098r306b2177],
4	staining	NN	O	staining	nsubj	6	SENT_129	[p6l345t2098r693b2200],
5	51	CD	NUMBER	51	num	6	SENT_129	[p6l2023t2098r2120b2177],
6	Overlap	NN	O	overlap	xcomp	1	SENT_129	[p6l121t2232r476b2332],
7	32	CD	NUMBER	32	dep	6	SENT_129	[p6l2024t2232r2129b2310],

1	Gender	NN	O	gender	_	0	SENT_130	[p6l9t2364r336b2442],

1	Male	JJ	O	male	_	0	SENT_131	[p6l118t2495r346b2573],
2	74	CD	NUMBER	74	tmod	1	SENT_131	[p6l2022t2495r2129b2573],
3	Female	JJ	O	female	dep	1	SENT_131	[p6l118t2626r447b2704],
4	32	CD	NUMBER	32	tmod	3	SENT_131	[p6l2024t2627r2129b2705],

1	Race/ethnicity	NN	O	race/ethnicity	_	0	SENT_132	[p6l7t2759r654b2861],

1	Non	NNP	O	Non	_	0	SENT_133	[p6l118t2889r743b2991],
2	.	.	O	.	_	0	SENT_133	[p6l118t2889r743b2991],

1	—	NN	O	—	_	0	SENT_134	[p6l118t2889r743b2991],
2	.	.	O	.	_	0	SENT_134	[p6l118t2889r743b2991],

1	Hispanic	JJ	MISC	hispanic	_	0	SENT_135	[p6l118t2889r743b2991],
2	white	JJ	O	white	amod	3	SENT_135	[p6l779t2889r1025b2968],
3	47	CD	NUMBER	47	dep	1	SENT_135	[p6l2021t2889r2126b2967],
4	Hispanic	JJ	O	hispanic	amod	3	SENT_135	[p6l120t3021r512b3123],
5	37	CD	NUMBER	37	tmod	4	SENT_135	[p6l2024t3022r2126b3101],
6	Other	JJ	O	other	amod	7	SENT_135	[p6l121t3155r374b3233],
7	22	CD	NUMBER	22	dep	1	SENT_135	[p6l2023t3155r2129b3232],

1	Disease	NN	O	disease	_	0	SENT_136	[p6l7t3286r352b3364],

1	Medulloblastoma	NN	O	medulloblastoma	_	0	SENT_137	[p6l118t3417r904b3495],
2	97	CD	NUMBER	97	dep	1	SENT_137	[p6l2023t3418r2126b3496],
3	PNET	NNP	O	PNET	dep	1	SENT_137	[p6l118t3551r396b3627],
4	9	CD	NUMBER	9	num	3	SENT_137	[p6l2051t3550r2099b3628],

1	Risk	NN	O	risk	_	0	SENT_138	[p6l7t3681r212b3759],

1	High	JJ	O	high	dep	3	SENT_139	[p7l119t33r341b135],
2	Average	JJ	O	average	dep	1	SENT_139	[p7l118t167r488b267],
3	Unknown	JJ	O	unknown	_	0	SENT_139	[p7l118t299r555b377],

1	Radiation	NNP	O	Radiation	_	0	SENT_140	[p7l7t430r442b508],
2	dose	NN	O	dose	dep	1	SENT_140	[p7l477t430r677b508],

1	High	JJ	O	high	amod	2	SENT_141	[p7l120t561r341b663],
2	Low	JJ	O	low	dep	6	SENT_141	[p7l118t696r319b772],
3	Focal	JJ	O	focal	amod	5	SENT_141	[p7l118t826r365b904],
4	only	RB	O	only	advmod	5	SENT_141	[p7l399t826r594b928],
5	None	NN	O	none	dep	2	SENT_141	[p7l118t959r358b1035],
6	Unknown	JJ	O	unknown	_	0	SENT_141	[p7l118t1090r555b1168],

1	Chemotherapy	NN	O	chemotherapy	_	0	SENT_142	[p7l8t1220r665b1322],

1	SJMB/CCG-A	JJ	O	sjmb/ccg-a	amod	4	SENT_143	[p7l123t1352r988b1431],
2	9961	CD	NUMBER	9961	num	4	SENT_143	[p7l123t1352r988b1431],
3	Other	JJ	O	other	amod	4	SENT_143	[p7l121t1483r374b1563],
4	regimen	NNS	O	regimen	_	0	SENT_143	[p7l404t1483r770b1585],
5	None	NN	O	none	dep	4	SENT_143	[p7l118t1618r358b1695],

1	NA	NNP	O	NA	nn	3	SENT_144	[p7l7t3211r121b3267],
2	NA	NNP	O	NA	nn	3	SENT_144	[p7l7t3306r121b3363],
3	NA	NNP	O	NA	_	0	SENT_144	[p7l7t3402r121b3459],

1	NA	NNP	O	NA	nn	3	SENT_145	[p7l1997t34r2153b111],
2	NA	NNP	O	NA	nn	3	SENT_145	[p7l1997t167r2153b244],
3	NA	NNP	O	NA	_	0	SENT_145	[p7l1997t299r2153b377],

1	rdtpb	NN	O	rdtpb	_	0	SENT_146	[p7l2051t826r2096b1167],
2	.	.	O	.	_	0	SENT_146	[p7l2051t826r2096b1167],
3	)	SYM	O	)	dep	1	SENT_146	[p7l2051t826r2096b1167],

1	ONUJ	NN	O	onuj	_	0	SENT_147	[p7l2074t3210r2110b3363],
2	!	.	O	!	_	0	SENT_147	[p7l2117t3211r2150b3458],

1	.	.	O	.	_	0	SENT_148	[p7l2117t3211r2150b3458],

1	—	NN	O	—	_	0	SENT_149	[p7l2117t3211r2150b3458],
2	.	.	O	.	_	0	SENT_149	[p7l2117t3211r2150b3458],

1	*	NN	O	*	_	0	SENT_150	[p7l2117t3211r2150b3458],
2	I	NN	O	i	dep	1	SENT_150	[p7l2117t3211r2150b3458],
3	.	.	O	.	_	0	SENT_150	[p7l2117t3211r2150b3458],

1	—	NN	O	—	_	0	SENT_151	[p7l2117t3211r2150b3458],
2	.	.	O	.	_	0	SENT_151	[p7l2117t3211r2150b3458],

1	KOo	SYM	O	koo	_	0	SENT_152	[p7l2117t3211r2150b3458],

1	IHC	NNP	ORGANIZATION	IHC	_	0	SENT_153	[p8l59t712r126b741],
2	,	,	O	,	_	0	SENT_153	[p8l59t712r126b741],
3	immunohistochemistry	NN	O	immunohistochemistry	appos	1	SENT_153	[p8l140t712r474b744],
4	;	:	O	;	_	0	SENT_153	[p8l140t712r474b744],
5	PNET	NNP	O	PNET	dep	1	SENT_153	[p8l487t713r579b741],
6	,	,	O	,	_	0	SENT_153	[p8l487t713r579b741],
7	primitive	JJ	O	primitive	amod	9	SENT_153	[p8l593t712r721b744],
8	neuroectodermal	JJ	O	neuroectodermal	amod	9	SENT_153	[p8l734t712r970b737],
9	tumor	NN	O	tumor	appos	5	SENT_153	[p8l983t716r1072b737],
10	.	.	O	.	_	0	SENT_153	[p8l983t716r1072b737],

1	Craniospinal	JJ	O	craniospinal	amod	3	SENT_154	[p8l1087t712r1266b744],
2	radiation	NN	O	radiation	nn	3	SENT_154	[p8l1278t712r1404b737],
3	dose	NN	O	dose	_	0	SENT_154	[p8l1417t712r1487b737],
4	:	:	O	:	_	0	SENT_154	[p8l1417t712r1487b737],
5	high	JJ	O	high	advmod	3	SENT_154	[p8l1502t712r1572b744],
6	,	,	O	,	_	0	SENT_154	[p8l1502t712r1572b744],
7	34.2-39	CD	NUMBER	34.2-39	num	9	SENT_154	[p8l1586t712r1725b737],
8	.6	CD	NUMBER	.6	num	9	SENT_154	[p8l1586t712r1725b737],
9	Gy	NN	O	gy	appos	3	SENT_154	[p8l1739t712r1780b744],
10	(	CD	NUMBER	(	num	11	SENT_154	[p8l1794t712r1908b742],
11	median	NN	O	median	dep	9	SENT_154	[p8l1794t712r1908b742],
12	36	CD	NUMBER	36	num	14	SENT_154	[p8l1921t712r1954b737],
13	Gy	NN	O	gy	nn	14	SENT_154	[p8l1968t712r2029b744],
14	)	NN	O	)	dep	11	SENT_154	[p8l1968t712r2029b744],
15	,	,	O	,	_	0	SENT_154	[p8l1968t712r2029b744],
16	low	JJ	O	low	advmod	11	SENT_154	[p8l2043t712r2099b741],
17	,	,	O	,	_	0	SENT_154	[p8l2043t712r2099b741],
18	18	CD	NUMBER	18	appos	3	SENT_154	[p8l62t755r172b780],
19	—	CD	NUMBER	—	number	20	SENT_154	[p8l62t755r172b780],
20	25.2	CD	NUMBER	25.2	num	21	SENT_154	[p8l62t755r172b780],
21	Gy	NN	O	gy	nsubj	23	SENT_154	[p8l185t755r227b787],
22	(	CD	NUMBER	(	num	23	SENT_154	[p8l242t755r355b786],
23	median	NN	O	median	rcmod	18	SENT_154	[p8l242t755r355b786],
24	23.4	CD	NUMBER	23.4	num	26	SENT_154	[p8l370t755r430b780],
25	Gy	NN	O	gy	nn	26	SENT_154	[p8l443t755r505b787],
26	)	NN	O	)	dep	23	SENT_154	[p8l443t755r505b787],
27	;	:	O	;	_	0	SENT_154	[p8l443t755r505b787],
28	Chemotherapy	NNP	O	Chemotherapy	dep	23	SENT_154	[p8l520t755r727b787],
29	(	CD	NUMBER	(	num	28	SENT_154	[p8l741t755r825b785],
30	other	JJ	O	other	amod	31	SENT_154	[p8l741t755r825b785],
31	regimen	NNS	O	regimen	nsubj	32	SENT_154	[p8l837t755r972b787],
32	)	VBP	O	)	rcmod	28	SENT_154	[p8l837t755r972b787],
33	,	,	O	,	_	0	SENT_154	[p8l837t755r972b787],
34	non-SJMB96	JJ	O	non-sjmb96	amod	40	SENT_154	[p8l986t755r1216b780],
35	/	:	O	/	punct	36	SENT_154	[p8l986t755r1216b780],
36	03	CD	NUMBER	03	dep	34	SENT_154	[p8l986t755r1216b780],
37	and	CC	O	and	_	0	SENT_154	[p8l1232t755r1282b780],
38	non-CCG-A9961	NN	O	non-ccg-a9961	nn	39	SENT_154	[p8l1295t755r1535b780],
39	treatment	NN	O	treatment	dep	34	SENT_154	[p8l1552t759r1686b780],
40	regimen	NN	O	regimen	dobj	23	SENT_154	[p8l1698t755r1821b787],
41	.	.	O	.	_	0	SENT_154	[p8l1698t755r1821b787],

1	Su	FW	O	su	nn	2	SENT_155	[p8l10t953r96b1018],
2	rvlval	FW	O	rvlval	_	0	SENT_155	[p8l106t949r314b1018],

1	Survival	NN	O	survival	nsubjpass	3	SENT_156	[p8l117t1106r378b1163],
2	was	VBD	O	be	auxpass	3	SENT_156	[p8l422t1124r541b1162],
3	assessed	VBN	O	assess	_	0	SENT_156	[p8l587t1106r853b1162],
4	by	IN	O	by	_	0	SENT_156	[p8l894t1106r973b1179],
5	age	NN	O	age	nn	8	SENT_156	[p8l1017t1124r1123b1179],
6	and	CC	O	and	_	0	SENT_156	[p8l1169t1106r1282b1162],
7	risk	NN	O	risk	conj_and	5	SENT_156	[p8l1322t1106r1442b1162],
8	grouping	NN	O	grouping	agent	3	SENT_156	[p8l1484t1106r1767b1179],
9	(	CD	NUMBER	(	num	12	SENT_156	[p8l1813t1106r2010b1175],
10	Table	NNP	O	Table	nn	12	SENT_156	[p8l1813t1106r2010b1175],
11	II	NNP	O	II	nn	12	SENT_156	[p8l2054t1107r2147b1175],
12	)	NN	O	)	dep	8	SENT_156	[p8l2054t1107r2147b1175],
13	.	.	O	.	_	0	SENT_156	[p8l2054t1107r2147b1175],

1	Eighty-six	CD	NUMBER	eighty-six	num	2	SENT_157	[p8l7t1204r337b1276],
2	patients	NNS	O	patient	nsubj	7	SENT_157	[p8l369t1204r615b1276],
3	were	VBD	O	be	cop	7	SENT_157	[p8l650t1222r802b1260],
4	at	IN	DURATION	at	quantmod	6	SENT_157	[p8l837t1213r893b1260],
5	least	JJS	DURATION	least	mwe	4	SENT_157	[p8l926t1204r1072b1260],
6	3	CD	DURATION	3	num	7	SENT_157	[p8l1106t1204r1138b1260],
7	years	NNS	NUMBER	year	_	0	SENT_157	[p8l1176t1222r1340b1276],
8	of	IN	O	of	_	0	SENT_157	[p8l1376t1204r1446b1260],
9	age	NN	O	age	prep_of	7	SENT_157	[p8l1475t1222r1583b1276],
10	at	IN	O	at	_	0	SENT_157	[p8l1618t1212r1674b1260],
11	diagnosis	NN	O	diagnosis	prep_at	9	SENT_157	[p8l1706t1204r2002b1276],
12	and	CC	O	and	_	0	SENT_157	[p8l2039t1204r2152b1260],
13	20	CD	NUMBER	20	nsubj	18	SENT_157	[p8l8t1301r85b1357],
14	were	VBD	O	be	cop	18	SENT_157	[p8l111t1319r264b1357],
15	less	JJR	DURATION	less	mwe	16	SENT_157	[p8l290t1301r406b1357],
16	than	IN	DURATION	than	quantmod	17	SENT_157	[p8l433t1301r569b1357],
17	3	CD	DURATION	3	num	18	SENT_157	[p8l597t1301r628b1357],
18	years	NNS	NUMBER	year	conj_and	7	SENT_157	[p8l658t1319r840b1374],
19	.	.	O	.	_	0	SENT_157	[p8l658t1319r840b1374],

1	Those	DT	O	those	det	2	SENT_158	[p8l870t1301r1062b1357],
2	younger	JJR	O	younger	nsubj	6	SENT_158	[p8l1088t1319r1349b1374],
3	than	IN	O	than	_	0	SENT_158	[p8l1372t1301r1508b1357],
4	3	CD	DURATION	3	num	5	SENT_158	[p8l1536t1301r1568b1357],
5	years	NNS	NUMBER	year	prep_than	2	SENT_158	[p8l1598t1319r1762b1374],
6	had	VBD	O	have	_	0	SENT_158	[p8l1789t1301r1903b1357],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_158	[p8l1931t1301r2148b1374, p8l8t1397r199b1470],
8	worse	JJR	O	worse	amod	10	SENT_158	[p8l228t1415r415b1453],
9	5-year	JJ	DURATION	5-year	amod	10	SENT_158	[p8l444t1397r646b1470],
10	PFS	NN	O	pf	dobj	6	SENT_158	[p8l671t1398r819b1464],
11	,	,	O	,	_	0	SENT_158	[p8l671t1398r819b1464],
12	but	CC	O	but	_	0	SENT_158	[p8l848t1397r949b1453],
13	not	RB	O	not	advmod	10	SENT_158	[p8l975t1406r1076b1453],
14	5-year	JJ	DURATION	5-year	amod	15	SENT_158	[p8l1104t1397r1305b1470],
15	OS	NN	O	os	pobj	13	SENT_158	[p8l1333t1398r1428b1454],
16	(	NN	O	(	nn	17	SENT_158	[p8l1461t1398r1533b1466],
17	P	NN	O	p	conj_but	10	SENT_158	[p8l1461t1398r1533b1466],
18	=	JJ	O	=	amod	17	SENT_158	[p8l1564t1423r1618b1442],
19	0.001	CD	NUMBER	0.001	tmod	18	SENT_158	[p8l1649t1398r1819b1454],
20	and	CC	O	and	_	0	SENT_158	[p8l1855t1397r1968b1453],
21	0.12	CD	NUMBER	0.12	conj_and	19	SENT_158	[p8l1995t1398r2148b1464],
22	,	,	O	,	_	0	SENT_158	[p8l1995t1398r2148b1464],
23	respectively	RB	O	respectively	advmod	24	SENT_158	[p8l6t1494r430b1567],
24	)	CD	NUMBER	)	rcmod	17	SENT_158	[p8l6t1494r430b1567],
25	.	.	O	.	_	0	SENT_158	[p8l6t1494r430b1567],

1	For	IN	O	for	_	0	SENT_159	[p8l468t1496r577b1550],
2	risk	NN	O	risk	nn	3	SENT_159	[p8l609t1494r729b1550],
3	grouping	NN	O	grouping	prep_for	10	SENT_159	[p8l763t1494r1064b1567],
4	,	,	O	,	_	0	SENT_159	[p8l763t1494r1064b1567],
5	the	DT	O	the	det	7	SENT_159	[p8l1101t1495r1196b1550],
6	5-year	JJ	DURATION	5-year	amod	7	SENT_159	[p8l1233t1494r1435b1567],
7	PFS	NN	O	pf	nsubj	10	SENT_159	[p8l1468t1495r1596b1551],
8	and	CC	O	and	_	0	SENT_159	[p8l1635t1495r1748b1550],
9	OS	NN	O	os	nsubj	10	SENT_159	[p8l1783t1495r1878b1551],
10	did	VBD	O	do	_	0	SENT_159	[p8l1917t1494r2017b1550],
11	not	RB	O	not	neg	12	SENT_159	[p8l2051t1503r2151b1550],
12	signiﬁcantly	JJ	O	signiﬁcantly	nsubj	13	SENT_159	[p8l10t1592r398b1665],
13	differ	VBP	O	differ	ccomp	10	SENT_159	[p8l439t1592r612b1648],
14	between	IN	O	between	_	0	SENT_159	[p8l651t1592r916b1648],
15	high-risk	JJ	O	high-risk	amod	17	SENT_159	[p8l955t1592r1242b1665],
16	(	NN	O	(	nn	17	SENT_159	[p8l1284t1593r1346b1661],
17	n	NN	O	n	prep_between	13	SENT_159	[p8l1284t1593r1346b1661],
18	=	JJ	O	=	amod	20	SENT_159	[p8l1377t1617r1431b1636],
19	33	CD	NUMBER	33	tmod	18	SENT_159	[p8l1465t1592r1564b1661],
20	)	NN	O	)	dobj	13	SENT_159	[p8l1465t1592r1564b1661],
21	and	CC	O	and	_	0	SENT_159	[p8l1609t1592r1721b1648],
22	average-risk	JJ	O	average-risk	amod	24	SENT_159	[p8l1763t1592r2153b1665],
23	(	NN	O	(	nn	24	SENT_159	[p8l10t1689r72b1757],
24	n	NN	O	n	conj_and	20	SENT_159	[p8l10t1689r72b1757],
25	:	:	O	:	_	0	SENT_159	[p8l103t1714r157b1733],
26	52	CD	NUMBER	52	num	28	SENT_159	[p8l190t1688r290b1757],
27	)	NN	O	)	nn	28	SENT_159	[p8l190t1688r290b1757],
28	categories	NNS	O	category	dep	24	SENT_159	[p8l319t1688r637b1761],
29	(	VBP	O	(	dep	28	SENT_159	[p8l667t1689r738b1757],
30	P	NN	O	p	dobj	29	SENT_159	[p8l667t1689r738b1757],
31	:	:	O	:	_	0	SENT_159	[p8l769t1714r823b1733],
32	0.22	CD	NUMBER	0.22	dep	24	SENT_159	[p8l855t1689r991b1745],
33	and	CC	O	and	_	0	SENT_159	[p8l1019t1688r1132b1744],
34	0.74	CD	NUMBER	0.74	dep	24	SENT_159	[p8l1158t1689r1310b1754],
35	,	,	O	,	_	0	SENT_159	[p8l1158t1689r1310b1754],
36	respectively	RB	O	respectively	advmod	37	SENT_159	[p8l1338t1688r1761b1761],
37	)	CD	NUMBER	)	rcmod	32	SENT_159	[p8l1338t1688r1761b1761],
38	.	.	O	.	_	0	SENT_159	[p8l1338t1688r1761b1761],

1	In	IN	O	in	_	0	SENT_160	[p8l115t1787r179b1841],
2	patients	NNS	O	patient	prep_in	11	SENT_160	[p8l214t1785r463b1858],
3	at	IN	DURATION	at	quantmod	5	SENT_160	[p8l502t1794r557b1841],
4	least	JJS	DURATION	least	mwe	3	SENT_160	[p8l593t1786r740b1841],
5	3	CD	DURATION	3	num	6	SENT_160	[p8l777t1786r808b1842],
6	years	NNS	NUMBER	year	npadvmod	2	SENT_160	[p8l848t1803r1015b1858],
7	of	IN	O	of	_	0	SENT_160	[p8l1054t1785r1123b1841],
8	age	NN	O	age	prep_of	2	SENT_160	[p8l1155t1803r1280b1858],
9	,	,	O	,	_	0	SENT_160	[p8l1155t1803r1280b1858],
10	there	EX	O	there	expl	11	SENT_160	[p8l1319t1785r1478b1841],
11	were	VBD	O	be	_	0	SENT_160	[p8l1513t1803r1667b1842],
12	no	DT	O	no	det	14	SENT_160	[p8l1703t1803r1781b1841],
13	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_160	[p8l1820t1785r2151b1858],
14	differences	NNS	O	difference	nsubj	11	SENT_160	[p8l8t1883r360b1939],
15	in	IN	O	in	_	0	SENT_160	[p8l403t1883r465b1938],
16	PFS	NN	O	pf	prep_in	14	SENT_160	[p8l505t1884r633b1939],
17	based	VBN	O	base	_	0	SENT_160	[p8l677t1883r860b1939],
18	on	IN	O	on	prepc_based_on	16	SENT_160	[p8l902t1901r979b1939],
19	the	DT	O	the	det	20	SENT_160	[p8l1020t1883r1116b1939],
20	GSTPI	NN	O	gstpus	pobj	16	SENT_160	[p8l1161t1884r1382b1940],
21	105	CD	NUMBER	105	num	20	SENT_160	[p8l1437t1883r1544b1939],
22	A	DT	O	a	det	27	SENT_160	[p8l1589t1884r1645b1938],
23	>	JJR	O	>	dep	24	SENT_160	[p8l1679t1895r1729b1941],
24	G	NN	O	g	amod	27	SENT_160	[p8l1761t1883r1816b1939],
25	genotype	NN	O	genotype	nn	27	SENT_160	[p8l1858t1891r2150b1956],
26	(	NN	O	(	nn	27	SENT_160	[p8l10t1980r72b2048],
27	n	NN	O	n	npadvmod	16	SENT_160	[p8l10t1980r72b2048],
28	:	:	O	:	_	0	SENT_160	[p8l104t2005r158b2024],
29	68	CD	NUMBER	68	number	30	SENT_160	[p8l191t1979r293b2048],
30	)	CD	NUMBER	)	dep	27	SENT_160	[p8l191t1979r293b2048],
31	or	CC	O	or	_	0	SENT_160	[p8l329t1997r394b2035],
32	GSTpi	NN	O	gstpus	nn	33	SENT_160	[p8l426t1979r636b2052],
33	expression	NN	O	expression	npadvmod	16	SENT_160	[p8l671t1979r1012b2052],
34	(	CD	NUMBER	(	num	35	SENT_160	[p8l1046t1980r1109b2048],
35	n	NN	O	n	dep	33	SENT_160	[p8l1046t1980r1109b2048],
36	=	JJ	O	=	amod	38	SENT_160	[p8l1141t2005r1195b2024],
37	46	CD	NUMBER	46	tmod	36	SENT_160	[p8l1226t1979r1329b2048],
38	)	NN	O	)	dep	35	SENT_160	[p8l1226t1979r1329b2048],
39	in	IN	O	in	_	0	SENT_160	[p8l1365t1979r1425b2035],
40	univariate	JJ	O	univariate	amod	43	SENT_160	[p8l1457t1979r1774b2035],
41	and	CC	O	and	_	0	SENT_160	[p8l1809t1979r1923b2035],
42	multivariable	JJ	O	multivariable	amod	43	SENT_160	[p8l1955t1979r2148b2035, p8l7t2076r263b2132],
43	analyses	NNS	O	analysis	prep_in	16	SENT_160	[p8l295t2077r580b2149],
44	.	.	O	.	_	0	SENT_160	[p8l295t2077r580b2149],

1	Among	IN	O	among	_	0	SENT_161	[p8l613t2077r852b2149],
2	the	DT	O	the	det	4	SENT_161	[p8l882t2077r978b2132],
3	41	CD	NUMBER	41	num	4	SENT_161	[p8l1007t2077r1079b2132],
4	patients	NNS	O	patient	prep_among	18	SENT_161	[p8l1115t2076r1363b2149],
5	in	IN	O	in	_	0	SENT_161	[p8l1394t2076r1454b2132],
6	the	DT	O	the	det	7	SENT_161	[p8l1484t2077r1580b2132],
7	GSTPI	NN	O	gstpus	prep_in	4	SENT_161	[p8l1613t2077r1834b2133],
8	105	CD	NUMBER	105	num	7	SENT_161	[p8l1877t2076r1984b2133],
9	AG	NNP	O	AG	nsubj	18	SENT_161	[p8l2017t2077r2152b2133],
10	/	:	O	/	punct	15	SENT_161	[p8l2017t2077r2152b2133],
11	GG	NNS	O	gg	nn	12	SENT_161	[p8l8t2174r121b2230],
12	group	NN	O	group	nsubj	15	SENT_161	[p8l150t2192r352b2247],
13	,	,	O	,	_	0	SENT_161	[p8l150t2192r352b2247],
14	there	EX	O	there	expl	15	SENT_161	[p8l385t2174r544b2230],
15	were	VBD	O	be	dep	9	SENT_161	[p8l572t2192r726b2230],
16	seven	CD	NUMBER	seven	num	17	SENT_161	[p8l758t2192r934b2230],
17	progressions	NNS	O	progression	nsubj	15	SENT_161	[p8l963t2174r1366b2247],
18	(	VBP	O	(	dep	43	SENT_161	[p8l1399t2174r1629b2247],
19	5-year	JJ	DURATION	5-year	amod	20	SENT_161	[p8l1399t2174r1629b2247],
20	PFS	NN	O	pf	dobj	18	SENT_161	[p8l1657t2174r1785b2230],
21	80.7	CD	NUMBER	80.7	num	20	SENT_161	[p8l1820t2175r1973b2240],
22	,	,	O	,	_	0	SENT_161	[p8l1820t2175r1973b2240],
23	95	CD	PERCENT	95	number	24	SENT_161	[p8l2006t2174r2147b2231],
24	%	NN	PERCENT	%	amod	25	SENT_161	[p8l2006t2174r2147b2231],
25	CI	NN	O	ci	appos	20	SENT_161	[p8l8t2271r86b2327],
26	63.3-90	CD	NUMBER	63.3-90	num	28	SENT_161	[p8l114t2270r456b2339],
27	.4	CD	NUMBER	.4	num	28	SENT_161	[p8l114t2270r456b2339],
28	)	NN	O	)	dep	25	SENT_161	[p8l114t2270r456b2339],
29	and	CC	O	and	_	0	SENT_161	[p8l487t2270r600b2326],
30	in	IN	O	in	_	0	SENT_161	[p8l627t2270r688b2326],
31	the	DT	O	the	det	33	SENT_161	[p8l714t2270r810b2326],
32	27	CD	NUMBER	27	num	33	SENT_161	[p8l838t2271r913b2326],
33	patients	NNS	O	patient	prep_in	40	SENT_161	[p8l942t2270r1190b2343],
34	with	IN	O	with	_	0	SENT_161	[p8l1219t2270r1360b2326],
35	the	DT	O	the	det	37	SENT_161	[p8l1387t2270r1483b2326],
36	AA	NNP	O	AA	nn	37	SENT_161	[p8l1510t2271r1624b2326],
37	genotype	NN	O	genotype	prep_with	33	SENT_161	[p8l1651t2278r1961b2343],
38	,	,	O	,	_	0	SENT_161	[p8l1651t2278r1961b2343],
39	there	EX	O	there	expl	40	SENT_161	[p8l1991t2270r2150b2326],
40	were	VBD	O	be	dep	43	SENT_161	[p8l9t2386r162b2425],
41	two	CD	NUMBER	two	num	42	SENT_161	[p8l202t2377r319b2425],
42	progressions	NNS	O	progression	nsubj	40	SENT_161	[p8l359t2368r762b2441],
43	(	VBP	O	(	_	0	SENT_161	[p8l806t2368r1035b2441],
44	5-year	JJ	DURATION	5-year	amod	45	SENT_161	[p8l806t2368r1035b2441],
45	PFS	NN	O	pf	dobj	43	SENT_161	[p8l1073t2369r1200b2425],
46	92.2	CD	PERCENT	92.2	num	47	SENT_161	[p8l1244t2369r1466b2435],
47	%	NN	PERCENT	%	nsubj	43	SENT_161	[p8l1244t2369r1466b2435],
48	,	,	O	,	_	0	SENT_161	[p8l1244t2369r1466b2435],
49	95	CD	PERCENT	95	number	50	SENT_161	[p8l1509t2368r1650b2425],
50	%	NN	PERCENT	%	amod	51	SENT_161	[p8l1509t2368r1650b2425],
51	CI	NN	O	ci	appos	47	SENT_161	[p8l1693t2369r1770b2425],
52	72.2-98	CD	NUMBER	72.2-98	num	53	SENT_161	[p8l1810t2369r2148b2435],
53	.0	NN	NUMBER	.0	dep	51	SENT_161	[p8l1810t2369r2148b2435],
54	;	:	O	;	_	0	SENT_161	[p8l1810t2369r2148b2435],
55	P	NN	O	p	dep	51	SENT_161	[p8l7t2469r56b2522],
56	=	JJ	O	=	amod	58	SENT_161	[p8l88t2492r142b2511],
57	0.38	CD	NUMBER	0.38	tmod	56	SENT_161	[p8l174t2467r355b2536],
58	)	NN	O	)	dep	55	SENT_161	[p8l174t2467r355b2536],
59	.	.	O	.	_	0	SENT_161	[p8l174t2467r355b2536],

1	Toxicities	NNS	O	toxicity	_	0	SENT_162	[p8l9t2641r378b2709],

1	In	IN	O	in	_	0	SENT_163	[p8l116t2807r181b2861],
2	univariate	JJ	O	univariate	amod	3	SENT_163	[p8l212t2805r529b2861],
3	analyses	NNS	O	analysis	prep_in	19	SENT_163	[p8l564t2805r850b2878],
4	,	,	O	,	_	0	SENT_163	[p8l564t2805r850b2878],
5	only	RB	O	only	advmod	7	SENT_163	[p8l887t2805r1026b2878],
6	the	DT	O	the	det	7	SENT_163	[p8l1059t2805r1155b2861],
7	GSTPI	NN	O	gstpus	nsubjpass	19	SENT_163	[p8l1190t2806r1411b2862],
8	105	CD	NUMBER	105	dep	7	SENT_163	[p8l1457t2805r1564b2862],
9	A	DT	O	a	det	12	SENT_163	[p8l1599t2806r1656b2861],
10	>	JJR	O	>	amod	12	SENT_163	[p8l1690t2817r1739b2863],
11	G	NN	O	g	nn	12	SENT_163	[p8l1772t2806r1827b2862],
12	genotype	NN	O	genotype	dep	7	SENT_163	[p8l1859t2814r2151b2878],
13	and	CC	O	and	_	0	SENT_163	[p8l10t2902r123b2958],
14	craniospinal	JJ	O	craniospinal	amod	16	SENT_163	[p8l150t2902r541b2975],
15	radiation	NN	O	radiation	nn	16	SENT_163	[p8l568t2902r854b2958],
16	dose	NN	O	dose	conj_and	12	SENT_163	[p8l881t2902r1025b2958],
17	were	VBD	O	be	auxpass	19	SENT_163	[p8l1051t2920r1205b2959],
18	signiﬁcantly	RB	O	signiﬁcantly	advmod	19	SENT_163	[p8l1234t2902r1628b2975],
19	associated	VBN	O	associate	_	0	SENT_163	[p8l1656t2902r1984b2958],
20	with	IN	O	with	_	0	SENT_163	[p8l2011t2902r2152b2959],
21	hearing	NN	O	hearing	nn	22	SENT_163	[p8l8t3000r247b3072],
22	loss	NN	O	loss	prep_with	19	SENT_163	[p8l279t3000r400b3056],
23	requiring	VBG	O	require	xcomp	19	SENT_163	[p8l431t3000r724b3072],
24	hearing	NN	O	hearing	nn	25	SENT_163	[p8l755t3000r995b3072],
25	aids	NNS	O	aid	nsubj	26	SENT_163	[p8l1029t3000r1153b3056],
26	(	VBP	O	(	ccomp	23	SENT_163	[p8l1187t3000r1250b3069],
27	n	NN	O	n	dobj	26	SENT_163	[p8l1187t3000r1250b3069],
28	=	JJ	O	=	advmod	26	SENT_163	[p8l1282t3025r1336b3044],
29	69	CD	NUMBER	69	num	30	SENT_163	[p8l1369t3000r1489b3069],
30	)	NN	O	)	dep	28	SENT_163	[p8l1369t3000r1489b3069],
31	.	.	O	.	_	0	SENT_163	[p8l1369t3000r1489b3069],

1	When	WRB	O	when	advmod	2	SENT_164	[p8l1522t3000r1714b3056],
2	compared	VBN	O	compare	advcl	32	SENT_164	[p8l1745t3000r2061b3072],
3	to	TO	O	to	_	0	SENT_164	[p8l2091t3008r2151b3056],
4	patients	NNS	O	patient	prep_to	2	SENT_164	[p8l7t3096r256b3169],
5	with	IN	O	with	_	0	SENT_164	[p8l296t3096r437b3152],
6	the	DT	O	the	det	10	SENT_164	[p8l475t3096r571b3152],
7	AA	NNP	O	AA	nn	10	SENT_164	[p8l610t3097r724b3152],
8	genotype	NN	O	genotype	nn	10	SENT_164	[p8l763t3104r1054b3169],
9	(	NN	O	(	nn	10	SENT_164	[p8l1096t3097r1158b3166],
10	n	NN	O	n	prep_with	4	SENT_164	[p8l1096t3097r1158b3166],
11	=	JJ	O	=	amod	13	SENT_164	[p8l1190t3122r1244b3141],
12	24	CD	NUMBER	24	tmod	11	SENT_164	[p8l1277t3097r1398b3165],
13	)	NN	O	)	dobj	2	SENT_164	[p8l1277t3097r1398b3165],
14	,	,	O	,	_	0	SENT_164	[p8l1277t3097r1398b3165],
15	patients	NNS	O	patient	nsubj	32	SENT_164	[p8l1438t3096r1687b3169],
16	with	IN	O	with	_	0	SENT_164	[p8l1727t3096r1868b3152],
17	the	DT	O	the	det	20	SENT_164	[p8l1906t3096r2002b3152],
18	AG	NNP	O	AG	nn	20	SENT_164	[p8l2041t3097r2152b3153],
19	(	NN	O	(	nn	20	SENT_164	[p8l11t3194r73b3263],
20	n	NN	O	n	prep_with	15	SENT_164	[p8l11t3194r73b3263],
21	:	:	O	:	_	0	SENT_164	[p8l106t3219r160b3238],
22	30	CD	NUMBER	30	num	23	SENT_164	[p8l193t3194r294b3262],
23	)	NN	O	)	dep	15	SENT_164	[p8l193t3194r294b3262],
24	and	CC	O	and	_	0	SENT_164	[p8l328t3194r441b3249],
25	GG	NNS	O	gg	dep	15	SENT_164	[p8l470t3194r583b3250],
26	(	CD	NUMBER	(	num	27	SENT_164	[p8l614t3194r677b3262],
27	n	NN	O	n	dep	25	SENT_164	[p8l614t3194r677b3262],
28	=	JJ	O	=	amod	31	SENT_164	[p8l709t3219r763b3238],
29	15	CD	NUMBER	15	num	31	SENT_164	[p8l802t3193r897b3263],
30	)	CD	NUMBER	)	num	31	SENT_164	[p8l802t3193r897b3263],
31	genotypes	NNS	O	genotype	dep	15	SENT_164	[p8l930t3202r1252b3266],
32	had	VBD	O	have	_	0	SENT_164	[p8l1282t3193r1397b3249],
33	greater	JJR	O	greater	amod	34	SENT_164	[p8l1427t3202r1649b3266],
34	risks	NNS	O	risk	dobj	32	SENT_164	[p8l1677t3193r1826b3249],
35	of	IN	O	of	_	0	SENT_164	[p8l1858t3193r1927b3249],
36	severe	JJ	O	severe	amod	39	SENT_164	[p8l1954t3211r2152b3250],
37	ototoxicity	NN	O	ototoxicity	nn	39	SENT_164	[p8l9t3291r356b3363],
38	(	CD	NUMBER	(	num	39	SENT_164	[p8l392t3291r714b3360],
39	ORAG	NN	O	orag	prep_of	34	SENT_164	[p8l392t3291r714b3360],
40	,	,	O	,	_	0	SENT_164	[p8l392t3291r714b3360],
41	AA	NN	O	aa	appos	34	SENT_164	[p8l392t3291r714b3360],
42	3.8	CD	NUMBER	3.8	dep	41	SENT_164	[p8l750t3291r863b3357],
43	,	,	O	,	_	0	SENT_164	[p8l750t3291r863b3357],
44	95	CD	PERCENT	95	number	45	SENT_164	[p8l900t3290r1040b3347],
45	%	NN	PERCENT	%	amod	46	SENT_164	[p8l900t3290r1040b3347],
46	CI	NN	O	ci	appos	34	SENT_164	[p8l1077t3291r1155b3347],
47	1.0	CD	NUMBER	1.0	number	48	SENT_164	[p8l1195t3291r1486b3357],
48	—	CD	NUMBER	—	num	49	SENT_164	[p8l1195t3291r1486b3357],
49	14.9	CD	NUMBER	14.9	dep	46	SENT_164	[p8l1195t3291r1486b3357],
50	;	:	O	;	_	0	SENT_164	[p8l1195t3291r1486b3357],
51	ORGG	NNP	O	ORGG	dep	34	SENT_164	[p8l1524t3291r1823b3360],
52	,	,	O	,	_	0	SENT_164	[p8l1524t3291r1823b3360],
53	AA	NNP	O	AA	appos	51	SENT_164	[p8l1524t3291r1823b3360],
54	4.4	CD	NUMBER	4.4	num	53	SENT_164	[p8l1855t3291r1971b3357],
55	,	,	O	,	_	0	SENT_164	[p8l1855t3291r1971b3357],
56	95	CD	PERCENT	95	num	57	SENT_164	[p8l2008t3290r2148b3348],
57	%	NN	PERCENT	%	appos	34	SENT_164	[p8l2008t3290r2148b3348],
58	CI	NN	O	ci	dep	57	SENT_164	[p8l9t3388r86b3444],
59	0.9	CD	NUMBER	0.9	num	58	SENT_164	[p8l112t3388r408b3454],
60	—	CD	NUMBER	—	number	61	SENT_164	[p8l112t3388r408b3454],
61	21.3	CD	NUMBER	21.3	dep	58	SENT_164	[p8l112t3388r408b3454],
62	,	,	O	,	_	0	SENT_164	[p8l112t3388r408b3454],
63	P	NN	O	p	appos	34	SENT_164	[p8l434t3389r483b3443],
64	=	JJ	O	=	amod	63	SENT_164	[p8l515t3413r569b3432],
65	0.04	CD	NUMBER	0.04	tmod	64	SENT_164	[p8l601t3388r758b3453],
66	;	:	O	;	_	0	SENT_164	[p8l601t3388r758b3453],
67	Fig	NN	O	fig	dep	63	SENT_164	[p8l786t3387r907b3460],
68	.	.	O	.	_	0	SENT_164	[p8l786t3387r907b3460],

1	1	CD	NUMBER	1	_	0	SENT_165	[p8l944t3388r1017b3456],
2	)	NN	O	)	dep	1	SENT_165	[p8l944t3388r1017b3456],
3	.	.	O	.	_	0	SENT_165	[p8l944t3388r1017b3456],

1	With	IN	O	with	_	0	SENT_166	[p8l1045t3387r1203b3443],
2	dominant	JJ	O	dominant	amod	3	SENT_166	[p8l1228t3387r1531b3443],
3	modeling	NN	O	modeling	prep_with	10	SENT_166	[p8l1555t3387r1875b3460],
4	,	,	O	,	_	0	SENT_166	[p8l1555t3387r1875b3460],
5	patients	NNS	O	patient	nsubj	10	SENT_166	[p8l1902t3387r2150b3460],
6	in	IN	O	in	_	0	SENT_166	[p8l8t3484r69b3540],
7	the	DT	O	the	det	9	SENT_166	[p8l109t3484r205b3540],
8	AG/GG	NNP	O	AG/GG	nn	9	SENT_166	[p8l247t3485r497b3541],
9	group	NN	O	group	prep_in	5	SENT_166	[p8l538t3502r721b3557],
10	had	VBD	O	have	_	0	SENT_166	[p8l762t3484r877b3540],
11	a	DT	O	a	det	13	SENT_166	[p8l919t3502r952b3540],
12	greater	JJR	O	greater	amod	13	SENT_166	[p8l993t3493r1216b3557],
13	risk	NN	O	risk	dobj	10	SENT_166	[p8l1254t3484r1375b3540],
14	of	IN	O	of	_	0	SENT_166	[p8l1415t3484r1484b3540],
15	severe	JJ	O	severe	amod	17	SENT_166	[p8l1522t3502r1720b3541],
16	hearing	NN	O	hearing	nn	17	SENT_166	[p8l1761t3484r2000b3557],
17	impairment	NN	O	impairment	prep_of	13	SENT_166	[p8l2042t3484r2149b3540, p8l7t3582r294b3654],
18	when	WRB	O	when	dep	17	SENT_166	[p8l325t3582r497b3638],
19	compared	VBN	O	compare	_	0	SENT_166	[p8l528t3582r844b3654],
20	to	TO	O	to	prepc_compared_to	10	SENT_166	[p8l875t3590r935b3638],
21	patients	NNS	O	patient	pobj	10	SENT_166	[p8l965t3582r1214b3654],
22	with	IN	O	with	_	0	SENT_166	[p8l1247t3582r1388b3638],
23	the	DT	O	the	det	25	SENT_166	[p8l1419t3582r1515b3638],
24	AA	NN	O	aa	nn	25	SENT_166	[p8l1547t3582r1660b3637],
25	genotype	NN	O	genotype	prep_with	21	SENT_166	[p8l1692t3590r1984b3654],
26	(	CD	NUMBER	(	num	27	SENT_166	[p8l2018t3582r2152b3651],
27	OR	NN	O	or	dep	34	SENT_166	[p8l2018t3582r2152b3651],
28	4.0	CD	NUMBER	4.0	dep	27	SENT_166	[p8l8t3679r124b3745],
29	,	,	O	,	_	0	SENT_166	[p8l8t3679r124b3745],
30	95	CD	PERCENT	95	num	31	SENT_166	[p8l173t3678r313b3735],
31	%	NN	PERCENT	%	appos	28	SENT_166	[p8l173t3678r313b3735],
32	CI	NN	O	ci	dep	34	SENT_166	[p8l362t3679r440b3735],
33	1.2	CD	NUMBER	1.2	num	32	SENT_166	[p8l493t3678r781b3745],
34	—	NN	O	—	dep	21	SENT_166	[p8l493t3678r781b3745],
35	13.6	CD	NUMBER	13.6	dep	34	SENT_166	[p8l493t3678r781b3745],
36	,	,	O	,	_	0	SENT_166	[p8l493t3678r781b3745],
37	P	NN	O	p	appos	35	SENT_166	[p8l828t3681r877b3734],
38	=	JJ	O	=	amod	21	SENT_166	[p8l908t3704r962b3723],
39	0.03	CD	NUMBER	0.03	tmod	38	SENT_166	[p8l995t3679r1152b3745],
40	;	:	O	;	_	0	SENT_166	[p8l995t3679r1152b3745],
41	Fig	NN	O	fig	dep	21	SENT_166	[p8l1200t3678r1321b3751],
42	.	.	O	.	_	0	SENT_166	[p8l1200t3678r1321b3751],

1	2	CD	NUMBER	2	num	2	SENT_167	[p8l1371t3679r1451b3748],
2	)	CD	NUMBER	)	_	0	SENT_167	[p8l1371t3679r1451b3748],
3	.	.	O	.	_	0	SENT_167	[p8l1371t3679r1451b3748],

1	Compared	VBN	O	compare	_	0	SENT_168	[p8l1501t3679r1834b3751],
2	to	TO	O	to	pcomp	1	SENT_168	[p8l1878t3687r1938b3734],
3	those	DT	O	those	pobj	2	SENT_168	[p8l1984t3679r2151b3734],

1	TABLE	NN	O	table	_	0	SENT_169	[p9l59t44r174b69],
2	II	CD	NUMBER	ii	dep	1	SENT_169	[p9l187t44r221b69],
3	.	.	O	.	_	0	SENT_169	[p9l187t44r221b69],

1	Five-Year	JJ	DURATION	five-year	amod	3	SENT_170	[p9l241t44r387b69],
2	Progression-Free	NNP	MISC	Progression-Free	nn	3	SENT_170	[p9l401t44r658b76],
3	Survival	NNP	MISC	Survival	_	0	SENT_170	[p9l672t44r798b69],
4	and	CC	O	and	_	0	SENT_170	[p9l812t44r867b69],
5	5-Year	JJ	DURATION	5-year	amod	7	SENT_170	[p9l881t44r980b69],
6	Overall	JJ	O	overall	amod	7	SENT_170	[p9l994t44r1106b69],
7	Survival	NN	O	survival	conj_and	3	SENT_170	[p9l1120t44r1246b69],
8	for	IN	O	for	_	0	SENT_170	[p9l1260t44r1304b69],
9	Known	VBN	O	know	prepc_for	7	SENT_170	[p9l1317t44r1425b69],
10	Prognostic	NNP	O	Prognostic	nn	11	SENT_170	[p9l1439t44r1598b76],
11	Factors	NNS	O	factor	dobj	9	SENT_170	[p9l1612t44r1724b69],
12	in	IN	O	in	_	0	SENT_170	[p9l1737t44r1766b69],
13	Medulloblastoma	NNP	ORGANIZATION	Medulloblastoma	nn	17	SENT_170	[p9l1779t44r2041b69],
14	Group	NNP	ORGANIZATION	Group	nn	17	SENT_170	[p9l59t118r147b150],
15	N	NNP	ORGANIZATION	N	nn	17	SENT_170	[p9l366t119r391b143],
16	Events	NNS	ORGANIZATION	event	nn	17	SENT_170	[p9l517t119r612b143],
17	PFS	NN	O	pf	prep_in	11	SENT_170	[p9l735t118r791b143],
18	95	CD	PERCENT	95	number	19	SENT_170	[p9l932t118r965b143],
19	%	NN	PERCENT	%	amod	22	SENT_170	[p9l969t118r994b143],
20	CI	NN	O	ci	nn	22	SENT_170	[p9l1007t118r1041b143],
21	P	NN	O	p	nn	22	SENT_170	[p9l1207t119r1228b142],
22	Events	NNS	O	event	dep	29	SENT_170	[p9l1378t119r1473b143],
23	OS	NN	O	os	prep	22	SENT_170	[p9l1604t118r1646b143],
24	95	CD	PERCENT	95	num	25	SENT_170	[p9l1794t118r1856b143],
25	%	NN	PERCENT	%	dep	23	SENT_170	[p9l1794t118r1856b143],
26	CI	NN	O	ci	nn	27	SENT_170	[p9l1868t118r1902b143],
27	P	NN	O	p	dep	29	SENT_170	[p9l2059t119r2081b142],
28	23	CD	DURATION	23	num	29	SENT_170	[p9l61t186r101b215],
29	years	NNS	NUMBER	year	dep	11	SENT_170	[p9l113t194r186b218],
30	86	CD	NUMBER	86	number	31	SENT_170	[p9l362t186r395b211],
31	18	CD	NUMBER	18	dep	29	SENT_170	[p9l551t186r581b211],
32	77.5	CD	NUMBER	77.5	num	34	SENT_170	[p9l734t186r793b211],
33	66.5-85	CD	NUMBER	66.5-85	num	34	SENT_170	[p9l917t186r1055b211],
34	.3	NN	NUMBER	.3	dep	31	SENT_170	[p9l917t186r1055b211],
35	0.001	CD	NUMBER	0.001	number	36	SENT_170	[p9l1178t186r1253b211],
36	14	CD	NUMBER	14	dep	41	SENT_170	[p9l1412t186r1443b210],
37	80.1	CD	NUMBER	80.1	number	38	SENT_170	[p9l1596t186r1653b211],
38	68.3-87	CD	NUMBER	68.3-87	num	40	SENT_170	[p9l1778t186r1917b211],
39	.9	CD	NUMBER	.9	number	40	SENT_170	[p9l1778t186r1917b211],
40	0.12	CD	NUMBER	0.12	npadvmod	41	SENT_170	[p9l2040t186r2100b211],
41	<	JJR	O	<	amod	11	SENT_170	[p9l61t227r101b253],
42	3	CD	DURATION	3	num	43	SENT_170	[p9l61t227r101b253],
43	years	NNS	NUMBER	year	dep	51	SENT_170	[p9l113t235r186b259],
44	20	CD	NUMBER	20	number	45	SENT_170	[p9l362t227r395b252],
45	10	CD	NUMBER	10	dep	43	SENT_170	[p9l551t227r582b252],
46	48.1	CD	NUMBER	48.1	num	47	SENT_170	[p9l733t227r791b252],
47	24.7-68	CD	NUMBER	24.7-68	dep	45	SENT_170	[p9l917t227r1055b252],
48	.3	NN	NUMBER	.3	dep	51	SENT_170	[p9l917t227r1055b252],
49	6	CD	NUMBER	6	num	48	SENT_170	[p9l1427t227r1443b252],
50	66.4	CD	NUMBER	66.4	num	51	SENT_170	[p9l1596t227r1656b252],
51	38.9-83	CD	NUMBER	38.9-83	dep	61	SENT_170	[p9l1779t227r1917b252],
52	.7	CD	NUMBER	.7	num	55	SENT_170	[p9l1779t227r1917b252],
53	High	JJ	O	high	amod	55	SENT_170	[p9l59t268r194b300],
54	—	NN	O	—	nn	55	SENT_170	[p9l59t268r194b300],
55	risk	NN	O	risk	dep	51	SENT_170	[p9l59t268r194b300],
56	33	CD	NUMBER	33	number	57	SENT_170	[p9l362t268r394b293],
57	9	CD	NUMBER	9	num	59	SENT_170	[p9l565t268r581b293],
58	70.9	CD	NUMBER	70.9	number	59	SENT_170	[p9l734t268r794b293],
59	51.1-83	CD	NUMBER	51.1-83	dep	55	SENT_170	[p9l917t268r1055b293],
60	.8	CD	NUMBER	.8	num	61	SENT_170	[p9l917t268r1055b293],
61	0.22	CD	NUMBER	0.22	dep	67	SENT_170	[p9l1178t268r1239b293],
62	6	CD	NUMBER	6	number	63	SENT_170	[p9l1427t268r1443b293],
63	79.2	CD	NUMBER	79.2	dep	61	SENT_170	[p9l1595t268r1656b293],
64	59.1-90	CD	NUMBER	59.1-90	num	65	SENT_170	[p9l1778t268r1915b293],
65	.1	NN	NUMBER	.1	dep	63	SENT_170	[p9l1778t268r1915b293],
66	0.74	CD	NUMBER	0.74	num	67	SENT_170	[p9l2040t268r2100b293],
67	Average-risk	NN	O	average-risk	dep	72	SENT_170	[p9l59t309r240b341],
68	52	CD	NUMBER	52	number	69	SENT_170	[p9l361t309r395b334],
69	9	CD	NUMBER	9	dep	67	SENT_170	[p9l565t309r581b334],
70	81.3	CD	NUMBER	81.3	dep	69	SENT_170	[p9l735t309r793b334],
71	67.0-89	CD	NUMBER	67.0-89	num	72	SENT_170	[p9l917t309r1055b334],
72	.8	CD	NUMBER	.8	dep	81	SENT_170	[p9l917t309r1055b334],
73	8	CD	NUMBER	8	number	74	SENT_170	[p9l1428t309r1442b334],
74	79.5	CD	NUMBER	79.5	dep	72	SENT_170	[p9l1595t309r1654b334],
75	61.8-89	CD	NUMBER	61.8-89	num	76	SENT_170	[p9l1778t309r1917b334],
76	.6	CD	NUMBER	.6	dep	74	SENT_170	[p9l1778t309r1917b334],
77	PFS	NN	O	pf	nn	81	SENT_170	[p9l58t381r124b410],
78	,	,	O	,	_	0	SENT_170	[p9l58t381r124b410],
79	5-year	JJ	DURATION	5-year	amod	81	SENT_170	[p9l139t381r228b413],
80	progression-free	JJ	O	progression-free	amod	81	SENT_170	[p9l241t381r471b413],
81	survival	NN	O	survival	dep	11	SENT_170	[p9l486t381r605b410],
82	;	:	O	;	_	0	SENT_170	[p9l486t381r605b410],
83	OS	NNP	O	OS	dep	3	SENT_170	[p9l620t381r671b410],
84	,	,	O	,	_	0	SENT_170	[p9l620t381r671b410],
85	5-year	JJ	DURATION	5-year	amod	87	SENT_170	[p9l686t381r776b413],
86	overall	JJ	O	overall	amod	87	SENT_170	[p9l789t381r885b406],
87	survival	NN	O	survival	appos	83	SENT_170	[p9l900t381r1017b406],
88	.	.	O	.	_	0	SENT_170	[p9l900t381r1017b406],

1	Pediatr	NNP	O	Pediatr	nn	4	SENT_171	[p9l58t430r157b453],
2	Blood	NNP	O	Blood	nn	4	SENT_171	[p9l164t430r245b453],
3	Cancer	NNP	O	Cancer	nn	4	SENT_171	[p9l255t430r352b454],
4	DOI	NNP	O	DOI	_	0	SENT_171	[p9l360t430r418b453],
5	10.1002	CD	NUMBER	10.1002	num	4	SENT_171	[p9l430t430r591b460],
6	/	:	O	/	punct	7	SENT_171	[p9l430t430r591b460],
7	pbc	NN	O	pbc	dep	4	SENT_171	[p9l430t430r591b460],

1	596	CD	NUMBER	596	num	2	SENT_172	[p9l9t622r133b682],
2	Rednam	NNP	O	Rednam	_	0	SENT_172	[p9l351t623r653b682],
3	et	FW	O	et	nn	4	SENT_172	[p9l680t627r744b682],
4	al.	FW	O	al.	dep	2	SENT_172	[p9l768t623r851b682],
5	.	.	O	.	_	0	SENT_172	[p9l768t623r851b682],

1	OR	NN	O	or	_	0	SENT_173	[p9l942t1198r1023b1239],
2	3.3	CD	NUMBER	3.3	num	1	SENT_173	[p9l1039t1198r1108b1239],
3	(	CD	NUMBER	(	num	4	SENT_173	[p9l1127t1198r1226b1250],
4	1-0	CD	NUMBER	1-0	dep	1	SENT_173	[p9l1127t1198r1226b1250],
5	,	,	O	,	_	0	SENT_173	[p9l1127t1198r1226b1250],
6	14-9	CD	NUMBER	14-9	num	8	SENT_173	[p9l1249t1198r1362b1250],
7	)	CD	NUMBER	)	num	8	SENT_173	[p9l1249t1198r1362b1250],
8	OR	NN	O	or	appos	4	SENT_173	[p9l1598t1193r1680b1235],
9	4.4	CD	NUMBER	4.4	number	10	SENT_173	[p9l1693t1193r1764b1235],
10	(	CD	NUMBER	(	num	11	SENT_173	[p9l1783t1193r1881b1246],
11	0.9	CD	NUMBER	0.9	dep	8	SENT_173	[p9l1783t1193r1881b1246],
12	,	,	O	,	_	0	SENT_173	[p9l1783t1193r1881b1246],
13	21-3	CD	NUMBER	21-3	num	14	SENT_173	[p9l1900t1193r2019b1247],
14	)	NN	O	)	appos	4	SENT_173	[p9l1900t1193r2019b1247],

1	Count	NN	O	count	_	0	SENT_174	[p9l14t1363r56b1502],

1	2	CD	NUMBER	2	_	0	SENT_175	[p9l553t2209r764b2265],
2	No	DT	O	no	det	4	SENT_175	[p9l798t2219r859b2261],
3	hearing	NN	O	hearing	nn	4	SENT_175	[p9l878t2219r1047b2272],
4	aid	NN	O	aid	dep	1	SENT_175	[p9l1066t2219r1131b2261],
5	:1	CD	NUMBER	:1	num	7	SENT_175	[p9l1243t2209r1450b2265],
6	Hearing	NN	O	hearing	nn	7	SENT_175	[p9l1484t2219r1659b2272],
7	aid	NN	O	aid	dep	1	SENT_175	[p9l1678t2219r1741b2261],

1	Fig	NN	O	fig	_	0	SENT_176	[p9l12t2392r121b2468],
2	.	.	O	.	_	0	SENT_176	[p9l12t2392r121b2468],

1	1	LS	NUMBER	1	_	0	SENT_177	[p9l162t2397r216b2450],
2	.	.	O	.	_	0	SENT_177	[p9l162t2397r216b2450],

1	Ototoxicity	NN	O	ototoxicity	_	0	SENT_178	[p9l299t2396r642b2465],
2	by	IN	O	by	_	0	SENT_178	[p9l676t2397r750b2465],
3	GSTP1	NN	O	gstp1	prep_by	1	SENT_178	[p9l785t2397r998b2450],
4	105	CD	NUMBER	105	num	3	SENT_178	[p9l1046t2396r1147b2450],
5	A	DT	O	a	det	8	SENT_178	[p9l1184t2397r1237b2449],
6	>	JJR	O	>	amod	8	SENT_178	[p9l1269t2407r1316b2451],
7	G	NN	O	g	nn	8	SENT_178	[p9l1347t2397r1399b2450],
8	genotype	NN	O	genotype	dep	1	SENT_178	[p9l1432t2405r1708b2465],
9	(	CD	NUMBER	(	num	12	SENT_178	[p9l1745t2396r2152b2462],
10	co-dominant	JJ	O	co-dominant	amod	12	SENT_178	[p9l1745t2396r2152b2462],
11	model	NN	O	model	nn	12	SENT_178	[p9l8t2484r237b2550],
12	)	NN	O	)	dep	8	SENT_178	[p9l8t2484r237b2550],
13	.	.	O	.	_	0	SENT_178	[p9l8t2484r237b2550],

1	OR	NN	O	or	_	0	SENT_179	[p9l263t2485r381b2548],
2	,	,	O	,	_	0	SENT_179	[p9l263t2485r381b2548],
3	odds	NNS	O	odds	nn	4	SENT_179	[p9l406t2485r545b2538],
4	ratios	NNS	O	ratio	appos	1	SENT_179	[p9l567t2484r733b2538],
5	with	IN	O	with	_	0	SENT_179	[p9l757t2484r890b2538],
6	95	CD	PERCENT	95	number	7	SENT_179	[p9l912t2484r1045b2538],
7	%	NN	PERCENT	%	amod	9	SENT_179	[p9l912t2484r1045b2538],
8	conﬁdence	NN	O	conﬁdence	nn	9	SENT_179	[p9l1070t2484r1396b2538],
9	intervals	NNS	O	interval	prep_with	4	SENT_179	[p9l1418t2484r1675b2538],
10	in	IN	O	in	_	0	SENT_179	[p9l1698t2484r1756b2537],
11	parentheses	NNS	O	parenthesis	prep_in	9	SENT_179	[p9l1775t2485r2147b2553],
12	;	:	O	;	_	0	SENT_179	[p9l1775t2485r2147b2553],
13	Ref	NNP	O	Ref	dep	1	SENT_179	[p9l8t2572r132b2635],
14	,	,	O	,	_	0	SENT_179	[p9l8t2572r132b2635],
15	reference	NN	O	reference	nn	16	SENT_179	[p9l162t2572r444b2626],
16	group	NN	O	group	appos	13	SENT_179	[p9l474t2589r664b2641],
17	.	.	O	.	_	0	SENT_179	[p9l474t2589r664b2641],

1	receiving	VBG	O	receive	_	0	SENT_180	[p9l7t2803r304b2876],
2	low	JJ	O	low	amod	3	SENT_180	[p9l341t2803r457b2859],
3	dose	NN	O	dose	dobj	1	SENT_180	[p9l495t2803r639b2859],
4	CSI	NNP	O	CSI	nsubj	14	SENT_180	[p9l677t2803r815b2869],
5	,	,	O	,	_	0	SENT_180	[p9l677t2803r815b2869],
6	patients	NNS	O	patient	appos	4	SENT_180	[p9l853t2803r1102b2876],
7	who	WP	O	who	nsubj	8	SENT_180	[p9l1141t2803r1275b2859],
8	received	VBD	O	receive	rcmod	6	SENT_180	[p9l1312t2803r1582b2859],
9	high	JJ	O	high	amod	10	SENT_180	[p9l1617t2803r1759b2876],
10	dose	NN	O	dose	dobj	8	SENT_180	[p9l1796t2803r1958b2869],
11	,	,	O	,	_	0	SENT_180	[p9l1796t2803r1958b2869],
12	were	VBD	O	be	cop	14	SENT_180	[p9l1997t2821r2150b2859],
13	more	RBR	O	more	advmod	14	SENT_180	[p9l8t2917r171b2956],
14	likely	JJ	O	likely	rcmod	3	SENT_180	[p9l197t2900r379b2972],
15	to	TO	O	to	aux	16	SENT_180	[p9l405t2908r465b2956],
16	experience	VB	O	experience	xcomp	14	SENT_180	[p9l492t2900r837b2972],
17	hearing	NN	O	hearing	nn	18	SENT_180	[p9l863t2900r1103b2972],
18	loss	NN	O	loss	dobj	16	SENT_180	[p9l1130t2900r1251b2956],
19	requiring	VBG	O	require	xcomp	16	SENT_180	[p9l1276t2900r1570b2972],
20	hearing	NN	O	hearing	nn	21	SENT_180	[p9l1596t2900r1835b2972],
21	aids	NNS	O	aid	dobj	19	SENT_180	[p9l1864t2900r1988b2956],
22	(	VBP	O	(	dep	1	SENT_180	[p9l2018t2900r2152b2969],
23	OR	NN	O	or	dobj	22	SENT_180	[p9l2018t2900r2152b2969],
24	3.1	CD	NUMBER	3.1	num	23	SENT_180	[p9l10t2997r123b3063],
25	,	,	O	,	_	0	SENT_180	[p9l10t2997r123b3063],
26	95	CD	PERCENT	95	number	27	SENT_180	[p9l154t2997r295b3054],
27	%	NN	PERCENT	%	amod	28	SENT_180	[p9l154t2997r295b3054],
28	CI	NN	O	ci	appos	23	SENT_180	[p9l325t2997r402b3053],
29	1.1-8	CD	NUMBER	1.1-8	num	30	SENT_180	[p9l437t2997r685b3063],
30	.8	CD	NUMBER	.8	nsubj	1	SENT_180	[p9l437t2997r685b3063],
31	,	,	O	,	_	0	SENT_180	[p9l437t2997r685b3063],
32	P	NN	O	p	appos	30	SENT_180	[p9l713t2999r762b3052],
33	=	JJ	O	=	amod	32	SENT_180	[p9l794t3022r848b3041],
34	0.04	CD	NUMBER	0.04	tmod	33	SENT_180	[p9l880t2997r1037b3063],
35	;	:	O	;	_	0	SENT_180	[p9l880t2997r1037b3063],
36	Fig	NN	O	fig	dep	32	SENT_180	[p9l1066t2997r1188b3069],
37	.	.	O	.	_	0	SENT_180	[p9l1066t2997r1188b3069],

1	3	CD	NUMBER	3	_	0	SENT_181	[p9l1220t2997r1299b3066],
2	)	NN	O	)	dep	1	SENT_181	[p9l1220t2997r1299b3066],
3	.	.	O	.	_	0	SENT_181	[p9l1220t2997r1299b3066],

1	Ototoxicity	NN	O	ototoxicity	nsubj	4	SENT_182	[p9l1330t2997r1694b3069],
2	did	VBD	O	do	aux	4	SENT_182	[p9l1722t2997r1823b3053],
3	not	RB	O	not	neg	4	SENT_182	[p9l1849t3005r1951b3053],
4	differ	VB	O	differ	_	0	SENT_182	[p9l1977t2997r2153b3053],
5	by	IN	O	by	_	0	SENT_182	[p9l7t3094r85b3167],
6	cumulative	JJ	O	cumulative	amod	10	SENT_182	[p9l130t3094r483b3150],
7	cisplatin	NN	O	cisplatin	nn	10	SENT_182	[p9l527t3094r799b3167],
8	dose	NN	O	dose	nn	10	SENT_182	[p9l842t3094r986b3150],
9	(	NN	O	(	nn	10	SENT_182	[p9l1031t3094r1380b3175],
10	ORh	NN	O	orh	prep_by	4	SENT_182	[p9l1031t3094r1380b3175],
11	,	,	O	,	_	0	SENT_182	[p9l1031t3094r1380b3175],
12	gh	NN	O	gh	appos	10	SENT_182	[p9l1031t3094r1380b3175],
13	,10	CD	NUMBER	,10	num	12	SENT_182	[p9l1031t3094r1380b3175],
14	W	NNP	O	W	dep	12	SENT_182	[p9l1031t3094r1380b3175],
15	0.3	CD	NUMBER	0.3	num	14	SENT_182	[p9l1423t3094r1537b3160],
16	,	,	O	,	_	0	SENT_182	[p9l1423t3094r1537b3160],
17	95	CD	PERCENT	95	number	18	SENT_182	[p9l1584t3094r1725b3151],
18	%	NN	PERCENT	%	amod	19	SENT_182	[p9l1584t3094r1725b3151],
19	CI	NN	O	ci	appos	10	SENT_182	[p9l1772t3094r1849b3150],
20	0.1-1	CD	NUMBER	0.1-1	num	21	SENT_182	[p9l1892t3094r2148b3161],
21	.2	NN	NUMBER	.2	dep	19	SENT_182	[p9l1892t3094r2148b3161],
22	,	,	O	,	_	0	SENT_182	[p9l1892t3094r2148b3161],
23	P	NN	O	p	appos	10	SENT_182	[p9l6t3193r56b3246],
24	=	JJ	O	=	amod	23	SENT_182	[p9l87t3216r141b3236],
25	0.08	CD	NUMBER	0.08	tmod	24	SENT_182	[p9l174t3191r331b3257],
26	;	:	O	;	_	0	SENT_182	[p9l174t3191r331b3257],
27	n	NN	O	n	dep	10	SENT_182	[p9l386t3208r424b3246],
28	=	JJ	O	=	amod	35	SENT_182	[p9l456t3216r510b3236],
29	67	CD	NUMBER	67	number	30	SENT_182	[p9l543t3191r644b3260],
30	)	CD	NUMBER	)	amod	35	SENT_182	[p9l543t3191r644b3260],
31	or	CC	O	or	_	0	SENT_182	[p9l699t3208r764b3247],
32	amifostine	JJ	O	amifostine	conj_or	30	SENT_182	[p9l816t3191r1152b3247],
33	use	NN	O	use	nn	35	SENT_182	[p9l1204t3208r1309b3247],
34	(	CD	NUMBER	(	num	35	SENT_182	[p9l1364t3191r1654b3271],
35	ORyeS	NN	O	orye	dep	27	SENT_182	[p9l1364t3191r1654b3271],
36	,	,	O	,	_	0	SENT_182	[p9l1364t3191r1654b3271],
37	no	DT	O	no	det	42	SENT_182	[p9l1364t3191r1654b3271],
38	0.5	CD	NUMBER	0.5	amod	42	SENT_182	[p9l1707t3190r1822b3257],
39	,	,	O	,	_	0	SENT_182	[p9l1707t3190r1822b3257],
40	95	CD	PERCENT	95	number	41	SENT_182	[p9l1877t3190r2018b3248],
41	%	NN	PERCENT	%	amod	42	SENT_182	[p9l1877t3190r2018b3248],
42	CI	NN	O	ci	appos	10	SENT_182	[p9l2074t3191r2151b3247],
43	0.2-1	CD	NUMBER	0.2-1	num	44	SENT_182	[p9l8t3288r264b3354],
44	.5	CD	NUMBER	.5	dep	42	SENT_182	[p9l8t3288r264b3354],
45	,	,	O	,	_	0	SENT_182	[p9l8t3288r264b3354],
46	P	NN	O	p	appos	10	SENT_182	[p9l292t3290r342b3343],
47	=	JJ	O	=	amod	46	SENT_182	[p9l373t3313r427b3332],
48	0.2	CD	NUMBER	0.2	tmod	47	SENT_182	[p9l459t3288r574b3354],
49	,	,	O	,	_	0	SENT_182	[p9l459t3288r574b3354],
50	n	NN	O	n	appos	10	SENT_182	[p9l603t3306r642b3343],
51	=	JJ	O	=	amod	53	SENT_182	[p9l673t3313r728b3332],
52	69	CD	NUMBER	69	tmod	51	SENT_182	[p9l761t3288r880b3357],
53	)	NN	O	)	dep	50	SENT_182	[p9l761t3288r880b3357],
54	.	.	O	.	_	0	SENT_182	[p9l761t3288r880b3357],

1	Multivariable	JJ	O	multivariable	amod	2	SENT_183	[p9l910t3288r1344b3344],
2	analyses	NNS	O	analysis	nsubj	3	SENT_183	[p9l1373t3288r1640b3360],
3	showed	VBD	O	show	_	0	SENT_183	[p9l1671t3288r1911b3344],
4	elevated	JJ	O	elevated	amod	5	SENT_183	[p9l1937t3288r2149b3344, p9l8t3385r82b3441],
5	ORs	NNS	O	or	dep	12	SENT_183	[p9l118t3385r255b3441],
6	for	IN	O	for	_	0	SENT_183	[p9l291t3385r384b3441],
7	GSTP1	NN	O	gstp1	prep_for	5	SENT_183	[p9l420t3386r641b3442],
8	105	CD	NUMBER	105	dep	12	SENT_183	[p9l689t3385r796b3441],
9	A	DT	O	a	det	12	SENT_183	[p9l834t3386r890b3440],
10	>	JJR	O	>	amod	12	SENT_183	[p9l924t3397r974b3443],
11	G	NN	O	g	nn	12	SENT_183	[p9l1007t3385r1062b3441],
12	genotype	NN	O	genotype	dep	16	SENT_183	[p9l1096t3394r1388b3458],
13	and	CC	O	and	_	0	SENT_183	[p9l1425t3385r1538b3441],
14	CSI	NNP	O	CSI	nn	15	SENT_183	[p9l1573t3385r1695b3441],
15	dose	NN	O	dose	conj_and	12	SENT_183	[p9l1730t3385r1874b3441],
16	Without	IN	O	without	dep	3	SENT_183	[p9l1908t3385r2152b3441],
17	statistical	JJ	O	statistical	amod	18	SENT_183	[p9l10t3481r311b3537],
18	signiﬁcance	NN	O	signiﬁcance	pobj	16	SENT_183	[p9l343t3481r723b3554],
19	(	CD	NUMBER	(	num	20	SENT_183	[p9l754t3482r999b3551],
20	ORSNP	NN	O	orsnp	dobj	3	SENT_183	[p9l754t3482r999b3551],
21	3.5	CD	NUMBER	3.5	dep	20	SENT_183	[p9l1029t3481r1143b3547],
22	,	,	O	,	_	0	SENT_183	[p9l1029t3481r1143b3547],
23	95	CD	PERCENT	95	number	24	SENT_183	[p9l1176t3481r1317b3538],
24	%	NN	PERCENT	%	amod	25	SENT_183	[p9l1176t3481r1317b3538],
25	CI	NN	O	ci	appos	20	SENT_183	[p9l1350t3482r1427b3537],
26	0.99-12	CD	NUMBER	0.99-12	num	27	SENT_183	[p9l1457t3482r1793b3548],
27	.1	NN	NUMBER	.1	dep	25	SENT_183	[p9l1457t3482r1793b3548],
28	,	,	O	,	_	0	SENT_183	[p9l1457t3482r1793b3548],
29	P	NN	O	p	appos	20	SENT_183	[p9l1823t3483r1873b3537],
30	=	JJ	O	=	amod	29	SENT_183	[p9l1904t3507r1958b3526],
31	0.05	CD	NUMBER	0.05	tmod	30	SENT_183	[p9l1991t3481r2148b3548],
32	;	:	O	;	_	0	SENT_183	[p9l1991t3481r2148b3548],
33	ORCS1	CD	NUMBER	orcs1	number	34	SENT_183	[p9l9t3579r212b3648],
34	2.6	CD	NUMBER	2.6	num	38	SENT_183	[p9l242t3579r357b3645],
35	,	,	O	,	_	0	SENT_183	[p9l242t3579r357b3645],
36	95	CD	PERCENT	95	number	37	SENT_183	[p9l391t3579r465b3636],
37	%	NN	PERCENT	%	amod	38	SENT_183	[p9l502t3579r560b3635],
38	CI	NN	O	ci	dep	20	SENT_183	[p9l595t3579r672b3635],
39	0.89-7	CD	NUMBER	0.89-7	num	40	SENT_183	[p9l703t3579r999b3645],
40	.8	CD	NUMBER	.8	dep	38	SENT_183	[p9l703t3579r999b3645],
41	,	,	O	,	_	0	SENT_183	[p9l703t3579r999b3645],
42	P	NN	O	p	appos	20	SENT_183	[p9l1031t3581r1080b3634],
43	=	JJ	O	=	amod	42	SENT_183	[p9l1112t3604r1166b3623],
44	0.08	CD	NUMBER	0.08	tmod	43	SENT_183	[p9l1198t3579r1355b3645],
45	;	:	O	;	_	0	SENT_183	[p9l1198t3579r1355b3645],
46	n	NN	O	n	dep	20	SENT_183	[p9l1389t3597r1427b3634],
47	=	JJ	O	=	amod	49	SENT_183	[p9l1459t3604r1513b3623],
48	69	CD	NUMBER	69	tmod	47	SENT_183	[p9l1547t3579r1666b3648],
49	)	NN	O	)	dep	46	SENT_183	[p9l1547t3579r1666b3648],
50	.	.	O	.	_	0	SENT_183	[p9l1547t3579r1666b3648],

1	To	TO	O	to	aux	2	SENT_184	[p9l115t3677r196b3732],
2	explore	VB	O	explore	_	0	SENT_184	[p9l240t3676r479b3749],
3	a	DT	O	a	det	5	SENT_184	[p9l524t3694r557b3732],
4	potential	JJ	O	potential	amod	5	SENT_184	[p9l598t3676r879b3749],
5	interaction	NN	O	interaction	dobj	2	SENT_184	[p9l923t3676r1267b3732],
6	between	IN	O	between	_	0	SENT_184	[p9l1309t3676r1577b3732],
7	the	DT	O	the	det	8	SENT_184	[p9l1620t3676r1716b3732],
8	GSTP1	NN	O	gstp1	prep_between	5	SENT_184	[p9l1763t3677r1984b3733],
9	105	CD	NUMBER	105	num	8	SENT_184	[p9l2041t3676r2148b3732],

1	A	DT	O	a	det	4	SENT_185	[p10l8t19r64b74],
2	>	JJR	O	>	amod	4	SENT_185	[p10l98t30r147b76],
3	G	NN	O	g	nn	4	SENT_185	[p10l180t19r235b75],
4	genotype	NN	O	genotype	nsubj	22	SENT_185	[p10l271t27r563b91],
5	and	CC	O	and	_	0	SENT_185	[p10l601t18r715b74],
6	CSI	NNP	O	CSI	nn	7	SENT_185	[p10l751t19r873b75],
7	dose	NN	O	dose	nsubj	22	SENT_185	[p10l909t18r1071b85],
8	,	,	O	,	_	0	SENT_185	[p10l909t18r1071b85],
9	patients	NNS	O	patient	nsubjpass	11	SENT_185	[p10l1109t18r1357b91],
10	were	VBD	O	be	auxpass	11	SENT_185	[p10l1396t36r1549b74],
11	divided	VBN	O	divide	parataxis	22	SENT_185	[p10l1587t18r1825b74],
12	into	IN	O	into	_	0	SENT_185	[p10l1860t18r1982b74],
13	four	CD	NUMBER	four	num	14	SENT_185	[p10l2019t18r2153b74],
14	groups	NNS	O	group	prep_into	11	SENT_185	[p10l9t134r223b188],
15	using	VBG	O	use	partmod	14	SENT_185	[p10l253t116r425b188],
16	all	DT	O	all	det	20	SENT_185	[p10l457t116r534b172],
17	2	CD	NUMBER	2	number	18	SENT_185	[p10l564t116r600b171],
18	X	NN	O	x	amod	20	SENT_185	[p10l640t131r679b170],
19	2	CD	NUMBER	2	num	20	SENT_185	[p10l720t116r756b171],
20	combinations	NNS	O	combination	dobj	15	SENT_185	[p10l786t116r1235b182],
21	,	,	O	,	_	0	SENT_185	[p10l786t116r1235b182],
22	ordered	VBN	O	order	_	0	SENT_185	[p10l1269t116r1512b172],
23	by	IN	O	by	_	0	SENT_185	[p10l1540t116r1619b188],
24	a	DT	O	a	det	26	SENT_185	[p10l1650t134r1683b172],
25	proposed	VBN	O	propose	amod	26	SENT_185	[p10l1710t116r2004b188],
26	risk	NN	O	risk	prep_by	22	SENT_185	[p10l2032t116r2153b172],
27	for	IN	O	for	_	0	SENT_185	[p10l8t213r101b269],
28	severe	JJ	O	severe	amod	31	SENT_185	[p10l127t231r326b269],
29	ototoxicity	NN	O	ototoxicity	nn	31	SENT_185	[p10l351t213r697b286],
30	(	NN	O	(	nn	31	SENT_185	[p10l725t214r788b282],
31	n	NN	O	n	prep_for	26	SENT_185	[p10l725t214r788b282],
32	=	JJ	O	=	amod	31	SENT_185	[p10l820t238r874b257],
33	69	CD	NUMBER	69	tmod	32	SENT_185	[p10l907t213r1003b279],
34	;	:	O	;	_	0	SENT_185	[p10l907t213r1003b279],
35	Table	NNP	O	Table	nn	36	SENT_185	[p10l1031t213r1207b269],
36	III	NNP	O	III	dep	37	SENT_185	[p10l1232t214r1352b282],
37	)	NN	O	)	parataxis	22	SENT_185	[p10l1232t214r1352b282],
38	.	.	O	.	_	0	SENT_185	[p10l1232t214r1352b282],

1	In	IN	O	in	_	0	SENT_186	[p10l1381t215r1447b268],
2	the	DT	O	the	det	4	SENT_186	[p10l1471t213r1567b269],
3	lowest	JJS	O	lowest	amod	4	SENT_186	[p10l1592t213r1799b269],
4	risk	NN	O	risk	prep_in	7	SENT_186	[p10l1822t213r1943b269],
5	group	NN	O	group	nsubj	7	SENT_186	[p10l1967t231r2150b286],
6	were	VBD	O	be	cop	7	SENT_186	[p10l8t327r161b365],
7	individuals	NNS	O	individual	_	0	SENT_186	[p10l199t309r552b365],
8	with	IN	O	with	_	0	SENT_186	[p10l589t309r731b365],
9	the	DT	O	the	det	11	SENT_186	[p10l766t309r862b365],
10	AA	NNP	O	AA	nn	11	SENT_186	[p10l899t310r1013b365],
11	genotype	NN	O	genotype	prep_with	7	SENT_186	[p10l1049t318r1341b382],
12	who	WP	O	who	nsubj	13	SENT_186	[p10l1377t309r1511b365],
13	received	VBD	O	receive	rcmod	11	SENT_186	[p10l1547t309r1819b365],
14	low	JJ	O	low	amod	16	SENT_186	[p10l1854t309r1969b365],
15	dose	NN	O	dose	nn	16	SENT_186	[p10l2007t309r2151b365],
16	CSI	NN	O	csus	dobj	13	SENT_186	[p10l9t407r130b463],
17	and	CC	O	and	_	0	SENT_186	[p10l158t407r271b463],
18	in	IN	O	in	_	0	SENT_186	[p10l294t407r356b462],
19	the	DT	O	the	det	22	SENT_186	[p10l381t407r477b463],
20	highest	JJS	O	highest	amod	22	SENT_186	[p10l501t407r734b479],
21	risk	NN	O	risk	nn	22	SENT_186	[p10l757t407r878b463],
22	group	NN	O	group	prep_in	24	SENT_186	[p10l903t424r1086b479],
23	were	VBD	O	be	cop	24	SENT_186	[p10l1113t424r1266b463],
24	those	DT	O	those	conj_and	13	SENT_186	[p10l1291t407r1459b463],
25	in	IN	O	in	_	0	SENT_186	[p10l1484t407r1546b462],
26	the	DT	O	the	det	28	SENT_186	[p10l1570t407r1666b463],
27	AG/GG	NNP	O	AG/GG	nn	28	SENT_186	[p10l1691t407r1941b463],
28	group	NN	O	group	prep_in	24	SENT_186	[p10l1967t424r2150b479],
29	who	WP	O	who	nsubj	30	SENT_186	[p10l8t504r143b560],
30	received	VBD	O	receive	rcmod	7	SENT_186	[p10l181t504r452b560],
31	high	JJ	O	high	amod	32	SENT_186	[p10l488t504r630b577],
32	dose	NN	O	dose	iobj	30	SENT_186	[p10l668t504r812b560],
33	CSI	NNP	O	CSI	dobj	30	SENT_186	[p10l851t504r989b560],
34	.	.	O	.	_	0	SENT_186	[p10l851t504r989b560],

1	Using	VBG	O	use	_	0	SENT_187	[p10l1030t504r1219b577],
2	the	DT	O	the	det	5	SENT_187	[p10l1257t504r1354b560],
3	lowest	JJS	O	lowest	amod	5	SENT_187	[p10l1392t504r1599b560],
4	risk	NN	O	risk	nn	5	SENT_187	[p10l1635t504r1756b560],
5	group	NN	O	group	dobj	1	SENT_187	[p10l1793t522r1976b577],
6	as	IN	O	as	_	0	SENT_187	[p10l2017t522r2078b560],
7	a	DT	O	a	det	8	SENT_187	[p10l2119t522r2152b560],
8	reference	NN	O	reference	prep_as	5	SENT_187	[p10l7t600r323b666],
9	,	,	O	,	_	0	SENT_187	[p10l7t600r323b666],
10	a	DT	O	a	det	15	SENT_187	[p10l388t618r421b656],
11	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_187	[p10l483t600r814b673],
12	dose	NN	O	dose	nn	15	SENT_187	[p10l873t600r1339b673],
13	—	NN	O	—	nn	15	SENT_187	[p10l873t600r1339b673],
14	response	NN	O	response	nn	15	SENT_187	[p10l873t600r1339b673],
15	pattern	NN	O	pattern	appos	8	SENT_187	[p10l1398t608r1621b673],
16	was	VBD	O	be	auxpass	17	SENT_187	[p10l1682t618r1802b656],
17	observed	VBN	O	observe	aux	1	SENT_187	[p10l1864t600r2152b656],
18	(	RB	O	(	advmod	17	SENT_187	[p10l10t697r369b777],
19	ORAA_high	NNP	O	ORAA_high	nsubj	1	SENT_187	[p10l10t697r369b777],
20	:	:	O	:	_	0	SENT_187	[p10l401t722r455b742],
21	{	CD	NUMBER	{	dep	19	SENT_187	[p10l494t697r602b763],
22	/	:	O	/	punct	24	SENT_187	[p10l494t697r602b763],
23	*	CD	NUMBER	*	num	24	SENT_187	[p10l494t697r602b763],
24	o	NN	O	o	dep	21	SENT_187	[p10l650t697r791b754],
25	*	CD	NUMBER	*	num	26	SENT_187	[p10l650t697r791b754],
26	*	NN	O	*	dep	24	SENT_187	[p10l840t697r917b753],
27	1	CD	NUMBER	1	num	29	SENT_187	[p10l962t697r1260b763],
28	*	NN	O	*	nn	29	SENT_187	[p10l962t697r1260b763],
29	ORAG/GG	NN	O	orag/gg	dep	26	SENT_187	[p10l1309t697r1726b766],
30	_	CD	NUMBER	_	num	31	SENT_187	[p10l1309t697r1726b766],
31	10W	NN	O	10w	dep	26	SENT_187	[p10l1309t697r1726b766],
32	:	:	O	:	_	0	SENT_187	[p10l1758t722r1812b742],
33	1	CD	NUMBER	1	number	34	SENT_187	[p10l1844t697r1958b763],
34	*	CD	NUMBER	*	dep	26	SENT_187	[p10l1844t697r1958b763],
35	]	CD	NUMBER	]	dep	34	SENT_187	[p10l2007t697r2148b754],
36	/	:	O	/	punct	24	SENT_187	[p10l2007t697r2148b754],
37	*	CD	NUMBER	*	dep	21	SENT_187	[p10l2007t697r2148b754],

1	p	NN	O	p	_	0	SENT_188	[p10l1872t1008r2068b1062],
2	=	JJ	O	=	amod	3	SENT_188	[p10l1872t1008r2068b1062],
3	0D3	NN	O	0d3	dep	1	SENT_188	[p10l1872t1008r2068b1062],

1	DR	NN	O	dr	_	0	SENT_189	[p10l1461t1133r1541b1176],
2	4	CD	NUMBER	4	dep	1	SENT_189	[p10l1557t1133r1887b1185],
3	.	.	O	.	_	0	SENT_189	[p10l1557t1133r1887b1185],

1	l'	NN	O	l'	_	0	SENT_190	[p10l1557t1133r1887b1185],
2	.	.	O	.	_	0	SENT_190	[p10l1557t1133r1887b1185],

1	I	PRP	O	I	nsubj	2	SENT_191	[p10l1557t1133r1887b1185],
2	(	VBP	O	(	_	0	SENT_191	[p10l1557t1133r1887b1185],
3	1.2,13.6	CD	NUMBER	1.2,13.6	number	4	SENT_191	[p10l1557t1133r1887b1185],
4	}	CD	NUMBER	}	dobj	2	SENT_191	[p10l1557t1133r1887b1185],

1	COLIFII	CD	NUMBER	colifii	_	0	SENT_192	[p10l17t1505r60b1654],

1	AA	NN	ORGANIZATION	aa	nn	3	SENT_193	[p10l633t2260r702b2303],
2	AGIGG	NN	ORGANIZATION	agigg	nn	3	SENT_193	[p10l1583t2260r1751b2303],
3	T	NN	O	t	_	0	SENT_193	[p10l555t2355r764b2413],
4	No	DT	O	no	det	9	SENT_193	[p10l798t2366r867b2409],
5	hearing	NN	O	hearing	nn	9	SENT_193	[p10l887t2366r1075b2417],
6	‘	NN	O	‘	nn	9	SENT_193	[p10l1094t2366r1168b2409],
7	aid	NN	O	aid	nn	9	SENT_193	[p10l1094t2366r1168b2409],
8	Ii	NN	O	ii	nn	9	SENT_193	[p10l1241t2355r1452b2413],
9	]	NN	O	]	dep	3	SENT_193	[p10l1241t2355r1452b2413],
10	!	.	O	!	_	0	SENT_193	[p10l1241t2355r1452b2413],

1	Hearing	NN	O	hearing	nn	2	SENT_194	[p10l1484t2366r1683b2417],
2	aid	NN	O	aid	_	0	SENT_194	[p10l1702t2366r1775b2409],

1	Fig	NN	O	fig	_	0	SENT_195	[p10l12t2521r121b2598],
2	.	.	O	.	_	0	SENT_195	[p10l12t2521r121b2598],

1	2	LS	NUMBER	2	_	0	SENT_196	[p10l148t2526r204b2579],
2	.	.	O	.	_	0	SENT_196	[p10l148t2526r204b2579],

1	Ototoxicity	NN	O	ototoxicity	_	0	SENT_197	[p10l287t2525r630b2594],
2	by	IN	O	by	_	0	SENT_197	[p10l652t2525r726b2594],
3	GSTP1	NN	O	gstp1	prep_by	1	SENT_197	[p10l750t2525r962b2579],
4	105	CD	NUMBER	105	num	3	SENT_197	[p10l998t2525r1099b2579],
5	A	DT	O	a	det	8	SENT_197	[p10l1125t2526r1178b2578],
6	>	JJR	O	>	amod	8	SENT_197	[p10l1210t2536r1256b2581],
7	G	NN	O	g	nn	8	SENT_197	[p10l1288t2525r1340b2579],
8	genotype	NN	O	genotype	dep	1	SENT_197	[p10l1361t2533r1637b2594],
9	(	CD	NUMBER	(	num	12	SENT_197	[p10l1662t2525r1972b2591],
10	dominant	JJ	O	dominant	amod	12	SENT_197	[p10l1662t2525r1972b2591],
11	model	NN	O	model	nn	12	SENT_197	[p10l1993t2525r2149b2579, p10l8t2613r101b2678],
12	)	NN	O	)	dep	8	SENT_197	[p10l1993t2525r2149b2579, p10l8t2613r101b2678],
13	.	.	O	.	_	0	SENT_197	[p10l1993t2525r2149b2579, p10l8t2613r101b2678],

1	OR	NN	O	or	_	0	SENT_198	[p10l143t2613r261b2676],
2	,	,	O	,	_	0	SENT_198	[p10l143t2613r261b2676],
3	odds	NNS	O	odds	nn	4	SENT_198	[p10l301t2613r440b2666],
4	ratios	NNS	O	ratio	appos	1	SENT_198	[p10l477t2613r644b2666],
5	with	IN	O	with	_	0	SENT_198	[p10l682t2613r815b2666],
6	95	CD	PERCENT	95	number	7	SENT_198	[p10l852t2613r985b2667],
7	%	NN	PERCENT	%	amod	9	SENT_198	[p10l852t2613r985b2667],
8	conﬁdence	NN	O	conﬁdence	nn	9	SENT_198	[p10l1025t2613r1351b2666],
9	intervals	NNS	O	interval	prep_with	4	SENT_198	[p10l1388t2613r1645b2666],
10	in	IN	O	in	_	0	SENT_198	[p10l1683t2613r1740b2665],
11	parentheses	NNS	O	parenthesis	prep_in	9	SENT_198	[p10l1776t2613r2147b2682],
12	;	:	O	;	_	0	SENT_198	[p10l1776t2613r2147b2682],
13	Ref	NNP	O	Ref	dep	1	SENT_198	[p10l8t2702r132b2765],
14	,	,	O	,	_	0	SENT_198	[p10l8t2702r132b2765],
15	reference	NN	O	reference	nn	16	SENT_198	[p10l162t2702r444b2755],
16	group	NN	O	group	appos	13	SENT_198	[p10l474t2719r664b2771],
17	.	.	O	.	_	0	SENT_198	[p10l474t2719r664b2771],

1	Pediatr	NNP	O	Pediatr	nn	4	SENT_199	[p10l7t2800r219b2850],
2	Blood	NNP	O	Blood	nn	4	SENT_199	[p10l235t2800r409b2850],
3	Cancer	NNP	O	Cancer	nn	4	SENT_199	[p10l430t2801r639b2851],
4	DOI	NNP	O	DOI	_	0	SENT_199	[p10l656t2801r781b2851],
5	10.1002	CD	NUMBER	10.1002	dep	4	SENT_199	[p10l809t2800r1154b2865],
6	/	:	O	/	punct	4	SENT_199	[p10l809t2800r1154b2865],
7	pbc	NN	O	pbc	nn	8	SENT_199	[p10l809t2800r1154b2865],
8	p	NN	O	p	dep	4	SENT_199	[p11l1867t162r2066b214],
9	=	JJ	O	=	amod	10	SENT_199	[p11l1867t162r2066b214],
10	0D4	NN	O	0d4	dep	8	SENT_199	[p11l1867t162r2066b214],

1	OR	NN	O	or	_	0	SENT_200	[p11l1452t281r1532b324],
2	3.1	CD	NUMBER	3.1	num	1	SENT_200	[p11l1549t281r1616b324],
3	(	NN	O	(	dep	1	SENT_200	[p11l1641t281r1745b333],
4	1.1	CD	NUMBER	1.1	num	3	SENT_200	[p11l1641t281r1745b333],
5	,	,	O	,	_	0	SENT_200	[p11l1641t281r1745b333],
6	8.8	CD	NUMBER	8.8	num	7	SENT_200	[p11l1764t281r1859b333],
7	)	NN	O	)	appos	3	SENT_200	[p11l1764t281r1859b333],

1	40	CD	NUMBER	40	num	2	SENT_201	[p11l98t524r144b583],
2	Count	NN	O	count	_	0	SENT_201	[p11l17t653r60b802],
3	30	CD	NUMBER	30	dep	2	SENT_201	[p11l98t731r144b789],

1	Lower	JJR	O	lower	amod	3	SENT_202	[p11l460t1408r616b1452],
2	Dose	NN	O	dose	nn	3	SENT_202	[p11l632t1408r764b1452],
3	cal	NN	O	cal	_	0	SENT_202	[p11l783t1408r870b1452],
4	Higher	JJR	O	higher	amod	6	SENT_202	[p11l1458t1408r1626b1460],
5	Dose	NN	O	dose	nn	6	SENT_202	[p11l1641t1408r1773b1452],
6	CSI	NN	O	csus	dep	3	SENT_202	[p11l1792t1408r1879b1452],

1	I	PRP	O	I	_	0	SENT_203	[p11l553t1505r764b1563],
2	No	DT	O	no	det	4	SENT_203	[p11l796t1513r865b1557],
3	hearing	NN	O	hearing	nn	4	SENT_203	[p11l885t1513r1073b1565],
4	aid	NN	O	aid	dep	1	SENT_203	[p11l1092t1513r1168b1557],
5	Zll	NN	O	zll	nn	7	SENT_203	[p11l1241t1505r1452b1563],
6	Hearing	NN	O	hearing	nn	7	SENT_203	[p11l1484t1513r1683b1565],
7	aid	NN	O	aid	dep	1	SENT_203	[p11l1700t1513r1775b1557],

1	Fig	NN	O	fig	_	0	SENT_204	[p11l13t1680r121b1757],
2	.	.	O	.	_	0	SENT_204	[p11l13t1680r121b1757],

1	3	LS	NUMBER	3	_	0	SENT_205	[p11l151t1685r207b1738],
2	.	.	O	.	_	0	SENT_205	[p11l151t1685r207b1738],

1	Ototoxicity	NN	O	ototoxicity	_	0	SENT_206	[p11l290t1684r633b1753],
2	by	IN	O	by	_	0	SENT_206	[p11l657t1684r732b1753],
3	craniospinal	JJ	O	craniospinal	amod	9	SENT_206	[p11l757t1684r1126b1753],
4	radiation	NN	O	radiation	nn	9	SENT_206	[p11l1151t1684r1421b1738],
5	(	NN	O	(	nn	9	SENT_206	[p11l1448t1684r1610b1750],
6	CSI	NNP	O	CSI	nn	9	SENT_206	[p11l1448t1684r1610b1750],
7	)	CD	NUMBER	)	num	9	SENT_206	[p11l1448t1684r1610b1750],
8	dose	NN	O	dose	nn	9	SENT_206	[p11l1637t1684r1773b1738],
9	group	NN	O	group	prep_by	1	SENT_206	[p11l1798t1701r1987b1753],
10	.	.	O	.	_	0	SENT_206	[p11l1798t1701r1987b1753],

1	Low	JJ	O	low	amod	2	SENT_207	[p11l2015t1685r2151b1738],
2	dose	NN	O	dose	dep	13	SENT_207	[p11l9t1771r145b1824],
3	CS1	NN	O	cs1	nn	13	SENT_207	[p11l195t1772r326b1834],
4	,	,	O	,	_	0	SENT_207	[p11l195t1772r326b1834],
5	l8	NN	O	l8	dep	13	SENT_207	[p11l385t1771r622b1825],
6	—	CD	NUMBER	—	num	13	SENT_207	[p11l385t1771r622b1825],
7	25.2	CD	NUMBER	25.2	num	13	SENT_207	[p11l385t1771r622b1825],
8	Gy	NN	O	gy	nn	13	SENT_207	[p11l651t1772r740b1840],
9	(	CD	NUMBER	(	num	13	SENT_207	[p11l792t1771r1037b1837],
10	median	NN	O	median	nn	13	SENT_207	[p11l792t1771r1037b1837],
11	23.4	CD	NUMBER	23.4	num	13	SENT_207	[p11l1088t1772r1217b1825],
12	Gy	NN	O	gy	nn	13	SENT_207	[p11l1246t1772r1379b1840],
13	)	NN	O	)	_	0	SENT_207	[p11l1246t1772r1379b1840],
14	;	:	O	;	_	0	SENT_207	[p11l1246t1772r1379b1840],
15	high	JJ	O	high	amod	17	SENT_207	[p11l1430t1771r1564b1840],
16	dose	NN	O	dose	nn	17	SENT_207	[p11l1613t1771r1749b1824],
17	CSI	NNP	O	CSI	dep	25	SENT_207	[p11l1800t1772r1931b1834],
18	,	,	O	,	_	0	SENT_207	[p11l1800t1772r1931b1834],
19	34.239.6	CD	NUMBER	34.239.6	num	20	SENT_207	[p11l1985t1772r2153b1825, p11l10t1859r138b1913],
20	Gy	NN	O	gy	appos	17	SENT_207	[p11l167t1860r256b1928],
21	(	CD	NUMBER	(	num	22	SENT_207	[p11l284t1859r529b1925],
22	median	NN	O	median	dep	20	SENT_207	[p11l284t1859r529b1925],
23	36	CD	NUMBER	36	num	25	SENT_207	[p11l556t1859r626b1913],
24	Gy	NN	O	gy	nn	25	SENT_207	[p11l656t1860r789b1928],
25	)	NN	O	)	parataxis	13	SENT_207	[p11l656t1860r789b1928],
26	;	:	O	;	_	0	SENT_207	[p11l656t1860r789b1928],
27	OR	NN	O	or	dep	30	SENT_207	[p11l817t1860r935b1922],
28	,	,	O	,	_	0	SENT_207	[p11l817t1860r935b1922],
29	odds	NNS	O	odds	nn	30	SENT_207	[p11l963t1859r1102b1913],
30	ratios	NNS	O	ratio	parataxis	13	SENT_207	[p11l1126t1859r1293b1913],
31	with	IN	O	with	_	0	SENT_207	[p11l1319t1859r1453b1913],
32	95	CD	PERCENT	95	number	33	SENT_207	[p11l1477t1859r1610b1913],
33	%	NN	PERCENT	%	amod	35	SENT_207	[p11l1477t1859r1610b1913],
34	conﬁdence	NN	O	conﬁdence	nn	35	SENT_207	[p11l1638t1859r1965b1913],
35	intervals	NNS	O	interval	prep_with	30	SENT_207	[p11l1989t1859r2150b1913, p11l8t1948r126b2001],
36	in	IN	O	in	_	0	SENT_207	[p11l156t1947r213b2000],
37	parentheses	NNS	O	parenthesis	prep_in	35	SENT_207	[p11l240t1947r612b2016],
38	;	:	O	;	_	0	SENT_207	[p11l240t1947r612b2016],
39	Ref	NNP	O	Ref	dep	42	SENT_207	[p11l645t1947r769b2010],
40	,	,	O	,	_	0	SENT_207	[p11l645t1947r769b2010],
41	reference	NN	O	reference	nn	42	SENT_207	[p11l800t1947r1082b2001],
42	group	NN	O	group	parataxis	13	SENT_207	[p11l1112t1964r1301b2016],
43	.	.	O	.	_	0	SENT_207	[p11l1112t1964r1301b2016],

1	CI	NN	O	ci	_	0	SENT_208	[p11l9t2178r87b2234],
2	0.6	CD	NUMBER	0.6	num	1	SENT_208	[p11l123t2178r421b2245],
3	—	CD	NUMBER	—	number	4	SENT_208	[p11l123t2178r421b2245],
4	12	CD	NUMBER	12	num	1	SENT_208	[p11l123t2178r421b2245],
5	.	.	O	.	_	0	SENT_208	[p11l123t2178r421b2245],

1	l	NN	O	l	_	0	SENT_209	[p11l123t2178r421b2245],
2	;	:	O	;	_	0	SENT_209	[p11l123t2178r421b2245],
3	ORAG	NNP	O	ORAG	dep	1	SENT_209	[p11l462t2179r897b2259],
4	,	,	O	,	_	0	SENT_209	[p11l462t2179r897b2259],
5	GG_high	NNP	O	GG_high	appos	1	SENT_209	[p11l462t2179r897b2259],
6	:	:	O	:	_	0	SENT_209	[p11l929t2203r983b2223],
7	8.4	CD	NUMBER	8.4	dep	5	SENT_209	[p11l1018t2178r1130b2245],
8	,	,	O	,	_	0	SENT_209	[p11l1018t2178r1130b2245],
9	95	CD	PERCENT	95	number	10	SENT_209	[p11l1170t2178r1311b2235],
10	%	NN	PERCENT	%	amod	12	SENT_209	[p11l1170t2178r1311b2235],
11	CI	NN	O	ci	nn	12	SENT_209	[p11l1351t2178r1429b2234],
12	l.	NN	O	l.	appos	7	SENT_209	[p11l1472t2178r1761b2245],
13	4	CD	NUMBER	4	dep	1	SENT_209	[p11l1472t2178r1761b2245],
14	—	CD	NUMBER	—	number	15	SENT_209	[p11l1472t2178r1761b2245],
15	49.9	CD	NUMBER	49.9	dep	13	SENT_209	[p11l1472t2178r1761b2245],
16	,	,	O	,	_	0	SENT_209	[p11l1472t2178r1761b2245],
17	phomogeneity	NN	O	phomogeneity	appos	1	SENT_209	[p11l1799t2178r2149b2251, p11l8t2276r167b2348],
18	=	JJ	O	=	amod	17	SENT_209	[p11l200t2301r254b2320],
19	0.03	CD	NUMBER	0.03	tmod	18	SENT_209	[p11l286t2276r441b2342],
20	,	,	O	,	_	0	SENT_209	[p11l286t2276r441b2342],
21	p	NN	O	p	nn	23	SENT_209	[p11l486t2276r718b2348],
22	—	NN	O	—	nn	23	SENT_209	[p11l486t2276r718b2348],
23	trend	NN	O	trend	appos	1	SENT_209	[p11l486t2276r718b2348],
24	=	JJ	O	=	amod	26	SENT_209	[p11l750t2301r804b2320],
25	0.005	CD	NUMBER	0.005	tmod	24	SENT_209	[p11l836t2276r1057b2345],
26	)	NN	O	)	dep	23	SENT_209	[p11l836t2276r1057b2345],
27	.	.	O	.	_	0	SENT_209	[p11l836t2276r1057b2345],

1	The	DT	O	the	det	2	SENT_210	[p11l1104t2276r1227b2332],
2	trend	NN	O	trend	nsubj	4	SENT_210	[p11l1270t2276r1434b2332],
3	remained	VBD	O	remain	cop	4	SENT_210	[p11l1476t2276r1776b2332],
4	signiﬁcant	JJ	O	signiﬁcant	dep	18	SENT_210	[p11l1821t2276r2152b2348],
5	when	WRB	O	when	advmod	6	SENT_210	[p11l9t2373r181b2429],
6	adjusting	VBG	O	adjust	advcl	4	SENT_210	[p11l219t2373r510b2445],
7	for	IN	O	for	_	0	SENT_210	[p11l547t2373r640b2429],
8	age	NN	O	age	nn	9	SENT_210	[p11l678t2391r786b2445],
9	group	NN	O	group	prep_for	6	SENT_210	[p11l823t2390r1025b2445],
10	,	,	O	,	_	0	SENT_210	[p11l823t2390r1025b2445],
11	cumulative	JJ	O	cumulative	amod	14	SENT_210	[p11l1065t2373r1419b2429],
12	cisplatin	NN	O	cisplatin	nn	14	SENT_210	[p11l1456t2373r1728b2445],
13	dose	NN	O	dose	nn	14	SENT_210	[p11l1765t2373r1910b2429],
14	group	NN	O	group	prep_for	6	SENT_210	[p11l1947t2391r2149b2445],
15	,	,	O	,	_	0	SENT_210	[p11l1947t2391r2149b2445],
16	and	CC	O	and	_	0	SENT_210	[p11l10t2470r123b2526],
17	amifostine	NN	O	amifostine	prep_for	6	SENT_210	[p11l154t2470r491b2526],
18	use	VBP	O	use	_	0	SENT_210	[p11l522t2488r626b2526],
19	(	CD	NUMBER	(	num	20	SENT_210	[p11l660t2471r732b2539],
20	P	NN	O	p	nsubj	21	SENT_210	[p11l660t2471r732b2539],
21	=	JJ	O	=	xcomp	18	SENT_210	[p11l764t2495r818b2515],
22	0.02	CD	NUMBER	0.02	nsubj	18	SENT_210	[p11l850t2470r1005b2536],
23	,	,	O	,	_	0	SENT_210	[p11l850t2470r1005b2536],
24	n	NN	O	n	appos	22	SENT_210	[p11l1038t2488r1077b2525],
25	=	JJ	O	=	amod	27	SENT_210	[p11l1108t2495r1163b2515],
26	67	CD	NUMBER	67	tmod	25	SENT_210	[p11l1196t2470r1315b2539],
27	)	NN	O	)	dep	24	SENT_210	[p11l1196t2470r1315b2539],
28	.	.	O	.	_	0	SENT_210	[p11l1196t2470r1315b2539],

1	Of	IN	O	of	_	0	SENT_211	[p11l117t2567r203b2623],
2	the	DT	O	the	det	4	SENT_211	[p11l226t2567r322b2623],
3	86	CD	NUMBER	86	num	4	SENT_211	[p11l353t2567r427b2623],
4	patients	NNS	O	patient	prep_of	10	SENT_211	[p11l455t2567r704b2639],
5	genotyped	VBD	O	genotype	partmod	4	SENT_211	[p11l734t2567r1084b2639],
6	,	,	O	,	_	0	SENT_211	[p11l734t2567r1084b2639],
7	17	CD	NUMBER	17	num	8	SENT_211	[p11l1123t2567r1191b2623],
8	patients	NNS	O	patient	nsubjpass	10	SENT_211	[p11l1220t2567r1469b2639],
9	were	VBD	O	be	auxpass	10	SENT_211	[p11l1498t2584r1652b2623],
10	excluded	VBN	O	exclude	_	0	SENT_211	[p11l1681t2567r1970b2623],
11	from	IN	O	from	_	0	SENT_211	[p11l1998t2567r2152b2623],
12	the	DT	O	the	det	14	SENT_211	[p11l8t2664r104b2720],
13	ototoxicity	NN	O	ototoxicity	nn	14	SENT_211	[p11l134t2664r481b2736],
14	analyses	NNS	O	analysis	prep_from	10	SENT_211	[p11l512t2664r798b2736],
15	:	:	O	:	_	0	SENT_211	[p11l512t2664r798b2736],
16	four	CD	NUMBER	four	dobj	10	SENT_211	[p11l833t2664r966b2720],
17	with	IN	O	with	_	0	SENT_211	[p11l994t2664r1135b2720],
18	pre-existing	JJ	O	pre-existing	amod	20	SENT_211	[p11l1162t2664r1545b2736],
19	hearing	NN	O	hearing	nn	20	SENT_211	[p11l1574t2664r1813b2736],
20	loss	NN	O	loss	prep_with	16	SENT_211	[p11l1843t2664r1983b2730],
21	,	,	O	,	_	0	SENT_211	[p11l1843t2664r1983b2730],
22	nine	CD	NUMBER	nine	conj_and	16	SENT_211	[p11l2014t2664r2151b2720],
23	who	WP	O	who	nsubjpass	25	SENT_211	[p11l8t2761r143b2817],
24	were	VBD	O	be	auxpass	25	SENT_211	[p11l174t2779r327b2817],
25	lost	VBN	O	lose	rcmod	22	SENT_211	[p11l358t2761r473b2817],
26	to	TO	O	to	_	0	SENT_211	[p11l503t2769r563b2817],
27	follow-up	JJ	O	follow-up	amod	33	SENT_211	[p11l595t2761r907b2834],
28	prior	JJ	O	prior	_	0	SENT_211	[p11l937t2761r1095b2834],
29	to	TO	O	to	_	0	SENT_211	[p11l1124t2770r1183b2817],
30	1	CD	DURATION	1	prep_prior_to	27	SENT_211	[p11l1223t2762r1246b2816],
31	year	NN	NUMBER	year	tmod	27	SENT_211	[p11l1284t2779r1422b2834],
32	post-primary	JJ	O	post-primary	amod	33	SENT_211	[p11l1450t2761r1865b2834],
33	therapy	NN	O	therapy	prep_to	25	SENT_211	[p11l1896t2761r2149b2834],
34	,	,	O	,	_	0	SENT_211	[p11l1896t2761r2149b2834],
35	and	CC	O	and	_	0	SENT_211	[p11l10t2857r123b2913],
36	four	CD	NUMBER	four	conj_and	16	SENT_211	[p11l172t2857r305b2913],
37	who	WP	O	who	nsubj	38	SENT_211	[p11l352t2857r487b2913],
38	received	VBD	O	receive	rcmod	36	SENT_211	[p11l536t2857r807b2913],
39	focal	JJ	O	focal	amod	40	SENT_211	[p11l855t2857r1014b2913],
40	radiation	NN	O	radiation	dobj	38	SENT_211	[p11l1063t2857r1349b2913],
41	alone	RB	O	alone	advmod	38	SENT_211	[p11l1399t2857r1586b2913],
42	.	.	O	.	_	0	SENT_211	[p11l1399t2857r1586b2913],

1	Among	IN	O	among	_	0	SENT_212	[p11l1639t2858r1878b2930],
2	the	DT	O	the	det	4	SENT_212	[p11l1928t2857r2024b2913],
3	69	CD	NUMBER	69	num	4	SENT_212	[p11l2074t2857r2149b2914],
4	patients	NNS	O	patient	prep_among	15	SENT_212	[p11l7t2955r256b3027],
5	in	IN	O	in	_	0	SENT_212	[p11l292t2955r353b3010],
6	the	DT	O	the	det	8	SENT_212	[p11l388t2955r484b3011],
7	ototoxicity	NN	O	ototoxicity	nn	8	SENT_212	[p11l520t2955r866b3027],
8	analyses	NNS	O	analysis	prep_in	4	SENT_212	[p11l904t2955r1190b3027],
9	,	,	O	,	_	0	SENT_212	[p11l904t2955r1190b3027],
10	68	CD	PERCENT	68	number	11	SENT_212	[p11l1230t2955r1304b3011],
11	(	CD	PERCENT	(	nsubj	15	SENT_212	[p11l1344t2955r1538b3024],
12	99	CD	PERCENT	99	num	13	SENT_212	[p11l1344t2955r1538b3024],
13	%	NN	PERCENT	%	dep	11	SENT_212	[p11l1344t2955r1538b3024],
14	)	CD	NUMBER	)	dep	11	SENT_212	[p11l1344t2955r1538b3024],
15	received	VBD	O	receive	_	0	SENT_212	[p11l1575t2955r1846b3011],
16	cisplatin	NN	O	cisplatin	nsubj	23	SENT_212	[p11l1880t2955r2152b3027],
17	and	CC	O	and	_	0	SENT_212	[p11l10t3052r123b3108],
18	69	CD	PERCENT	69	num	19	SENT_212	[p11l150t3052r226b3109],
19	(	NN	PERCENT	(	conj_and	16	SENT_212	[p11l256t3052r491b3121],
20	100	CD	PERCENT	100	number	21	SENT_212	[p11l256t3052r491b3121],
21	%	NN	PERCENT	%	amod	19	SENT_212	[p11l256t3052r491b3121],
22	)	CD	NUMBER	)	dep	19	SENT_212	[p11l256t3052r491b3121],
23	received	VBD	O	receive	ccomp	15	SENT_212	[p11l518t3052r790b3108],
24	CS1	NN	O	cs1	dobj	23	SENT_212	[p11l816t3052r938b3108],
25	with	IN	O	with	_	0	SENT_212	[p11l965t3052r1106b3108],
26	24	CD	NUMBER	24	prep_with	23	SENT_212	[p11l1133t3052r1210b3107],
27	of	IN	O	of	_	0	SENT_212	[p11l1238t3052r1307b3108],
28	69	CD	NUMBER	69	num	29	SENT_212	[p11l1330t3052r1405b3109],
29	patients	NNS	O	patient	prep_of	26	SENT_212	[p11l1432t3052r1681b3125],
30	(	IN	O	(	_	0	SENT_212	[p11l1712t3052r1906b3121],
31	35	CD	PERCENT	35	num	32	SENT_212	[p11l1712t3052r1906b3121],
32	%	NN	PERCENT	%	nsubj	34	SENT_212	[p11l1712t3052r1906b3121],
33	)	CD	NUMBER	)	dep	32	SENT_212	[p11l1712t3052r1906b3121],
34	requiring	VBG	O	require	prepc_(	23	SENT_212	[p11l1934t3052r2150b3125, p11l8t3148r108b3221],
35	hearing	NN	O	hearing	nn	36	SENT_212	[p11l145t3148r384b3221],
36	aids	NNS	O	aid	dobj	34	SENT_212	[p11l423t3148r565b3204],
37	.	.	O	.	_	0	SENT_212	[p11l423t3148r565b3204],

1	In	IN	O	in	_	0	SENT_213	[p11l606t3150r672b3204],
2	analyses	NNS	O	analysis	nsubj	3	SENT_213	[p11l709t3148r977b3221],
3	involving	VBG	O	involve	prepc_in	20	SENT_213	[p11l1015t3148r1318b3221],
4	the	DT	O	the	det	7	SENT_213	[p11l1355t3148r1451b3204],
5	cumulative	JJ	O	cumulative	amod	7	SENT_213	[p11l1489t3148r1843b3204],
6	cisplatin	NN	O	cisplatin	nn	7	SENT_213	[p11l1880t3148r2152b3221],
7	dose	NN	O	dose	dobj	3	SENT_213	[p11l9t3246r171b3312],
8	,	,	O	,	_	0	SENT_213	[p11l9t3246r171b3312],
9	two	CD	NUMBER	two	num	10	SENT_213	[p11l205t3255r323b3303],
10	children	NNS	O	child	nsubjpass	20	SENT_213	[p11l355t3246r634b3312],
11	,	,	O	,	_	0	SENT_213	[p11l355t3246r634b3312],
12	for	IN	O	for	_	0	SENT_213	[p11l669t3246r762b3302],
13	whom	WP	O	whom	rel	17	SENT_213	[p11l792t3246r991b3302],
14	dose	NN	O	dose	nn	15	SENT_213	[p11l1023t3246r1167b3302],
15	information	NN	O	information	nsubj	17	SENT_213	[p11l1199t3246r1578b3302],
16	was	VBD	O	be	cop	17	SENT_213	[p11l1609t3264r1730b3302],
17	unavailable	JJ	O	unavailable	rcmod	10	SENT_213	[p11l1763t3246r2148b3312],
18	,	,	O	,	_	0	SENT_213	[p11l1763t3246r2148b3312],
19	were	VBD	O	be	auxpass	20	SENT_213	[p11l8t3361r162b3399],
20	excluded	VBN	O	exclude	_	0	SENT_213	[p11l224t3343r528b3399],
21	.	.	O	.	_	0	SENT_213	[p11l224t3343r528b3399],

1	The	DT	O	the	det	5	SENT_214	[p11l594t3343r717b3399],
2	median	JJ	O	median	amod	5	SENT_214	[p11l778t3343r1014b3399],
3	cumulative	JJ	O	cumulative	amod	5	SENT_214	[p11l1076t3343r1429b3399],
4	cisplatin	NN	O	cisplatin	nn	5	SENT_214	[p11l1492t3343r1763b3416],
5	dose	NN	O	dose	nsubj	9	SENT_214	[p11l1824t3343r1968b3399],
6	was	VBD	O	be	cop	9	SENT_214	[p11l2029t3361r2150b3399],
7	300	CD	NUMBER	300	num	9	SENT_214	[p11l10t3440r126b3496],
8	mg/m2	NN	O	mg/m2	nn	9	SENT_214	[p11l155t3423r372b3512],
9	(	NN	O	(	_	0	SENT_214	[p11l401t3440r602b3512],
10	range	NN	O	range	nn	13	SENT_214	[p11l401t3440r602b3512],
11	0-720	CD	NUMBER	0-720	num	13	SENT_214	[p11l630t3440r828b3496],
12	mg/m2	NN	O	mg/m2	nn	13	SENT_214	[p11l858t3423r1117b3512],
13	)	NN	O	)	dep	9	SENT_214	[p11l858t3423r1117b3512],
14	.	.	O	.	_	0	SENT_214	[p11l858t3423r1117b3512],

1	The	DT	O	the	det	5	SENT_215	[p11l1148t3439r1271b3495],
2	mean	NN	O	mean	nn	5	SENT_215	[p11l1298t3457r1471b3495],
3	cumulative	JJ	O	cumulative	amod	5	SENT_215	[p11l1499t3439r1853b3495],
4	cisplatin	NN	O	cisplatin	nn	5	SENT_215	[p11l1880t3439r2152b3512],
5	doses	NNS	O	dose	nsubj	11	SENT_215	[p11l9t3537r183b3593],
6	for	IN	O	for	_	0	SENT_215	[p11l229t3537r322b3593],
7	those	DT	O	those	prep_for	5	SENT_215	[p11l364t3537r531b3593],
8	requiring	VBG	O	require	partmod	7	SENT_215	[p11l575t3537r869b3609],
9	hearing	NN	O	hearing	nn	10	SENT_215	[p11l912t3537r1152b3609],
10	aids	NNS	O	aid	dobj	8	SENT_215	[p11l1199t3537r1323b3593],
11	(	VBP	O	(	_	0	SENT_215	[p11l1371t3537r1574b3606],
12	302.6	CD	NUMBER	302.6	num	13	SENT_215	[p11l1371t3537r1574b3606],
13	mg/m2	NN	O	mg/m2	dobj	11	SENT_215	[p11l1603t3520r1837b3609],
14	,	,	O	,	_	0	SENT_215	[p11l1603t3520r1837b3609],
15	95	CD	PERCENT	95	number	16	SENT_215	[p11l1885t3537r2026b3594],
16	%	NN	PERCENT	%	amod	17	SENT_215	[p11l1885t3537r2026b3594],
17	CI	NN	O	ci	appos	13	SENT_215	[p11l2074t3537r2151b3593],
18	263	CD	NUMBER	263	dep	17	SENT_215	[p11l9t3634r432b3703],
19	.	.	O	.	_	0	SENT_215	[p11l9t3634r432b3703],

1	l	NN	O	l	_	0	SENT_216	[p11l9t3634r432b3703],
2	—	CD	NUMBER	—	number	3	SENT_216	[p11l9t3634r432b3703],
3	342	CD	NUMBER	342	num	1	SENT_216	[p11l9t3634r432b3703],
4	.	.	O	.	_	0	SENT_216	[p11l9t3634r432b3703],

1	l	NN	O	l	nn	2	SENT_217	[p11l9t3634r432b3703],
2	)	NN	O	)	_	0	SENT_217	[p11l9t3634r432b3703],
3	and	CC	O	and	_	0	SENT_217	[p11l497t3634r610b3690],
4	those	DT	O	those	conj_and	2	SENT_217	[p11l669t3634r836b3690],
5	not	RB	O	not	neg	8	SENT_217	[p11l897t3643r999b3690],
6	(	JJ	O	(	amod	8	SENT_217	[p11l1060t3634r1260b3703],
7	328.5	CD	NUMBER	328.5	num	8	SENT_217	[p11l1060t3634r1260b3703],
8	mg/m2	NN	O	mg/m2	dep	2	SENT_217	[p11l1292t3617r1526b3707],
9	,	,	O	,	_	0	SENT_217	[p11l1292t3617r1526b3707],
10	95	CD	PERCENT	95	number	11	SENT_217	[p11l1590t3634r1731b3691],
11	%	NN	PERCENT	%	amod	12	SENT_217	[p11l1590t3634r1731b3691],
12	CI	NN	O	ci	appos	8	SENT_217	[p11l1795t3634r1872b3690],
13	294.4362	CD	NUMBER	294.4362	dep	12	SENT_217	[p11l1934t3634r2153b3691, p11l10t3730r211b3799],
14	.	.	O	.	_	0	SENT_217	[p11l1934t3634r2153b3691, p11l10t3730r211b3799],

1	l	NN	O	l	tmod	8	SENT_218	[p11l1934t3634r2153b3691, p11l10t3730r211b3799],
2	)	CD	NUMBER	)	nsubj	8	SENT_218	[p11l1934t3634r2153b3691, p11l10t3730r211b3799],
3	were	VBD	O	be	cop	8	SENT_218	[p11l245t3748r398b3786],
4	not	RB	O	not	neg	8	SENT_218	[p11l429t3739r531b3786],
5	statistically	RB	O	statistically	advmod	6	SENT_218	[p11l563t3730r926b3803],
6	different	JJ	O	different	amod	8	SENT_218	[p11l958t3730r1232b3786],
7	(	NN	O	(	nn	8	SENT_218	[p11l1264t3731r1336b3799],
8	P	NN	O	p	_	0	SENT_218	[p11l1264t3731r1336b3799],
9	=	JJ	O	=	amod	8	SENT_218	[p11l1368t3756r1422b3775],
10	0.31	CD	NUMBER	0.31	num	11	SENT_218	[p11l1454t3731r1635b3799],
11	)	NN	O	)	dep	9	SENT_218	[p11l1454t3731r1635b3799],
12	.	.	O	.	_	0	SENT_218	[p11l1454t3731r1635b3799],

1	There	EX	O	there	expl	2	SENT_219	[p12l116t19r301b75],
2	were	VBD	O	be	_	0	SENT_219	[p12l344t37r497b75],
3	no	DT	O	no	det	4	SENT_219	[p12l541t37r618b75],
4	differences	NNS	O	difference	iobj	2	SENT_219	[p12l663t19r1015b75],
5	in	IN	O	in	_	0	SENT_219	[p12l1060t19r1121b74],
6	other	JJ	O	other	amod	7	SENT_219	[p12l1165t19r1329b75],
7	toxicities	NNS	O	toxicity	prep_in	4	SENT_219	[p12l1371t19r1663b75],
8	based	VBN	O	base	partmod	7	SENT_219	[p12l1708t19r1890b75],
9	on	IN	O	on	_	0	SENT_219	[p12l1934t37r2012b75],
10	the	DT	O	the	det	11	SENT_219	[p12l2055t19r2151b75],
11	GSTPI	NN	O	gstpus	prep_on	8	SENT_219	[p12l11t117r232b173],
12	105	CD	NUMBER	105	num	11	SENT_219	[p12l285t116r392b172],
13	A	DT	O	a	det	16	SENT_219	[p12l435t117r492b171],
14	>	JJR	O	>	amod	16	SENT_219	[p12l525t128r575b174],
15	G	NN	O	g	nn	16	SENT_219	[p12l608t116r663b172],
16	genotype	NN	O	genotype	dep	4	SENT_219	[p12l702t125r1011b189],
17	.	.	O	.	_	0	SENT_219	[p12l702t125r1011b189],

1	Additionally	RB	O	additionally	advmod	14	SENT_220	[p12l1054t116r1472b189],
2	,	,	O	,	_	0	SENT_220	[p12l1054t116r1472b189],
3	no	DT	O	no	det	4	SENT_220	[p12l1514t134r1592b172],
4	relationship	NN	O	relationship	nsubjpass	14	SENT_220	[p12l1631t116r2010b189],
5	between	IN	O	between	_	0	SENT_220	[p12l2050t116r2149b172, p12l8t221r199b268],
6	the	DT	O	the	det	7	SENT_220	[p12l227t212r323b268],
7	toxicities	NNS	O	toxicity	prep_between	4	SENT_220	[p12l353t212r646b268],
8	and	CC	O	and	_	0	SENT_220	[p12l678t212r791b268],
9	the	DT	O	the	det	12	SENT_220	[p12l820t212r916b268],
10	GSTpi	NNP	O	GSTpi	nn	12	SENT_220	[p12l947t212r1157b285],
11	IHC	NNP	ORGANIZATION	IHC	nn	12	SENT_220	[p12l1187t213r1321b269],
12	score	NN	NUMBER	score	prep_between	4	SENT_220	[p12l1354t230r1519b268],
13	was	VBD	O	be	auxpass	14	SENT_220	[p12l1547t230r1668b268],
14	demonstrated	VBN	O	demonstrate	_	0	SENT_220	[p12l1699t212r2147b268],
15	.	.	O	.	_	0	SENT_220	[p12l1699t212r2147b268],

1	DISCUSSION	NN	O	discussion	_	0	SENT_221	[p12l14t390r537b454],

1	We	PRP	O	we	nsubj	2	SENT_222	[p12l114t552r219b607],
2	observed	VBD	O	observe	_	0	SENT_222	[p12l258t551r546b607],
3	that	IN	O	that	complm	15	SENT_222	[p12l582t551r702b607],
4	patients	NNS	O	patient	nsubj	15	SENT_222	[p12l737t551r986b623],
5	in	IN	O	in	_	0	SENT_222	[p12l1025t551r1086b606],
6	the	DT	O	the	det	7	SENT_222	[p12l1123t551r1219b607],
7	GSTPI	NN	O	gstpus	prep_in	4	SENT_222	[p12l1259t551r1480b607],
8	105	CD	NUMBER	105	num	10	SENT_222	[p12l1532t551r1639b607],
9	AG/GG	NN	O	ag/gg	nn	10	SENT_222	[p12l1679t551r1929b607],
10	group	NN	O	group	dep	7	SENT_222	[p12l1967t569r2151b623],
11	were	VBD	O	be	cop	15	SENT_222	[p12l8t666r162b704],
12	four	CD	NUMBER	four	num	13	SENT_222	[p12l201t648r334b704],
13	times	NNS	O	time	npadvmod	14	SENT_222	[p12l370t648r541b704],
14	more	RBR	O	more	advmod	15	SENT_222	[p12l581t666r744b704],
15	likely	JJ	O	likely	ccomp	2	SENT_222	[p12l783t648r964b721],
16	to	TO	O	to	aux	17	SENT_222	[p12l1003t656r1062b704],
17	require	VB	O	require	xcomp	15	SENT_222	[p12l1100t648r1327b721],
18	hearing	NN	O	hearing	nn	19	SENT_222	[p12l1365t648r1604b721],
19	aids	NNS	O	aid	dobj	17	SENT_222	[p12l1645t648r1769b704],
20	than	IN	O	than	_	0	SENT_222	[p12l1809t648r1946b704],
21	those	DT	O	those	prep_than	17	SENT_222	[p12l1984t648r2151b704],
22	with	IN	O	with	_	0	SENT_222	[p12l8t745r149b801],
23	the	DT	O	the	det	25	SENT_222	[p12l177t745r274b801],
24	AA	NNP	O	AA	nn	25	SENT_222	[p12l303t745r416b800],
25	genotype	NN	O	genotype	prep_with	21	SENT_222	[p12l445t753r754b817],
26	.	.	O	.	_	0	SENT_222	[p12l445t753r754b817],

1	Moreover	RB	O	moreover	advmod	22	SENT_223	[p12l787t746r1115b811],
2	,	,	O	,	_	0	SENT_223	[p12l787t746r1115b811],
3	exploratory	NN	O	exploratory	nn	4	SENT_223	[p12l1147t745r1515b817],
4	analyses	NNS	O	analysis	nsubj	22	SENT_223	[p12l1546t745r1832b817],
5	,	,	O	,	_	0	SENT_223	[p12l1546t745r1832b817],
6	based	VBN	O	base	partmod	4	SENT_223	[p12l1862t745r2045b801],
7	on	IN	O	on	_	0	SENT_223	[p12l2074t762r2151b801],
8	combinations	NNS	O	combination	prep_on	6	SENT_223	[p12l9t842r439b898],
9	of	IN	O	of	_	0	SENT_223	[p12l475t842r544b898],
10	the	DT	O	the	det	11	SENT_223	[p12l572t842r668b898],
11	GSTPI	NN	O	gstpus	prep_of	8	SENT_223	[p12l705t842r926b898],
12	105	CD	NUMBER	105	num	11	SENT_223	[p12l973t842r1080b898],
13	A	DT	O	a	det	16	SENT_223	[p12l1117t842r1173b897],
14	>	JJR	O	>	amod	16	SENT_223	[p12l1206t853r1256b900],
15	G	NN	O	g	nn	16	SENT_223	[p12l1289t842r1344b898],
16	genotype	NN	O	genotype	tmod	6	SENT_223	[p12l1377t850r1669b914],
17	and	CC	O	and	_	0	SENT_223	[p12l1704t842r1817b898],
18	CSI	NNP	O	CSI	nn	20	SENT_223	[p12l1851t842r1973b898],
19	dose	NN	O	dose	nn	20	SENT_223	[p12l2007t842r2151b898],
20	group	NN	O	group	conj_and	16	SENT_223	[p12l9t957r211b1012],
21	,	,	O	,	_	0	SENT_223	[p12l9t957r211b1012],
22	suggests	VBZ	O	suggest	_	0	SENT_223	[p12l263t948r528b1012],
23	a	DT	O	a	det	25	SENT_223	[p12l579t957r611b995],
24	novel	JJ	O	novel	amod	25	SENT_223	[p12l657t939r832b995],
25	interaction	NN	O	interaction	dobj	22	SENT_223	[p12l879t939r1240b1005],
26	,	,	O	,	_	0	SENT_223	[p12l879t939r1240b1005],
27	characterized	VBN	O	characterize	partmod	25	SENT_223	[p12l1290t939r1718b995],
28	by	IN	O	by	_	0	SENT_223	[p12l1764t939r1843b1012],
29	the	DT	O	the	det	31	SENT_223	[p12l1890t939r1986b995],
30	risk	NN	O	risk	nn	31	SENT_223	[p12l2032t939r2153b995],
31	allele	NN	O	allele	agent	27	SENT_223	[p12l10t1035r181b1091],
32	conferring	VBG	O	confer	partmod	31	SENT_223	[p12l230t1035r562b1108],
33	greater	JJR	O	greater	amod	34	SENT_223	[p12l611t1044r834b1108],
34	risk	NN	O	risk	dobj	32	SENT_223	[p12l879t1035r1000b1091],
35	in	IN	O	in	_	0	SENT_223	[p12l1046t1035r1107b1091],
36	individuals	NNS	O	individual	prep_in	32	SENT_223	[p12l1154t1035r1507b1092],
37	treated	VBN	O	treat	partmod	36	SENT_223	[p12l1556t1035r1775b1091],
38	with	IN	O	with	_	0	SENT_223	[p12l1822t1035r1963b1091],
39	high	JJ	O	high	amod	41	SENT_223	[p12l2010t1035r2152b1108],
40	radiation	NN	O	radiation	nn	41	SENT_223	[p12l7t1133r294b1189],
41	doses	NNS	O	dose	prep_with	37	SENT_223	[p12l324t1133r498b1189],
42	than	IN	O	than	_	0	SENT_223	[p12l530t1133r667b1189],
43	those	DT	O	those	prep_than	37	SENT_223	[p12l697t1133r865b1189],
44	treated	VBN	O	treat	partmod	43	SENT_223	[p12l896t1133r1114b1189],
45	with	IN	O	with	_	0	SENT_223	[p12l1145t1133r1285b1189],
46	low	JJ	O	low	amod	47	SENT_223	[p12l1316t1133r1432b1189],
47	doses	NNS	O	dose	prep_with	44	SENT_223	[p12l1464t1133r1655b1189],
48	.	.	O	.	_	0	SENT_223	[p12l1464t1133r1655b1189],

1	The	DT	O	the	det	3	SENT_224	[p12l116t1230r238b1286],
2	primary	JJ	O	primary	amod	3	SENT_224	[p12l301t1230r554b1303],
3	mechanism	NN	O	mechanism	nsubj	7	SENT_224	[p12l617t1230r984b1286],
4	of	IN	O	of	_	0	SENT_224	[p12l1047t1230r1116b1286],
5	platinum-induced	JJ	O	platinum-induced	amod	6	SENT_224	[p12l1172t1230r1741b1303],
6	ototoxicity	NN	O	ototoxicity	prep_of	3	SENT_224	[p12l1804t1230r2151b1303],
7	occurs	VBZ	O	occur	dep	24	SENT_224	[p12l9t1344r215b1382],
8	through	IN	O	through	_	0	SENT_224	[p12l245t1326r493b1399],
9	the	DT	O	the	det	10	SENT_224	[p12l521t1326r618b1382],
10	generation	NN	O	generation	prep_through	7	SENT_224	[p12l646t1326r984b1399],
11	of	IN	O	of	_	0	SENT_224	[p12l1014t1326r1083b1382],
12	free	JJ	O	free	amod	13	SENT_224	[p12l1105t1326r1227b1382],
13	radicals	NNS	O	radical	prep_of	10	SENT_224	[p12l1256t1326r1522b1392],
14	,	,	O	,	_	0	SENT_224	[p12l1256t1326r1522b1392],
15	leading	VBG	O	lead	xcomp	7	SENT_224	[p12l1554t1326r1789b1399],
16	to	TO	O	to	_	0	SENT_224	[p12l1818t1335r1878b1382],
17	apoptosis	NN	O	apoptosis	prep_to	15	SENT_224	[p12l1909t1335r2149b1399, p12l11t1424r89b1480],
18	of	IN	O	of	_	0	SENT_224	[p12l128t1424r197b1480],
19	the	DT	O	the	det	22	SENT_224	[p12l228t1424r324b1480],
20	cochlear	JJ	O	cochlear	amod	22	SENT_224	[p12l361t1424r633b1480],
21	outer	JJ	O	outer	amod	22	SENT_224	[p12l669t1432r833b1480],
22	hair	NN	O	hair	prep_of	17	SENT_224	[p12l867t1424r993b1480],
23	cells	NNS	O	cell	nsubj	24	SENT_224	[p12l1028t1424r1171b1480],
24	[	VBP	O	[	_	0	SENT_224	[p12l1215t1424r1357b1492],
25	19	CD	NUMBER	19	num	26	SENT_224	[p12l1215t1424r1357b1492],
26	]	CD	NUMBER	]	dobj	24	SENT_224	[p12l1215t1424r1357b1492],
27	.	.	O	.	_	0	SENT_224	[p12l1215t1424r1357b1492],

1	This	DT	O	this	nsubj	2	SENT_225	[p12l1397t1424r1537b1480],
2	produces	VBZ	O	produce	_	0	SENT_225	[p12l1573t1424r1861b1496],
3	sensorineural	JJ	O	sensorineural	amod	8	SENT_225	[p12l1902t1424r2149b1480, p12l8t1521r207b1577],
4	hearing	NN	O	hearing	nn	8	SENT_225	[p12l233t1521r473b1594],
5	loss	NN	O	loss	nn	8	SENT_225	[p12l500t1521r621b1577],
6	(	CD	NUMBER	(	num	8	SENT_225	[p12l651t1521r907b1590],
7	SNHL	NN	O	snhl	nn	8	SENT_225	[p12l651t1521r907b1590],
8	)	NN	O	)	dobj	2	SENT_225	[p12l651t1521r907b1590],
9	with	IN	O	with	_	0	SENT_225	[p12l936t1521r1077b1577],
10	the	DT	O	the	det	12	SENT_225	[p12l1103t1521r1199b1577],
11	high	JJ	O	high	amod	12	SENT_225	[p12l1225t1521r1367b1594],
12	frequencies	NNS	O	frequency	prep_with	8	SENT_225	[p12l1393t1521r1761b1594],
13	most	RBS	O	most	advmod	14	SENT_225	[p12l1789t1530r1944b1577],
14	likely	JJ	O	likely	amod	8	SENT_225	[p12l1970t1521r2151b1594],
15	affected	VBN	O	affect	partmod	8	SENT_225	[p12l10t1617r281b1673],
16	.	.	O	.	_	0	SENT_225	[p12l10t1617r281b1673],

1	The	DT	O	the	det	3	SENT_226	[p12l316t1617r439b1673],
2	hearing	NN	O	hearing	nn	3	SENT_226	[p12l471t1617r710b1690],
3	loss	NN	O	loss	nsubj	9	SENT_226	[p12l742t1617r863b1673],
4	is	VBZ	O	be	cop	6	SENT_226	[p12l896t1617r946b1673],
5	typically	RB	O	typically	advmod	6	SENT_226	[p12l978t1617r1258b1690],
6	permanent	JJ	O	permanent	_	0	SENT_226	[p12l1290t1625r1630b1690],
7	and	CC	O	and	_	0	SENT_226	[p12l1663t1617r1776b1673],
8	may	MD	O	may	aux	9	SENT_226	[p12l1806t1635r1943b1690],
9	occur	VB	O	occur	conj_or	9	SENT_226	[p12l1975t1635r2153b1673],
10	during	IN	O	during	_	0	SENT_226	[p12l9t1715r215b1787],
11	therapy	NN	O	therapy	prep_during	9	SENT_226	[p12l241t1715r480b1787],
12	or	CC	O	or	_	0	SENT_226	[p12l507t1733r573b1771],
13	in	IN	O	in	_	0	SENT_226	[p12l596t1715r657b1770],
14	the	DT	DURATION	the	det	15	SENT_226	[p12l681t1715r777b1771],
15	months	NNS	DURATION	month	prep_in	9	SENT_226	[p12l803t1715r1036b1771],
16	afterwards	RB	O	afterwards	advmod	9	SENT_226	[p12l1064t1715r1416b1771],
17	.	.	O	.	_	0	SENT_226	[p12l1064t1715r1416b1771],

1	Months	NNS	DURATION	month	nsubj	24	SENT_227	[p12l1445t1715r1687b1771],
2	to	TO	O	to	_	0	SENT_227	[p12l1714t1723r1773b1771],
3	years	NNS	DATE	year	prep_to	1	SENT_227	[p12l1799t1733r1966b1787],
4	later	RB	DATE	later	advmod	10	SENT_227	[p12l1992t1715r2149b1781],
5	,	,	O	,	_	0	SENT_227	[p12l1992t1715r2149b1781],
6	radiation	NN	O	radiation	nn	7	SENT_227	[p12l7t1812r294b1868],
7	therapy	NN	O	therapy	nsubj	10	SENT_227	[p12l324t1812r563b1885],
8	may	MD	O	may	aux	10	SENT_227	[p12l594t1830r731b1885],
9	also	RB	O	also	advmod	10	SENT_227	[p12l763t1812r888b1868],
10	cause	VB	O	cause	rcmod	3	SENT_227	[p12l921t1830r1096b1868],
11	SNHL	NNP	ORGANIZATION	SNHL	dobj	10	SENT_227	[p12l1129t1812r1352b1878],
12	,	,	O	,	_	0	SENT_227	[p12l1129t1812r1352b1878],
13	usually	RB	O	usually	advmod	14	SENT_227	[p12l1385t1812r1615b1885],
14	high-frequency	VBP	O	high-frequency	dep	11	SENT_227	[p12l1646t1812r2149b1885],
15	,	,	O	,	_	0	SENT_227	[p12l1646t1812r2149b1885],
16	via	IN	O	via	_	0	SENT_227	[p12l8t1908r106b1964],
17	cochlear	JJ	O	cochlear	amod	18	SENT_227	[p12l136t1908r408b1964],
18	injury	NN	O	injury	prep_via	11	SENT_227	[p12l437t1908r627b1981],
19	mediated	VBN	O	mediate	partmod	18	SENT_227	[p12l658t1908r953b1964],
20	by	IN	O	by	_	0	SENT_227	[p12l981t1908r1060b1981],
21	reactive	JJ	O	reactive	amod	23	SENT_227	[p12l1090t1908r1342b1964],
22	oxygen	NN	O	oxygen	nn	23	SENT_227	[p12l1374t1926r1608b1981],
23	species	NNS	O	species	agent	19	SENT_227	[p12l1641t1908r1867b1981],
24	[	VBP	O	[	_	0	SENT_227	[p12l1905t1909r2147b1976],
25	20,21	CD	NUMBER	20,21	number	26	SENT_227	[p12l1905t1909r2147b1976],
26	]	CD	NUMBER	]	dobj	24	SENT_227	[p12l1905t1909r2147b1976],
27	.	.	O	.	_	0	SENT_227	[p12l1905t1909r2147b1976],

1	Genetic	JJ	O	genetic	amod	2	SENT_228	[p12l9t2005r256b2062],
2	variations	NNS	O	variation	_	0	SENT_228	[p12l291t2005r604b2061],
3	in	IN	O	in	_	0	SENT_228	[p12l640t2005r700b2061],
4	GSTs	NNS	O	gst	prep_in	2	SENT_228	[p12l735t2006r931b2072],
5	,	,	O	,	_	0	SENT_228	[p12l735t2006r931b2072],
6	a	DT	O	a	det	9	SENT_228	[p12l970t2023r1003b2061],
7	major	JJ	O	major	amod	9	SENT_228	[p12l1035t2005r1223b2078],
8	enzyme	NN	O	enzyme	nn	9	SENT_228	[p12l1256t2023r1504b2078],
9	family	NN	O	family	appos	4	SENT_228	[p12l1539t2005r1746b2078],
10	involved	VBN	O	involve	partmod	9	SENT_228	[p12l1781t2005r2058b2062],
11	in	IN	O	in	prep	10	SENT_228	[p12l2091t2005r2151b2061],

1	GSTPI	NN	O	gstpus	_	0	SENT_229	[p12l1199t2153r1319b2182],
2	and	CC	O	and	_	0	SENT_229	[p12l1332t2153r1394b2181],
3	Ototoxicity	NN	O	ototoxicity	conj_and	1	SENT_229	[p12l1407t2153r1594b2189],
4	in	IN	O	in	_	0	SENT_229	[p12l1605t2153r1637b2181],
5	Medulloblastoma	NN	O	medulloblastoma	prep_in	1	SENT_229	[p12l1649t2153r1942b2181],
6	597	CD	NUMBER	597	num	5	SENT_229	[p12l2043t2153r2100b2181],

1	TABLE	NN	O	table	_	0	SENT_230	[p12l59t2239r174b2264],
2	HI	NN	O	hus	dep	1	SENT_230	[p12l187t2239r235b2264],
3	.	.	O	.	_	0	SENT_230	[p12l187t2239r235b2264],

1	Risk	NN	O	risk	_	0	SENT_231	[p12l254t2239r322b2264],
2	of	IN	O	of	_	0	SENT_231	[p12l335t2239r366b2264],
3	Severe	JJ	O	severe	amod	4	SENT_231	[p12l377t2239r475b2265],
4	Ototoxicity	NN	O	ototoxicity	prep_of	1	SENT_231	[p12l489t2239r656b2271],
5	by	IN	O	by	_	0	SENT_231	[p12l670t2239r706b2271],
6	Combination	NN	O	combination	prep_by	4	SENT_231	[p12l720t2239r916b2265],
7	of	IN	O	of	_	0	SENT_231	[p12l930t2239r961b2264],
8	GST	NN	O	gst	nn	9	SENT_231	[p12l971t2239r1039b2265],
9	P1	NN	O	p1	prep_of	6	SENT_231	[p12l1036t2239r1074b2264],
10	105	CD	NUMBER	105	num	9	SENT_231	[p12l1091t2239r1141b2264],
11	A	DT	O	a	det	14	SENT_231	[p12l1154t2239r1179b2264],
12	>	JJR	O	>	amod	14	SENT_231	[p12l1194t2244r1216b2265],
13	G	NN	O	g	nn	14	SENT_231	[p12l1230t2239r1255b2265],
14	Genotype	NN	O	genotype	dep	1	SENT_231	[p12l1270t2239r1413b2271],
15	and	CC	O	and	_	0	SENT_231	[p12l1427t2239r1482b2264],
16	Craniospinal	JJ	O	craniospinal	amod	20	SENT_231	[p12l1497t2239r1690b2271],
17	Radiation	NNP	O	Radiation	nn	20	SENT_231	[p12l1704t2239r1852b2264],
18	Dose	NNP	O	Dose	nn	20	SENT_231	[p12l1865t2239r1936b2264],
19	Group	NNP	O	Group	nn	20	SENT_231	[p12l1951t2239r2049b2271],
20	Genotype	NN	O	genotype	dep	1	SENT_231	[p12l59t2310r267b2342],
21	.	.	O	.	_	0	SENT_231	[p12l59t2310r267b2342],

1	—	NN	O	—	_	0	SENT_232	[p12l59t2310r267b2342],
2	.	.	O	.	_	0	SENT_232	[p12l59t2310r267b2342],

1	CSI	NNP	O	CSI	nn	4	SENT_233	[p12l59t2310r267b2342],
2	dose	NN	O	dose	nn	4	SENT_233	[p12l278t2310r341b2335],
3	group	NN	O	group	nn	4	SENT_233	[p12l352t2318r433b2342],
4	N	NN	O	n	dep	13	SENT_233	[p12l675t2311r699b2335],
5	(	CD	NUMBER	(	num	7	SENT_233	[p12l711t2310r826b2342],
6	hearing	NN	O	hearing	nn	7	SENT_233	[p12l711t2310r826b2342],
7	aid	NN	O	aid	dep	4	SENT_233	[p12l838t2310r890b2340],
8	)	CD	NUMBER	)	dep	7	SENT_233	[p12l838t2310r890b2340],
9	N	NN	O	n	dep	13	SENT_233	[p12l1132t2311r1157b2335],
10	(	CD	NUMBER	(	num	9	SENT_233	[p12l1169t2310r1213b2340],
11	no	DT	O	no	det	13	SENT_233	[p12l1169t2310r1213b2340],
12	hearing	NN	O	hearing	nn	13	SENT_233	[p12l1224t2310r1329b2342],
13	aid	NN	O	aid	dep	26	SENT_233	[p12l1341t2310r1393b2340],
14	)	CD	NUMBER	)	num	15	SENT_233	[p12l1341t2310r1393b2340],
15	OR	NN	O	or	dep	13	SENT_233	[p12l1663t2310r1710b2335],
16	95	CD	PERCENT	95	number	17	SENT_233	[p12l1985t2310r2047b2335],
17	%	NN	PERCENT	%	num	25	SENT_233	[p12l1985t2310r2047b2335],
18	CI	NN	O	ci	nn	25	SENT_233	[p12l2059t2310r2093b2335],
19	AA	NN	O	aa	nn	25	SENT_233	[p12l58t2378r178b2403],
20	—	CD	NUMBER	—	num	25	SENT_233	[p12l58t2378r178b2403],
21	low	JJ	O	low	amod	25	SENT_233	[p12l58t2378r178b2403],
22	3	CD	NUMBER	3	number	23	SENT_233	[p12l784t2378r798b2403],
23	16	CD	NUMBER	16	dep	21	SENT_233	[p12l1250t2378r1280b2403],
24	1	CD	NUMBER	1	dep	23	SENT_233	[p12l1639t2378r1649b2403],
25	(	NN	O	(	dep	15	SENT_233	[p12l1664t2378r1735b2409],
26	Ref	NN	O	ref	dep	29	SENT_233	[p12l1664t2378r1735b2409],
27	)	CD	NUMBER	)	num	26	SENT_233	[p12l1664t2378r1735b2409],
28	NA	NNP	O	NA	nn	29	SENT_233	[p12l2015t2378r2064b2403],
29	AA	NNP	O	AA	dep	36	SENT_233	[p12l58t2419r189b2451],
30	—	RB	O	—	advmod	31	SENT_233	[p12l58t2419r189b2451],
31	high	JJ	O	high	amod	33	SENT_233	[p12l58t2419r189b2451],
32	1	CD	NUMBER	1	number	33	SENT_233	[p12l787t2419r797b2443],
33	4	CD	NUMBER	4	dep	29	SENT_233	[p12l1264t2419r1281b2443],
34	1.3	CD	NUMBER	1.3	dep	33	SENT_233	[p12l1668t2419r1706b2444],
35	0.1	CD	NUMBER	0.1	num	36	SENT_233	[p12l1978t2419r2100b2444],
36	—	NN	O	—	dep	45	SENT_233	[p12l1978t2419r2100b2444],
37	17.4	CD	NUMBER	17.4	num	38	SENT_233	[p12l1978t2419r2100b2444],
38	AG/GG	NN	O	ag/gg	dep	36	SENT_233	[p12l58t2460r238b2485],
39	—	RB	O	—	advmod	40	SENT_233	[p12l58t2460r238b2485],
40	low	JJ	O	low	amod	38	SENT_233	[p12l58t2460r238b2485],
41	9	CD	NUMBER	9	number	42	SENT_233	[p12l784t2460r799b2485],
42	18	CD	NUMBER	18	amod	38	SENT_233	[p12l1250t2460r1279b2485],
43	2.7	CD	NUMBER	2.7	num	45	SENT_233	[p12l1665t2460r1707b2485],
44	0.6	CD	NUMBER	0.6	num	45	SENT_233	[p12l1978t2460r2097b2485],
45	—	NN	O	—	dep	51	SENT_233	[p12l1978t2460r2097b2485],
46	12.1	CD	NUMBER	12.1	num	47	SENT_233	[p12l1978t2460r2097b2485],
47	AG/GG	NN	O	ag/gg	dep	45	SENT_233	[p12l59t2501r248b2533],
48	—	RB	O	—	advmod	49	SENT_233	[p12l59t2501r248b2533],
49	high	JJ	O	high	amod	47	SENT_233	[p12l59t2501r248b2533],
50	11	CD	NUMBER	11	num	51	SENT_233	[p12l769t2501r797b2525],
51	7	CD	NUMBER	7	_	0	SENT_233	[p12l1264t2502r1280b2526],
52	8.4	CD	NUMBER	8.4	number	53	SENT_233	[p12l1666t2501r1707b2526],
53	1.4	CD	NUMBER	1.4	num	54	SENT_233	[p12l1981t2501r2100b2526],
54	—	NN	O	—	dep	51	SENT_233	[p12l1981t2501r2100b2526],
55	49.9	CD	NUMBER	49.9	amod	54	SENT_233	[p12l1981t2501r2100b2526],

1	CSI	NNP	O	CSI	_	0	SENT_234	[p12l59t2588r120b2617],
2	,	,	O	,	_	0	SENT_234	[p12l59t2588r120b2617],
3	craniospinal	JJ	O	craniospinal	amod	5	SENT_234	[p12l138t2588r309b2620],
4	radiation	NN	O	radiation	nn	5	SENT_234	[p12l326t2588r451b2613],
5	dose	NN	O	dose	appos	1	SENT_234	[p12l468t2588r539b2613],
6	:	:	O	:	_	0	SENT_234	[p12l468t2588r539b2613],
7	high	JJ	O	high	advmod	10	SENT_234	[p12l557t2588r620b2620],
8	34.2-39	CD	NUMBER	34.2-39	num	10	SENT_234	[p12l637t2588r776b2613],
9	.6	CD	NUMBER	.6	num	10	SENT_234	[p12l637t2588r776b2613],
10	Gy	NN	O	gy	dep	1	SENT_234	[p12l789t2588r831b2620],
11	(	CD	NUMBER	(	num	12	SENT_234	[p12l848t2588r962b2619],
12	median	NN	O	median	dep	10	SENT_234	[p12l848t2588r962b2619],
13	36	CD	NUMBER	36	num	15	SENT_234	[p12l980t2588r1013b2613],
14	Gy	NN	O	gy	nn	15	SENT_234	[p12l1026t2588r1087b2620],
15	)	NN	O	)	dep	12	SENT_234	[p12l1026t2588r1087b2620],
16	,	,	O	,	_	0	SENT_234	[p12l1026t2588r1087b2620],
17	low	JJ	O	low	advmod	12	SENT_234	[p12l1105t2588r1161b2617],
18	,	,	O	,	_	0	SENT_234	[p12l1105t2588r1161b2617],
19	18	CD	NUMBER	18	appos	10	SENT_234	[p12l1182t2588r1292b2613],
20	—	CD	NUMBER	—	number	21	SENT_234	[p12l1182t2588r1292b2613],
21	25.2	CD	NUMBER	25.2	num	22	SENT_234	[p12l1182t2588r1292b2613],
22	Gy	NN	O	gy	dep	19	SENT_234	[p12l1306t2588r1347b2620],
23	(	CD	NUMBER	(	num	24	SENT_234	[p12l1365t2588r1479b2619],
24	median	NN	O	median	dep	19	SENT_234	[p12l1365t2588r1479b2619],
25	23.4	CD	NUMBER	23.4	num	27	SENT_234	[p12l1496t2588r1556b2613],
26	Gy	NN	O	gy	nn	27	SENT_234	[p12l1569t2588r1631b2620],
27	)	NN	O	)	dep	24	SENT_234	[p12l1569t2588r1631b2620],
28	;	:	O	;	_	0	SENT_234	[p12l1569t2588r1631b2620],
29	Ref	NNP	O	Ref	dep	1	SENT_234	[p12l1649t2588r1707b2617],
30	,	,	O	,	_	0	SENT_234	[p12l1649t2588r1707b2617],
31	reference	NN	O	reference	nn	32	SENT_234	[p12l1724t2588r1855b2613],
32	group	NN	O	group	appos	29	SENT_234	[p12l1872t2596r1960b2620],
33	.	.	O	.	_	0	SENT_234	[p12l1872t2596r1960b2620],

1	In	IN	O	in	_	0	SENT_235	[p12l1978t2589r2006b2613],
2	crude	NN	O	crude	prep_in	4	SENT_235	[p12l2023t2588r2100b2613],
3	analyses	NNS	O	analysis	nsubj	13	SENT_235	[p12l59t2629r177b2662],
4	(	VBP	O	(	_	0	SENT_235	[p12l191t2629r304b2660],
5	above	IN	O	above	_	0	SENT_235	[p12l191t2629r304b2660],
6	)	NN	O	)	prep_above	4	SENT_235	[p12l191t2629r304b2660],
7	,	,	O	,	_	0	SENT_235	[p12l191t2629r304b2660],
8	p-homogeneity	NN	O	p-homogeneity	dep	9	SENT_235	[p12l317t2629r530b2662],
9	=	JJ	O	=	conj_and	4	SENT_235	[p12l544t2640r568b2649],
10	0.03	CD	NUMBER	0.03	tmod	9	SENT_235	[p12l582t2629r641b2655],
11	and	CC	O	and	_	0	SENT_235	[p12l656t2629r705b2654],
12	p-trend	NN	O	p-trend	dep	13	SENT_235	[p12l717t2629r819b2662],
13	=	JJ	O	=	conj_and	4	SENT_235	[p12l833t2640r857b2649],
14	0.005	CD	NUMBER	0.005	tmod	13	SENT_235	[p12l871t2629r956b2655],
15	.	.	O	.	_	0	SENT_235	[p12l871t2629r956b2655],

1	After	IN	O	after	_	0	SENT_236	[p12l970t2629r1044b2654],
2	adjusting	VBG	O	adjust	pcomp	1	SENT_236	[p12l1057t2629r1184b2662],
3	for	IN	O	for	_	0	SENT_236	[p12l1197t2629r1238b2654],
4	age	NN	O	age	nn	5	SENT_236	[p12l1250t2637r1297b2662],
5	group	NN	O	group	prep_for	2	SENT_236	[p12l1310t2637r1399b2662],
6	,	,	O	,	_	0	SENT_236	[p12l1310t2637r1399b2662],
7	cumulative	JJ	O	cumulative	amod	10	SENT_236	[p12l1412t2629r1568b2654],
8	cisplatin	NN	O	cisplatin	nn	10	SENT_236	[p12l1580t2629r1699b2662],
9	dose	NN	O	dose	nn	10	SENT_236	[p12l1712t2629r1775b2654],
10	group	NN	O	group	prep_for	2	SENT_236	[p12l1787t2637r1876b2662],
11	,	,	O	,	_	0	SENT_236	[p12l1787t2637r1876b2662],
12	and	CC	O	and	_	0	SENT_236	[p12l1890t2629r1940b2654],
13	an1ifostine	NN	O	an1ifostine	nn	14	SENT_236	[p12l1952t2629r2100b2654],
14	use	NN	O	use	conj_and	5	SENT_236	[p12l7t2699r122b2745],
15	,	,	O	,	_	0	SENT_236	[p12l7t2699r122b2745],
16	p-trend	NN	O	p-trend	prep_for	2	SENT_236	[p12l153t2682r372b2751],
17	=	JJ	O	=	amod	16	SENT_236	[p12l402t2706r453b2724],
18	0.02	CD	NUMBER	0.02	tmod	17	SENT_236	[p12l483t2682r628b2735],
19	.	.	O	.	_	0	SENT_236	[p12l483t2682r628b2735],

1	clearing	VBG	O	clear	dep	8	SENT_237	[p12l8t2912r264b2985],
2	free	JJ	O	free	amod	3	SENT_237	[p12l311t2912r433b2968],
3	radicals	NNS	O	radical	dobj	1	SENT_237	[p12l478t2912r745b2979],
4	,	,	O	,	_	0	SENT_237	[p12l478t2912r745b2979],
5	are	VBP	O	be	cop	8	SENT_237	[p12l795t2930r889b2968],
6	an	DT	O	a	det	8	SENT_237	[p12l937t2930r1009b2968],
7	ideal	JJ	O	ideal	amod	8	SENT_237	[p12l1054t2912r1208b2968],
8	mechanism	NN	O	mechanism	_	0	SENT_237	[p12l1255t2912r1620b2968],
9	to	TO	O	to	aux	10	SENT_237	[p12l1665t2921r1724b2968],
10	explain	VB	O	explain	infmod	8	SENT_237	[p12l1771t2912r2006b2985],
11	the	DT	O	the	det	12	SENT_237	[p12l2051t2913r2147b2968],
12	differences	NNS	O	difference	dobj	10	SENT_237	[p12l8t3010r360b3066],
13	in	IN	O	in	_	0	SENT_237	[p12l411t3010r472b3065],
14	ototoxicity	NN	O	ototoxicity	nn	15	SENT_237	[p12l523t3010r869b3082],
15	susceptibility	NN	O	susceptibility	prep_in	12	SENT_237	[p12l923t3010r1347b3082],
16	after	IN	O	after	_	0	SENT_237	[p12l1400t3010r1545b3066],
17	medulloblastoma	NN	O	medulloblastoma	nn	18	SENT_237	[p12l1594t3010r2148b3066],
18	therapy	NN	O	therapy	prep_after	10	SENT_237	[p12l7t3106r258b3179],
19	.	.	O	.	_	0	SENT_237	[p12l7t3106r258b3179],

1	Supporting	VBG	O	support	csubj	12	SENT_238	[p12l297t3106r649b3179],
2	the	DT	O	the	det	3	SENT_238	[p12l683t3106r779b3162],
3	role	NN	O	role	dobj	1	SENT_238	[p12l812t3106r936b3162],
4	of	IN	O	of	_	0	SENT_238	[p12l971t3106r1040b3162],
5	GSTs	NNS	O	gst	prep_of	3	SENT_238	[p12l1068t3107r1246b3163],
6	in	IN	O	in	_	0	SENT_238	[p12l1281t3106r1342b3162],
7	medulloblastoma	NN	O	medulloblastoma	nn	8	SENT_238	[p12l1375t3106r1929b3162],
8	toxicities	NNS	O	toxicity	prep_in	5	SENT_238	[p12l1961t3106r2145b3162, p12l7t3203r138b3259],
9	is	VBZ	O	be	cop	12	SENT_238	[p12l170t3203r220b3259],
10	a	DT	O	a	det	12	SENT_238	[p12l253t3221r286b3259],
11	prior	JJ	O	prior	amod	12	SENT_238	[p12l315t3203r472b3276],
12	study	NN	O	study	_	0	SENT_238	[p12l503t3204r671b3276],
13	from	IN	O	from	_	0	SENT_238	[p12l702t3203r857b3259],
14	our	PRP$	O	we	poss	15	SENT_238	[p12l887t3221r992b3259],
15	group	NN	O	group	prep_from	12	SENT_238	[p12l1022t3221r1222b3276],
16	.	.	O	.	_	0	SENT_238	[p12l1022t3221r1222b3276],

1	We	PRP	O	we	nsubj	2	SENT_239	[p12l1255t3205r1359b3260],
2	demonstrated	VBD	O	demonstrate	dep	17	SENT_239	[p12l1391t3203r1822b3259],
3	that	IN	O	that	complm	9	SENT_239	[p12l1852t3204r1972b3259],
4	children	NNS	O	child	nsubj	9	SENT_239	[p12l2002t3203r2145b3259, p12l8t3301r148b3357],
5	with	IN	O	with	_	0	SENT_239	[p12l179t3301r320b3357],
6	medulloblastoma	NN	O	medulloblastoma	nn	8	SENT_239	[p12l351t3301r905b3357],
7	(	CD	NUMBER	(	num	8	SENT_239	[p12l937t3301r1000b3370],
8	n	NN	O	n	prep_with	4	SENT_239	[p12l937t3301r1000b3370],
9	=	JJ	O	=	ccomp	2	SENT_239	[p12l1032t3326r1086b3345],
10	42	CD	NUMBER	42	number	11	SENT_239	[p12l1116t3301r1220b3370],
11	)	CD	NUMBER	)	dobj	9	SENT_239	[p12l1116t3301r1220b3370],
12	having	VBG	O	have	partmod	11	SENT_239	[p12l1252t3301r1468b3373],
13	GSTM1	NN	O	gstm1	nn	16	SENT_239	[p12l1503t3301r1741b3357],
14	and	CC	O	and	_	0	SENT_239	[p12l1780t3301r1893b3357],
15	GSTT1	NN	O	gstt1	nn	16	SENT_239	[p12l1926t3301r2141b3357],
16	deletions	NNS	O	deletion	dobj	12	SENT_239	[p12l8t3398r294b3454],
17	were	VBD	O	be	_	0	SENT_239	[p12l329t3416r482b3454],
18	at	IN	O	at	_	0	SENT_239	[p12l516t3407r571b3454],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_239	[p12l605t3398r996b3470],
20	greater	JJR	O	greater	amod	21	SENT_239	[p12l1031t3406r1253b3470],
21	risk	NN	O	risk	prep_at	17	SENT_239	[p12l1283t3398r1404b3454],
22	for	IN	O	for	_	0	SENT_239	[p12l1434t3398r1526b3454],
23	any	DT	O	any	det	30	SENT_239	[p12l1558t3416r1670b3470],
24	acute	JJ	O	acute	amod	30	SENT_239	[p12l1704t3406r1870b3454],
25	toxicity	NN	O	toxicity	nn	30	SENT_239	[p12l1903t3398r2147b3470],
26	(	NN	O	(	nn	30	SENT_239	[p12l10t3495r89b3564],
27	2	CD	NUMBER	2	num	30	SENT_239	[p12l10t3495r89b3564],
28	grade	NN	O	grade	nn	30	SENT_239	[p12l97t3494r272b3567],
29	3	CD	NUMBER	3	num	30	SENT_239	[p12l299t3495r360b3564],
30	)	NN	O	)	nsubj	31	SENT_239	[p12l299t3495r360b3564],
31	requiring	VBG	O	require	prepc_for	17	SENT_239	[p12l386t3494r679b3567],
32	therapy	NN	O	therapy	nn	33	SENT_239	[p12l705t3495r944b3567],
33	modiﬁcation	NN	O	modiﬁcation	dobj	31	SENT_239	[p12l969t3494r1373b3550],
34	(	CD	NUMBER	(	num	35	SENT_239	[p12l1401t3495r1518b3564],
35	Z1	NN	O	z1	dep	46	SENT_239	[p12l1401t3495r1518b3564],
36	null	JJ	O	null	amod	37	SENT_239	[p12l1550t3494r1672b3550],
37	genotype	NN	O	genotype	dep	35	SENT_239	[p12l1698t3503r2007b3567],
38	:	:	O	:	_	0	SENT_239	[p12l1698t3503r2007b3567],
39	OR	NN	O	or	dep	37	SENT_239	[p12l2040t3495r2148b3551],
40	6.4	CD	NUMBER	6.4	num	39	SENT_239	[p12l9t3592r122b3658],
41	,	,	O	,	_	0	SENT_239	[p12l9t3592r122b3658],
42	95	CD	PERCENT	95	num	43	SENT_239	[p12l158t3592r299b3649],
43	%	NN	PERCENT	%	appos	39	SENT_239	[p12l158t3592r299b3649],
44	CI	NN	O	ci	dep	46	SENT_239	[p12l335t3592r412b3648],
45	1.2	CD	NUMBER	1.2	number	46	SENT_239	[p12l452t3592r687b3661],
46	—	CD	NUMBER	—	dep	31	SENT_239	[p12l452t3592r687b3661],
47	34	CD	NUMBER	34	num	48	SENT_239	[p12l452t3592r687b3661],
48	)	NN	O	)	dep	46	SENT_239	[p12l452t3592r687b3661],
49	and	CC	O	and	_	0	SENT_239	[p12l723t3592r836b3648],
50	cognitive	JJ	O	cognitive	amod	51	SENT_239	[p12l868t3592r1163b3664],
51	impairment	NN	O	impairment	conj_and	46	SENT_239	[p12l1195t3592r1565b3664],
52	(	CD	NUMBER	(	number	53	SENT_239	[p12l1599t3592r1761b3661],
53	27.2	CD	NUMBER	27.2	num	58	SENT_239	[p12l1599t3592r1761b3661],
54	point	NN	O	point	nn	58	SENT_239	[p12l1793t3592r1958b3664],
55	postradiation	NN	O	postradiation	nn	58	SENT_239	[p12l1987t3600r2145b3664, p12l6t3689r292b3745],
56	full-scale	JJ	O	full-scale	amod	58	SENT_239	[p12l340t3689r637b3745],
57	IQ	NNP	O	IQ	nn	58	SENT_239	[p12l686t3689r769b3758],
58	drop	NN	O	drop	dep	51	SENT_239	[p12l817t3689r979b3761],
59	,	,	O	,	_	0	SENT_239	[p12l817t3689r979b3761],
60	P	NN	O	p	appos	51	SENT_239	[p12l1028t3691r1078b3744],
61	=	JJ	O	=	amod	60	SENT_239	[p12l1109t3714r1163b3733],
62	0.002	CD	NUMBER	0.002	tmod	61	SENT_239	[p12l1195t3689r1397b3758],
63	)	CD	NUMBER	)	num	66	SENT_239	[p12l1195t3689r1397b3758],
64	[	NN	O	[	nn	66	SENT_239	[p12l1453t3689r1595b3757],
65	22	CD	NUMBER	22	num	66	SENT_239	[p12l1453t3689r1595b3757],
66	]	NN	O	]	nsubj	17	SENT_239	[p12l1453t3689r1595b3757],
67	.	.	O	.	_	0	SENT_239	[p12l1453t3689r1595b3757],

1	No	DT	O	no	det	2	SENT_240	[p12l1647t3690r1742b3745],
2	association	NN	O	association	nsubjpass	11	SENT_240	[p12l1793t3689r2148b3745],
3	between	IN	O	between	_	0	SENT_240	[p13l6t20r274b76],
4	ototoxicity	NN	O	ototoxicity	prep_between	2	SENT_240	[p13l334t19r679b92],
5	and	CC	O	and	_	0	SENT_240	[p13l741t19r854b75],
6	GSTMI	NN	O	gstmus	conj_and	4	SENT_240	[p13l916t20r1154b76],
7	and	CC	O	and	_	0	SENT_240	[p13l1221t20r1334b75],
8	GSTT1	NN	O	gstt1	nn	9	SENT_240	[p13l1396t20r1611b76],
9	deletions	NNS	O	deletion	prep_between	2	SENT_240	[p13l1678t19r1964b75],
10	was	VBD	O	be	auxpass	11	SENT_240	[p13l2025t37r2146b76],
11	detected	VBN	O	detect	_	0	SENT_240	[p13l8t117r290b173],
12	.	.	O	.	_	0	SENT_240	[p13l8t117r290b173],

1	While	IN	O	while	mark	20	SENT_241	[p13l113t214r309b270],
2	the	DT	O	the	det	3	SENT_241	[p13l347t214r444b270],
3	inﬂuence	NN	O	inﬂuence	nsubjpass	20	SENT_241	[p13l482t214r775b270],
4	of	IN	O	of	_	0	SENT_241	[p13l814t214r883b270],
5	the	DT	O	the	det	6	SENT_241	[p13l916t214r1012b270],
6	GSTP1	NN	O	gstp1	prep_of	3	SENT_241	[p13l1053t214r1274b270],
7	105	CD	NUMBER	105	num	6	SENT_241	[p13l1325t214r1433b270],
8	A	DT	O	a	det	11	SENT_241	[p13l1474t214r1530b269],
9	>	JJR	O	>	amod	11	SENT_241	[p13l1564t225r1613b272],
10	G	NN	O	g	nn	11	SENT_241	[p13l1646t214r1701b270],
11	genotype	NN	O	genotype	dep	6	SENT_241	[p13l1739t222r2031b286],
12	on	IN	O	on	_	0	SENT_241	[p13l2070t232r2148b270],
13	ototoxicity	NN	O	ototoxicity	prep_on	11	SENT_241	[p13l8t310r354b383],
14	in	IN	O	in	_	0	SENT_241	[p13l382t310r442b366],
15	medulloblastoma	NN	O	medulloblastoma	prep_in	13	SENT_241	[p13l469t311r1023b366],
16	has	VBZ	O	have	aux	20	SENT_241	[p13l1049t311r1153b366],
17	not	RB	O	not	neg	20	SENT_241	[p13l1181t319r1282b366],
18	been	VBN	O	be	auxpass	20	SENT_241	[p13l1308t310r1459b366],
19	previously	RB	DATE	previously	advmod	20	SENT_241	[p13l1485t310r1821b383],
20	explored	VBN	O	explore	advcl	31	SENT_241	[p13l1849t310r2144b383],
21	,	,	O	,	_	0	SENT_241	[p13l1849t310r2144b383],
22	its	PRP$	O	its	poss	23	SENT_241	[p13l7t408r79b464],
23	role	NN	O	role	nsubjpass	31	SENT_241	[p13l112t408r235b464],
24	in	IN	O	in	_	0	SENT_241	[p13l268t408r329b463],
25	ototoxicity	NN	O	ototoxicity	prep_in	23	SENT_241	[p13l361t408r707b480],
26	in	IN	O	in	_	0	SENT_241	[p13l739t408r800b463],
27	other	JJ	O	other	amod	28	SENT_241	[p13l833t408r996b464],
28	malignancies	NNS	O	malignancy	prep_in	25	SENT_241	[p13l1027t408r1448b480],
29	has	VBZ	O	have	aux	31	SENT_241	[p13l1482t408r1585b464],
30	been	VBN	O	be	auxpass	31	SENT_241	[p13l1617t408r1768b464],
31	studied	VBN	O	study	_	0	SENT_241	[p13l1803t408r2047b464],
32	.	.	O	.	_	0	SENT_241	[p13l1803t408r2047b464],

1	In	IN	O	in	_	0	SENT_242	[p13l2083t409r2148b463],
2	173	CD	NUMBER	173	num	3	SENT_242	[p13l15t505r121b561],
3	adults	NNS	O	adult	prep_in	14	SENT_242	[p13l152t505r339b561],
4	with	IN	O	with	_	0	SENT_242	[p13l366t505r506b561],
5	testicular	JJ	O	testicular	amod	6	SENT_242	[p13l531t505r826b561],
6	cancer	NN	O	cancer	prep_with	3	SENT_242	[p13l851t522r1060b561],
7	treated	VBN	O	treat	partmod	6	SENT_242	[p13l1083t505r1302b561],
8	with	IN	O	with	_	0	SENT_242	[p13l1327t505r1467b561],
9	cisplatin-based	JJ	O	cisplatin-based	amod	10	SENT_242	[p13l1493t505r1974b577],
10	regimens	NNS	O	regimen	prep_with	7	SENT_242	[p13l1997t505r2146b577, p13l7t619r192b668],
11	,	,	O	,	_	0	SENT_242	[p13l1997t505r2146b577, p13l7t619r192b668],
12	hearing	NN	O	hearing	nsubjpass	14	SENT_242	[p13l217t601r456b674],
13	was	VBD	O	be	auxpass	14	SENT_242	[p13l480t619r601b657],
14	evaluated	VBN	O	evaluate	_	0	SENT_242	[p13l625t601r929b658],
15	with	IN	O	with	_	0	SENT_242	[p13l951t601r1092b658],
16	the	DT	O	the	det	17	SENT_242	[p13l1114t602r1210b657],
17	threshold	NN	O	threshold	prep_with	14	SENT_242	[p13l1233t601r1531b657],
18	for	IN	O	for	_	0	SENT_242	[p13l1554t601r1647b657],
19	impairment	NN	O	impairment	prep_for	17	SENT_242	[p13l1667t601r2038b674],
20	set	VBN	O	set	partmod	19	SENT_242	[p13l2062t610r2148b657],
21	at	IN	O	at	_	0	SENT_242	[p13l9t707r64b755],
22	the	DT	O	the	det	24	SENT_242	[p13l92t699r188b755],
23	75th	JJ	ORDINAL	75th	amod	24	SENT_242	[p13l218t698r358b755],
24	percentile	NN	O	percentile	prep_at	20	SENT_242	[p13l385t699r719b771],
25	,	,	O	,	_	0	SENT_242	[p13l385t699r719b771],
26	based	VBN	O	base	partmod	24	SENT_242	[p13l750t699r933b755],
27	on	IN	O	on	_	0	SENT_242	[p13l962t716r1039b755],
28	Norwegian	JJ	MISC	norwegian	amod	29	SENT_242	[p13l1067t699r1421b771],
29	men	NNS	O	man	prep_on	26	SENT_242	[p13l1450t716r1587b755],
30	in	IN	O	in	_	0	SENT_242	[p13l1615t699r1676b754],
31	their	PRP$	O	they	poss	32	SENT_242	[p13l1704t699r1851b755],
32	ﬁfties	NNS	O	ﬁfties	prep_in	29	SENT_242	[p13l1879t699r2057b755],
33	in	IN	O	in	_	0	SENT_242	[p13l2087t699r2148b754],
34	the	DT	O	the	det	36	SENT_242	[p13l7t796r103b852],
35	general	JJ	O	general	amod	36	SENT_242	[p13l129t796r363b868],
36	population	NN	O	population	prep_in	26	SENT_242	[p13l387t796r732b868],
37	[	CD	NUMBER	[	number	38	SENT_242	[p13l762t796r904b864],
38	23	CD	NUMBER	23	num	39	SENT_242	[p13l762t796r904b864],
39	]	NN	O	]	dep	26	SENT_242	[p13l762t796r904b864],
40	.	.	O	.	_	0	SENT_242	[p13l762t796r904b864],

1	The	DT	O	the	det	2	SENT_243	[p13l933t796r1056b852],
2	investigators	NNS	O	investigator	nsubj	3	SENT_243	[p13l1081t796r1486b868],
3	found	VBD	O	find	_	0	SENT_243	[p13l1513t796r1698b852],
4	a	DT	O	a	det	6	SENT_243	[p13l1725t813r1758b852],
5	greater	JJR	O	greater	amod	6	SENT_243	[p13l1783t804r2005b868],
6	risk	NN	O	risk	dobj	3	SENT_243	[p13l2028t796r2149b852],
7	of	IN	O	of	_	0	SENT_243	[p13l8t893r77b949],
8	hearing	NN	O	hearing	nn	9	SENT_243	[p13l95t893r335b966],
9	loss	NN	O	loss	prep_of	6	SENT_243	[p13l361t893r481b949],
10	in	IN	O	in	_	0	SENT_243	[p13l507t893r568b948],
11	the	DT	O	the	det	13	SENT_243	[p13l592t893r688b949],
12	AG/AA	NNP	O	AG/AA	nn	13	SENT_243	[p13l712t893r961b949],
13	group	NN	O	group	prep_in	3	SENT_243	[p13l986t911r1170b966],
14	when	WRB	O	when	advmod	15	SENT_243	[p13l1196t893r1367b949],
15	compared	VBN	O	compare	advcl	3	SENT_243	[p13l1392t893r1708b966],
16	to	TO	O	to	_	0	SENT_243	[p13l1731t901r1791b949],
17	those	DT	O	those	prep_to	15	SENT_243	[p13l1816t893r1983b949],
18	with	IN	O	with	_	0	SENT_243	[p13l2007t893r2148b949],
19	the	DT	O	the	det	21	SENT_243	[p13l7t990r103b1046],
20	GG	NNS	O	gg	nn	21	SENT_243	[p13l142t990r255b1046],
21	genotype	NN	O	genotype	prep_with	17	SENT_243	[p13l292t998r583b1062],
22	(	CD	NUMBER	(	num	23	SENT_243	[p13l623t990r757b1059],
23	OR	NN	O	or	dep	17	SENT_243	[p13l623t990r757b1059],
24	4.3	CD	NUMBER	4.3	dep	23	SENT_243	[p13l793t990r909b1056],
25	,	,	O	,	_	0	SENT_243	[p13l793t990r909b1056],
26	95	CD	PERCENT	95	number	27	SENT_243	[p13l950t989r1091b1046],
27	%	NN	PERCENT	%	amod	28	SENT_243	[p13l950t989r1091b1046],
28	CI	NN	O	ci	appos	17	SENT_243	[p13l1132t990r1209b1046],
29	1.3	CD	NUMBER	1.3	dep	28	SENT_243	[p13l1254t990r1568b1059],
30	—	CD	NUMBER	—	number	31	SENT_243	[p13l1254t990r1568b1059],
31	14.4	CD	NUMBER	14.4	num	32	SENT_243	[p13l1254t990r1568b1059],
32	)	NN	O	)	dobj	15	SENT_243	[p13l1254t990r1568b1059],
33	.	.	O	.	_	0	SENT_243	[p13l1254t990r1568b1059],

1	The	DT	O	the	det	2	SENT_244	[p13l1609t990r1732b1046],
2	relationship	NN	O	relationship	nsubj	22	SENT_244	[p13l1768t990r2146b1062],
3	between	IN	O	between	_	0	SENT_244	[p13l6t1087r274b1143],
4	the	DT	O	the	det	5	SENT_244	[p13l314t1087r410b1143],
5	GSTP1	NN	O	gstp1	prep_between	2	SENT_244	[p13l454t1087r675b1143],
6	105	CD	NUMBER	105	num	5	SENT_244	[p13l729t1087r836b1143],
7	A	DT	O	a	det	10	SENT_244	[p13l881t1087r937b1142],
8	>	JJR	O	>	amod	10	SENT_244	[p13l970t1098r1020b1145],
9	G	NN	O	g	nn	10	SENT_244	[p13l1053t1087r1108b1143],
10	genotype	NN	O	genotype	nsubjpass	14	SENT_244	[p13l1149t1095r1440b1159],
11	and	CC	O	and	_	0	SENT_244	[p13l1483t1087r1596b1143],
12	ototoxicity	NN	O	ototoxicity	nsubjpass	14	SENT_244	[p13l1638t1087r1983b1159],
13	was	VBD	O	be	auxpass	14	SENT_244	[p13l2025t1105r2146b1143],
14	evaluated	VBN	O	evaluate	rcmod	2	SENT_244	[p13l8t1184r311b1240],
15	in	IN	O	in	_	0	SENT_244	[p13l355t1184r416b1239],
16	two	CD	NUMBER	two	num	18	SENT_244	[p13l460t1193r577b1240],
17	other	JJ	O	other	amod	18	SENT_244	[p13l623t1184r787b1240],
18	studies	NNS	O	study	prep_in	14	SENT_244	[p13l833t1184r1050b1240],
19	with	IN	O	with	_	0	SENT_244	[p13l1096t1184r1236b1240],
20	no	DT	O	no	det	21	SENT_244	[p13l1280t1202r1357b1240],
21	association	NN	O	association	prep_with	18	SENT_244	[p13l1404t1184r1759b1240],
22	discovered	VBD	O	discover	_	0	SENT_244	[p13l1803t1184r2148b1240],

1	[	NN	O	[	_	0	SENT_245	[p13l13t1280r255b1349],
2	24,25	CD	NUMBER	24,25	num	3	SENT_245	[p13l13t1280r255b1349],
3	]	NN	O	]	dep	1	SENT_245	[p13l13t1280r255b1349],
4	.	.	O	.	_	0	SENT_245	[p13l13t1280r255b1349],

1	In	IN	O	in	_	0	SENT_246	[p13l296t1282r361b1336],
2	both	DT	O	both	det	3	SENT_246	[p13l396t1281r538b1337],
3	studies	NNS	O	study	prep_in	20	SENT_246	[p13l577t1281r812b1347],
4	,	,	O	,	_	0	SENT_246	[p13l577t1281r812b1347],
5	children	NNS	O	child	prep_in	20	SENT_246	[p13l852t1281r1114b1337],
6	and	CC	O	and	_	0	SENT_246	[p13l1151t1281r1264b1337],
7	young	JJ	O	young	amod	8	SENT_246	[p13l1300t1298r1498b1353],
8	adults	NNS	O	adult	prep_in	20	SENT_246	[p13l1537t1281r1724b1337],
9	with	IN	O	with	_	0	SENT_246	[p13l1762t1281r1903b1337],
10	cancer	NN	O	cancer	prep_with	8	SENT_246	[p13l1939t1298r2148b1337],
11	(	CD	NUMBER	(	num	10	SENT_246	[p13l10t1379r165b1450],
12	e.g.	FW	O	e.g.	dep	10	SENT_246	[p13l10t1379r165b1450],
13	,	,	O	,	_	0	SENT_246	[p13l10t1379r165b1450],
14	osteosarcoma	NN	O	osteosarcoma	appos	10	SENT_246	[p13l212t1386r664b1444],
15	,	,	O	,	_	0	SENT_246	[p13l212t1386r664b1444],
16	neuroblastoma	NN	O	neuroblastoma	appos	14	SENT_246	[p13l711t1378r1200b1444],
17	,	,	O	,	_	0	SENT_246	[p13l711t1378r1200b1444],
18	brain	NN	O	brain	nn	19	SENT_246	[p13l1246t1378r1411b1434],
19	tumors	NNS	O	tumor	nsubj	20	SENT_246	[p13l1454t1378r1699b1447],
20	)	VBP	O	)	_	0	SENT_246	[p13l1454t1378r1699b1447],
21	treated	VBN	O	treat	csubjpass	26	SENT_246	[p13l1745t1378r1963b1434],
22	with	IN	O	with	_	0	SENT_246	[p13l2007t1378r2148b1434],
23	cisplatin-based	JJ	O	cisplatin-based	amod	24	SENT_246	[p13l8t1475r489b1548],
24	regimens	NNS	O	regimen	prep_with	21	SENT_246	[p13l518t1475r810b1548],
25	were	VBD	O	be	auxpass	26	SENT_246	[p13l842t1493r995b1531],
26	assessed	VBN	O	assess	ccomp	20	SENT_246	[p13l1028t1475r1311b1531],
27	.	.	O	.	_	0	SENT_246	[p13l1028t1475r1311b1531],

1	None	NN	O	none	nsubj	7	SENT_247	[p13l114t1573r286b1628],
2	of	IN	O	of	_	0	SENT_247	[p13l318t1572r387b1628],
3	the	DT	O	the	det	5	SENT_247	[p13l412t1572r508b1628],
4	above	JJ	O	above	amod	5	SENT_247	[p13l541t1572r728b1628],
5	studies	NNS	O	study	prep_of	1	SENT_247	[p13l762t1572r978b1628],
6	have	VBP	O	have	aux	7	SENT_247	[p13l1010t1572r1159b1628],
7	compared	VBN	O	compare	_	0	SENT_247	[p13l1191t1572r1506b1644],
8	the	DT	O	the	det	9	SENT_247	[p13l1537t1572r1633b1628],
9	role	NN	O	role	dobj	7	SENT_247	[p13l1663t1572r1787b1628],
10	of	IN	O	of	_	0	SENT_247	[p13l1819t1572r1888b1628],
11	GSTP1	NN	O	gstp1	nn	12	SENT_247	[p13l1915t1572r2140b1628],
12	genotype	NN	O	genotype	prep_of	9	SENT_247	[p13l8t1677r300b1741],
13	between	IN	O	between	_	0	SENT_247	[p13l323t1669r590b1725],
14	those	DT	O	those	prep_between	12	SENT_247	[p13l613t1669r780b1725],
15	who	WP	O	who	nsubj	16	SENT_247	[p13l803t1669r937b1725],
16	received	VBD	O	receive	rcmod	14	SENT_247	[p13l960t1669r1231b1725],
17	radiation	NN	O	radiation	dobj	16	SENT_247	[p13l1252t1669r1538b1725],
18	and	CC	O	and	_	0	SENT_247	[p13l1563t1669r1676b1725],
19	those	DT	O	those	dobj	16	SENT_247	[p13l1698t1669r1866b1725],
20	who	WP	O	who	nsubj	21	SENT_247	[p13l1888t1669r2022b1725],
21	did	VBD	O	do	rcmod	19	SENT_247	[p13l2047t1669r2148b1725],
22	not	RB	O	not	neg	21	SENT_247	[p13l7t1775r124b1822],
23	.	.	O	.	_	0	SENT_247	[p13l7t1775r124b1822],

1	Moreover	RB	O	moreover	advmod	6	SENT_248	[p13l160t1768r488b1833],
2	,	,	O	,	_	0	SENT_248	[p13l160t1768r488b1833],
3	few	JJ	O	few	amod	4	SENT_248	[p13l523t1766r639b1822],
4	studies	NNS	O	study	nsubj	6	SENT_248	[p13l675t1766r892b1822],
5	have	VBP	O	have	aux	6	SENT_248	[p13l925t1766r1073b1822],
6	assessed	VBN	O	assess	_	0	SENT_248	[p13l1108t1766r1376b1822],
7	the	DT	O	the	det	8	SENT_248	[p13l1408t1766r1504b1822],
8	role	NN	O	role	dobj	6	SENT_248	[p13l1536t1766r1659b1822],
9	of	IN	O	of	_	0	SENT_248	[p13l1693t1766r1762b1822],
10	the	DT	O	the	det	11	SENT_248	[p13l1789t1766r1885b1822],
11	GSTP1	NN	O	gstp1	prep_of	8	SENT_248	[p13l1921t1767r2141b1823],
12	105	CD	NUMBER	105	num	11	SENT_248	[p13l15t1862r122b1919],
13	A	DT	O	a	det	16	SENT_248	[p13l151t1863r207b1918],
14	>	JJR	O	>	amod	16	SENT_248	[p13l241t1874r291b1920],
15	G	NN	O	g	nn	16	SENT_248	[p13l323t1863r378b1919],
16	genotype	NN	O	genotype	xcomp	6	SENT_248	[p13l405t1871r696b1935],
17	on	IN	O	on	_	0	SENT_248	[p13l724t1880r802b1918],
18	radiation-associated	JJ	O	radiation-associated	amod	19	SENT_248	[p13l827t1862r1470b1918],
19	toxicities	NNS	O	toxicity	prep_on	16	SENT_248	[p13l1496t1862r1806b1918],
20	.	.	O	.	_	0	SENT_248	[p13l1496t1862r1806b1918],

1	Two	CD	NUMBER	two	num	3	SENT_249	[p13l1837t1864r1975b1918],
2	such	JJ	O	such	amod	3	SENT_249	[p13l2005t1862r2148b1918],
3	studies	NNS	O	study	nsubjpass	5	SENT_249	[p13l10t1960r227b2016],
4	were	VBD	O	be	auxpass	5	SENT_249	[p13l271t1978r424b2016],
5	conducted	VBN	O	conduct	_	0	SENT_249	[p13l467t1960r796b2016],
6	in	IN	O	in	_	0	SENT_249	[p13l838t1960r899b2015],
7	women	NNS	O	woman	prep_in	5	SENT_249	[p13l941t1978r1175b2016],
8	with	IN	O	with	_	0	SENT_249	[p13l1217t1960r1358b2016],
9	breast	NN	O	breast	nn	10	SENT_249	[p13l1398t1960r1591b2016],
10	cancer	NN	O	cancer	prep_with	5	SENT_249	[p13l1632t1978r1841b2016],
11	who	WP	O	who	nsubj	12	SENT_249	[p13l1882t1960r2017b2016],
12	received	VBD	O	receive	rcmod	10	SENT_249	[p13l2059t1978r2145b2016, p13l8t2057r214b2113],

1	adjuvant	JJ	O	adjuvant	amod	3	SENT_250	[p13l255t2057r528b2130],
2	radiation	NN	O	radiation	nn	3	SENT_250	[p13l567t2057r853b2113],
3	[	NN	O	[	_	0	SENT_250	[p13l899t2057r1141b2125],
4	26,27	CD	NUMBER	26,27	num	5	SENT_250	[p13l899t2057r1141b2125],
5	]	NN	O	]	dep	3	SENT_250	[p13l899t2057r1141b2125],
6	.	.	O	.	_	0	SENT_250	[p13l899t2057r1141b2125],

1	A	DT	O	a	det	3	SENT_251	[p13l1185t2058r1241b2112],
2	greater	JJR	O	greater	amod	3	SENT_251	[p13l1282t2066r1504b2130],
3	risk	NN	O	risk	nsubjpass	9	SENT_251	[p13l1542t2057r1663b2113],
4	of	IN	O	of	_	0	SENT_251	[p13l1702t2057r1772b2113],
5	acute	JJ	O	acute	amod	7	SENT_251	[p13l1809t2066r1975b2113],
6	skin	NN	O	skin	nn	7	SENT_251	[p13l2018t2057r2148b2113],
7	toxicities	NNS	O	toxicity	prep_of	3	SENT_251	[p13l7t2153r300b2209],
8	was	VBD	O	be	auxpass	9	SENT_251	[p13l329t2171r450b2209],
9	reported	VBN	O	report	dep	40	SENT_251	[p13l479t2153r747b2226],
10	in	IN	O	in	_	0	SENT_251	[p13l775t2153r835b2209],
11	women	NNS	O	woman	prep_in	9	SENT_251	[p13l864t2171r1098b2209],
12	with	IN	O	with	_	0	SENT_251	[p13l1127t2153r1268b2209],
13	the	DT	O	the	det	17	SENT_251	[p13l1295t2153r1391b2209],
14	GSTP1	NN	O	gstp1	nn	17	SENT_251	[p13l1423t2154r1644b2210],
15	105	CD	NUMBER	105	num	17	SENT_251	[p13l1686t2153r1793b2210],
16	GG	NNS	O	gg	nn	17	SENT_251	[p13l1826t2154r1938b2210],
17	genotype	NN	O	genotype	prep_with	11	SENT_251	[p13l1967t2171r2145b2226, p13l7t2259r143b2323],
18	(	CD	NUMBER	(	num	19	SENT_251	[p13l174t2252r308b2320],
19	HR	NN	DURATION	hr	dep	17	SENT_251	[p13l174t2252r308b2320],
20	2.3	CD	NUMBER	2.3	dep	17	SENT_251	[p13l335t2251r450b2317],
21	,	,	O	,	_	0	SENT_251	[p13l335t2251r450b2317],
22	95	CD	PERCENT	95	number	23	SENT_251	[p13l481t2251r622b2308],
23	%	NN	PERCENT	%	amod	25	SENT_251	[p13l481t2251r622b2308],
24	CI	NN	O	ci	nn	25	SENT_251	[p13l653t2251r731b2307],
25	l.	NN	O	l.	prep_with	11	SENT_251	[p13l766t2251r1061b2320],
26	04	CD	NUMBER	04	number	27	SENT_251	[p13l766t2251r1061b2320],
27	—	CD	NUMBER	—	num	25	SENT_251	[p13l766t2251r1061b2320],
28	5.0	CD	NUMBER	5.0	num	29	SENT_251	[p13l766t2251r1061b2320],
29	)	NN	O	)	dep	25	SENT_251	[p13l766t2251r1061b2320],
30	and	CC	O	and	_	0	SENT_251	[p13l1093t2251r1206b2307],
31	a	DT	O	a	det	34	SENT_251	[p13l1234t2269r1267b2307],
32	slightly	RB	O	slightly	advmod	33	SENT_251	[p13l1296t2251r1532b2323],
33	greater	JJR	O	greater	amod	34	SENT_251	[p13l1561t2259r1784b2323],
34	proportion	NN	O	proportion	conj_and	17	SENT_251	[p13l1809t2251r2148b2323],
35	of	IN	O	of	_	0	SENT_251	[p13l8t2348r77b2404],
36	late	JJ	O	late	amod	37	SENT_251	[p13l107t2348r220b2404],
37	pleural	JJ	O	pleural	prep_of	34	SENT_251	[p13l254t2348r477b2421],
38	thickening	VBG	O	thicken	xcomp	9	SENT_251	[p13l512t2348r849b2421],
39	was	VBD	O	be	auxpass	40	SENT_251	[p13l885t2366r1006b2404],
40	observed	VBN	O	observe	_	0	SENT_251	[p13l1043t2348r1330b2404],
41	in	IN	O	in	_	0	SENT_251	[p13l1364t2348r1424b2403],
42	women	NNS	O	woman	prep_in	40	SENT_251	[p13l1459t2366r1694b2404],
43	with	IN	O	with	_	0	SENT_251	[p13l1728t2348r1869b2404],
44	the	DT	O	the	det	46	SENT_251	[p13l1903t2348r1998b2404],
45	GG	NNS	O	gg	nn	46	SENT_251	[p13l2035t2348r2148b2404],
46	genotype	NN	O	genotype	prep_with	42	SENT_251	[p13l8t2453r300b2517],
47	(	CD	NUMBER	(	num	48	SENT_251	[p13l341t2445r476b2513],
48	OR	NN	O	or	dep	46	SENT_251	[p13l341t2445r476b2513],
49	1.1	CD	NUMBER	1.1	nsubjpass	40	SENT_251	[p13l521t2445r629b2511],
50	,	,	O	,	_	0	SENT_251	[p13l521t2445r629b2511],
51	P	NN	O	p	appos	49	SENT_251	[p13l668t2446r717b2500],
52	=	JJ	O	=	amod	54	SENT_251	[p13l749t2470r803b2489],
53	0.004	CD	NUMBER	0.004	tmod	52	SENT_251	[p13l835t2445r1056b2513],
54	)	NN	O	)	dep	51	SENT_251	[p13l835t2445r1056b2513],
55	.	.	O	.	_	0	SENT_251	[p13l835t2445r1056b2513],

1	More	RBR	O	more	advmod	2	SENT_252	[p13l1098t2446r1269b2500],
2	recently	RB	DATE	recently	advmod	24	SENT_252	[p13l1308t2444r1579b2517],
3	,	,	O	,	_	0	SENT_252	[p13l1308t2444r1579b2517],
4	in	IN	O	in	_	0	SENT_252	[p13l1621t2444r1681b2500],
5	patients	NNS	O	patient	prep_in	24	SENT_252	[p13l1718t2444r1966b2517],
6	with	IN	O	with	_	0	SENT_252	[p13l2007t2444r2148b2500],
7	esophageal	NN	O	esophageal	nn	8	SENT_252	[p13l8t2542r362b2614],
8	adenocarcinoma	NN	O	adenocarcinoma	prep_with	5	SENT_252	[p13l388t2542r913b2598],
9	treated	VBN	O	treat	partmod	8	SENT_252	[p13l936t2542r1154b2598],
10	with	IN	O	with	_	0	SENT_252	[p13l1177t2542r1318b2598],
11	cisplatin-based	JJ	O	cisplatin-based	amod	12	SENT_252	[p13l1341t2542r1822b2614],
12	radiochemotherapy	NN	O	radiochemotherapy	prep_with	9	SENT_252	[p13l1844t2542r2145b2598, p13l7t2639r362b2712],
13	,	,	O	,	_	0	SENT_252	[p13l1844t2542r2145b2598, p13l7t2639r362b2712],
14	those	DT	O	those	nsubj	24	SENT_252	[p13l404t2639r571b2695],
15	in	IN	O	in	_	0	SENT_252	[p13l612t2639r673b2694],
16	the	DT	O	the	det	18	SENT_252	[p13l712t2639r808b2695],
17	GS	NN	MISC	g	nn	18	SENT_252	[p13l852t2640r946b2696],
18	TPI	NN	MISC	tpus	prep_in	14	SENT_252	[p13l950t2640r1073b2694],
19	105	CD	NUMBER	105	num	21	SENT_252	[p13l1126t2639r1233b2695],
20	AG/GG	NN	O	ag/gg	nn	21	SENT_252	[p13l1276t2639r1525b2695],
21	group	NN	O	group	dep	18	SENT_252	[p13l1566t2657r1749b2712],
22	were	VBD	O	be	cop	24	SENT_252	[p13l1790t2657r1943b2695],
23	more	RBR	O	more	advmod	24	SENT_252	[p13l1983t2657r2147b2695],
24	likely	JJ	O	likely	_	0	SENT_252	[p13l7t2735r188b2808],
25	to	TO	O	to	aux	26	SENT_252	[p13l236t2744r296b2791],
26	experience	VB	O	experience	xcomp	24	SENT_252	[p13l345t2735r691b2808],
27	grade	NN	O	grade	dobj	26	SENT_252	[p13l738t2735r913b2808],
28	3-4	CD	NUMBER	3-4	num	30	SENT_252	[p13l964t2736r1079b2792],
29	radiation-attributable	JJ	O	radiation-attributable	amod	30	SENT_252	[p13l1126t2735r1805b2791],
30	toxicities	NNS	O	toxicity	nsubj	31	SENT_252	[p13l1853t2735r2145b2791],
31	(	VBP	O	(	rcmod	27	SENT_252	[p13l10t2834r165b2905],
32	e.g.	FW	O	e.g.	dobj	31	SENT_252	[p13l10t2834r165b2905],
33	,	,	O	,	_	0	SENT_252	[p13l10t2834r165b2905],
34	dysphagia	NN	O	dysphagia	nn	35	SENT_252	[p13l216t2833r563b2905],
35	)	NN	O	)	appos	27	SENT_252	[p13l216t2833r563b2905],
36	than	IN	O	than	_	0	SENT_252	[p13l613t2833r749b2889],
37	those	DT	O	those	prep_than	35	SENT_252	[p13l796t2833r963b2889],
38	with	IN	O	with	_	0	SENT_252	[p13l1009t2833r1150b2889],
39	the	DT	O	the	det	41	SENT_252	[p13l1196t2833r1292b2889],
40	AA	NN	O	aa	nn	41	SENT_252	[p13l1339t2833r1453b2888],
41	genotype	NN	O	genotype	prep_with	37	SENT_252	[p13l1500t2841r1792b2905],
42	(	CD	PERCENT	(	num	44	SENT_252	[p13l1842t2833r2008b2902],
43	31	CD	PERCENT	31	num	44	SENT_252	[p13l1842t2833r2008b2902],
44	%	NN	PERCENT	%	dep	37	SENT_252	[p13l1842t2833r2008b2902],
45	vs.	CC	O	vs.	prep	44	SENT_252	[p13l2058t2851r2143b2889],
46	o	NN	PERCENT	o	nn	47	SENT_252	[p13l8t2930r129b2997],
47	%	NN	PERCENT	%	dep	45	SENT_252	[p13l8t2930r129b2997],
48	,	,	O	,	_	0	SENT_252	[p13l8t2930r129b2997],
49	P	NN	O	p	appos	37	SENT_252	[p13l161t2932r210b2985],
50	:	:	O	:	_	0	SENT_252	[p13l242t2955r296b2975],
51	0.005	CD	NUMBER	0.005	number	52	SENT_252	[p13l328t2930r530b2999],
52	)	CD	NUMBER	)	num	53	SENT_252	[p13l328t2930r530b2999],
53	[	NN	O	[	dep	27	SENT_252	[p13l568t2930r710b2998],
54	28	CD	NUMBER	28	num	55	SENT_252	[p13l568t2930r710b2998],
55	]	NN	O	]	dep	27	SENT_252	[p13l568t2930r710b2998],
56	.	.	O	.	_	0	SENT_252	[p13l568t2930r710b2998],

1	The	DT	O	the	det	3	SENT_253	[p13l114t3026r237b3082],
2	GS	NN	MISC	g	nn	3	SENT_253	[p13l265t3027r360b3083],
3	TPI	NN	MISC	tpus	nsubjpass	10	SENT_253	[p13l364t3027r486b3082],
4	105	CD	NUMBER	105	dep	3	SENT_253	[p13l524t3026r631b3083],
5	A	DT	O	a	det	8	SENT_253	[p13l659t3027r716b3082],
6	>	JJR	O	>	amod	8	SENT_253	[p13l749t3038r798b3084],
7	G	NN	O	g	nn	8	SENT_253	[p13l831t3027r887b3083],
8	SNP	NN	O	snp	dep	3	SENT_253	[p13l912t3027r1054b3083],
9	is	VBZ	O	be	auxpass	10	SENT_253	[p13l1079t3026r1129b3082],
10	characterized	VBN	O	characterize	_	0	SENT_253	[p13l1155t3026r1583b3082],
11	by	IN	O	by	_	0	SENT_253	[p13l1607t3026r1685b3099],
12	an	DT	O	a	det	13	SENT_253	[p13l1712t3044r1785b3082],
13	adenine	NN	LOCATION	adenine	agent	10	SENT_253	[p13l1811t3026r2057b3082],
14	or	CC	O	or	_	0	SENT_253	[p13l2084t3044r2149b3082],
15	guanine	NN	O	guanine	agent	10	SENT_253	[p13l8t3123r260b3196],
16	at	IN	O	at	_	0	SENT_253	[p13l288t3132r343b3179],
17	position	NN	O	position	prep_at	13	SENT_253	[p13l367t3123r625b3196],
18	313	CD	NUMBER	313	num	17	SENT_253	[p13l653t3124r765b3180],
19	resulting	VBG	O	result	xcomp	10	SENT_253	[p13l794t3123r1091b3196],
20	,	,	O	,	_	0	SENT_253	[p13l794t3123r1091b3196],
21	respectively	RB	O	respectively	advmod	19	SENT_253	[p13l1119t3123r1518b3196],
22	,	,	O	,	_	0	SENT_253	[p13l1119t3123r1518b3196],
23	in	IN	O	in	_	0	SENT_253	[p13l1546t3123r1607b3179],
24	an	DT	O	a	det	25	SENT_253	[p13l1634t3141r1706b3179],
25	isoleucine	NN	O	isoleucine	prep_in	19	SENT_253	[p13l1732t3123r2056b3179],
26	or	CC	O	or	_	0	SENT_253	[p13l2084t3141r2149b3179],
27	Valine	NN	PERSON	valine	conj_or	25	SENT_253	[p13l7t3221r200b3277],
28	at	IN	O	at	_	0	SENT_253	[p13l248t3230r304b3277],
29	codon	NN	O	codon	prep_at	25	SENT_253	[p13l349t3221r543b3277],
30	105	CD	NUMBER	105	num	29	SENT_253	[p13l596t3221r722b3277],
31	.	.	O	.	_	0	SENT_253	[p13l596t3221r722b3277],

1	Its	PRP$	O	its	poss	3	SENT_254	[p13l773t3223r849b3277],
2	functional	JJ	O	functional	amod	3	SENT_254	[p13l896t3221r1220b3277],
3	signiﬁcance	NN	O	signiﬁcance	nsubj	4	SENT_254	[p13l1270t3221r1648b3294],
4	varies	VBZ	O	vary	_	0	SENT_254	[p13l1693t3221r1879b3277],
5	by	IN	O	by	_	0	SENT_254	[p13l1926t3221r2004b3294],
6	the	DT	O	the	det	7	SENT_254	[p13l2051t3221r2147b3277],
7	exposure	NN	O	exposure	prep_by	4	SENT_254	[p13l8t3335r293b3390],
8	with	IN	O	with	_	0	SENT_254	[p13l332t3317r473b3373],
9	the	DT	O	the	det	10	SENT_254	[p13l511t3317r607b3373],
10	G-allele	NN	MISC	g-allele	prep_with	7	SENT_254	[p13l649t3317r904b3374],
11	conferring	VBG	O	confer	partmod	10	SENT_254	[p13l944t3317r1276b3390],
12	increased	VBN	O	increase	amod	14	SENT_254	[p13l1316t3317r1619b3373],
13	GSTpi	NN	MISC	gstpus	nn	14	SENT_254	[p13l1659t3317r1868b3390],
14	activity	NN	O	activity	dobj	11	SENT_254	[p13l1910t3317r2146b3390],
15	to	TO	O	to	_	0	SENT_254	[p13l7t3423r67b3470],
16	platinum	NN	O	platinum	nn	17	SENT_254	[p13l113t3414r400b3487],
17	agents	NNS	O	agent	prep_to	14	SENT_254	[p13l447t3423r648b3487],
18	in	FW	O	in	prep	14	SENT_254	[p13l698t3417r755b3470],
19	vitro	FW	O	vitro	nn	20	SENT_254	[p13l800t3417r945b3471],
20	[	FW	O	[	pobj	18	SENT_254	[p13l999t3415r1140b3482],
21	29	CD	NUMBER	29	num	22	SENT_254	[p13l999t3415r1140b3482],
22	]	NN	O	]	dep	20	SENT_254	[p13l999t3415r1140b3482],
23	.	.	O	.	_	0	SENT_254	[p13l999t3415r1140b3482],

1	The	DT	O	the	det	3	SENT_255	[p13l1191t3414r1314b3470],
2	variable	JJ	O	variable	amod	3	SENT_255	[p13l1359t3414r1614b3471],
3	metabolism	NN	O	metabolism	nsubj	34	SENT_255	[p13l1662t3414r2037b3470],
4	of	IN	O	of	_	0	SENT_255	[p13l2084t3414r2153b3470],
5	cisplatin	NN	O	cisplatin	prep_of	3	SENT_255	[p13l8t3512r278b3585],
6	by	IN	O	by	_	0	SENT_255	[p13l313t3512r391b3585],
7	GSTP1	NN	O	gstp1	prep_by	5	SENT_255	[p13l430t3513r651b3569],
8	105	CD	NUMBER	105	num	7	SENT_255	[p13l700t3512r807b3568],
9	A	DT	O	a	det	12	SENT_255	[p13l846t3513r902b3567],
10	>	JJR	O	>	amod	12	SENT_255	[p13l936t3524r985b3570],
11	G	NN	O	g	nn	12	SENT_255	[p13l1018t3512r1073b3568],
12	genotype	NN	O	genotype	nsubjpass	16	SENT_255	[p13l1108t3521r1400b3585],
13	may	MD	O	may	aux	16	SENT_255	[p13l1436t3530r1572b3585],
14	not	RB	O	not	neg	16	SENT_255	[p13l1608t3520r1709b3568],
15	be	VB	O	be	auxpass	16	SENT_255	[p13l1743t3512r1817b3568],
16	mediated	VBN	O	mediate	rcmod	3	SENT_255	[p13l1853t3512r2147b3568],
17	by	IN	O	by	_	0	SENT_255	[p13l6t3608r85b3681],
18	the	DT	O	the	det	23	SENT_255	[p13l118t3608r214b3664],
19	GSTpi	NNP	MISC	GSTpi	nn	23	SENT_255	[p13l249t3608r459b3681],
20	free	JJ	O	free	amod	23	SENT_255	[p13l493t3608r615b3664],
21	radical	NN	O	radical	nn	23	SENT_255	[p13l647t3608r865b3664],
22	detoxiﬁcation	NN	O	detoxiﬁcation	nn	23	SENT_255	[p13l900t3608r1339b3664],
23	activity	NN	O	activity	agent	16	SENT_255	[p13l1374t3608r1623b3681],
24	,	,	O	,	_	0	SENT_255	[p13l1374t3608r1623b3681],
25	but	CC	O	but	_	0	SENT_255	[p13l1658t3608r1760b3664],
26	rather	RB	O	rather	advmod	28	SENT_255	[p13l1791t3608r1979b3664],
27	may	MD	O	may	aux	28	SENT_255	[p13l2010t3626r2147b3681],
28	depend	VB	O	depend	rcmod	3	SENT_255	[p13l8t3706r238b3778],
29	on	IN	O	on	_	0	SENT_255	[p13l277t3723r354b3761],
30	interactions	NNS	O	interaction	prep_on	28	SENT_255	[p13l391t3705r763b3761],
31	with	IN	O	with	_	0	SENT_255	[p13l803t3705r944b3762],
32	other	JJ	O	other	amod	33	SENT_255	[p13l982t3706r1146b3761],
33	pathways	NNS	O	pathway	prep_with	30	SENT_255	[p13l1182t3705r1482b3778],
34	[	VBP	O	[	_	0	SENT_255	[p13l1527t3706r1669b3773],
35	30	CD	NUMBER	30	num	36	SENT_255	[p13l1527t3706r1669b3773],
36	]	CD	NUMBER	]	dobj	34	SENT_255	[p13l1527t3706r1669b3773],
37	.	.	O	.	_	0	SENT_255	[p13l1527t3706r1669b3773],

1	For	IN	O	for	_	0	SENT_256	[p13l1710t3707r1822b3761],
2	example	NN	O	example	pobj	1	SENT_256	[p13l1857t3705r2145b3778],
3	,	,	O	,	_	0	SENT_256	[p13l1857t3705r2145b3778],

1	Pediatr	NNP	O	Pediatr	nn	4	SENT_257	[p14l6t24r218b74],
2	Blood	NNP	O	Blood	nn	4	SENT_257	[p14l234t24r408b75],
3	Cancer	NNP	O	Cancer	nn	4	SENT_257	[p14l429t25r637b75],
4	DOI	NNP	O	DOI	nsubjpass	22	SENT_257	[p14l655t25r779b75],
5	10.1002	CD	NUMBER	10.1002	num	4	SENT_257	[p14l807t24r1151b89],
6	/	:	O	/	punct	8	SENT_257	[p14l807t24r1151b89],
7	pbc	NN	O	pbc	nn	8	SENT_257	[p14l807t24r1151b89],
8	JNK/SAPK	NN	O	jnk/sapk	dep	4	SENT_257	[p14l7t116r380b172],
9	pathway	NN	O	pathway	nn	10	SENT_257	[p14l404t115r675b188],
10	activity	NN	O	activity	dep	8	SENT_257	[p14l703t115r952b188],
11	,	,	O	,	_	0	SENT_257	[p14l703t115r952b188],
12	which	WDT	O	which	nsubjpass	15	SENT_257	[p14l982t115r1177b171],
13	may	MD	O	may	aux	15	SENT_257	[p14l1203t133r1339b188],
14	be	VB	O	be	auxpass	15	SENT_257	[p14l1365t115r1439b171],
15	modulated	VBN	O	modulate	rcmod	4	SENT_257	[p14l1466t115r1805b171],
16	by	IN	O	by	_	0	SENT_257	[p14l1830t115r1909b188],
17	GSTpi	NN	O	gstpus	nn	18	SENT_257	[p14l1937t115r2146b188],
18	expression	NN	O	expression	agent	15	SENT_257	[p14l8t212r366b285],
19	,	,	O	,	_	0	SENT_257	[p14l8t212r366b285],
20	has	VBZ	O	have	aux	22	SENT_257	[p14l404t213r508b268],
21	been	VBN	O	be	auxpass	22	SENT_257	[p14l545t213r696b268],
22	shown	VBN	O	show	_	0	SENT_257	[p14l736t213r938b269],
23	to	TO	O	to	_	0	SENT_257	[p14l975t221r1034b268],
24	inﬂuence	NN	O	inﬂuence	nn	27	SENT_257	[p14l1072t212r1364b268],
25	cisplatin-mediated	JJ	O	cisplatin-mediated	amod	27	SENT_257	[p14l1402t212r1996b285],
26	cell	NN	O	cell	nn	27	SENT_257	[p14l2033t212r2147b268],
27	death	NN	O	death	prep_to	22	SENT_257	[p14l8t309r195b365],
28	.	.	O	.	_	0	SENT_257	[p14l8t309r195b365],

1	There	EX	O	there	expl	2	SENT_258	[p14l240t309r425b365],
2	are	VBP	O	be	_	0	SENT_258	[p14l467t327r561b365],
3	no	DT	O	no	det	4	SENT_258	[p14l601t327r678b365],
4	data	NNS	O	datum	nsubj	2	SENT_258	[p14l720t309r852b365],
5	on	IN	O	on	prep	4	SENT_258	[p14l893t327r970b365],
6	the	DT	O	the	det	8	SENT_258	[p14l1009t309r1105b365],
7	functional	JJ	O	functional	amod	8	SENT_258	[p14l1146t309r1470b365],
8	implications	NNS	O	implication	dep	16	SENT_258	[p14l1510t309r1905b382],
9	of	IN	O	of	_	0	SENT_258	[p14l1948t309r2017b365],
10	the	DT	O	the	det	11	SENT_258	[p14l2051t309r2147b365],
11	GSTPI	NN	O	gstpus	prep_of	8	SENT_258	[p14l10t407r231b463],
12	105	CD	NUMBER	105	dep	16	SENT_258	[p14l272t406r379b463],
13	A	DT	O	a	det	16	SENT_258	[p14l411t407r467b462],
14	>	JJR	O	>	amod	16	SENT_258	[p14l501t418r550b464],
15	G	NN	O	g	nn	16	SENT_258	[p14l583t407r638b462],
16	genotype	NN	O	genotype	dep	5	SENT_258	[p14l666t415r958b479],
17	on	IN	O	on	_	0	SENT_258	[p14l987t424r1065b462],
18	radiation-associated	JJ	O	radiation-associated	amod	21	SENT_258	[p14l1092t406r1736b462],
19	reactive	JJ	O	reactive	amod	21	SENT_258	[p14l1762t406r2015b462],
20	oxygen	NN	O	oxygen	nn	21	SENT_258	[p14l2043t424r2145b462, p14l7t521r161b576],
21	species	NNS	O	species	prep_on	16	SENT_258	[p14l202t503r446b576],
22	,	,	O	,	_	0	SENT_258	[p14l202t503r446b576],
23	although	IN	O	although	mark	27	SENT_258	[p14l489t503r767b576],
24	it	PRP	O	it	nsubjpass	27	SENT_258	[p14l804t503r848b559],
25	may	MD	O	may	aux	27	SENT_258	[p14l885t521r1021b576],
26	be	VB	O	be	auxpass	27	SENT_258	[p14l1058t503r1133b559],
27	inferred	VBN	O	infer	advcl	2	SENT_258	[p14l1170t503r1424b559],
28	from	IN	O	from	_	0	SENT_258	[p14l1461t503r1616b559],
29	clinical	JJ	O	clinical	amod	30	SENT_258	[p14l1653t503r1888b559],
30	studies	NNS	O	study	prep_from	27	SENT_258	[p14l1929t503r2146b559],
31	that	IN	O	that	complm	36	SENT_258	[p14l7t601r127b657],
32	the	DT	O	the	det	35	SENT_258	[p14l157t601r253b657],
33	G	NN	O	g	nn	35	SENT_258	[p14l285t601r541b657],
34	—	CD	NUMBER	—	num	35	SENT_258	[p14l285t601r541b657],
35	allele	NN	O	allele	nsubj	36	SENT_258	[p14l285t601r541b657],
36	leads	VBZ	O	lead	ccomp	27	SENT_258	[p14l572t601r734b657],
37	to	TO	O	to	_	0	SENT_258	[p14l765t609r825b657],
38	decreased	VBN	O	decrease	amod	40	SENT_258	[p14l857t601r1172b657],
39	GSTpi	NN	O	gstpus	nn	40	SENT_258	[p14l1204t601r1414b673],
40	activity	NN	O	activity	prep_to	36	SENT_258	[p14l1447t601r1683b673],
41	[	CD	NUMBER	[	number	42	SENT_258	[p14l1720t601r1982b668],
42	26	CD	NUMBER	26	num	43	SENT_258	[p14l1720t601r1982b668],
43	—	NN	O	—	dobj	36	SENT_258	[p14l1720t601r1982b668],
44	28	CD	NUMBER	28	num	45	SENT_258	[p14l1720t601r1982b668],
45	]	NN	O	]	dep	43	SENT_258	[p14l1720t601r1982b668],
46	.	.	O	.	_	0	SENT_258	[p14l1720t601r1982b668],

1	Our	PRP$	O	we	poss	2	SENT_259	[p14l116t698r238b754],
2	ﬁnding	NN	O	ﬁnding	nsubj	29	SENT_259	[p14l277t697r500b770],
3	of	IN	O	of	_	0	SENT_259	[p14l539t697r608b753],
4	the	DT	O	the	det	7	SENT_259	[p14l642t697r738b753],
5	GSTPI	NN	O	gstpus	nn	7	SENT_259	[p14l780t698r1001b754],
6	105	CD	NUMBER	105	num	7	SENT_259	[p14l1053t697r1160b754],
7	G	NN	O	g	prep_of	2	SENT_259	[p14l1204t697r1460b754],
8	—	CD	NUMBER	—	num	9	SENT_259	[p14l1204t697r1460b754],
9	allele	NN	O	allele	nsubj	22	SENT_259	[p14l1204t697r1460b754],
10	as	IN	O	as	_	0	SENT_259	[p14l1500t715r1562b753],
11	a	DT	O	a	det	13	SENT_259	[p14l1604t715r1637b753],
12	risk	NN	O	risk	nn	13	SENT_259	[p14l1673t697r1794b753],
13	factor	NN	O	factor	prep_as	9	SENT_259	[p14l1831t697r2019b753],
14	for	IN	O	for	_	0	SENT_259	[p14l2056t697r2149b753],
15	severe	JJ	O	severe	amod	16	SENT_259	[p14l10t812r207b851],
16	ototoxicity	NN	O	ototoxicity	prep_for	13	SENT_259	[p14l246t794r591b867],
17	in	IN	O	in	_	0	SENT_259	[p14l627t794r688b850],
18	children	NNS	O	child	prep_in	16	SENT_259	[p14l725t794r986b850],
19	with	IN	O	with	_	0	SENT_259	[p14l1022t794r1163b850],
20	medulloblastoma/PNET	NN	O	medulloblastoma/pnet	prep_with	18	SENT_259	[p14l1198t794r1974b851],
21	may	MD	O	may	aux	22	SENT_259	[p14l2011t812r2147b867],
22	appear	VB	O	appear	rcmod	7	SENT_259	[p14l9t909r221b964],
23	to	TO	O	to	aux	24	SENT_259	[p14l248t900r307b948],
24	contradict	VB	O	contradict	xcomp	22	SENT_259	[p14l337t892r657b948],
25	results	NNS	O	result	dobj	24	SENT_259	[p14l683t892r890b948],
26	observed	VBN	O	observe	partmod	25	SENT_259	[p14l921t892r1208b948],
27	by	IN	O	by	_	0	SENT_259	[p14l1233t892r1312b964],
28	others	NNS	O	other	agent	26	SENT_259	[p14l1341t892r1533b948],
29	[	VBP	O	[	_	0	SENT_259	[p14l1568t892r1810b959],
30	23,29	CD	NUMBER	23,29	number	31	SENT_259	[p14l1568t892r1810b959],
31	]	CD	NUMBER	]	dobj	29	SENT_259	[p14l1568t892r1810b959],
32	.	.	O	.	_	0	SENT_259	[p14l1568t892r1810b959],

1	However	RB	O	however	advmod	6	SENT_260	[p14l1842t893r2145b958],
2	,	,	O	,	_	0	SENT_260	[p14l1842t893r2145b958],
3	previous	JJ	O	previous	amod	5	SENT_260	[p14l6t988r279b1061],
4	clinical	JJ	O	clinical	amod	5	SENT_260	[p14l328t988r563b1044],
5	investigations	NNS	O	investigation	nsubj	6	SENT_260	[p14l610t988r1051b1061],
6	included	VBD	O	include	_	0	SENT_260	[p14l1099t988r1375b1044],
7	subjects	NNS	O	subject	dobj	6	SENT_260	[p14l1424t988r1676b1061],
8	on	IN	O	on	_	0	SENT_260	[p14l1725t1006r1803b1044],
9	cisplatinbased	JJ	O	cisplatinbased	amod	10	SENT_260	[p14l1850t988r2144b1061, p14l6t1086r189b1141],
10	regimens	NNS	O	regimen	prep_on	6	SENT_260	[p14l215t1085r506b1158],
11	without	IN	O	without	_	0	SENT_260	[p14l536t1085r780b1142],
12	radiation	NN	O	radiation	prep_without	6	SENT_260	[p14l806t1085r1108b1152],
13	,	,	O	,	_	0	SENT_260	[p14l806t1085r1108b1152],
14	a	DT	O	a	det	16	SENT_260	[p14l1141t1103r1174b1141],
15	central	JJ	O	central	amod	16	SENT_260	[p14l1201t1085r1417b1141],
16	component	NN	O	component	appos	12	SENT_260	[p14l1446t1094r1802b1158],
17	of	IN	O	of	_	0	SENT_260	[p14l1830t1085r1899b1141],
18	medulloblastoma	NN	O	medulloblastoma	nn	19	SENT_260	[p14l1921t1085r2145b1141, p14l7t1183r360b1239],
19	therapy	NN	O	therapy	prep_of	16	SENT_260	[p14l383t1183r622b1255],
20	[	CD	NUMBER	[	number	21	SENT_260	[p14l653t1182r916b1251],
21	23	CD	NUMBER	23	num	22	SENT_260	[p14l653t1182r916b1251],
22	—	NN	O	—	dep	16	SENT_260	[p14l653t1182r916b1251],
23	25	CD	NUMBER	25	num	24	SENT_260	[p14l653t1182r916b1251],
24	]	NN	O	]	dep	22	SENT_260	[p14l653t1182r916b1251],
25	.	.	O	.	_	0	SENT_260	[p14l653t1182r916b1251],

1	Additionally	RB	O	additionally	advmod	9	SENT_261	[p14l945t1183r1362b1255],
2	,	,	O	,	_	0	SENT_261	[p14l945t1183r1362b1255],
3	prior	RB	O	prior	advmod	9	SENT_261	[p14l1389t1183r1546b1255],
4	in	FW	O	in	nn	7	SENT_261	[p14l1571t1185r1628b1239],
5	vitro	FW	O	vitro	dep	7	SENT_261	[p14l1652t1185r1797b1239],
6	functional	JJ	O	functional	amod	7	SENT_261	[p14l1823t1183r2147b1239],
7	studies	NNS	O	study	advmod	9	SENT_261	[p14l10t1279r227b1335],
8	were	VBD	O	be	auxpass	9	SENT_261	[p14l269t1297r421b1336],
9	performed	VBN	O	perform	_	0	SENT_261	[p14l461t1279r796b1352],
10	with	IN	O	with	_	0	SENT_261	[p14l836t1279r976b1336],
11	cisplatin	NN	O	cisplatin	prep_with	9	SENT_261	[p14l1017t1279r1287b1352],
12	alone	RB	O	alone	advmod	9	SENT_261	[p14l1328t1280r1516b1346],
13	,	,	O	,	_	0	SENT_261	[p14l1328t1280r1516b1346],
14	without	IN	O	without	_	0	SENT_261	[p14l1559t1279r1804b1336],
15	radiation	NN	O	radiation	prep_without	9	SENT_261	[p14l1842t1279r2145b1346],
16	,	,	O	,	_	0	SENT_261	[p14l1842t1279r2145b1346],
17	which	WDT	O	which	nsubj	19	SENT_261	[p14l8t1377r202b1433],
18	may	MD	O	may	aux	19	SENT_261	[p14l241t1394r377b1449],
19	interact	VB	O	interact	rcmod	15	SENT_261	[p14l417t1377r658b1433],
20	with	IN	O	with	_	0	SENT_261	[p14l697t1377r838b1433],
21	GST	NN	O	gst	nn	23	SENT_261	[p14l879t1377r1026b1433],
22	pi	NN	O	pi	nn	23	SENT_261	[p14l1027t1377r1088b1449],
23	[	NN	O	[	prep_with	19	SENT_261	[p14l1134t1377r1377b1445],
24	29,31	CD	NUMBER	29,31	num	25	SENT_261	[p14l1134t1377r1377b1445],
25	]	NN	O	]	nsubjpass	9	SENT_261	[p14l1134t1377r1377b1445],
26	.	.	O	.	_	0	SENT_261	[p14l1134t1377r1377b1445],

1	We	PRP	O	we	nsubj	2	SENT_262	[p14l1419t1378r1523b1433],
2	found	VBD	O	find	_	0	SENT_262	[p14l1564t1377r1749b1433],
3	that	IN	O	that	complm	7	SENT_262	[p14l1788t1377r1908b1433],
4	severe	JJ	O	severe	amod	5	SENT_262	[p14l1949t1394r2148b1433],
5	ototoxicity	NN	O	ototoxicity	nsubjpass	7	SENT_262	[p14l8t1474r354b1546],
6	is	VBZ	O	be	auxpass	7	SENT_262	[p14l406t1474r456b1530],
7	associated	VBN	O	associate	ccomp	2	SENT_262	[p14l511t1474r838b1530],
8	with	IN	O	with	_	0	SENT_262	[p14l890t1474r1031b1530],
9	the	DT	O	the	det	11	SENT_262	[p14l1081t1474r1178b1530],
10	combined	JJ	O	combined	amod	11	SENT_262	[p14l1230t1474r1546b1530],
11	exposure	NN	O	exposure	prep_with	7	SENT_262	[p14l1597t1492r1883b1546],
12	of	IN	O	of	_	0	SENT_262	[p14l1936t1474r2005b1530],
13	the	DT	O	the	det	16	SENT_262	[p14l2051t1474r2147b1530],
14	GSTPI	NN	O	gstpus	nn	16	SENT_262	[p14l10t1571r231b1627],
15	105	CD	NUMBER	105	num	16	SENT_262	[p14l276t1570r383b1627],
16	G	NN	O	g	prep_of	11	SENT_262	[p14l420t1570r675b1627],
17	—	CD	NUMBER	—	num	18	SENT_262	[p14l420t1570r675b1627],
18	allele	NN	O	allele	dobj	7	SENT_262	[p14l420t1570r675b1627],
19	with	IN	O	with	_	0	SENT_262	[p14l706t1570r847b1627],
20	high	JJ	O	high	amod	22	SENT_262	[p14l877t1570r1019b1643],
21	dose	NN	O	dose	nn	22	SENT_262	[p14l1051t1571r1194b1626],
22	CSI	NNP	O	CSI	prep_with	18	SENT_262	[p14l1227t1571r1365b1627],
23	.	.	O	.	_	0	SENT_262	[p14l1227t1571r1365b1627],

1	This	DT	O	this	nsubj	3	SENT_263	[p14l1400t1570r1539b1626],
2	is	VBZ	O	be	cop	3	SENT_263	[p14l1573t1570r1622b1626],
3	consistent	JJ	O	consistent	dep	20	SENT_263	[p14l1656t1570r1976b1626],
4	with	IN	O	with	_	0	SENT_263	[p14l2007t1570r2148b1626],
5	the	DT	O	the	det	7	SENT_263	[p14l7t1668r103b1724],
6	clinical	JJ	O	clinical	amod	7	SENT_263	[p14l134t1668r368b1724],
7	evidence	NN	O	evidence	prep_with	3	SENT_263	[p14l399t1668r680b1724],
8	showing	VBG	O	show	xcomp	3	SENT_263	[p14l713t1668r977b1740],
9	that	IN	O	that	complm	15	SENT_263	[p14l1007t1668r1127b1724],
10	the	DT	O	the	det	13	SENT_263	[p14l1156t1668r1251b1724],
11	G	NN	O	g	nn	13	SENT_263	[p14l1282t1668r1538b1724],
12	—	CD	NUMBER	—	num	13	SENT_263	[p14l1282t1668r1538b1724],
13	allele	NN	O	allele	nsubjpass	15	SENT_263	[p14l1282t1668r1538b1724],
14	is	VBZ	O	be	auxpass	15	SENT_263	[p14l1568t1668r1618b1724],
15	associated	VBN	O	associate	ccomp	8	SENT_263	[p14l1650t1668r1978b1724],
16	with	IN	O	with	_	0	SENT_263	[p14l2007t1668r2148b1724],
17	greater	JJR	O	greater	amod	19	SENT_263	[p14l8t1774r231b1837],
18	radiation-related	JJ	O	radiation-related	amod	19	SENT_263	[p14l268t1765r801b1821],
19	toxicities	NNS	O	toxicity	prep_with	15	SENT_263	[p14l841t1765r1133b1821],
20	[	VBP	O	[	_	0	SENT_263	[p14l1181t1765r1443b1833],
21	26	CD	NUMBER	26	num	22	SENT_263	[p14l1181t1765r1443b1833],
22	—	CD	NUMBER	—	dobj	20	SENT_263	[p14l1181t1765r1443b1833],
23	28	CD	NUMBER	28	num	24	SENT_263	[p14l1181t1765r1443b1833],
24	]	NN	O	]	nsubj	20	SENT_263	[p14l1181t1765r1443b1833],
25	.	.	O	.	_	0	SENT_263	[p14l1181t1765r1443b1833],

1	We	PRP	O	we	nsubj	4	SENT_264	[p14l1486t1766r1590b1821],
2	did	VBD	O	do	aux	4	SENT_264	[p14l1631t1765r1732b1821],
3	not	RB	O	not	neg	4	SENT_264	[p14l1771t1773r1873b1821],
4	ﬁnd	VB	O	ﬁnd	_	0	SENT_264	[p14l1913t1765r2035b1821],
5	an	DT	O	a	det	6	SENT_264	[p14l2075t1783r2148b1821],
6	association	NN	O	association	dobj	4	SENT_264	[p14l9t1862r363b1918],
7	between	IN	O	between	_	0	SENT_264	[p14l397t1862r664b1918],
8	severe	JJ	O	severe	amod	10	SENT_264	[p14l701t1880r899b1918],
9	hearing	NN	O	hearing	nn	10	SENT_264	[p14l934t1862r1173b1935],
10	loss	NN	O	loss	prep_between	6	SENT_264	[p14l1209t1862r1329b1918],
11	and	CC	O	and	_	0	SENT_264	[p14l1367t1862r1480b1918],
12	the	DT	O	the	det	15	SENT_264	[p14l1513t1862r1610b1918],
13	cumulative	JJ	O	cumulative	amod	15	SENT_264	[p14l1645t1862r1999b1918],
14	cisplatin	NN	O	cisplatin	nn	15	SENT_264	[p14l2034t1862r2145b1918, p14l6t1959r189b2031],
15	dose	NN	O	dose	conj_and	10	SENT_264	[p14l229t1959r390b2015],
16	.	.	O	.	_	0	SENT_264	[p14l229t1959r390b2015],

1	Several	JJ	O	several	amod	2	SENT_265	[p14l435t1959r669b2015],
2	groups	NNS	O	group	nsubj	4	SENT_265	[p14l710t1976r924b2031],
3	have	VBP	O	have	aux	4	SENT_265	[p14l964t1959r1112b2015],
4	suggested	VBN	O	suggest	_	0	SENT_265	[p14l1155t1959r1467b2031],
5	that	IN	O	that	complm	17	SENT_265	[p14l1506t1959r1626b2015],
6	the	DT	O	the	det	7	SENT_265	[p14l1664t1959r1760b2015],
7	correlation	NN	O	correlation	nsubj	17	SENT_265	[p14l1801t1959r2148b2015],
8	between	IN	O	between	_	0	SENT_265	[p14l6t2056r274b2112],
9	ototoxicity	NN	O	ototoxicity	prep_between	7	SENT_265	[p14l316t2056r662b2128],
10	and	CC	O	and	_	0	SENT_265	[p14l705t2056r818b2112],
11	the	DT	O	the	det	14	SENT_265	[p14l859t2056r955b2112],
12	cumulative	JJ	O	cumulative	amod	14	SENT_265	[p14l998t2056r1350b2112],
13	cisplatin	NN	O	cisplatin	nn	14	SENT_265	[p14l1393t2056r1664b2128],
14	dose	NN	O	dose	prep_between	7	SENT_265	[p14l1706t2056r1850b2112],
15	is	VBZ	O	be	cop	17	SENT_265	[p14l1891t2056r1941b2112],
16	more	RBR	O	more	advmod	17	SENT_265	[p14l1984t2074r2147b2112],
17	pronounced	JJ	O	pronounced	ccomp	4	SENT_265	[p14l6t2153r386b2226],
18	above	IN	O	above	_	0	SENT_265	[p14l428t2153r614b2209],
19	400	CD	NUMBER	400	num	20	SENT_265	[p14l655t2153r773b2209],
20	mg/m2	NN	O	mg/m2	prep_above	17	SENT_265	[p14l802t2136r1019b2226],
21	[	CD	NUMBER	[	number	22	SENT_265	[p14l1066t2154r1308b2221],
22	32,33	CD	NUMBER	32,33	num	23	SENT_265	[p14l1066t2154r1308b2221],
23	]	NN	O	]	dep	17	SENT_265	[p14l1066t2154r1308b2221],
24	.	.	O	.	_	0	SENT_265	[p14l1066t2154r1308b2221],

1	The	DT	O	the	det	2	SENT_266	[p14l1353t2153r1476b2209],
2	importance	NN	O	importance	nsubjpass	14	SENT_266	[p14l1517t2153r1877b2226],
3	of	IN	O	of	_	0	SENT_266	[p14l1920t2153r1989b2209],
4	CSI	NNP	O	CSI	prep_of	2	SENT_266	[p14l2026t2154r2147b2209],
5	as	IN	O	as	_	0	SENT_266	[p14l9t2267r70b2306],
6	opposed	VBN	O	oppose	amod	7	SENT_266	[p14l115t2250r380b2322],
7	cisplatin	NN	O	cisplatin	prep_as	4	SENT_266	[p14l422t2250r692b2322],
8	in	IN	O	in	_	0	SENT_266	[p14l734t2250r794b2305],
9	our	PRP$	O	we	poss	10	SENT_266	[p14l837t2267r942b2306],
10	study	NN	O	study	prep_in	7	SENT_266	[p14l985t2250r1154b2322],
11	may	MD	O	may	aux	14	SENT_266	[p14l1196t2267r1332b2322],
12	be	VB	O	be	auxpass	14	SENT_266	[p14l1373t2250r1447b2306],
13	partly	RB	O	partly	advmod	14	SENT_266	[p14l1488t2250r1675b2322],
14	explained	VBN	O	explain	_	0	SENT_266	[p14l1717t2250r2029b2322],
15	by	IN	O	by	_	0	SENT_266	[p14l2068t2250r2147b2322],
16	the	DT	O	the	det	21	SENT_266	[p14l7t2347r103b2403],
17	relatively	RB	O	relatively	advmod	18	SENT_266	[p14l132t2347r433b2419],
18	lower	JJR	O	lower	amod	21	SENT_266	[p14l463t2347r643b2403],
19	cumulative	JJ	O	cumulative	amod	21	SENT_266	[p14l671t2347r1024b2403],
20	cisplatin	NN	O	cisplatin	nn	21	SENT_266	[p14l1054t2347r1324b2419],
21	doses	NNS	O	dose	agent	14	SENT_266	[p14l1354t2347r1527b2403],
22	to	TO	O	to	_	0	SENT_266	[p14l1558t2355r1618b2403],
23	which	WDT	O	which	dobj	27	SENT_266	[p14l1646t2347r1840b2403],
24	our	PRP$	O	we	poss	25	SENT_266	[p14l1870t2365r1975b2403],
25	population	NN	O	population	nsubjpass	27	SENT_266	[p14l2001t2364r2145b2419, p14l7t2445r230b2501],
26	was	VBD	O	be	auxpass	27	SENT_266	[p14l273t2463r393b2501],
27	exposed	VBN	O	expose	prepc_to	14	SENT_266	[p14l439t2445r700b2518],
28	(	RB	O	(	advmod	27	SENT_266	[p14l745t2445r1005b2514],
29	median	JJ	O	median	amod	32	SENT_266	[p14l745t2445r1005b2514],
30	300	CD	NUMBER	300	tmod	29	SENT_266	[p14l1050t2446r1166b2501],
31	mg/m2	NN	O	mg/m2	nn	32	SENT_266	[p14l1195t2428r1454b2518],
32	)	NN	O	)	dobj	27	SENT_266	[p14l1195t2428r1454b2518],
33	.	.	O	.	_	0	SENT_266	[p14l1195t2428r1454b2518],

1	Moreover	RB	O	moreover	advmod	14	SENT_267	[p14l1501t2447r1830b2511],
2	,	,	O	,	_	0	SENT_267	[p14l1501t2447r1830b2511],
3	cisplatin	NN	O	cisplatin	nn	5	SENT_267	[p14l1877t2445r2148b2518],
4	dose	NN	O	dose	nn	5	SENT_267	[p14l8t2542r152b2598],
5	modiﬁcations	NNS	O	modiﬁcations	nsubj	14	SENT_267	[p14l194t2542r647b2608],
6	,	,	O	,	_	0	SENT_267	[p14l194t2542r647b2608],
7	which	WDT	O	which	nsubj	9	SENT_267	[p14l692t2542r887b2598],
8	were	VBD	O	be	cop	9	SENT_267	[p14l928t2560r1081b2598],
9	widespread	JJ	O	widespread	rcmod	5	SENT_267	[p14l1123t2542r1487b2614],
10	in	IN	O	in	_	0	SENT_267	[p14l1528t2542r1590b2597],
11	our	PRP$	O	we	poss	12	SENT_267	[p14l1632t2560r1737b2598],
12	study	NN	O	study	prep_in	9	SENT_267	[p14l1781t2542r1962b2614],
13	,	,	O	,	_	0	SENT_267	[p14l1781t2542r1962b2614],
14	confounded	VBD	O	confound	_	0	SENT_267	[p14l2007t2560r2145b2598, p14l7t2639r269b2695],
15	the	DT	O	the	det	16	SENT_267	[p14l308t2639r404b2695],
16	association	NN	O	association	dobj	14	SENT_267	[p14l446t2639r800b2695],
17	between	IN	O	between	_	0	SENT_267	[p14l838t2639r1106b2695],
18	cumulative	JJ	O	cumulative	amod	20	SENT_267	[p14l1146t2639r1499b2695],
19	cisplatin	NN	O	cisplatin	nn	20	SENT_267	[p14l1539t2639r1809b2711],
20	dose	NN	O	dose	prep_between	16	SENT_267	[p14l1850t2639r1994b2695],
21	and	CC	O	and	_	0	SENT_267	[p14l2035t2639r2148b2695],
22	ototoxicity	NN	O	ototoxicity	prep_between	16	SENT_267	[p14l8t2736r366b2809],
23	.	.	O	.	_	0	SENT_267	[p14l8t2736r366b2809],

1	We	PRP	O	we	nsubj	15	SENT_268	[p14l113t2834r218b2888],
2	also	RB	O	also	advmod	3	SENT_268	[p14l252t2832r377b2888],
3	evaluated	VBD	O	evaluate	_	0	SENT_268	[p14l410t2832r714b2889],
4	the	DT	O	the	det	5	SENT_268	[p14l745t2832r841b2888],
5	relationship	NN	O	relationship	dobj	3	SENT_268	[p14l873t2832r1251b2905],
6	between	IN	O	between	_	0	SENT_268	[p14l1283t2832r1550b2888],
7	tumor	NN	O	tumor	nn	9	SENT_268	[p14l1582t2841r1774b2888],
8	GSTpi	NN	MISC	gstpus	nn	9	SENT_268	[p14l1805t2832r2015b2905],
9	expression	NN	O	expression	prep_between	5	SENT_268	[p14l2048t2850r2146b2888, p14l6t2930r273b3002],
10	and	CC	O	and	_	0	SENT_268	[p14l309t2930r422b2986],
11	outcomes	NNS	O	outcome	prep_between	5	SENT_268	[p14l458t2938r762b2986],
12	in	IN	O	in	_	0	SENT_268	[p14l798t2930r860b2985],
13	medulloblastoma/PNET	NN	O	medulloblastoma/pnet	prep_in	3	SENT_268	[p14l894t2930r1670b2986],
14	and	CC	O	and	_	0	SENT_268	[p14l1702t2930r1815b2986],
15	found	VBD	O	find	conj_and	3	SENT_268	[p14l1849t2930r2035b2986],
16	no	DT	O	no	det	17	SENT_268	[p14l2069t2948r2147b2986],
17	associations	NNS	O	association	dobj	15	SENT_268	[p14l9t3027r410b3083],
18	.	.	O	.	_	0	SENT_268	[p14l9t3027r410b3083],

1	IHC	NNP	ORGANIZATION	IHC	nn	2	SENT_269	[p14l443t3027r577b3083],
2	staining	NN	O	staining	nsubj	8	SENT_269	[p14l610t3027r859b3100],
3	may	MD	O	may	aux	8	SENT_269	[p14l888t3045r1024b3100],
4	not	RB	O	not	neg	8	SENT_269	[p14l1054t3036r1155b3083],
5	be	VB	O	be	cop	8	SENT_269	[p14l1182t3027r1256b3083],
6	the	DT	O	the	det	8	SENT_269	[p14l1285t3027r1381b3083],
7	best	JJS	O	best	amod	8	SENT_269	[p14l1409t3027r1538b3083],
8	method	NN	O	method	_	0	SENT_269	[p14l1566t3027r1806b3083],
9	of	IN	O	of	_	0	SENT_269	[p14l1835t3027r1904b3083],
10	assessing	VBG	O	assess	prepc_of	8	SENT_269	[p14l1929t3045r2145b3083, p14l7t3123r107b3196],
11	GSTpi	NN	MISC	gstpus	nn	12	SENT_269	[p14l135t3123r345b3196],
12	activity	NN	O	activity	dobj	10	SENT_269	[p14l374t3123r623b3196],
13	,	,	O	,	_	0	SENT_269	[p14l374t3123r623b3196],
14	particularly	RB	O	particularly	advmod	16	SENT_269	[p14l651t3123r1021b3196],
15	when	WRB	O	when	advmod	16	SENT_269	[p14l1048t3123r1220b3179],
16	using	VBG	O	use	dep	8	SENT_269	[p14l1245t3123r1417b3196],
17	tumor	NN	O	tumor	nn	18	SENT_269	[p14l1443t3132r1635b3179],
18	tissue	NN	O	tissue	dobj	16	SENT_269	[p14l1659t3123r1839b3179],
19	in	IN	O	in	_	0	SENT_269	[p14l1867t3123r1927b3179],
20	which	WDT	O	which	rel	25	SENT_269	[p14l1953t3123r2148b3179],
21	the	DT	O	the	det	22	SENT_269	[p14l7t3221r103b3277],
22	activity	NN	O	activity	nsubjpass	25	SENT_269	[p14l134t3221r370b3294],
23	may	MD	O	may	aux	25	SENT_269	[p14l399t3239r535b3294],
24	be	VB	O	be	auxpass	25	SENT_269	[p14l562t3221r637b3277],
25	disregulated	VBN	O	disregulate	rcmod	18	SENT_269	[p14l666t3221r1073b3294],
26	.	.	O	.	_	0	SENT_269	[p14l666t3221r1073b3294],

1	Instead	RB	O	instead	advmod	11	SENT_270	[p14l1105t3221r1352b3287],
2	,	,	O	,	_	0	SENT_270	[p14l1105t3221r1352b3287],
3	substrate-speciﬁc	JJ	O	substrate-speciﬁc	amod	5	SENT_270	[p14l1386t3221r1938b3294],
4	activity	NN	O	activity	nn	5	SENT_270	[p14l1969t3221r2145b3277, p14l7t3318r90b3391],
5	assays	NNS	O	assay	nsubj	11	SENT_270	[p14l123t3336r322b3391],
6	in	IN	O	in	_	0	SENT_270	[p14l354t3318r415b3373],
7	normal	JJ	O	normal	amod	8	SENT_270	[p14l445t3318r671b3374],
8	tissue	NN	O	tissue	prep_in	5	SENT_270	[p14l701t3318r882b3374],
9	may	MD	O	may	aux	11	SENT_270	[p14l913t3336r1049b3391],
10	be	VB	O	be	cop	11	SENT_270	[p14l1078t3318r1153b3374],
11	preferable	JJ	O	preferable	_	0	SENT_270	[p14l1183t3318r1525b3391],
12	.	.	O	.	_	0	SENT_270	[p14l1183t3318r1525b3391],

1	Hearing	NN	O	hearing	nn	2	SENT_271	[p14l114t3414r371b3487],
2	loss	NN	O	loss	nsubj	6	SENT_271	[p14l408t3414r529b3470],
3	remains	VBZ	O	remain	cop	6	SENT_271	[p14l565t3414r817b3470],
4	a	DT	O	a	det	6	SENT_271	[p14l856t3432r889b3470],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_271	[p14l927t3414r1258b3487],
6	problem	NN	O	problem	_	0	SENT_271	[p14l1291t3414r1560b3487],
7	for	IN	O	for	_	0	SENT_271	[p14l1595t3414r1688b3470],
8	patients	NNS	O	patient	prep_for	6	SENT_271	[p14l1721t3414r1969b3487],
9	with	IN	O	with	_	0	SENT_271	[p14l2007t3414r2148b3470],
10	medulloblastoma	NN	O	medulloblastoma	prep_with	8	SENT_271	[p14l7t3512r576b3568],
11	.	.	O	.	_	0	SENT_271	[p14l7t3512r576b3568],

1	As	IN	O	as	_	0	SENT_272	[p14l615t3513r701b3568],
2	many	JJ	O	many	amod	7	SENT_272	[p14l737t3530r913b3585],
3	as	IN	O	as	_	0	SENT_272	[p14l950t3530r1011b3568],
4	half	JJ	O	half	amod	5	SENT_272	[p14l1047t3512r1177b3568],
5	experience	NN	O	experience	prep_as	2	SENT_272	[p14l1207t3512r1552b3585],
6	impaired	JJ	O	impaired	amod	7	SENT_272	[p14l1588t3512r1873b3585],
7	hearing	NN	O	hearing	prep_as	17	SENT_272	[p14l1907t3512r2147b3585],
8	with	IN	O	with	_	0	SENT_272	[p14l8t3609r148b3665],
9	roughly	RB	O	roughly	advmod	10	SENT_272	[p14l171t3609r420b3682],
10	one-quarter	NN	DURATION	one-quarter	prep_with	7	SENT_272	[p14l446t3618r815b3682],
11	of	IN	O	of	_	0	SENT_272	[p14l839t3609r908b3665],
12	all	DT	O	all	det	13	SENT_272	[p14l929t3609r1006b3665],
13	patients	NNS	O	patient	prep_of	10	SENT_272	[p14l1029t3609r1277b3682],
14	needing	VBG	O	need	csubj	17	SENT_272	[p14l1303t3609r1555b3682],
15	hearing	NN	O	hearing	nn	16	SENT_272	[p14l1580t3609r1819b3682],
16	aids	NNS	O	aid	dobj	14	SENT_272	[p14l1845t3609r1970b3665],
17	[	VBP	O	[	_	0	SENT_272	[p14l2001t3609r2143b3677],
18	34	CD	NUMBER	34	num	19	SENT_272	[p14l2001t3609r2143b3677],
19	]	CD	NUMBER	]	dobj	17	SENT_272	[p14l2001t3609r2143b3677],
20	.	.	O	.	_	0	SENT_272	[p14l2001t3609r2143b3677],

1	Hearing	NN	O	hearing	nn	2	SENT_273	[p14l7t3705r263b3778],
2	loss	NN	O	loss	nsubj	5	SENT_273	[p14l298t3705r419b3761],
3	can	MD	O	can	aux	5	SENT_273	[p14l454t3723r563b3761],
4	substantially	RB	O	substantially	advmod	5	SENT_273	[p14l598t3705r1000b3778],
5	diminish	VB	O	diminish	_	0	SENT_273	[p14l1035t3705r1314b3761],
6	quality	NN	O	quality	dobj	5	SENT_273	[p14l1348t3705r1568b3778],
7	of	IN	O	of	_	0	SENT_273	[p14l1603t3705r1672b3761],
8	life	NN	O	life	prep_of	6	SENT_273	[p14l1700t3705r1821b3761],
9	.	.	O	.	_	0	SENT_273	[p14l1700t3705r1821b3761],

1	Cisplatin	NNP	O	Cisplatin	nn	3	SENT_274	[p14l1859t3705r2148b3778],
2	dose	NN	O	dose	nn	3	SENT_274	[p15l8t19r151b75],
3	modiﬁcations	NNS	O	modiﬁcations	nsubj	16	SENT_274	[p15l177t19r611b75],
4	for	IN	O	for	_	0	SENT_274	[p15l638t19r731b75],
5	early	JJ	O	early	amod	6	SENT_274	[p15l754t19r912b92],
6	ototoxicity	NN	O	ototoxicity	prep_for	3	SENT_274	[p15l939t19r1297b92],
7	,	,	O	,	_	0	SENT_274	[p15l939t19r1297b92],
8	conformal	JJ	O	conformal	amod	10	SENT_274	[p15l1325t19r1653b75],
9	radiation	NN	O	radiation	nn	10	SENT_274	[p15l1678t19r1964b75],
10	techniques	NNS	O	technique	prep_for	3	SENT_274	[p15l1988t19r2145b75, p15l7t115r232b188],
11	,	,	O	,	_	0	SENT_274	[p15l1988t19r2145b75, p15l7t115r232b188],
12	and	CC	O	and	_	0	SENT_274	[p15l293t115r406b171],
13	amifostine	NN	O	amifostine	nn	14	SENT_274	[p15l464t115r799b171],
14	prophylaxis	NNS	O	prophylaxis	conj_and	6	SENT_274	[p15l855t115r1232b188],
15	have	VBP	O	have	aux	16	SENT_274	[p15l1290t115r1438b171],
16	decreased	VBN	O	decrease	_	0	SENT_274	[p15l1496t115r1811b171],
17	this	DT	O	this	det	18	SENT_274	[p15l1867t115r1980b171],
18	impairment	NN	O	impairment	dobj	16	SENT_274	[p15l2038t115r2145b171, p15l6t212r309b285],
19	,	,	O	,	_	0	SENT_274	[p15l2038t115r2145b171, p15l6t212r309b285],
20	but	CC	O	but	_	0	SENT_274	[p15l345t212r448b268],
21	have	VBP	O	have	aux	23	SENT_274	[p15l480t212r627b268],
22	not	RB	O	not	neg	23	SENT_274	[p15l663t221r764b268],
23	eliminated	VBN	O	eliminate	conj_but	16	SENT_274	[p15l797t212r1136b268],
24	it	PRP	O	it	nsubj	25	SENT_274	[p15l1170t212r1214b268],
25	[	JJ	O	[	xcomp	23	SENT_274	[p15l1252t212r1494b280],
26	35,36	CD	NUMBER	35,36	num	27	SENT_274	[p15l1252t212r1494b280],
27	]	NN	O	]	nsubj	23	SENT_274	[p15l1252t212r1494b280],
28	.	.	O	.	_	0	SENT_274	[p15l1252t212r1494b280],

1	If	IN	O	if	mark	21	SENT_275	[p15l1533t212r1589b268],
2	our	PRP$	O	we	poss	3	SENT_275	[p15l1619t230r1724b268],
3	ﬁnding	NN	O	ﬁnding	nsubjpass	21	SENT_275	[p15l1757t212r1981b285],
4	of	IN	O	of	_	0	SENT_275	[p15l2016t212r2085b268],
5	a	DT	O	a	det	6	SENT_275	[p15l2115t230r2148b268],
6	GSTPI	NN	O	gstpus	prep_of	3	SENT_275	[p15l10t310r231b366],
7	105	CD	NUMBER	105	num	6	SENT_275	[p15l275t309r381b366],
8	A	DT	O	a	det	12	SENT_275	[p15l414t310r471b365],
9	>	JJR	O	>	dep	10	SENT_275	[p15l504t321r553b368],
10	G	NN	O	g	amod	12	SENT_275	[p15l586t310r642b366],
11	SNP-ototoxicity	NN	O	snp-ototoxicity	nn	12	SENT_275	[p15l673t309r1191b382],
12	link	NN	O	link	dep	6	SENT_275	[p15l1221t309r1346b365],
13	and	CC	O	and	_	0	SENT_275	[p15l1375t310r1488b365],
14	its	PRP$	O	its	poss	15	SENT_275	[p15l1518t309r1590b365],
15	association	NN	O	association	conj_and	6	SENT_275	[p15l1623t309r1977b365],
16	with	IN	O	with	_	0	SENT_275	[p15l2007t309r2148b365],
17	radiation	NN	O	radiation	nn	18	SENT_275	[p15l6t406r292b462],
18	dose	NN	O	dose	prep_with	15	SENT_275	[p15l341t406r485b462],
19	can	MD	O	can	aux	21	SENT_275	[p15l534t424r644b462],
20	be	VB	O	be	auxpass	21	SENT_275	[p15l691t406r765b462],
21	validated	VBN	O	validate	advcl	25	SENT_275	[p15l812t406r1121b472],
22	,	,	O	,	_	0	SENT_275	[p15l812t406r1121b472],
23	we	PRP	O	we	nsubj	25	SENT_275	[p15l1173t424r1264b462],
24	can	MD	O	can	aux	25	SENT_275	[p15l1313t424r1422b462],
25	identify	VB	O	identify	_	0	SENT_275	[p15l1470t406r1719b479],
26	a	DT	O	a	det	27	SENT_275	[p15l1769t424r1802b462],
27	group	NN	O	group	dobj	25	SENT_275	[p15l1851t424r2034b479],
28	of	IN	O	of	_	0	SENT_275	[p15l2084t406r2153b462],
29	patients	NNS	O	patient	prep_of	27	SENT_275	[p15l6t503r254b576],
30	at	IN	O	at	_	0	SENT_275	[p15l288t511r344b559],
31	elevated	JJ	O	elevated	amod	32	SENT_275	[p15l374t503r637b559],
32	risk	NN	O	risk	prep_at	25	SENT_275	[p15l666t503r787b559],
33	for	IN	O	for	_	0	SENT_275	[p15l815t503r908b559],
34	severe	JJ	O	severe	amod	36	SENT_275	[p15l940t521r1138b559],
35	hearing	NN	O	hearing	nn	36	SENT_275	[p15l1168t503r1407b576],
36	loss	NN	O	loss	prep_for	32	SENT_275	[p15l1438t503r1577b559],
37	.	.	O	.	_	0	SENT_275	[p15l1438t503r1577b559],

1	With	IN	O	with	_	0	SENT_276	[p15l1610t503r1768b559],
2	this	DT	O	this	det	3	SENT_276	[p15l1797t503r1910b559],
3	group	NN	O	group	prep_with	14	SENT_276	[p15l1943t521r2145b576],
4	,	,	O	,	_	0	SENT_276	[p15l1943t521r2145b576],
5	more	RBR	O	more	advmod	6	SENT_276	[p15l7t618r170b656],
6	sensitive	JJ	O	sensitive	amod	8	SENT_276	[p15l212t600r488b657],
7	screening	NN	O	screening	nn	8	SENT_276	[p15l529t600r832b673],
8	methods	NNS	O	method	nsubjpass	14	SENT_276	[p15l872t600r1141b656],
9	for	IN	O	for	_	0	SENT_276	[p15l1182t600r1275b656],
10	early	JJ	O	early	amod	11	SENT_276	[p15l1313t601r1471b673],
11	ototoxicity	NN	O	ototoxicity	prep_for	8	SENT_276	[p15l1512t600r1858b673],
12	may	MD	O	may	aux	14	SENT_276	[p15l1898t618r2034b673],
13	be	VB	O	be	auxpass	14	SENT_276	[p15l2072t601r2147b656],
14	applied	VBN	O	apply	_	0	SENT_276	[p15l9t697r260b770],
15	,	,	O	,	_	0	SENT_276	[p15l9t697r260b770],
16	radiation	NN	O	radiation	nn	18	SENT_276	[p15l301t697r587b753],
17	dose	NN	O	dose	nn	18	SENT_276	[p15l628t697r771b753],
18	reductions	NNS	O	reduction	nsubjpass	21	SENT_276	[p15l810t697r1143b753],
19	may	MD	O	may	aux	21	SENT_276	[p15l1184t715r1320b770],
20	be	VB	O	be	auxpass	21	SENT_276	[p15l1359t697r1433b753],
21	considered	VBN	O	consider	dep	14	SENT_276	[p15l1474t697r1837b763],
22	,	,	O	,	_	0	SENT_276	[p15l1474t697r1837b763],
23	or	CC	O	or	_	0	SENT_276	[p15l1881t715r1946b753],
24	more	JJR	O	more	nsubjpass	37	SENT_276	[p15l1984t715r2147b753],
25	targeted	VBN	O	target	partmod	24	SENT_276	[p15l7t794r265b867],
26	cytoprotectant	JJ	O	cytoprotectant	amod	27	SENT_276	[p15l336t803r794b867],
27	strategies	NNS	O	strategy	dobj	25	SENT_276	[p15l867t794r1165b867],
28	than	IN	O	than	mark	32	SENT_276	[p15l1237t795r1374b850],
29	are	VBP	O	be	aux	32	SENT_276	[p15l1446t812r1540b850],
30	currently	RB	DATE	currently	advmod	32	SENT_276	[p15l1612t794r1899b867],
31	being	VBG	O	be	auxpass	32	SENT_276	[p15l1969t794r2146b867],
32	employed	VBN	O	employ	advcl	25	SENT_276	[p15l8t891r323b964],
33	with	IN	O	with	_	0	SENT_276	[p15l354t891r495b948],
34	amifostine	NN	O	amifostine	prep_with	32	SENT_276	[p15l526t891r862b947],
35	may	MD	O	may	aux	37	SENT_276	[p15l893t909r1029b964],
36	be	VB	O	be	auxpass	37	SENT_276	[p15l1059t892r1133b947],
37	implemented	VBN	O	implement	conj_or	14	SENT_276	[p15l1165t891r1600b964],
38	.	.	O	.	_	0	SENT_276	[p15l1165t891r1600b964],

1	598	CD	NUMBER	598	num	2	SENT_277	[p15l9t997r132b1057],
2	Rednam	NNP	O	Rednam	_	0	SENT_277	[p15l350t998r652b1057],
3	et	FW	O	et	nn	4	SENT_277	[p15l679t1002r743b1057],
4	al.	FW	O	al.	dep	2	SENT_277	[p15l767t998r850b1057],
5	.	.	O	.	_	0	SENT_277	[p15l767t998r850b1057],

1	This	DT	O	this	det	2	SENT_278	[p15l115t1179r254b1235],
2	study	NN	O	study	nsubj	5	SENT_278	[p15l290t1179r458b1251],
3	is	VBZ	O	be	cop	5	SENT_278	[p15l490t1179r540b1235],
4	the	DT	O	the	det	5	SENT_278	[p15l573t1179r669b1235],
5	ﬁrst	JJ	O	ﬁrst	_	0	SENT_278	[p15l702t1179r823b1235],
6	evaluating	VBG	O	evaluate	partmod	5	SENT_278	[p15l855t1179r1183b1251],
7	the	DT	O	the	det	8	SENT_278	[p15l1216t1179r1312b1235],
8	relationship	NN	O	relationship	dep	17	SENT_278	[p15l1343t1179r1721b1251],
9	between	IN	O	between	_	0	SENT_278	[p15l1753t1179r2020b1235],
10	the	DT	O	the	det	11	SENT_278	[p15l2052t1179r2148b1235],
11	germline	NN	O	germline	prep_between	8	SENT_278	[p15l9t1276r292b1348],
12	GSTPI	NN	O	gstpus	dep	17	SENT_278	[p15l325t1276r546b1332],
13	105	CD	NUMBER	105	num	12	SENT_278	[p15l588t1276r695b1332],
14	A	DT	O	a	det	17	SENT_278	[p15l728t1276r784b1331],
15	>	JJR	O	>	amod	17	SENT_278	[p15l818t1287r867b1334],
16	G	NN	O	g	nn	17	SENT_278	[p15l900t1276r955b1332],
17	genotype	NN	O	genotype	dep	6	SENT_278	[p15l985t1284r1294b1348],
18	,	,	O	,	_	0	SENT_278	[p15l985t1284r1294b1348],
19	tumor	NN	O	tumor	nn	21	SENT_278	[p15l1326t1284r1518b1332],
20	GSTpi	NN	O	gstpus	nn	21	SENT_278	[p15l1547t1276r1757b1348],
21	expression	NN	O	expression	dep	6	SENT_278	[p15l1788t1276r2145b1348],
22	,	,	O	,	_	0	SENT_278	[p15l1788t1276r2145b1348],
23	and	CC	O	and	_	0	SENT_278	[p15l9t1373r122b1429],
24	ototoxicity	NN	O	ototoxicity	dep	6	SENT_278	[p15l147t1373r493b1445],
25	in	IN	O	in	_	0	SENT_278	[p15l518t1373r579b1428],
26	patients	NNS	O	patient	prep_in	6	SENT_278	[p15l602t1373r850b1445],
27	with	IN	O	with	_	0	SENT_278	[p15l876t1373r1017b1429],
28	medulloblastoma/PNET	NN	O	medulloblastoma/pnet	prep_with	26	SENT_278	[p15l1041t1373r1827b1429],
29	.	.	O	.	_	0	SENT_278	[p15l1041t1373r1827b1429],

1	Our	PRP$	O	we	poss	2	SENT_279	[p15l1857t1373r1980b1429],
2	population	NN	O	population	nsubjpass	6	SENT_279	[p15l2002t1391r2146b1445, p15l7t1470r230b1526],
3	was	VBD	O	be	auxpass	6	SENT_279	[p15l271t1487r392b1526],
4	largely	RB	O	largely	advmod	5	SENT_279	[p15l435t1470r655b1542],
5	uniformly	RB	O	uniformly	advmod	6	SENT_279	[p15l696t1470r1016b1542],
6	treated	VBN	O	treat	_	0	SENT_279	[p15l1057t1470r1276b1526],
7	with	IN	O	with	_	0	SENT_279	[p15l1317t1470r1457b1526],
8	approximately	RB	O	approximately	quantmod	9	SENT_279	[p15l1500t1470r1961b1542],
9	66	CD	PERCENT	66	num	10	SENT_279	[p15l2004t1470r2145b1526],
10	%	NN	PERCENT	%	prep_with	6	SENT_279	[p15l2004t1470r2145b1526],
11	treated	VBN	O	treat	partmod	10	SENT_279	[p15l8t1567r226b1623],
12	on	IN	O	on	_	0	SENT_279	[p15l272t1585r349b1623],
13	the	DT	O	the	det	17	SENT_279	[p15l394t1567r490b1623],
14	SJMB96/03	NN	O	sjmb96/03	nn	17	SENT_279	[p15l537t1567r912b1624],
15	or	CC	O	or	_	0	SENT_279	[p15l962t1584r1027b1623],
16	CCG-A9961	NN	O	ccg-a9961	conj_or	14	SENT_279	[p15l1071t1567r1471b1624],
17	protocols	NNS	O	protocol	prep_on	11	SENT_279	[p15l1522t1567r1819b1639],
18	with	IN	O	with	_	0	SENT_279	[p15l1866t1567r2007b1623],
19	the	DT	O	the	det	20	SENT_279	[p15l2051t1567r2147b1623],
20	remainder	NN	O	remainder	prep_with	11	SENT_279	[p15l7t1664r334b1720],
21	mostly	RB	O	mostly	advmod	22	SENT_279	[p15l364t1664r580b1737],
22	treated	VBN	O	treat	partmod	20	SENT_279	[p15l612t1664r831b1720],
23	with	IN	O	with	_	0	SENT_279	[p15l861t1664r1002b1720],
24	regimens	NNS	O	regimen	prep_with	22	SENT_279	[p15l1032t1664r1323b1737],
25	including	VBG	O	include	_	0	SENT_279	[p15l1356t1664r1657b1737],
26	the	DT	O	the	det	28	SENT_279	[p15l1689t1664r1785b1720],
27	same	JJ	O	same	amod	28	SENT_279	[p15l1820t1682r1980b1720],
28	chemotherapy	NN	O	chemotherapy	prep_including	24	SENT_279	[p15l2012t1664r2146b1720, p15l8t1761r361b1833],
29	.	.	O	.	_	0	SENT_279	[p15l2012t1664r2146b1720, p15l8t1761r361b1833],

1	Additionally	RB	O	additionally	_	0	SENT_280	[p15l393t1761r810b1833],
2	,	,	O	,	_	0	SENT_280	[p15l393t1761r810b1833],
3	with	IN	O	with	_	0	SENT_280	[p15l841t1761r982b1817],
4	a	DT	O	a	det	6	SENT_280	[p15l1010t1778r1044b1817],
5	median	JJ	O	median	amod	6	SENT_280	[p15l1070t1761r1306b1817],
6	follow-up	NN	O	follow-up	prep_with	10	SENT_280	[p15l1333t1761r1645b1833],
7	in	IN	O	in	_	0	SENT_280	[p15l1674t1761r1735b1816],
8	survivors	NNS	O	survivor	prep_in	6	SENT_280	[p15l1765t1761r2055b1817],
9	of	IN	O	of	dep	10	SENT_280	[p15l2084t1761r2153b1817],
10	over	IN	O	over	dep	1	SENT_280	[p15l9t1876r149b1914],
11	7	CD	DURATION	7	num	12	SENT_280	[p15l186t1859r221b1914],
12	years	NNS	NUMBER	year	pobj	10	SENT_280	[p15l263t1875r447b1930],
13	,	,	O	,	_	0	SENT_280	[p15l263t1875r447b1930],
14	adequate	JJ	O	adequate	amod	15	SENT_280	[p15l490t1858r773b1930],
15	time	NN	O	time	appos	12	SENT_280	[p15l812t1858r953b1914],
16	elapsed	VBN	O	elapse	partmod	15	SENT_280	[p15l994t1858r1233b1930],
17	to	TO	O	to	aux	18	SENT_280	[p15l1271t1866r1331b1914],
18	assess	VB	O	assess	xcomp	16	SENT_280	[p15l1372t1876r1562b1914],
19	the	DT	O	the	det	20	SENT_280	[p15l1603t1858r1699b1914],
20	outcomes	NNS	O	outcome	dobj	18	SENT_280	[p15l1739t1866r2043b1914],
21	of	IN	O	of	_	0	SENT_280	[p15l2084t1858r2153b1914],
22	interest	NN	O	interest	prep_of	20	SENT_280	[p15l8t1955r259b2011],
23	.	.	O	.	_	0	SENT_280	[p15l8t1955r259b2011],

1	The	DT	O	the	det	2	SENT_281	[p15l293t1955r416b2011],
2	analyses	NNS	O	analysis	nsubj	3	SENT_281	[p15l448t1955r715b2028],
3	accounted	VBD	O	account	_	0	SENT_281	[p15l748t1955r1071b2011],
4	for	IN	O	for	_	0	SENT_281	[p15l1101t1955r1194b2011],
5	the	DT	O	the	det	7	SENT_281	[p15l1222t1955r1318b2011],
6	potential	JJ	O	potential	amod	7	SENT_281	[p15l1347t1955r1628b2028],
7	confounders	NNS	O	confounder	prep_for	3	SENT_281	[p15l1659t1955r2052b2011],
8	of	IN	O	of	_	0	SENT_281	[p15l2084t1955r2153b2011],
9	age	NN	O	age	prep_of	7	SENT_281	[p15l9t2069r135b2124],
10	,	,	O	,	_	0	SENT_281	[p15l9t2069r135b2124],
11	cumulative	JJ	O	cumulative	amod	13	SENT_281	[p15l187t2051r540b2107],
12	cisplatin	NN	O	cisplatin	nn	13	SENT_281	[p15l590t2051r861b2124],
13	dose	NN	O	dose	conj_and	9	SENT_281	[p15l910t2051r1072b2118],
14	,	,	O	,	_	0	SENT_281	[p15l910t2051r1072b2118],
15	and	CC	O	and	_	0	SENT_281	[p15l1125t2051r1238b2107],
16	amifostine	NN	O	amifostine	nn	17	SENT_281	[p15l1287t2051r1623b2107],
17	use	NN	O	use	conj_and	9	SENT_281	[p15l1672t2069r1793b2107],
18	.	.	O	.	_	0	SENT_281	[p15l1672t2069r1793b2107],

1	Although	IN	O	although	mark	6	SENT_282	[p15l1846t2051r2148b2124],
2	genetic	JJ	O	genetic	amod	3	SENT_282	[p15l9t2149r237b2221],
3	admixture	NN	O	admixture	nsubjpass	6	SENT_282	[p15l273t2149r596b2205],
4	was	VBD	O	be	auxpass	6	SENT_282	[p15l628t2166r749b2205],
5	not	RB	O	not	neg	6	SENT_282	[p15l783t2157r884b2205],
6	included	VBN	O	include	advcl	13	SENT_282	[p15l916t2149r1193b2205],
7	in	IN	O	in	_	0	SENT_282	[p15l1224t2149r1285b2204],
8	the	DT	O	the	det	9	SENT_282	[p15l1318t2149r1414b2205],
9	analyses	NNS	O	analysis	prep_in	6	SENT_282	[p15l1449t2149r1734b2221],
10	,	,	O	,	_	0	SENT_282	[p15l1449t2149r1734b2221],
11	the	DT	O	the	det	12	SENT_282	[p15l1770t2149r1866b2205],
12	patients	NNS	O	patient	nsubj	13	SENT_282	[p15l1898t2149r2147b2221],
13	were	VBD	O	be	_	0	SENT_282	[p15l8t2264r161b2302],
14	almost	RB	O	almost	advmod	15	SENT_282	[p15l208t2246r419b2302],
15	exclusively	RB	O	exclusively	dep	13	SENT_282	[p15l463t2246r823b2319],
16	non-Hispanic	JJ	MISC	non-hispanic	amod	17	SENT_282	[p15l868t2246r1297b2319],
17	Caucasian	JJ	MISC	caucasian	dep	15	SENT_282	[p15l1343t2246r1688b2313],
18	,	,	O	,	_	0	SENT_282	[p15l1343t2246r1688b2313],
19	Hispanic	JJ	O	hispanic	dep	13	SENT_282	[p15l1736t2246r2036b2319],
20	,	,	O	,	_	0	SENT_282	[p15l1736t2246r2036b2319],
21	or	CC	O	or	_	0	SENT_282	[p15l2084t2264r2149b2302],
22	African-American	JJ	MISC	african-american	dep	13	SENT_282	[p15l7t2342r596b2398],
23	and	CC	O	and	_	0	SENT_282	[p15l635t2342r748b2398],
24	the	DT	O	the	det	27	SENT_282	[p15l783t2342r879b2398],
25	reported	VBN	O	report	amod	27	SENT_282	[p15l915t2342r1183b2415],
26	allelic	JJ	O	allelic	amod	27	SENT_282	[p15l1220t2342r1413b2398],
27	frequencies	NNS	O	frequency	nsubj	42	SENT_282	[p15l1452t2342r1819b2415],
28	for	IN	O	for	_	0	SENT_282	[p15l1857t2342r1950b2398],
29	these	DT	O	these	det	31	SENT_282	[p15l1984t2342r2147b2398],
30	three	CD	NUMBER	three	num	31	SENT_282	[p15l8t2440r166b2496],
31	groups	NNS	O	group	prep_for	27	SENT_282	[p15l201t2458r415b2512],
32	is	VBZ	O	be	cop	39	SENT_282	[p15l451t2440r500b2496],
33	very	RB	O	very	advmod	39	SENT_282	[p15l536t2457r675b2512],
34	similar	JJ	O	similar	amod	36	SENT_282	[p15l712t2440r933b2496],
35	(	NN	O	(	nn	36	SENT_282	[p15l968t2440r1164b2509],
36	MAF	NN	O	maf	pobj	33	SENT_282	[p15l968t2440r1164b2509],
37	39-42	CD	PERCENT	39-42	num	38	SENT_282	[p15l1199t2440r1487b2509],
38	%	NN	PERCENT	%	dep	36	SENT_282	[p15l1199t2440r1487b2509],
39	)	CD	NUMBER	)	conj_and	13	SENT_282	[p15l1199t2440r1487b2509],
40	and	CC	O	and	_	0	SENT_282	[p15l1525t2440r1638b2496],
41	was	VBD	O	be	cop	42	SENT_282	[p15l1672t2458r1793b2496],
42	consistent	JJ	O	consistent	conj_and	13	SENT_282	[p15l1829t2440r2149b2496],
43	with	IN	O	with	_	0	SENT_282	[p15l8t2537r149b2593],
44	those	DT	O	those	prep_with	42	SENT_282	[p15l179t2537r346b2593],
45	observed	VBN	O	observe	partmod	44	SENT_282	[p15l378t2537r665b2593],
46	in	IN	O	in	_	0	SENT_282	[p15l694t2537r755b2592],
47	our	PRP$	O	we	poss	48	SENT_282	[p15l786t2555r892b2593],
48	study	NN	O	study	prep_in	45	SENT_282	[p15l924t2537r1104b2610],
49	.	.	O	.	_	0	SENT_282	[p15l924t2537r1104b2610],

1	Our	PRP$	O	we	poss	2	SENT_283	[p15l116t2634r239b2689],
2	study	NN	O	study	nsubj	3	SENT_283	[p15l281t2633r450b2706],
3	had	VBD	O	have	_	0	SENT_283	[p15l491t2633r606b2689],
4	several	JJ	O	several	amod	5	SENT_283	[p15l650t2633r870b2689],
5	limitations	NNS	O	limitation	dobj	3	SENT_283	[p15l912t2633r1270b2689],
6	.	.	O	.	_	0	SENT_283	[p15l912t2633r1270b2689],

1	This	DT	O	this	nsubj	5	SENT_284	[p15l1315t2633r1455b2689],
2	was	VBD	O	be	cop	5	SENT_284	[p15l1498t2651r1618b2689],
3	a	DT	O	a	det	5	SENT_284	[p15l1663t2651r1696b2689],
4	retrospective	JJ	O	retrospective	amod	5	SENT_284	[p15l1735t2633r2147b2706],
5	study	NN	O	study	_	0	SENT_284	[p15l10t2731r179b2803],
6	spanning	VBG	O	span	partmod	5	SENT_284	[p15l223t2731r507b2803],
7	over	IN	O	over	_	0	SENT_284	[p15l549t2749r689b2787],
8	two	CD	DURATION	two	num	9	SENT_284	[p15l727t2739r845b2787],
9	decades	NNS	DURATION	decade	prep_over	6	SENT_284	[p15l887t2731r1156b2797],
10	,	,	O	,	_	0	SENT_284	[p15l887t2731r1156b2797],
11	during	IN	O	during	_	0	SENT_284	[p15l1200t2731r1406b2803],
12	which	WDT	O	which	det	13	SENT_284	[p15l1447t2731r1641b2787],
13	time	NN	O	time	rel	17	SENT_284	[p15l1681t2731r1823b2787],
14	radiation	NN	O	radiation	nn	15	SENT_284	[p15l1862t2731r2148b2787],
15	techniques	NNS	O	technique	nsubj	17	SENT_284	[p15l8t2828r349b2901],
16	have	VBP	O	have	aux	17	SENT_284	[p15l377t2828r525b2884],
17	progressed	VBN	O	progress	rcmod	9	SENT_284	[p15l551t2828r898b2901],
18	and	CC	O	and	_	0	SENT_284	[p15l926t2828r1039b2884],
19	toxicity	NN	O	toxicity	nn	20	SENT_284	[p15l1065t2828r1309b2901],
20	monitoring	NN	O	monitoring	nsubj	24	SENT_284	[p15l1337t2828r1691b2901],
21	and	CC	O	and	_	0	SENT_284	[p15l1721t2828r1834b2884],
22	interventions	NNS	O	intervention	conj_and	20	SENT_284	[p15l1859t2828r2146b2884, p15l8t2924r160b2980],
23	have	VBP	O	have	aux	24	SENT_284	[p15l199t2924r347b2980],
24	evolved	VBN	O	evolve	conj_and	5	SENT_284	[p15l386t2924r651b2980],
25	.	.	O	.	_	0	SENT_284	[p15l386t2924r651b2980],

1	Also	RB	O	also	advmod	12	SENT_285	[p15l692t2924r859b2991],
2	,	,	O	,	_	0	SENT_285	[p15l692t2924r859b2991],
3	radiation	NN	O	radiation	nn	5	SENT_285	[p15l898t2924r1184b2980],
4	oncology	NN	O	oncology	nn	5	SENT_285	[p15l1222t2924r1518b2997],
5	reports	NNS	O	report	nsubj	12	SENT_285	[p15l1555t2932r1776b2997],
6	specifying	VBG	O	specify	partmod	5	SENT_285	[p15l1817t2924r2147b2997],
7	the	DT	O	the	det	9	SENT_285	[p15l8t3022r104b3078],
8	cochlear	JJ	O	cochlear	amod	9	SENT_285	[p15l133t3022r405b3078],
9	doses	NNS	O	dose	dobj	6	SENT_285	[p15l432t3022r606b3078],
10	were	VBD	O	be	cop	12	SENT_285	[p15l635t3040r788b3078],
11	not	RB	O	not	neg	12	SENT_285	[p15l817t3030r919b3078],
12	available	JJ	O	available	_	0	SENT_285	[p15l947t3022r1232b3078],
13	for	IN	O	for	_	0	SENT_285	[p15l1260t3022r1353b3078],
14	a	DT	O	a	det	16	SENT_285	[p15l1381t3040r1414b3078],
15	substantial	JJ	O	substantial	amod	16	SENT_285	[p15l1443t3022r1782b3078],
16	proportion	NN	O	proportion	prep_for	12	SENT_285	[p15l1809t3022r2148b3094],
17	of	IN	O	of	_	0	SENT_285	[p15l9t3119r78b3175],
18	the	DT	O	the	det	19	SENT_285	[p15l101t3119r197b3175],
19	subjects	NNS	O	subject	prep_of	16	SENT_285	[p15l230t3119r500b3192],
20	.	.	O	.	_	0	SENT_285	[p15l230t3119r500b3192],

1	However	RB	O	however	advmod	12	SENT_286	[p15l534t3120r836b3185],
2	,	,	O	,	_	0	SENT_286	[p15l534t3120r836b3185],
3	since	IN	O	since	mark	6	SENT_286	[p15l870t3119r1030b3175],
4	most	JJS	O	most	amod	5	SENT_286	[p15l1060t3128r1215b3175],
5	patients	NNS	O	patient	nsubj	6	SENT_286	[p15l1242t3119r1491b3192],
6	received	VBD	O	receive	advcl	12	SENT_286	[p15l1521t3119r1791b3175],
7	conformal	JJ	O	conformal	amod	8	SENT_286	[p15l1820t3119r2148b3175],
8	radiation	NN	O	radiation	dobj	6	SENT_286	[p15l7t3215r309b3281],
9	,	,	O	,	_	0	SENT_286	[p15l7t3215r309b3281],
10	it	PRP	O	it	nsubjpass	12	SENT_286	[p15l344t3215r388b3271],
11	was	VBD	O	be	auxpass	12	SENT_286	[p15l419t3233r539b3271],
12	presumed	VBN	O	presume	_	0	SENT_286	[p15l571t3215r883b3288],
13	that	IN	O	that	complm	23	SENT_286	[p15l914t3215r1034b3271],
14	the	DT	O	the	det	16	SENT_286	[p15l1064t3215r1160b3271],
15	radiation	NN	O	radiation	nn	16	SENT_286	[p15l1191t3215r1477b3271],
16	dose	NN	O	dose	nsubjpass	23	SENT_286	[p15l1509t3215r1652b3271],
17	to	TO	O	to	_	0	SENT_286	[p15l1684t3224r1744b3271],
18	the	DT	O	the	det	19	SENT_286	[p15l1776t3215r1872b3271],
19	cochlea	NN	O	cochlea	prep_to	16	SENT_286	[p15l1904t3215r2149b3271],
20	could	MD	O	could	aux	23	SENT_286	[p15l8t3313r185b3368],
21	be	VB	O	be	auxpass	23	SENT_286	[p15l208t3312r282b3368],
22	reasonably	RB	O	reasonably	advmod	23	SENT_286	[p15l306t3312r653b3385],
23	approximated	VBN	O	approximate	ccomp	12	SENT_286	[p15l679t3312r1119b3385],
24	by	IN	O	by	_	0	SENT_286	[p15l1142t3312r1221b3385],
25	the	DT	O	the	det	27	SENT_286	[p15l1245t3312r1341b3368],
26	minimum	NN	O	minimum	nn	27	SENT_286	[p15l1366t3312r1678b3368],
27	dose	NN	O	dose	agent	23	SENT_286	[p15l1702t3312r1846b3368],
28	to	TO	O	to	_	0	SENT_286	[p15l1871t3321r1931b3368],
29	which	WDT	O	which	rel	37	SENT_286	[p15l1954t3312r2148b3369],
30	all	DT	O	all	det	31	SENT_286	[p15l9t3410r86b3466],
31	tissues	NNS	O	tissue	nsubjpass	37	SENT_286	[p15l126t3410r337b3466],
32	in	IN	O	in	_	0	SENT_286	[p15l378t3410r439b3465],
33	the	DT	O	the	det	35	SENT_286	[p15l478t3410r574b3466],
34	craniospinal	JJ	O	craniospinal	amod	35	SENT_286	[p15l615t3410r1005b3483],
35	axis	NN	O	axis	prep_in	31	SENT_286	[p15l1047t3410r1171b3466],
36	were	VBD	O	be	auxpass	37	SENT_286	[p15l1213t3428r1366b3466],
37	exposed	VBN	O	expose	rcmod	27	SENT_286	[p15l1407t3410r1667b3483],
38	(	CD	NUMBER	(	dobj	37	SENT_286	[p15l1709t3410r1847b3479],
39	i.e.	FW	O	i.e.	tmod	37	SENT_286	[p15l1709t3410r1847b3479],
40	,	,	O	,	_	0	SENT_286	[p15l1709t3410r1847b3479],
41	the	DT	O	the	det	44	SENT_286	[p15l1889t3410r1985b3466],
42	CSI	NNP	O	CSI	nn	44	SENT_286	[p15l2027t3410r2148b3466],
43	dose	NN	O	dose	nn	44	SENT_286	[p15l8t3506r195b3575],
44	)	NN	O	)	appos	39	SENT_286	[p15l8t3506r195b3575],
45	.	.	O	.	_	0	SENT_286	[p15l8t3506r195b3575],

1	The	DT	O	the	det	2	SENT_287	[p15l238t3506r361b3562],
2	need	NN	O	need	nsubjpass	17	SENT_287	[p15l400t3506r551b3562],
3	for	IN	O	for	_	0	SENT_287	[p15l590t3506r682b3562],
4	using	VBG	O	use	prepc_for	2	SENT_287	[p15l719t3506r890b3579],
5	the	DT	O	the	det	7	SENT_287	[p15l929t3506r1025b3562],
6	CSI	NNP	O	CSI	nn	7	SENT_287	[p15l1066t3507r1187b3563],
7	dose	NN	O	dose	dobj	4	SENT_287	[p15l1227t3506r1370b3562],
8	as	IN	O	as	_	0	SENT_287	[p15l1411t3524r1473b3562],
9	a	DT	O	a	det	10	SENT_287	[p15l1514t3524r1548b3562],
10	surrogate	NN	O	surrogate	prep_as	4	SENT_287	[p15l1588t3515r1882b3579],
11	for	IN	O	for	_	0	SENT_287	[p15l1922t3506r2014b3562],
12	the	DT	O	the	det	14	SENT_287	[p15l2052t3506r2148b3562],
13	cochlear	JJ	O	cochlear	amod	14	SENT_287	[p15l8t3604r280b3659],
14	dose	NN	O	dose	prep_for	10	SENT_287	[p15l315t3603r458b3659],
15	will	MD	O	will	aux	17	SENT_287	[p15l493t3603r615b3660],
16	be	VB	O	be	auxpass	17	SENT_287	[p15l649t3603r723b3659],
17	avoided	VBN	O	avoid	_	0	SENT_287	[p15l761t3603r1011b3659],
18	in	IN	O	in	_	0	SENT_287	[p15l1045t3603r1106b3659],
19	our	PRP$	O	we	poss	22	SENT_287	[p15l1141t3621r1247b3659],
20	future	JJ	DATE	future	amod	22	SENT_287	[p15l1281t3603r1469b3659],
21	prospective	JJ	O	prospective	amod	22	SENT_287	[p15l1504t3603r1872b3676],
22	studies	NNS	O	study	prep_in	17	SENT_287	[p15l1910t3603r2144b3659],
23	.	.	O	.	_	0	SENT_287	[p15l1910t3603r2144b3659],

1	Additionally	RB	O	additionally	advmod	18	SENT_288	[p15l8t3701r425b3774],
2	,	,	O	,	_	0	SENT_288	[p15l8t3701r425b3774],
3	while	IN	O	while	mark	11	SENT_288	[p15l456t3701r632b3757],
4	patients	NNS	O	patient	nsubjpass	11	SENT_288	[p15l660t3701r908b3774],
5	with	IN	O	with	_	0	SENT_288	[p15l938t3701r1078b3757],
6	known	JJ	O	known	amod	9	SENT_288	[p15l1106t3701r1321b3757],
7	pre-existing	JJ	O	pre-existing	amod	9	SENT_288	[p15l1348t3701r1729b3774],
8	hearing	NN	O	hearing	nn	9	SENT_288	[p15l1757t3701r1997b3774],
9	loss	NN	O	loss	prep_with	4	SENT_288	[p15l2026t3701r2147b3757],
10	were	VBD	O	be	auxpass	11	SENT_288	[p16l8t36r161b74],
11	excluded	VBN	O	exclude	advcl	18	SENT_288	[p16l189t18r478b74],
12	from	IN	O	from	_	0	SENT_288	[p16l504t18r659b74],
13	the	DT	O	the	det	14	SENT_288	[p16l684t18r780b74],
14	analyses	NNS	O	analysis	prep_from	11	SENT_288	[p16l809t18r1095b91],
15	,	,	O	,	_	0	SENT_288	[p16l809t18r1095b91],
16	it	PRP	O	it	nsubj	18	SENT_288	[p16l1124t18r1168b74],
17	is	VBZ	O	be	cop	18	SENT_288	[p16l1194t18r1244b74],
18	possible	JJ	O	possible	_	0	SENT_288	[p16l1270t18r1532b91],
19	that	IN	O	that	complm	28	SENT_288	[p16l1559t18r1680b74],
20	some	DT	O	some	det	21	SENT_288	[p16l1708t36r1872b74],
21	patients	NNS	O	patient	nsubjpass	28	SENT_288	[p16l1898t18r2147b91],
22	with	IN	O	with	_	0	SENT_288	[p16l8t115r149b171],
23	prior	JJ	O	prior	amod	26	SENT_288	[p16l180t115r336b188],
24	mild	JJ	O	mild	amod	26	SENT_288	[p16l366t115r513b171],
25	hearing	NN	O	hearing	nn	26	SENT_288	[p16l543t115r782b188],
26	loss	NN	O	loss	prep_with	21	SENT_288	[p16l815t115r936b171],
27	were	VBD	O	be	auxpass	28	SENT_288	[p16l969t133r1123b172],
28	included	VBN	O	include	ccomp	18	SENT_288	[p16l1155t115r1431b171],
29	due	JJ	O	due	acomp	28	SENT_288	[p16l1463t115r1576b171],
30	to	TO	O	to	_	0	SENT_288	[p16l1608t124r1667b171],
31	lacking	VBG	O	lack	prepc_to	29	SENT_288	[p16l1700t115r1935b188],
32	documentation	NN	O	documentation	dobj	31	SENT_288	[p16l1968t116r2146b171, p16l8t213r344b269],
33	.	.	O	.	_	0	SENT_288	[p16l1968t116r2146b171, p16l8t213r344b269],

1	Lastly	RB	O	lastly	advmod	12	SENT_289	[p16l372t213r584b286],
2	,	,	O	,	_	0	SENT_289	[p16l372t213r584b286],
3	the	DT	O	the	det	6	SENT_289	[p16l610t213r706b269],
4	study	NN	O	study	nn	6	SENT_289	[p16l733t213r902b286],
5	sample	NN	O	sample	nn	6	SENT_289	[p16l929t213r1151b286],
6	size	NN	O	size	nsubj	12	SENT_289	[p16l1179t213r1298b269],
7	was	VBD	O	be	cop	12	SENT_289	[p16l1321t231r1441b269],
8	small	JJ	O	small	amod	12	SENT_289	[p16l1470t213r1639b269],
9	and	CC	O	and	_	0	SENT_289	[p16l1665t213r1778b269],
10	limited	JJ	O	limited	amod	12	SENT_289	[p16l1801t213r2028b269],
11	the	DT	O	the	det	12	SENT_289	[p16l2052t213r2148b269],
12	precision	NN	O	precision	_	0	SENT_289	[p16l7t309r301b382],
13	of	IN	O	of	_	0	SENT_289	[p16l332t309r402b365],
14	our	PRP$	O	we	poss	16	SENT_289	[p16l427t327r533b365],
15	statistical	JJ	O	statistical	amod	16	SENT_289	[p16l565t309r864b365],
16	estimates	NNS	O	estimate	prep_of	12	SENT_289	[p16l896t309r1209b365],
17	.	.	O	.	_	0	SENT_289	[p16l896t309r1209b365],

1	In	IN	O	in	_	0	SENT_290	[p16l115t408r180b462],
2	the	DT	DATE	the	det	3	SENT_290	[p16l225t407r321b462],
3	future	NN	DATE	future	prep_in	6	SENT_290	[p16l367t406r574b473],
4	,	,	O	,	_	0	SENT_290	[p16l367t406r574b473],
5	we	PRP	O	we	nsubj	6	SENT_290	[p16l623t424r713b463],
6	plan	VBP	O	plan	_	0	SENT_290	[p16l758t407r896b479],
7	to	TO	O	to	aux	10	SENT_290	[p16l941t415r1001b462],
8	more	RBR	O	more	advmod	10	SENT_290	[p16l1047t424r1209b462],
9	extensively	RB	O	extensively	advmod	10	SENT_290	[p16l1256t406r1617b479],
10	investigate	VB	O	investigate	ccomp	6	SENT_290	[p16l1662t406r2006b479],
11	the	DT	O	the	det	12	SENT_290	[p16l2051t406r2147b462],
12	relationship	NN	O	relationship	dobj	10	SENT_290	[p16l7t504r385b576],
13	between	IN	O	between	_	0	SENT_290	[p16l423t504r690b560],
14	clinical	JJ	O	clinical	amod	15	SENT_290	[p16l728t504r963b560],
15	outcomes	NNS	O	outcome	prep_between	12	SENT_290	[p16l1002t512r1306b560],
16	in	IN	O	in	_	0	SENT_290	[p16l1345t504r1406b559],
17	medulloblastoma	NN	O	medulloblastoma	nn	20	SENT_290	[p16l1443t504r1997b560],
18	and	CC	O	and	_	0	SENT_290	[p16l2036t504r2149b560],
19	glutathione	NN	O	glutathione	nn	20	SENT_290	[p16l9t600r368b673],
20	S-transferases	NNS	MISC	s-transferase	prep_in	15	SENT_290	[p16l420t600r865b657],
21	and	CC	O	and	_	0	SENT_290	[p16l918t600r1031b656],
22	other	JJ	O	other	amod	23	SENT_290	[p16l1081t600r1244b656],
23	detoxiﬁcation	NN	O	detoxiﬁcation	prep_in	15	SENT_290	[p16l1293t600r1880b657],
24	/	:	O	/	punct	28	SENT_290	[p16l1293t600r1880b657],
25	free	JJ	O	free	amod	28	SENT_290	[p16l1293t600r1880b657],
26	radical	JJ	O	radical	amod	28	SENT_290	[p16l1929t600r2148b656],
27	clearance	NN	O	clearance	nn	28	SENT_290	[p16l8t698r310b753],
28	enzymes	NNS	O	enzyme	dep	10	SENT_290	[p16l339t715r617b770],
29	including	VBG	O	include	_	0	SENT_290	[p16l645t697r947b770],
30	glutathione	NN	O	glutathione	nn	31	SENT_290	[p16l975t697r1335b770],
31	peroxidases	NNS	O	peroxidase	prep_including	28	SENT_290	[p16l1361t697r1757b770],
32	,	,	O	,	_	0	SENT_290	[p16l1361t697r1757b770],
33	glutathione	NN	O	glutathione	nn	34	SENT_290	[p16l1788t697r2147b770],
34	reductase	NN	O	reductase	prep_including	28	SENT_290	[p16l7t795r327b861],
35	,	,	O	,	_	0	SENT_290	[p16l7t795r327b861],
36	superoxide	NN	O	superoxide	nn	37	SENT_290	[p16l364t795r711b867],
37	dismutases	NNS	O	dismutase	prep_including	28	SENT_290	[p16l743t795r1110b861],
38	,	,	O	,	_	0	SENT_290	[p16l743t795r1110b861],
39	catalase	NN	O	catalase	prep_including	28	SENT_290	[p16l1144t795r1414b861],
40	,	,	O	,	_	0	SENT_290	[p16l1144t795r1414b861],
41	and	CC	O	and	_	0	SENT_290	[p16l1449t795r1562b851],
42	metallothioneins	NNS	O	metallothionein	prep_including	28	SENT_290	[p16l1592t795r2143b851],
43	.	.	O	.	_	0	SENT_290	[p16l1592t795r2143b851],

1	These	DT	O	these	det	2	SENT_291	[p16l8t891r197b947],
2	studies	NNS	O	study	nsubjpass	5	SENT_291	[p16l223t891r440b947],
3	will	MD	O	will	aux	5	SENT_291	[p16l465t891r587b947],
4	be	VB	O	be	auxpass	5	SENT_291	[p16l609t891r683b947],
5	performed	VBN	O	perform	_	0	SENT_291	[p16l706t891r1040b964],
6	with	IN	O	with	_	0	SENT_291	[p16l1063t891r1204b947],
7	a	DT	O	a	det	11	SENT_291	[p16l1227t909r1261b947],
8	larger	JJR	O	larger	amod	11	SENT_291	[p16l1282t891r1482b964],
9	,	,	O	,	_	0	SENT_291	[p16l1282t891r1482b964],
10	independent	JJ	O	independent	amod	11	SENT_291	[p16l1508t891r1900b964],
11	sample	NN	O	sample	prep_with	5	SENT_291	[p16l1924t891r2147b964],
12	of	IN	O	of	_	0	SENT_291	[p16l9t988r78b1044],
13	patients	NNS	O	patient	prep_of	11	SENT_291	[p16l96t988r345b1061],
14	and	CC	O	and	_	0	SENT_291	[p16l373t989r486b1044],
15	may	MD	O	may	aux	16	SENT_291	[p16l510t1006r646b1061],
16	provide	VB	O	provide	conj_and	5	SENT_291	[p16l671t988r915b1061],
17	a	DT	O	a	det	20	SENT_291	[p16l941t1006r974b1044],
18	more	RBR	O	more	advmod	19	SENT_291	[p16l998t1006r1161b1044],
19	comprehensive	JJ	O	comprehensive	amod	20	SENT_291	[p16l1187t988r1669b1061],
20	understanding	NN	O	understanding	dobj	16	SENT_291	[p16l1694t988r2147b1061],
21	of	IN	O	of	_	0	SENT_291	[p16l9t1086r78b1142],
22	the	DT	O	the	det	23	SENT_291	[p16l101t1086r197b1142],
23	role	NN	O	role	prep_of	20	SENT_291	[p16l225t1086r349b1142],
24	that	WDT	O	that	dobj	31	SENT_291	[p16l379t1086r499b1142],
25	detoxiﬁcation	NN	O	detoxiﬁcation	nn	30	SENT_291	[p16l527t1086r966b1142],
26	and	CC	O	and	_	0	SENT_291	[p16l997t1086r1110b1142],
27	free	JJ	O	free	conj_and	25	SENT_291	[p16l1138t1086r1261b1142],
28	radical	JJ	O	radical	amod	30	SENT_291	[p16l1289t1086r1507b1142],
29	clearance	NN	O	clearance	nn	30	SENT_291	[p16l1538t1086r1839b1142],
30	enzymes	NNS	O	enzyme	nsubj	38	SENT_291	[p16l1869t1103r2147b1158],
31	play	VBP	O	play	rcmod	23	SENT_291	[p16l7t1182r144b1255],
32	in	IN	O	in	_	0	SENT_291	[p16l175t1182r236b1238],
33	medulloblastoma	NN	O	medulloblastoma	nn	34	SENT_291	[p16l266t1182r820b1238],
34	outcomes	NNS	O	outcome	prep_in	31	SENT_291	[p16l851t1191r1155b1238],
35	and	CC	O	and	_	0	SENT_291	[p16l1189t1182r1302b1238],
36	may	MD	O	may	aux	38	SENT_291	[p16l1331t1200r1467b1255],
37	ultimately	RB	O	ultimately	advmod	38	SENT_291	[p16l1498t1182r1823b1255],
38	inﬂuence	VB	O	inﬂuence	conj_and	31	SENT_291	[p16l1855t1182r2147b1238],
39	future	JJ	DATE	future	amod	41	SENT_291	[p16l8t1279r197b1335],
40	therapeutic	JJ	O	therapeutic	amod	41	SENT_291	[p16l229t1279r584b1352],
41	strategies	NNS	O	strategy	dobj	38	SENT_291	[p16l619t1279r933b1352],
42	.	.	O	.	_	0	SENT_291	[p16l619t1279r933b1352],

1	REFERENCES	NNS	O	reference	_	0	SENT_292	[p16l13t1513r512b1578],

1	1	LS	NUMBER	1	_	0	SENT_293	[p16l42t1702r71b1736],
2	.	.	O	.	_	0	SENT_293	[p16l42t1702r71b1736],

1	Pizzo	NNP	ORGANIZATION	Pizzo	nn	2	SENT_294	[p16l112t1702r219b1736],
2	PA	NN	ORGANIZATION	pa	_	0	SENT_294	[p16l248t1702r315b1742],
3	,	,	O	,	_	0	SENT_294	[p16l248t1702r315b1742],
4	Poplack	NNP	PERSON	Poplack	nn	5	SENT_294	[p16l344t1702r503b1746],
5	DG	NNS	O	dg	appos	2	SENT_294	[p16l529t1702r608b1736],
6	.	.	O	.	_	0	SENT_294	[p16l529t1702r608b1736],

1	Principles	NNS	O	principle	_	0	SENT_295	[p16l638t1702r833b1746],
2	and	CC	O	and	_	0	SENT_295	[p16l862t1702r931b1736],
3	practice	NN	O	practice	conj_and	1	SENT_295	[p16l957t1702r1112b1746],
4	of	IN	O	of	_	0	SENT_295	[p16l1141t1702r1183b1736],
5	pediatric	JJ	O	pediatric	amod	6	SENT_295	[p16l1207t1702r1378b1746],
6	oncology	NN	O	oncology	prep_of	1	SENT_295	[p16l1407t1702r1595b1746],
7	,	,	O	,	_	0	SENT_295	[p16l1407t1702r1595b1746],
8	6th	JJ	ORDINAL	6th	amod	9	SENT_295	[p16l1626t1702r1687b1736],
9	edition	NN	O	edition	appos	6	SENT_295	[p16l1714t1702r1860b1736],
10	.	.	O	.	_	0	SENT_295	[p16l1714t1702r1860b1736],

1	Philadelphia	NNP	LOCATION	Philadelphia	_	0	SENT_296	[p16l1889t1702r2145b1746],
2	:	:	O	:	_	0	SENT_296	[p16l1889t1702r2145b1746],

1	Lippincott	NNP	ORGANIZATION	Lippincott	nn	2	SENT_297	[p16l111t1763r317b1807],
2	Williams	NNP	ORGANIZATION	Williams	_	0	SENT_297	[p16l334t1763r511b1797],
3	&	CC	ORGANIZATION	&	_	0	SENT_297	[p16l532t1763r567b1797],
4	Wilkins	NNP	ORGANIZATION	Wilkins	conj_and	2	SENT_297	[p16l585t1763r751b1803],
5	;	:	O	;	_	0	SENT_297	[p16l585t1763r751b1803],
6	2011	CD	DATE	2011	dep	2	SENT_297	[p16l772t1763r878b1797],
7	.	.	O	.	_	0	SENT_297	[p16l772t1763r878b1797],

1	pp	NN	O	pp	_	0	SENT_298	[p16l898t1774r946b1807],
2	772-782	CD	NUMBER	772-782	dep	1	SENT_298	[p16l966t1763r1146b1797],
3	.	.	O	.	_	0	SENT_298	[p16l966t1763r1146b1797],

1	2	LS	NUMBER	2	_	0	SENT_299	[p16l38t1824r71b1858],
2	.	.	O	.	_	0	SENT_299	[p16l38t1824r71b1858],

1	McNeil	NNP	ORGANIZATION	McNeil	nn	2	SENT_300	[p16l111t1824r260b1858],
2	DE	NN	ORGANIZATION	de	_	0	SENT_300	[p16l276t1825r350b1864],
3	,	,	O	,	_	0	SENT_300	[p16l276t1825r350b1864],
4	Cote	NNP	O	Cote	nn	5	SENT_300	[p16l368t1824r459b1858],
5	TR	NN	O	tr	appos	2	SENT_300	[p16l474t1825r546b1864],
6	,	,	O	,	_	0	SENT_300	[p16l474t1825r546b1864],
7	Clegg	NNP	PERSON	Clegg	nn	8	SENT_300	[p16l563t1824r679b1868],
8	L	NNP	PERSON	L	appos	2	SENT_300	[p16l693t1825r733b1864],
9	,	,	O	,	_	0	SENT_300	[p16l693t1825r733b1864],
10	et	FW	O	et	nn	11	SENT_300	[p16l750t1829r785b1858],
11	al.	FW	O	al.	appos	2	SENT_300	[p16l800t1824r843b1858],
12	.	.	O	.	_	0	SENT_300	[p16l800t1824r843b1858],

1	Incidence	NN	O	incidence	nsubj	14	SENT_301	[p16l861t1824r1051b1858],
2	and	CC	O	and	_	0	SENT_301	[p16l1067t1824r1136b1858],
3	trends	NNS	O	trend	conj_and	1	SENT_301	[p16l1151t1824r1269b1858],
4	in	IN	O	in	_	0	SENT_301	[p16l1284t1824r1322b1858],
5	pediatric	JJ	O	pediatric	amod	6	SENT_301	[p16l1336t1824r1507b1868],
6	malignancies	NNS	O	malignancy	prep_in	1	SENT_301	[p16l1523t1824r1780b1868],
7	medulloblastomal	JJ	O	medulloblastomal	amod	8	SENT_301	[p16l1796t1824r2149b1859],
8	primitive	JJ	O	primitive	amod	10	SENT_301	[p16l111t1884r290b1929],
9	neuroectodermal	JJ	O	neuroectodermal	amod	10	SENT_301	[p16l310t1884r639b1918],
10	tumor	NN	O	tumor	dep	6	SENT_301	[p16l660t1889r787b1918],
11	:	:	O	:	_	0	SENT_301	[p16l660t1889r787b1918],
12	A	DT	O	a	det	13	SENT_301	[p16l810t1884r844b1918],
13	SEER	NN	O	seer	dep	6	SENT_301	[p16l866t1884r984b1918],
14	update	VBP	O	update	_	0	SENT_301	[p16l1003t1884r1144b1928],
15	.	.	O	.	_	0	SENT_301	[p16l1003t1884r1144b1928],

1	Surveillance	NN	O	surveillance	_	0	SENT_302	[p16l1167t1884r1410b1918],
2	epidemiology	NN	O	epidemiology	nn	5	SENT_302	[p16l1431t1884r1700b1928],
3	and	CC	O	and	_	0	SENT_302	[p16l1721t1884r1791b1918],
4	end	NN	O	end	nn	5	SENT_302	[p16l1811t1884r1880b1918],
5	results	NNS	O	result	dep	1	SENT_302	[p16l1899t1884r2037b1918],
6	.	.	O	.	_	0	SENT_302	[p16l1899t1884r2037b1918],

1	Med	NNP	MISC	Med	nn	3	SENT_303	[p16l2059t1884r2149b1918],
2	Pediatr	NNP	MISC	Pediatr	nn	3	SENT_303	[p16l112t1946r251b1981],
3	Oncol	NNP	MISC	Oncol	_	0	SENT_303	[p16l269t1946r387b1981],
4	2002	CD	DATE	2002	num	3	SENT_303	[p16l406t1946r761b1987],
5	;	:	O	;	_	0	SENT_303	[p16l406t1946r761b1987],
6	39:190	CD	NUMBER	39:190	number	7	SENT_303	[p16l406t1946r761b1987],
7	-194	CD	NUMBER	-194	dep	3	SENT_303	[p16l406t1946r761b1987],
8	.	.	O	.	_	0	SENT_303	[p16l406t1946r761b1987],

1	3	LS	NUMBER	3	_	0	SENT_304	[p16l39t2008r71b2042],
2	.	.	O	.	_	0	SENT_304	[p16l39t2008r71b2042],

1	Gajjar	NNP	PERSON	Gajjar	nn	2	SENT_305	[p16l112t2007r235b2052],
2	A	NNP	O	A	_	0	SENT_305	[p16l258t2008r302b2048],
3	,	,	O	,	_	0	SENT_305	[p16l258t2008r302b2048],
4	Chintagumpala	NNP	O	Chintagumpala	nn	5	SENT_305	[p16l327t2007r628b2052],
5	M	NNP	O	M	appos	2	SENT_305	[p16l651t2008r704b2048],
6	,	,	O	,	_	0	SENT_305	[p16l651t2008r704b2048],
7	Ashley	NNP	PERSON	Ashley	nn	8	SENT_305	[p16l729t2007r866b2052],
8	D	NNP	PERSON	D	appos	2	SENT_305	[p16l889t2008r934b2048],
9	,	,	O	,	_	0	SENT_305	[p16l889t2008r934b2048],
10	et	FW	O	et	nn	11	SENT_305	[p16l960t2013r995b2041],
11	al.	FW	O	al.	appos	2	SENT_305	[p16l1019t2007r1062b2041],
12	.	.	O	.	_	0	SENT_305	[p16l1019t2007r1062b2041],

1	Risk-adapted	JJ	O	risk-adapted	amod	3	SENT_306	[p16l1089t2007r1347b2052],
2	craniospinal	JJ	O	craniospinal	amod	3	SENT_306	[p16l1371t2007r1609b2052],
3	radiotherapy	NN	O	radiotherapy	_	0	SENT_306	[p16l1632t2007r1880b2052],
4	followed	VBN	O	follow	partmod	3	SENT_306	[p16l1904t2007r2077b2041],
5	by	IN	O	by	_	0	SENT_306	[p16l2099t2007r2148b2052],
6	high-dose	JJ	O	high-dose	amod	7	SENT_306	[p16l111t2068r304b2113],
7	chemotherapy	NN	O	chemotherapy	agent	4	SENT_306	[p16l330t2068r607b2113],
8	and	CC	O	and	_	0	SENT_306	[p16l634t2068r703b2103],
9	stem-cell	NN	O	stem-cell	nn	10	SENT_306	[p16l730t2068r908b2103],
10	rescue	NN	O	rescue	agent	4	SENT_306	[p16l933t2079r1058b2102],
11	in	IN	O	in	_	0	SENT_306	[p16l1083t2068r1121b2102],
12	children	NNS	O	child	prep_in	7	SENT_306	[p16l1146t2068r1306b2102],
13	with	IN	O	with	_	0	SENT_306	[p16l1332t2068r1418b2102],
14	newly	RB	O	newly	advmod	15	SENT_306	[p16l1444t2068r1561b2113],
15	diagnosed	VBN	O	diagnose	amod	16	SENT_306	[p16l1587t2068r1785b2113],
16	medulloblastoma	NN	O	medulloblastoma	prep_with	4	SENT_306	[p16l1810t2068r2149b2102],
17	(	CD	NUMBER	(	dep	3	SENT_306	[p16l113t2130r178b2172],
18	St.	NNP	ORGANIZATION	St.	nn	21	SENT_306	[p16l113t2130r178b2172],
19	Jude	NNP	ORGANIZATION	Jude	nn	21	SENT_306	[p16l197t2130r286b2164],
20	Medulloblastoma-96	NNP	O	Medulloblastoma-96	nn	21	SENT_306	[p16l303t2129r738b2172],
21	)	NNP	O	)	dep	17	SENT_306	[p16l303t2129r738b2172],
22	:	:	O	:	_	0	SENT_306	[p16l303t2129r738b2172],
23	Long-term	JJ	O	long-term	amod	24	SENT_306	[p16l758t2130r968b2174],
24	results	NNS	O	result	dep	3	SENT_306	[p16l984t2130r1110b2164],
25	from	IN	O	from	_	0	SENT_306	[p16l1129t2129r1223b2164],
26	a	DT	O	a	det	30	SENT_306	[p16l1241t2140r1261b2164],
27	prospective	JJ	O	prospective	amod	30	SENT_306	[p16l1278t2129r1513b2174],
28	,	,	O	,	_	0	SENT_306	[p16l1278t2129r1513b2174],
29	multicentre	JJ	O	multicentre	amod	30	SENT_306	[p16l1531t2129r1754b2164],
30	trial	NN	O	trial	prep_from	24	SENT_306	[p16l1771t2129r1860b2164],
31	.	.	O	.	_	0	SENT_306	[p16l1771t2129r1860b2164],

1	Lancet	NNP	O	Lancet	nn	2	SENT_307	[p16l1879t2130r2013b2164],
2	Oncol	NNP	O	Oncol	_	0	SENT_307	[p16l2030t2130r2148b2164],
3	2006	CD	DATE	2006	num	2	SENT_307	[p16l112t2191r443b2232],
4	;	:	O	;	_	0	SENT_307	[p16l112t2191r443b2232],
5	7:813	CD	NUMBER	7:813	number	6	SENT_307	[p16l112t2191r443b2232],
6	-820	CD	NUMBER	-820	dep	2	SENT_307	[p16l112t2191r443b2232],
7	.	.	O	.	_	0	SENT_307	[p16l112t2191r443b2232],

1	Pediatr	NNP	O	Pediatr	nn	4	SENT_308	[p16l7t2393r218b2443],
2	Blood	NNP	O	Blood	nn	4	SENT_308	[p16l235t2393r408b2444],
3	Cancer	NNP	O	Cancer	nn	4	SENT_308	[p16l429t2394r638b2444],
4	DOI	NNP	O	DOI	_	0	SENT_308	[p16l655t2394r780b2444],
5	10.1002	CD	NUMBER	10.1002	num	4	SENT_308	[p16l808t2393r1152b2458],
6	/	:	O	/	punct	7	SENT_308	[p16l808t2393r1152b2458],
7	pbc	NN	O	pbc	dep	4	SENT_308	[p16l808t2393r1152b2458],

1	4	LS	NUMBER	4	_	0	SENT_309	[p16l30t2620r63b2654],
2	.	.	O	.	_	0	SENT_309	[p16l30t2620r63b2654],

1	Packer	NNP	PERSON	Packer	nn	2	SENT_310	[p16l105t2620r239b2654],
2	RJ	NN	PERSON	rj	_	0	SENT_310	[p16l257t2621r319b2660],
3	,	,	O	,	_	0	SENT_310	[p16l257t2621r319b2660],
4	Gajjar	NNP	PERSON	Gajjar	nn	5	SENT_310	[p16l341t2620r464b2664],
5	A	NNP	O	A	appos	2	SENT_310	[p16l483t2620r528b2660],
6	,	,	O	,	_	0	SENT_310	[p16l483t2620r528b2660],
7	Vezina	NNP	O	Vezina	nn	8	SENT_310	[p16l549t2620r684b2654],
8	G	NNP	O	G	appos	2	SENT_310	[p16l704t2620r748b2660],
9	,	,	O	,	_	0	SENT_310	[p16l704t2620r748b2660],
10	et	FW	O	et	nn	11	SENT_310	[p16l770t2625r805b2654],
11	al.	FW	O	al.	appos	2	SENT_310	[p16l826t2620r869b2654],
12	.	.	O	.	_	0	SENT_310	[p16l826t2620r869b2654],

1	Phase	NN	O	phase	nn	3	SENT_311	[p16l891t2620r1005b2654],
2	III	CD	NUMBER	iii	num	3	SENT_311	[p16l1025t2621r1074b2654],
3	Study	NN	O	study	nsubj	8	SENT_311	[p16l1095t2620r1207b2664],
4	of	IN	O	of	_	0	SENT_311	[p16l1228t2620r1270b2654],
5	craniospinal	JJ	O	craniospinal	amod	7	SENT_311	[p16l1287t2620r1527b2664],
6	radiation	NN	O	radiation	nn	7	SENT_311	[p16l1547t2620r1722b2654],
7	therapy	NN	O	therapy	prep_of	3	SENT_311	[p16l1742t2620r1889b2664],
8	followed	VBN	O	follow	_	0	SENT_311	[p16l1909t2620r2083b2654],
9	by	IN	O	by	_	0	SENT_311	[p16l2102t2620r2150b2664],
10	adjuvant	JJ	O	adjuvant	amod	11	SENT_311	[p16l106t2681r274b2725],
11	chemotherapy	NN	O	chemotherapy	prep_by	8	SENT_311	[p16l297t2681r575b2725],
12	for	IN	O	for	_	0	SENT_311	[p16l599t2681r656b2715],
13	newly	RB	O	newly	advmod	14	SENT_311	[p16l679t2681r797b2725],
14	diagnosed	VBN	O	diagnose	amod	16	SENT_311	[p16l821t2681r1020b2725],
15	average-risk	JJ	O	average-risk	amod	16	SENT_311	[p16l1045t2681r1287b2725],
16	medulloblastoma	NN	O	medulloblastoma	prep_for	11	SENT_311	[p16l1309t2681r1659b2715],
17	.	.	O	.	_	0	SENT_311	[p16l1309t2681r1659b2715],

1	J	NNP	O	J	nn	3	SENT_312	[p16l1684t2682r1702b2715],
2	Clin	NNP	O	Clin	nn	3	SENT_312	[p16l1727t2681r1810b2715],
3	Oncol	NNP	O	Oncol	_	0	SENT_312	[p16l1834t2681r1952b2715],
4	2006	CD	DATE	2006	num	3	SENT_312	[p16l1977t2681r2148b2721],
5	;	:	O	;	_	0	SENT_312	[p16l1977t2681r2148b2721],
6	24	CD	NUMBER	24	num	8	SENT_312	[p16l1977t2681r2148b2721],
7	:	:	O	:	_	0	SENT_312	[p16l1977t2681r2148b2721],
8	4202-4208	CD	DURATION	4202-4208	dep	3	SENT_312	[p16l105t2741r336b2776],
9	.	.	O	.	_	0	SENT_312	[p16l105t2741r336b2776],

1	5	CD	NUMBER	5	_	0	SENT_313	[p16l31t2803r63b2837],
2	.	.	O	.	_	0	SENT_313	[p16l31t2803r63b2837],

1	Pomeroy	NNP	PERSON	Pomeroy	nn	2	SENT_314	[p16l105t2804r282b2847],
2	SL	NNP	O	SL	_	0	SENT_314	[p16l307t2803r372b2837],
3	.	.	O	.	_	0	SENT_314	[p16l307t2803r372b2837],

1	Epidemiology	NNP	O	Epidemiology	_	0	SENT_315	[p16l397t2803r684b2848],
2	,	,	O	,	_	0	SENT_315	[p16l397t2803r684b2848],
3	treatment	NN	O	treatment	conj_and	1	SENT_315	[p16l710t2808r907b2844],
4	,	,	O	,	_	0	SENT_315	[p16l710t2808r907b2844],
5	and	CC	O	and	_	0	SENT_315	[p16l933t2803r1002b2837],
6	prognosis	NN	O	prognosis	conj_and	1	SENT_315	[p16l1025t2803r1215b2847],
7	of	IN	O	of	_	0	SENT_315	[p16l1240t2803r1283b2837],
8	medulloblastoma	NN	O	medulloblastoma	prep_of	6	SENT_315	[p16l1303t2803r1652b2837],
9	.	.	O	.	_	0	SENT_315	[p16l1303t2803r1652b2837],

1	UpToDate	NNP	O	UpToDate	_	0	SENT_316	[p16l1679t2804r1892b2848],
2	.	.	O	.	_	0	SENT_316	[p16l1679t2804r1892b2848],

1	http://www	NN	O	http://www	_	0	SENT_317	[p16l1917t2803r2148b2847],
2	.	.	O	.	_	0	SENT_317	[p16l1917t2803r2148b2847],

1	uptodate	NN	O	uptodate	_	0	SENT_318	[p16l105t2864r1703b2909],
2	.	.	O	.	_	0	SENT_318	[p16l105t2864r1703b2909],

1	corn/contents/epidemiology-treatment-and	NN	O	corn/contents/epidemiology-treatment-and	_	0	SENT_319	[p16l105t2864r1703b2909],
2	-	:	O	-	_	0	SENT_319	[p16l105t2864r1703b2909],
3	prognosis-of-medulloblastoma	NN	O	prognosis-of-medulloblastoma	dep	1	SENT_319	[p16l105t2864r1703b2909],
4	.	.	O	.	_	0	SENT_319	[p16l105t2864r1703b2909],

1	Accessed	VBN	O	access	_	0	SENT_320	[p16l1723t2864r1904b2898],
2	October	NNP	DATE	October	tmod	1	SENT_320	[p16l1922t2864r2075b2899],
3	21	CD	DATE	21	num	2	SENT_320	[p16l2093t2865r2149b2905],
4	,	,	DATE	,	_	0	SENT_320	[p16l2093t2865r2149b2905],
5	2011	CD	DATE	2011	num	2	SENT_320	[p16l106t2926r210b2961],
6	.	.	O	.	_	0	SENT_320	[p16l106t2926r210b2961],

1	6	CD	NUMBER	6	_	0	SENT_321	[p16l31t2987r63b3022],
2	.	.	O	.	_	0	SENT_321	[p16l31t2987r63b3022],

1	Hoffman	NNP	PERSON	Hoffman	nn	2	SENT_322	[p16l105t2987r281b3022],
2	KE	NNP	PERSON	KE	_	0	SENT_322	[p16l298t2988r372b3028],
3	,	,	O	,	_	0	SENT_322	[p16l298t2988r372b3028],
4	Yock	NNP	PERSON	Yock	nn	5	SENT_322	[p16l391t2988r492b3022],
5	TI	NNP	PERSON	TI	appos	2	SENT_322	[p16l508t2988r563b3022],
6	.	.	O	.	_	0	SENT_322	[p16l508t2988r563b3022],

1	Radiation	NNP	O	Radiation	nn	2	SENT_323	[p16l583t2987r774b3022],
2	therapy	NN	O	therapy	_	0	SENT_323	[p16l790t2988r937b3032],
3	for	IN	O	for	_	0	SENT_323	[p16l954t2987r1012b3022],
4	pediatric	JJ	O	pediatric	amod	8	SENT_323	[p16l1026t2987r1198b3032],
5	central	JJ	O	central	amod	8	SENT_323	[p16l1217t2988r1350b3022],
6	nervous	JJ	O	nervous	amod	8	SENT_323	[p16l1367t2998r1521b3022],
7	system	NN	O	system	nn	8	SENT_323	[p16l1539t2993r1674b3032],
8	tumors	NNS	O	tumor	prep_for	2	SENT_323	[p16l1690t2993r1836b3022],
9	.	.	O	.	_	0	SENT_323	[p16l1690t2993r1836b3022],

1	J	NNP	O	J	nn	3	SENT_324	[p16l1855t2988r1873b3022],
2	Child	NNP	O	Child	nn	3	SENT_324	[p16l1890t2987r1999b3022],
3	Neurol	NNP	O	Neurol	_	0	SENT_324	[p16l2015t2988r2150b3022],

1	2009	CD	DATE	2009	_	0	SENT_325	[p16l106t3050r511b3090],
2	;	:	O	;	_	0	SENT_325	[p16l106t3050r511b3090],
3	24	CD	NUMBER	24	num	5	SENT_325	[p16l106t3050r511b3090],
4	:	:	O	:	_	0	SENT_325	[p16l106t3050r511b3090],
5	l387-1396	CD	NUMBER	l387-1396	dep	1	SENT_325	[p16l106t3050r511b3090],
6	.	.	O	.	_	0	SENT_325	[p16l106t3050r511b3090],

1	Northcott	NNP	ORGANIZATION	Northcott	nn	2	SENT_326	[p17l105t17r294b51],
2	PA	NN	ORGANIZATION	pa	_	0	SENT_326	[p17l307t17r375b57],
3	,	,	O	,	_	0	SENT_326	[p17l307t17r375b57],
4	Korshunov	NNP	PERSON	Korshunov	nn	5	SENT_326	[p17l391t17r606b51],
5	A	NNP	O	A	appos	2	SENT_326	[p17l619t17r664b57],
6	,	,	O	,	_	0	SENT_326	[p17l619t17r664b57],
7	Witt	NNP	PERSON	Witt	nn	8	SENT_326	[p17l679t17r766b51],
8	H	NNP	O	H	appos	2	SENT_326	[p17l779t18r824b57],
9	,	,	O	,	_	0	SENT_326	[p17l779t18r824b57],
10	et	FW	O	et	nn	11	SENT_326	[p17l840t22r875b51],
11	al.	FW	O	al.	appos	2	SENT_326	[p17l889t17r933b51],
12	.	.	O	.	_	0	SENT_326	[p17l889t17r933b51],

1	Medulloblastoma	NN	O	medulloblastoma	nsubj	2	SENT_327	[p17l949t17r1295b51],
2	comprises	VBZ	O	comprise	_	0	SENT_327	[p17l1308t17r1506b61],
3	four	CD	NUMBER	four	num	6	SENT_327	[p17l1521t17r1602b51],
4	distinct	JJ	O	distinct	amod	6	SENT_327	[p17l1615t17r1760b51],
5	molecular	JJ	O	molecular	amod	6	SENT_327	[p17l1774t17r1972b51],
6	variants	NNS	O	variant	dobj	2	SENT_327	[p17l1985t17r2148b51],
7	.	.	O	.	_	0	SENT_327	[p17l1985t17r2148b51],

1	J	NNP	O	J	nn	3	SENT_328	[p17l105t79r123b113],
2	Clin	NNP	O	Clin	nn	3	SENT_328	[p17l142t78r225b113],
3	Oncol	NNP	O	Oncol	_	0	SENT_328	[p17l244t78r362b113],
4	2011	CD	DATE	2011	num	3	SENT_328	[p17l382t78r787b119],
5	;	:	O	;	_	0	SENT_328	[p17l382t78r787b119],
6	29	CD	NUMBER	29	num	8	SENT_328	[p17l382t78r787b119],
7	:	:	O	:	_	0	SENT_328	[p17l382t78r787b119],
8	l408	CD	NUMBER	l408	dep	3	SENT_328	[p17l382t78r787b119],
9	—	CD	NUMBER	—	num	10	SENT_328	[p17l382t78r787b119],
10	l4l4	NN	O	l4l4	dep	8	SENT_328	[p17l382t78r787b119],
11	.	.	O	.	_	0	SENT_328	[p17l382t78r787b119],

1	Cho	NNP	O	Cho	nn	2	SENT_329	[p17l106t139r185b174],
2	YJ	NN	O	yj	_	0	SENT_329	[p17l205t140r269b180],
3	,	,	O	,	_	0	SENT_329	[p17l205t140r269b180],
4	Tsherniak	NN	O	tsherniak	nn	5	SENT_329	[p17l290t140r487b174],
5	A	NN	O	a	appos	2	SENT_329	[p17l505t140r549b180],
6	,	,	O	,	_	0	SENT_329	[p17l505t140r549b180],
7	Tamayo	NNP	PERSON	Tamayo	nn	8	SENT_329	[p17l571t140r727b184],
8	P	NN	O	p	appos	2	SENT_329	[p17l747t140r778b180],
9	,	,	O	,	_	0	SENT_329	[p17l747t140r778b180],
10	et	FW	O	et	nn	11	SENT_329	[p17l800t145r834b174],
11	al.	FW	O	al.	appos	2	SENT_329	[p17l854t139r898b174],
12	.	.	O	.	_	0	SENT_329	[p17l854t139r898b174],

1	Integrative	JJ	MISC	integrative	amod	3	SENT_330	[p17l919t139r1130b184],
2	genomic	JJ	O	genomic	amod	3	SENT_330	[p17l1149t139r1317b184],
3	analysis	NN	O	analysis	_	0	SENT_330	[p17l1338t139r1494b184],
4	of	IN	O	of	_	0	SENT_330	[p17l1515t139r1557b174],
5	medulloblastoma	NN	O	medulloblastoma	nn	6	SENT_330	[p17l1573t139r1914b174],
6	identiﬁes	NNS	O	identiﬁes	prep_of	3	SENT_330	[p17l1931t139r2110b174],
7	a	DT	O	a	det	9	SENT_330	[p17l2130t150r2151b174],
8	molecular	JJ	O	molecular	amod	9	SENT_330	[p17l105t201r303b235],
9	subgroup	NN	O	subgroup	dep	6	SENT_330	[p17l322t200r502b245],
10	that	WDT	O	that	nsubj	11	SENT_330	[p17l521t201r594b235],
11	drives	VBZ	O	drive	rcmod	9	SENT_330	[p17l613t200r730b235],
12	poor	JJ	O	poor	amod	14	SENT_330	[p17l748t211r839b245],
13	clinical	JJ	O	clinical	amod	14	SENT_330	[p17l857t200r1001b235],
14	outcome	NN	O	outcome	dobj	11	SENT_330	[p17l1020t206r1198b235],
15	.	.	O	.	_	0	SENT_330	[p17l1020t206r1198b235],

1	J	NNP	O	J	nn	3	SENT_331	[p17l1219t201r1237b235],
2	Clin	NNP	O	Clin	nn	3	SENT_331	[p17l1256t201r1340b235],
3	Oncol	NNP	O	Oncol	_	0	SENT_331	[p17l1359t201r1477b235],
4	2011	CD	DATE	2011	num	3	SENT_331	[p17l1497t201r1902b241],
5	;	:	O	;	_	0	SENT_331	[p17l1497t201r1902b241],
6	29:1424	CD	NUMBER	29:1424	number	7	SENT_331	[p17l1497t201r1902b241],
7	—	CD	NUMBER	—	dep	3	SENT_331	[p17l1497t201r1902b241],
8	1430	CD	DATE	1430	dep	7	SENT_331	[p17l1497t201r1902b241],
9	.	.	O	.	_	0	SENT_331	[p17l1497t201r1902b241],

1	Mcllwain	NNP	PERSON	Mcllwain	nn	2	SENT_332	[p17l105t262r296b296],
2	CC	NN	O	cc	_	0	SENT_332	[p17l315t262r390b302],
3	,	,	O	,	_	0	SENT_332	[p17l315t262r390b302],
4	Townsend	NNP	PERSON	Townsend	nn	5	SENT_332	[p17l411t262r610b296],
5	DM	NN	O	dm	appos	2	SENT_332	[p17l629t263r717b302],
6	,	,	O	,	_	0	SENT_332	[p17l629t263r717b302],
7	Tew	NN	PERSON	tew	nn	8	SENT_332	[p17l737t263r819b296],
8	KD	NN	O	kd	appos	5	SENT_332	[p17l840t263r918b296],
9	.	.	O	.	_	0	SENT_332	[p17l840t263r918b296],

1	Glutathione	NN	O	glutathione	nn	3	SENT_333	[p17l940t262r1171b296],
2	S-transferase	NN	O	s-transferase	nn	3	SENT_333	[p17l1192t262r1447b296],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_333	[p17l1465t262r1782b306],
4	:	:	O	:	_	0	SENT_333	[p17l1465t262r1782b306],
5	Cancer	NNP	O	Cancer	nn	6	SENT_333	[p17l1805t262r1944b296],
6	incidence	NN	O	incidence	dep	3	SENT_333	[p17l1962t262r2150b296],
7	and	CC	O	and	_	0	SENT_333	[p17l106t323r176b357],
8	therapy	NN	O	therapy	dep	3	SENT_333	[p17l194t323r347b367],
9	.	.	O	.	_	0	SENT_333	[p17l194t323r347b367],

1	Oncogene	NN	O	oncogene	_	0	SENT_334	[p17l369t323r567b367],
2	2006	CD	DATE	2006	num	1	SENT_334	[p17l587t323r992b363],
3	;	:	O	;	_	0	SENT_334	[p17l587t323r992b363],
4	25:1639	CD	DURATION	25:1639	number	5	SENT_334	[p17l587t323r992b363],
5	-1648	CD	DURATION	-1648	dep	1	SENT_334	[p17l587t323r992b363],
6	.	.	O	.	_	0	SENT_334	[p17l587t323r992b363],

1	Kilbum	NNP	PERSON	Kilbum	nn	2	SENT_335	[p17l106t384r257b418],
2	L	NNP	PERSON	L	_	0	SENT_335	[p17l279t385r319b424],
3	,	,	O	,	_	0	SENT_335	[p17l279t385r319b424],
4	Okcu	NNP	PERSON	Okcu	nn	5	SENT_335	[p17l344t384r449b418],
5	MF	NN	PERSON	mf	appos	2	SENT_335	[p17l471t385r547b424],
6	,	,	O	,	_	0	SENT_335	[p17l471t385r547b424],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_335	[p17l572t385r685b428],
8	T	NN	PERSON	t	appos	2	SENT_335	[p17l708t385r744b425],
9	,	,	O	,	_	0	SENT_335	[p17l708t385r744b425],
10	et	FW	O	et	nn	11	SENT_335	[p17l769t389r804b418],
11	al.	FW	O	al.	appos	2	SENT_335	[p17l827t384r871b418],
12	.	.	O	.	_	0	SENT_335	[p17l827t384r871b418],

1	Glutathione	NN	O	glutathione	nn	3	SENT_336	[p17l896t384r1127b418],
2	S-transferase	NN	O	s-transferase	nn	3	SENT_336	[p17l1152t384r1407b418],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	5	SENT_336	[p17l1428t384r1734b428],
4	are	VBP	O	be	auxpass	5	SENT_336	[p17l1759t395r1816b418],
5	associated	VBN	O	associate	_	0	SENT_336	[p17l1840t384r2042b418],
6	with	IN	O	with	_	0	SENT_336	[p17l2065t384r2151b418],
7	survival	NN	O	survival	prep_with	5	SENT_336	[p17l107t445r260b479],
8	in	IN	O	in	_	0	SENT_336	[p17l279t445r317b479],
9	anaplastic	JJ	O	anaplastic	amod	11	SENT_336	[p17l336t445r531b489],
10	glioma	NN	O	glioma	nn	11	SENT_336	[p17l551t445r687b489],
11	patients	NNS	O	patient	prep_in	7	SENT_336	[p17l705t445r868b489],
12	.	.	O	.	_	0	SENT_336	[p17l705t445r868b489],

1	Cancer	NN	O	cancer	_	0	SENT_337	[p17l889t445r1028b479],
2	2010	CD	DATE	2010	num	1	SENT_337	[p17l1046t445r1476b485],
3	;	:	O	;	_	0	SENT_337	[p17l1046t445r1476b485],
4	116:2242	CD	DURATION	116:2242	number	5	SENT_337	[p17l1046t445r1476b485],
5	-2249	CD	DURATION	-2249	dep	1	SENT_337	[p17l1046t445r1476b485],
6	.	.	O	.	_	0	SENT_337	[p17l1046t445r1476b485],

1	Okcu	NNP	MISC	Okcu	nn	2	SENT_338	[p17l106t505r211b539],
2	MF	NN	MISC	mf	_	0	SENT_338	[p17l224t506r301b546],
3	,	,	O	,	_	0	SENT_338	[p17l224t506r301b546],
4	Selvan	NNP	PERSON	Selvan	nn	5	SENT_338	[p17l318t505r449b539],
5	M	NNP	O	M	appos	2	SENT_338	[p17l463t506r516b546],
6	,	,	O	,	_	0	SENT_338	[p17l463t506r516b546],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_338	[p17l531t506r644b549],
8	LE	NNP	PERSON	LE	appos	2	SENT_338	[p17l658t506r729b546],
9	,	,	O	,	_	0	SENT_338	[p17l658t506r729b546],
10	et	FW	O	et	nn	11	SENT_338	[p17l745t510r780b539],
11	al.	FW	O	al.	appos	2	SENT_338	[p17l794t505r838b539],
12	.	.	O	.	_	0	SENT_338	[p17l794t505r838b539],

1	Glutathione	NN	MISC	glutathione	nn	3	SENT_339	[p17l855t505r1086b539],
2	S-transferase	NN	MISC	s-transferase	nn	3	SENT_339	[p17l1102t505r1356b539],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_339	[p17l1370t505r1676b550],
4	and	CC	O	and	_	0	SENT_339	[p17l1691t505r1761b539],
5	survival	NN	O	survival	conj_and	3	SENT_339	[p17l1776t505r1930b539],
6	in	IN	O	in	_	0	SENT_339	[p17l1944t505r1981b539],
7	primary	JJ	O	primary	amod	9	SENT_339	[p17l1995t505r2150b549],
8	malignant	JJ	O	malignant	amod	9	SENT_339	[p17l105t566r303b610],
9	glioma	NN	O	glioma	prep_in	3	SENT_339	[p17l321t566r466b610],
10	.	.	O	.	_	0	SENT_339	[p17l321t566r466b610],

1	Clin	NNP	O	Clin	nn	3	SENT_340	[p17l488t566r571b600],
2	Cancer	NNP	O	Cancer	nn	3	SENT_340	[p17l590t566r730b600],
3	Res	NNP	O	Res	_	0	SENT_340	[p17l747t567r819b600],
4	2004	CD	DATE	2004	num	3	SENT_340	[p17l839t566r1245b607],
5	;	:	O	;	_	0	SENT_340	[p17l839t566r1245b607],
6	10:2618	CD	NUMBER	10:2618	number	7	SENT_340	[p17l839t566r1245b607],
7	—	CD	NUMBER	—	dep	3	SENT_340	[p17l839t566r1245b607],
8	2625	CD	DATE	2625	dep	7	SENT_340	[p17l839t566r1245b607],
9	.	.	O	.	_	0	SENT_340	[p17l839t566r1245b607],

1	Armstrong	NNP	O	Armstrong	nn	2	SENT_341	[p17l105t628r317b672],
2	TS	NN	O	t	_	0	SENT_341	[p17l334t627r401b668],
3	,	,	O	,	_	0	SENT_341	[p17l334t627r401b668],
4	Cao	NNP	O	Cao	nn	5	SENT_341	[p17l420t628r498b662],
5	Y	NN	O	y	appos	2	SENT_341	[p17l516t628r554b668],
6	,	,	O	,	_	0	SENT_341	[p17l516t628r554b668],
7	Scheurer	NNP	PERSON	Scheurer	nn	8	SENT_341	[p17l574t627r748b662],
8	ME	NNP	O	ME	appos	2	SENT_341	[p17l764t628r847b668],
9	,	,	O	,	_	0	SENT_341	[p17l764t628r847b668],
10	et	FW	O	et	nn	11	SENT_341	[p17l867t633r901b661],
11	al.	FW	O	al.	appos	2	SENT_341	[p17l919t627r963b661],
12	.	.	O	.	_	0	SENT_341	[p17l919t627r963b661],

1	Risk	NN	O	risk	nn	2	SENT_342	[p17l982t627r1072b661],
2	analysis	NN	O	analysis	_	0	SENT_342	[p17l1089t627r1245b672],
3	of	IN	O	of	_	0	SENT_342	[p17l1263t627r1306b661],
4	severe	JJ	O	severe	amod	5	SENT_342	[p17l1321t638r1443b662],
5	myelotoxicity	NN	O	myelotoxicity	prep_of	2	SENT_342	[p17l1460t627r1734b672],
6	with	IN	O	with	_	0	SENT_342	[p17l1751t627r1838b662],
7	temozolornide	NN	O	temozolornide	prep_with	5	SENT_342	[p17l1855t627r2147b661],
8	:	:	O	:	_	0	SENT_342	[p17l1855t627r2147b661],
9	The	DT	O	the	det	10	SENT_342	[p17l105t689r180b723],
10	effects	NNS	O	effect	dep	2	SENT_342	[p17l199t688r328b723],
11	of	IN	O	of	_	0	SENT_342	[p17l348t688r390b723],
12	clinical	JJ	O	clinical	amod	15	SENT_342	[p17l406t688r550b723],
13	and	CC	O	and	_	0	SENT_342	[p17l570t689r640b723],
14	genetic	JJ	O	genetic	conj_and	12	SENT_342	[p17l658t689r799b733],
15	factors	NNS	O	factor	prep_of	10	SENT_342	[p17l818t688r961b723],
16	.	.	O	.	_	0	SENT_342	[p17l818t688r961b723],

1	Neuro	NNP	O	Neuro	nn	2	SENT_343	[p17l981t689r1103b723],
2	Oncol	NNP	O	Oncol	_	0	SENT_343	[p17l1124t689r1242b723],
3	2009	CD	DATE	2009	num	2	SENT_343	[p17l1261t688r1617b729],
4	;	:	O	;	_	0	SENT_343	[p17l1261t688r1617b729],
5	11:825	CD	NUMBER	11:825	number	6	SENT_343	[p17l1261t688r1617b729],
6	-832	CD	NUMBER	-832	dep	2	SENT_343	[p17l1261t688r1617b729],
7	.	.	O	.	_	0	SENT_343	[p17l1261t688r1617b729],

1	Zielinska	FW	O	zielinska	_	0	SENT_344	[p17l105t749r289b784],
2	E	NN	O	e	dep	1	SENT_344	[p17l307t750r347b790],
3	,	,	O	,	_	0	SENT_344	[p17l307t750r347b790],
4	Zubowska	NN	O	zubowska	nn	5	SENT_344	[p17l368t749r572b784],
5	M	NN	O	m	dep	1	SENT_344	[p17l590t750r643b790],
6	,	,	O	,	_	0	SENT_344	[p17l590t750r643b790],
7	Misiura	NNP	PERSON	Misiura	nn	9	SENT_344	[p17l665t749r818b784],
8	K.	NNP	PERSON	K.	nn	9	SENT_344	[p17l837t750r880b784],
9	Role	NN	PERSON	role	conj_and	2	SENT_344	[p17l902t750r994b784],
10	of	IN	O	of	_	0	SENT_344	[p17l1015t749r1057b784],
11	GSTM1	NN	O	gstm1	prep_of	9	SENT_344	[p17l1074t750r1244b790],
12	,	,	O	,	_	0	SENT_344	[p17l1074t750r1244b790],
13	GSTP1	NN	O	gstp1	appos	11	SENT_344	[p17l1266t750r1419b790],
14	,	,	O	,	_	0	SENT_344	[p17l1266t750r1419b790],
15	and	CC	O	and	_	0	SENT_344	[p17l1441t750r1511b784],
16	GSTT1	NN	O	gstt1	nn	18	SENT_344	[p17l1531t750r1672b784],
17	gene	NN	O	gene	nn	18	SENT_344	[p17l1696t760r1787b794],
18	polymorphism	NN	O	polymorphism	dep	1	SENT_344	[p17l1806t749r2095b794],
19	in	IN	O	in	_	0	SENT_344	[p17l2113t750r2151b783],
20	ifosfamide	NN	O	ifosfamide	nn	21	SENT_344	[p17l105t811r315b845],
21	metabolism	NN	O	metabolism	prep_in	18	SENT_344	[p17l329t811r560b845],
22	affecting	VBG	O	affect	partmod	1	SENT_344	[p17l574t811r746b855],
23	neurotoxicity	NN	O	neurotoxicity	dobj	22	SENT_344	[p17l761t811r1023b855],
24	and	CC	O	and	_	0	SENT_344	[p17l1039t811r1109b845],
25	nephrotoxicity	NN	O	nephrotoxicity	dobj	22	SENT_344	[p17l1122t811r1409b855],
26	in	IN	O	in	_	0	SENT_344	[p17l1424t811r1461b844],
27	children	NNS	O	child	prep_in	23	SENT_344	[p17l1475t811r1646b845],
28	.	.	O	.	_	0	SENT_344	[p17l1475t811r1646b845],

1	J	NNP	O	J	nn	4	SENT_345	[p17l1663t812r1681b845],
2	Pediatr	NNP	O	Pediatr	nn	4	SENT_345	[p17l1695t811r1835b845],
3	Hematol	NNP	O	Hematol	nn	4	SENT_345	[p17l1848t811r2017b845],
4	Oncol	NNP	O	Oncol	_	0	SENT_345	[p17l2032t811r2150b845],
5	2005	CD	DATE	2005	num	4	SENT_345	[p17l106t873r462b913],
6	;	:	O	;	_	0	SENT_345	[p17l106t873r462b913],
7	27:582	CD	NUMBER	27:582	number	8	SENT_345	[p17l106t873r462b913],
8	-589	CD	NUMBER	-589	dep	4	SENT_345	[p17l106t873r462b913],
9	.	.	O	.	_	0	SENT_345	[p17l106t873r462b913],

1	Lo	NNP	O	Lo	nn	2	SENT_346	[p17l105t935r158b968],
2	HW	NNP	O	HW	_	0	SENT_346	[p17l174t935r261b974],
3	,	,	O	,	_	0	SENT_346	[p17l174t935r261b974],
4	Ali-Osman	NNP	O	Ali-Osman	nn	7	SENT_346	[p17l278t934r496b968],
5	F.	NNP	O	F.	nn	7	SENT_346	[p17l511t935r544b968],
6	Genetic	NNP	O	Genetic	nn	7	SENT_346	[p17l562t934r713b968],
7	polymorphism	NN	O	polymorphism	appos	2	SENT_346	[p17l728t934r1017b978],
8	and	CC	O	and	_	0	SENT_346	[p17l1032t934r1101b968],
9	function	NN	O	function	appos	2	SENT_346	[p17l1116t934r1280b968],
10	of	IN	O	of	_	0	SENT_346	[p17l1295t934r1338b968],
11	glutathione	NN	O	glutathione	nn	12	SENT_346	[p17l1351t934r1571b978],
12	S-transferases	NNS	O	s-transferase	prep_of	7	SENT_346	[p17l1588t934r1861b968],
13	in	IN	O	in	_	0	SENT_346	[p17l1877t934r1914b968],
14	tumor	NN	O	tumor	nn	16	SENT_346	[p17l1929t939r2047b968],
15	drug	NN	O	drug	nn	16	SENT_346	[p17l2062t934r2150b978],
16	resistance	NN	O	resistance	prep_in	12	SENT_346	[p17l105t995r309b1029],
17	.	.	O	.	_	0	SENT_346	[p17l105t995r309b1029],

1	Curr	NNP	O	Curr	nn	3	SENT_347	[p17l330t995r420b1029],
2	Opin	NNP	O	Opin	nn	3	SENT_347	[p17l438t995r534b1039],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_347	[p17l552t995r762b1029],
4	2007	CD	DATE	2007	num	3	SENT_347	[p17l782t995r1113b1036],
5	;	:	O	;	_	0	SENT_347	[p17l782t995r1113b1036],
6	7:367	CD	NUMBER	7:367	number	7	SENT_347	[p17l782t995r1113b1036],
7	-374	CD	NUMBER	-374	dep	3	SENT_347	[p17l782t995r1113b1036],
8	.	.	O	.	_	0	SENT_347	[p17l782t995r1113b1036],

1	Zschenker	NN	O	zschenker	nn	2	SENT_348	[p17l105t1055r311b1089],
2	O	NN	O	o	_	0	SENT_348	[p17l332t1055r375b1096],
3	,	,	O	,	_	0	SENT_348	[p17l332t1055r375b1096],
4	Raabe	NN	PERSON	raabe	nn	5	SENT_348	[p17l398t1055r520b1089],
5	A	NN	O	a	appos	2	SENT_348	[p17l542t1055r586b1096],
6	,	,	O	,	_	0	SENT_348	[p17l542t1055r586b1096],
7	Boeckelmann	NNP	O	Boeckelmann	nn	8	SENT_348	[p17l609t1055r880b1089],
8	IK	NNP	O	IK	appos	2	SENT_348	[p17l901t1056r962b1096],
9	,	,	O	,	_	0	SENT_348	[p17l901t1056r962b1096],
10	et	FW	O	et	nn	11	SENT_348	[p17l985t1060r1020b1089],
11	al.	FW	O	al.	appos	2	SENT_348	[p17l1042t1055r1085b1089],
12	.	.	O	.	_	0	SENT_348	[p17l1042t1055r1085b1089],

1	Association	NNP	O	Association	_	0	SENT_349	[p17l1109t1055r1340b1089],
2	of	IN	O	of	_	0	SENT_349	[p17l1362t1055r1405b1089],
3	single	JJ	O	single	amod	5	SENT_349	[p17l1424t1055r1539b1099],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_349	[p17l1561t1055r1765b1089],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_349	[p17l1786t1055r2092b1099],
6	in	IN	O	in	_	0	SENT_349	[p17l2113t1055r2150b1089],
7	ATM	NNP	O	ATM	prep_in	5	SENT_349	[p17l105t1117r219b1157],
8	,	,	O	,	_	0	SENT_349	[p17l105t1117r219b1157],
9	GSTP1	NN	O	gstp1	appos	1	SENT_349	[p17l238t1116r391b1157],
10	,	,	O	,	_	0	SENT_349	[p17l238t1116r391b1157],
11	SOD2	NN	O	sod2	appos	1	SENT_349	[p17l411t1116r541b1157],
12	,	,	O	,	_	0	SENT_349	[p17l411t1116r541b1157],
13	TGFB1	NN	O	tgfb1	appos	1	SENT_349	[p17l560t1116r720b1157],
14	,	,	O	,	_	0	SENT_349	[p17l560t1116r720b1157],
15	XPD	NN	O	xpd	appos	1	SENT_349	[p17l738t1117r834b1150],
16	and	CC	O	and	_	0	SENT_349	[p17l853t1116r922b1150],
17	XRCC1	NN	O	xrcc1	appos	1	SENT_349	[p17l938t1116r1091b1151],
18	with	IN	O	with	_	0	SENT_349	[p17l1113t1116r1199b1150],
19	clinical	JJ	O	clinical	amod	22	SENT_349	[p17l1216t1116r1360b1150],
20	and	CC	O	and	_	0	SENT_349	[p17l1378t1116r1448b1150],
21	cellular	JJ	O	cellular	conj_and	19	SENT_349	[p17l1465t1116r1613b1150],
22	radiosensitivity	NN	O	radiosensitivity	prep_with	9	SENT_349	[p17l1628t1116r1938b1160],
23	.	.	O	.	_	0	SENT_349	[p17l1628t1116r1938b1160],

1	Radiother	NNP	O	Radiother	nn	3	SENT_350	[p17l1956t1116r2151b1150],
2	Oncol	NNP	O	Oncol	nn	3	SENT_350	[p17l106t1178r224b1213],
3	20l0	NN	O	20l0	_	0	SENT_350	[p17l244t1178r550b1219],
4	;	:	O	;	_	0	SENT_350	[p17l244t1178r550b1219],
5	97:26	CD	NUMBER	97:26	number	6	SENT_350	[p17l244t1178r550b1219],
6	—	CD	NUMBER	—	dep	3	SENT_350	[p17l244t1178r550b1219],
7	32	CD	NUMBER	32	dep	6	SENT_350	[p17l244t1178r550b1219],
8	.	.	O	.	_	0	SENT_350	[p17l244t1178r550b1219],

1	Ali-Osman	JJ	MISC	ali-osman	amod	2	SENT_351	[p17l105t1239r323b1274],
2	F	NN	MISC	f	_	0	SENT_351	[p17l342t1240r376b1280],
3	,	,	O	,	_	0	SENT_351	[p17l342t1240r376b1280],
4	Brunner	NNP	PERSON	Brunner	nn	5	SENT_351	[p17l397t1240r559b1274],
5	JM	NN	O	jm	appos	2	SENT_351	[p17l577t1240r650b1280],
6	,	,	O	,	_	0	SENT_351	[p17l577t1240r650b1280],
7	Kutluk	NNP	O	Kutluk	nn	8	SENT_351	[p17l672t1239r808b1274],
8	TM	NNP	O	TM	appos	2	SENT_351	[p17l826t1240r909b1280],
9	,	,	O	,	_	0	SENT_351	[p17l826t1240r909b1280],
10	et	FW	O	et	nn	11	SENT_351	[p17l931t1245r966b1274],
11	al.	FW	O	al.	appos	2	SENT_351	[p17l987t1240r1030b1274],
12	.	.	O	.	_	0	SENT_351	[p17l987t1240r1030b1274],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_352	[p17l1052t1239r1261b1284],
2	signiﬁcance	NN	O	signiﬁcance	_	0	SENT_352	[p17l1284t1239r1516b1284],
3	of	IN	O	of	_	0	SENT_352	[p17l1537t1239r1580b1274],
4	glutathione	NN	O	glutathione	nn	7	SENT_352	[p17l1597t1239r1817b1284],
5	S-transferase	NN	O	s-transferase	nn	7	SENT_352	[p17l1839t1239r2093b1274],
6	pi	NN	O	pi	nn	7	SENT_352	[p17l2113t1239r2150b1284],
7	expression	NN	O	expression	prep_of	2	SENT_352	[p17l105t1300r314b1345],
8	and	CC	O	and	_	0	SENT_352	[p17l334t1300r404b1335],
9	subcellular	JJ	O	subcellular	amod	10	SENT_352	[p17l423t1301r638b1335],
10	localization	NN	O	localization	prep_of	2	SENT_352	[p17l655t1300r885b1335],
11	in	IN	O	in	_	0	SENT_352	[p17l904t1300r942b1334],
12	human	JJ	O	human	amod	13	SENT_352	[p17l959t1301r1093b1335],
13	gliomas	NNS	O	glioma	prep_in	2	SENT_352	[p17l1112t1300r1276b1345],
14	.	.	O	.	_	0	SENT_352	[p17l1112t1300r1276b1345],

1	Clin	NNP	O	Clin	nn	3	SENT_353	[p17l1298t1301r1382b1335],
2	Cancer	NNP	O	Cancer	nn	3	SENT_353	[p17l1400t1301r1540b1335],
3	Res	NNP	O	Res	_	0	SENT_353	[p17l1557t1301r1629b1335],
4	1997	CD	DATE	1997	num	3	SENT_353	[p17l1653t1300r2029b1341],
5	;	:	O	;	_	0	SENT_353	[p17l1653t1300r2029b1341],
6	3:2253	CD	NUMBER	3:2253	number	7	SENT_353	[p17l1653t1300r2029b1341],
7	—	CD	NUMBER	—	dep	3	SENT_353	[p17l1653t1300r2029b1341],
8	2261	CD	DATE	2261	dep	7	SENT_353	[p17l1653t1300r2029b1341],
9	.	.	O	.	_	0	SENT_353	[p17l1653t1300r2029b1341],

1	Joshi	NNP	PERSON	Joshi	nn	2	SENT_354	[p17l105t1362r205b1396],
2	MB	NNP	O	MB	_	0	SENT_354	[p17l220t1363r306b1402],
3	,	,	O	,	_	0	SENT_354	[p17l220t1363r306b1402],
4	Shirota	NNP	PERSON	Shirota	nn	5	SENT_354	[p17l324t1362r465b1396],
5	Y	NN	PERSON	y	appos	2	SENT_354	[p17l479t1363r518b1402],
6	,	,	O	,	_	0	SENT_354	[p17l479t1363r518b1402],
7	Danenberg	NNP	PERSON	Danenberg	nn	8	SENT_354	[p17l534t1362r749b1406],
8	KD	NN	O	kd	appos	2	SENT_354	[p17l765t1363r844b1402],
9	,	,	O	,	_	0	SENT_354	[p17l765t1363r844b1402],
10	et	FW	O	et	nn	11	SENT_354	[p17l861t1367r897b1396],
11	al.	FW	O	al.	appos	2	SENT_354	[p17l912t1362r956b1396],
12	.	.	O	.	_	0	SENT_354	[p17l912t1362r956b1396],

1	High	JJ	O	high	amod	3	SENT_355	[p17l973t1362r1071b1406],
2	gene	NN	O	gene	nn	3	SENT_355	[p17l1087t1372r1178b1406],
3	expression	NN	O	expression	nsubj	13	SENT_355	[p17l1194t1362r1403b1406],
4	of	IN	O	of	_	0	SENT_355	[p17l1417t1362r1460b1396],
5	TS1	NN	O	ts1	prep_of	3	SENT_355	[p17l1472t1362r1564b1402],
6	,	,	O	,	_	0	SENT_355	[p17l1472t1362r1564b1402],
7	GSTP1	NN	O	gstp1	prep_of	3	SENT_355	[p17l1581t1362r1734b1402],
8	,	,	O	,	_	0	SENT_355	[p17l1581t1362r1734b1402],
9	and	CC	O	and	_	0	SENT_355	[p17l1752t1362r1822b1396],
10	ERCCl	NN	O	erccl	prep_of	3	SENT_355	[p17l1836t1362r1984b1396],
11	are	VBP	O	be	cop	13	SENT_355	[p17l2005t1373r2063b1396],
12	risk	NN	O	risk	nn	13	SENT_355	[p17l2077t1362r2152b1396],
13	factors	NNS	O	factor	_	0	SENT_355	[p17l105t1423r237b1457],
14	for	IN	O	for	_	0	SENT_355	[p17l254t1423r311b1457],
15	survival	NN	O	survival	prep_for	13	SENT_355	[p17l327t1423r481b1457],
16	in	IN	O	in	_	0	SENT_355	[p17l496t1423r534b1456],
17	patients	NNS	O	patient	prep_in	15	SENT_355	[p17l548t1423r701b1467],
18	treated	VBN	O	treat	partmod	17	SENT_355	[p17l717t1423r852b1457],
19	with	IN	O	with	_	0	SENT_355	[p17l867t1423r953b1457],
20	trimodality	NN	O	trimodality	nn	21	SENT_355	[p17l968t1423r1187b1467],
21	therapy	NN	O	therapy	prep_with	18	SENT_355	[p17l1203t1423r1350b1467],
22	for	IN	O	for	_	0	SENT_355	[p17l1366t1423r1423b1457],
23	esophageal	NN	O	esophageal	nn	24	SENT_355	[p17l1438t1423r1655b1467],
24	cancer	NN	O	cancer	prep_for	21	SENT_355	[p17l1671t1434r1806b1457],
25	.	.	O	.	_	0	SENT_355	[p17l1671t1434r1806b1457],

1	Clin	NNP	O	Clin	nn	3	SENT_356	[p17l1825t1423r1908b1457],
2	Cancer	NNP	O	Cancer	nn	3	SENT_356	[p17l1924t1423r2064b1457],
3	Res	NNP	O	Res	_	0	SENT_356	[p17l2078t1424r2150b1457],
4	2005	CD	DATE	2005	num	3	SENT_356	[p17l106t1485r511b1525],
5	;	:	O	;	_	0	SENT_356	[p17l106t1485r511b1525],
6	11:2215	CD	NUMBER	11:2215	number	7	SENT_356	[p17l106t1485r511b1525],
7	—	CD	NUMBER	—	num	8	SENT_356	[p17l106t1485r511b1525],
8	222l	NN	O	222l	dep	3	SENT_356	[p17l106t1485r511b1525],
9	.	.	O	.	_	0	SENT_356	[p17l106t1485r511b1525],

1	Surowiak	NNP	MISC	Surowiak	nn	2	SENT_357	[p17l106t1546r293b1580],
2	P	NN	O	p	_	0	SENT_357	[p17l310t1547r342b1586],
3	,	,	O	,	_	0	SENT_357	[p17l310t1547r342b1586],
4	Materna	NNP	PERSON	Materna	nn	5	SENT_357	[p17l361t1547r526b1580],
5	V	NNP	PERSON	V	appos	2	SENT_357	[p17l544t1547r583b1586],
6	,	,	O	,	_	0	SENT_357	[p17l544t1547r583b1586],
7	Kaplenko	NNP	O	Kaplenko	appos	2	SENT_357	[p17l604t1546r793b1590],
8	I	PRP	O	I	dep	7	SENT_357	[p17l812t1547r838b1587],
9	,	,	O	,	_	0	SENT_357	[p17l812t1547r838b1587],
10	et	FW	O	et	nn	11	SENT_357	[p17l859t1551r894b1580],
11	al.	FW	O	al.	appos	2	SENT_357	[p17l913t1546r957b1580],
12	.	.	O	.	_	0	SENT_357	[p17l913t1546r957b1580],

1	Augmented	JJ	O	augmented	amod	2	SENT_358	[p17l978t1546r1207b1590],
2	expression	NN	O	expression	_	0	SENT_358	[p17l1226t1546r1435b1590],
3	of	IN	O	of	_	0	SENT_358	[p17l1454t1546r1497b1580],
4	metallothionein	NN	O	metallothionein	nn	8	SENT_358	[p17l1512t1546r1822b1580],
5	and	CC	O	and	_	0	SENT_358	[p17l1842t1546r1911b1580],
6	glutathione	NN	O	glutathione	nn	8	SENT_358	[p17l1930t1546r2150b1590],
7	S-transferase	NN	O	s-transferase	nn	8	SENT_358	[p17l106t1606r361b1640],
8	pi	NN	O	pi	prep_of	2	SENT_358	[p17l375t1606r412b1651],
9	as	IN	O	as	_	0	SENT_358	[p17l428t1617r466b1640],
10	unfavorable	JJ	O	unfavorable	amod	12	SENT_358	[p17l481t1606r715b1640],
11	prognostic	JJ	O	prognostic	amod	12	SENT_358	[p17l729t1606r936b1650],
12	factors	NNS	O	factor	prep_as	2	SENT_358	[p17l951t1606r1083b1640],
13	in	IN	O	in	_	0	SENT_358	[p17l1099t1606r1136b1640],
14	cisplatin-treated	JJ	O	cisplatin-treated	amod	17	SENT_358	[p17l1151t1606r1468b1651],
15	ovarian	JJ	O	ovarian	amod	17	SENT_358	[p17l1483t1606r1628b1640],
16	cancer	NN	O	cancer	nn	17	SENT_358	[p17l1643t1617r1771b1640],
17	patients	NNS	O	patient	prep_in	2	SENT_358	[p17l1784t1606r1947b1651],
18	.	.	O	.	_	0	SENT_358	[p17l1784t1606r1947b1651],

1	Virchows	NNP	O	Virchows	nn	2	SENT_359	[p17l1964t1606r2150b1640],
2	Arch	NNP	O	Arch	_	0	SENT_359	[p17l105t1668r202b1703],
3	2005	CD	DATE	2005	num	2	SENT_359	[p17l222t1668r602b1709],
4	;	:	O	;	_	0	SENT_359	[p17l222t1668r602b1709],
5	447:626	CD	NUMBER	447:626	num	6	SENT_359	[p17l222t1668r602b1709],
6	—	NN	O	—	dep	2	SENT_359	[p17l222t1668r602b1709],
7	633	CD	NUMBER	633	dep	6	SENT_359	[p17l222t1668r602b1709],
8	.	.	O	.	_	0	SENT_359	[p17l222t1668r602b1709],

1	Tabuchi	NNP	PERSON	Tabuchi	nn	2	SENT_360	[p17l105t1729r262b1763],
2	K	NNP	PERSON	K	_	0	SENT_360	[p17l281t1730r325b1770],
3	,	,	O	,	_	0	SENT_360	[p17l281t1730r325b1770],
4	Nishimura	NNP	PERSON	Nishimura	nn	5	SENT_360	[p17l344t1729r552b1763],
5	B	NNP	O	B	appos	2	SENT_360	[p17l569t1730r611b1770],
6	,	,	O	,	_	0	SENT_360	[p17l569t1730r611b1770],
7	Nakamagoe	NNP	O	Nakamagoe	nn	8	SENT_360	[p17l630t1729r865b1774],
8	M	NNP	O	M	appos	2	SENT_360	[p17l883t1730r936b1770],
9	,	,	O	,	_	0	SENT_360	[p17l883t1730r936b1770],
10	et	FW	O	et	nn	11	SENT_360	[p17l955t1735r991b1763],
11	al.	FW	O	al.	appos	2	SENT_360	[p17l1009t1729r1052b1763],
12	.	.	O	.	_	0	SENT_360	[p17l1009t1729r1052b1763],

1	Ototoxicity	NNP	O	Ototoxicity	_	0	SENT_361	[p17l1073t1729r1307b1774],
2	:	:	O	:	_	0	SENT_361	[p17l1073t1729r1307b1774],
3	Mechanisms	NNS	O	mechanism	dep	1	SENT_361	[p17l1328t1729r1575b1763],
4	of	IN	O	of	_	0	SENT_361	[p17l1595t1729r1637b1763],
5	cochlear	JJ	O	cochlear	amod	6	SENT_361	[p17l1652t1729r1819b1763],
6	impairment	NN	O	impairment	prep_of	3	SENT_361	[p17l1836t1729r2064b1774],
7	and	CC	O	and	_	0	SENT_361	[p17l2082t1729r2151b1763],
8	its	PRP$	O	its	poss	9	SENT_361	[p17l105t1790r150b1824],
9	prevention	NN	O	prevention	prep_of	3	SENT_361	[p17l169t1790r387b1835],
10	.	.	O	.	_	0	SENT_361	[p17l169t1790r387b1835],

1	Curr	NNP	ORGANIZATION	Curr	nn	4	SENT_362	[p17l409t1790r499b1825],
2	Med	NNP	ORGANIZATION	Med	nn	4	SENT_362	[p17l516t1790r606b1824],
3	Chem	NNP	ORGANIZATION	Chem	nn	4	SENT_362	[p17l624t1790r741b1825],
4	20l1	NN	O	20l1	_	0	SENT_362	[p17l760t1790r1165b1831],
5	;	:	O	;	_	0	SENT_362	[p17l760t1790r1165b1831],
6	l8	NN	O	l8	dep	4	SENT_362	[p17l760t1790r1165b1831],
7	:4866	CD	NUMBER	:4866	num	6	SENT_362	[p17l760t1790r1165b1831],
8	—	CD	NUMBER	—	number	9	SENT_362	[p17l760t1790r1165b1831],
9	4871	CD	NUMBER	4871	dep	6	SENT_362	[p17l760t1790r1165b1831],
10	.	.	O	.	_	0	SENT_362	[p17l760t1790r1165b1831],

1	Low	JJ	O	low	amod	2	SENT_363	[p17l105t1852r193b1886],
2	WK	NN	DURATION	wk	_	0	SENT_363	[p17l208t1852r300b1892],
3	,	,	O	,	_	0	SENT_363	[p17l208t1852r300b1892],
4	Tan	NNP	O	Tan	nn	5	SENT_363	[p17l317t1852r390b1886],
5	MG	NN	O	mg	appos	2	SENT_363	[p17l404t1852r493b1892],
6	,	,	O	,	_	0	SENT_363	[p17l404t1852r493b1892],
7	Chua	NNP	O	Chua	nn	8	SENT_363	[p17l511t1852r614b1886],
8	AW	NNP	O	AW	appos	2	SENT_363	[p17l629t1852r712b1892],
9	,	,	O	,	_	0	SENT_363	[p17l629t1852r712b1892],
10	et	FW	O	et	nn	11	SENT_363	[p17l729t1857r764b1886],
11	al.	FW	O	al.	appos	2	SENT_363	[p17l780t1852r824b1886],
12	12th	JJ	ORDINAL	12th	amod	16	SENT_363	[p17l847t1851r929b1886],
13	Yahya	NNP	O	Yahya	nn	16	SENT_363	[p17l944t1851r1068b1896],
14	Cohen	NNP	O	Cohen	nn	16	SENT_363	[p17l1083t1852r1210b1886],
15	Memorial	NNP	O	Memorial	nn	16	SENT_363	[p17l1225t1852r1419b1886],
16	Lecture	NNP	O	Lecture	dep	11	SENT_363	[p17l1435t1852r1595b1886],
17	:	:	O	:	_	0	SENT_363	[p17l1435t1852r1595b1886],
18	The	DT	O	the	det	22	SENT_363	[p17l1614t1852r1689b1886],
19	cellular	JJ	O	cellular	amod	22	SENT_363	[p17l1706t1852r1854b1886],
20	and	CC	O	and	_	0	SENT_363	[p17l1870t1852r1939b1886],
21	molecular	JJ	O	molecular	conj_and	19	SENT_363	[p17l1953t1852r2151b1886],
22	basis	NN	O	basis	dep	2	SENT_363	[p17l105t1913r202b1947],
23	of	IN	O	of	_	0	SENT_363	[p17l221t1913r264b1947],
24	radiation-induced	JJ	O	radiation-induced	amod	27	SENT_363	[p17l279t1913r627b1947],
25	sensori-neural	JJ	O	sensori-neural	amod	27	SENT_363	[p17l646t1913r923b1947],
26	hearing	NN	O	hearing	nn	27	SENT_363	[p17l941t1913r1088b1957],
27	loss	NN	O	loss	prep_of	22	SENT_363	[p17l1107t1913r1192b1947],
28	.	.	O	.	_	0	SENT_363	[p17l1107t1913r1192b1947],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_364	[p17l1213t1913r1297b1947],
2	Acad	NNP	O	Acad	nn	4	SENT_364	[p17l1315t1913r1419b1947],
3	Med	NNP	O	Med	nn	4	SENT_364	[p17l1437t1913r1527b1947],
4	Singapore	NNP	LOCATION	Singapore	_	0	SENT_364	[p17l1546t1913r1743b1957],
5	2009	CD	DATE	2009	num	4	SENT_364	[p17l1762t1913r2069b1953],
6	;	:	O	;	_	0	SENT_364	[p17l1762t1913r2069b1953],
7	38:9	CD	NUMBER	38:9	num	8	SENT_364	[p17l1762t1913r2069b1953],
8	l-94	NN	O	l-94	dep	4	SENT_364	[p17l1762t1913r2069b1953],
9	.	.	O	.	_	0	SENT_364	[p17l1762t1913r2069b1953],

1	Jereczek-Fossa	NNP	PERSON	Jereczek-Fossa	nn	2	SENT_365	[p17l105t1974r402b2008],
2	BA	NN	O	ba	_	0	SENT_365	[p17l418t1974r495b2014],
3	,	,	O	,	_	0	SENT_365	[p17l418t1974r495b2014],
4	Zarowski	NNP	O	Zarowski	nn	5	SENT_365	[p17l513t1974r697b2008],
5	A	NNP	O	A	appos	2	SENT_365	[p17l714t1974r759b2014],
6	,	,	O	,	_	0	SENT_365	[p17l714t1974r759b2014],
7	Milani	NNP	PERSON	Milani	nn	8	SENT_365	[p17l777t1974r908b2008],
8	F	NN	O	f	appos	2	SENT_365	[p17l925t1975r958b2014],
9	,	,	O	,	_	0	SENT_365	[p17l925t1975r958b2014],
10	et	FW	O	et	nn	11	SENT_365	[p17l977t1979r1012b2008],
11	al.	FW	O	al.	appos	2	SENT_365	[p17l1029t1974r1073b2008],
12	.	.	O	.	_	0	SENT_365	[p17l1029t1974r1073b2008],

1	Radiotherapy-induced	JJ	O	radiotherapy-induced	amod	2	SENT_366	[p17l1092t1974r1531b2018],
2	ear	NN	O	ear	_	0	SENT_366	[p17l1547t1985r1607b2008],
3	toxicity	NN	O	toxicity	dep	2	SENT_366	[p17l1622t1974r1780b2018],
4	.	.	O	.	_	0	SENT_366	[p17l1622t1974r1780b2018],

1	Cancer	NNP	O	Cancer	nn	3	SENT_367	[p17l1800t1974r1939b2008],
2	Treat	NNP	O	Treat	nn	3	SENT_367	[p17l1955t1975r2057b2008],
3	Rev	NN	O	rev	_	0	SENT_367	[p17l2073t1975r2150b2008],
4	2003	CD	DATE	2003	num	3	SENT_367	[p17l106t2036r462b2076],
5	;	:	O	;	_	0	SENT_367	[p17l106t2036r462b2076],
6	29:417	CD	NUMBER	29:417	number	7	SENT_367	[p17l106t2036r462b2076],
7	-430	CD	NUMBER	-430	dep	3	SENT_367	[p17l106t2036r462b2076],
8	.	.	O	.	_	0	SENT_367	[p17l106t2036r462b2076],

1	Barahmani	JJ	PERSON	barahmani	amod	2	SENT_368	[p17l105t2097r320b2131],
2	N	NN	PERSON	n	_	0	SENT_368	[p17l338t2098r383b2137],
3	,	,	O	,	_	0	SENT_368	[p17l338t2098r383b2137],
4	Carpentieri	NNP	PERSON	Carpentieri	nn	5	SENT_368	[p17l403t2097r624b2141],
5	S	NNP	O	S	appos	2	SENT_368	[p17l643t2097r679b2137],
6	,	,	O	,	_	0	SENT_368	[p17l643t2097r679b2137],
7	Li	NNP	PERSON	Li	nn	8	SENT_368	[p17l698t2097r740b2131],
8	XN	NNP	PERSON	XN	appos	2	SENT_368	[p17l759t2098r839b2137],
9	,	,	O	,	_	0	SENT_368	[p17l759t2098r839b2137],
10	et	FW	O	et	nn	11	SENT_368	[p17l859t2102r894b2131],
11	al.	FW	O	al.	appos	2	SENT_368	[p17l912t2097r955b2131],
12	.	.	O	.	_	0	SENT_368	[p17l912t2097r955b2131],

1	Glutathione	NN	O	glutathione	nn	3	SENT_369	[p17l976t2097r1207b2131],
2	S-transferase	NN	O	s-transferase	nn	3	SENT_369	[p17l1227t2097r1482b2131],
3	M1	NN	O	m1	nsubj	8	SENT_369	[p17l1499t2097r1562b2131],
4	and	CC	O	and	_	0	SENT_369	[p17l1585t2097r1654b2131],
5	T1	NN	O	t1	nn	6	SENT_369	[p17l1672t2097r1721b2131],
6	polymorphisms	NNS	O	polymorphism	conj_and	3	SENT_369	[p17l1743t2097r2048b2141],
7	may	MD	O	may	aux	8	SENT_369	[p17l2067t2108r2150b2141],
8	predict	VB	O	predict	_	0	SENT_369	[p17l105t2157r243b2201],
9	adverse	JJ	O	adverse	amod	10	SENT_369	[p17l257t2157r405b2191],
10	effects	NNS	O	effect	dobj	8	SENT_369	[p17l419t2157r547b2191],
11	after	IN	O	after	_	0	SENT_369	[p17l564t2157r653b2191],
12	therapy	NN	O	therapy	prep_after	8	SENT_369	[p17l667t2157r814b2202],
13	in	IN	O	in	_	0	SENT_369	[p17l829t2157r865b2191],
14	children	NNS	O	child	prep_in	12	SENT_369	[p17l880t2157r1040b2191],
15	with	IN	O	with	_	0	SENT_369	[p17l1056t2157r1142b2191],
16	medulloblastoma	NN	O	medulloblastoma	prep_with	14	SENT_369	[p17l1156t2157r1505b2191],
17	.	.	O	.	_	0	SENT_369	[p17l1156t2157r1505b2191],

1	Neuro	NNP	O	Neuro	nn	2	SENT_370	[p17l1522t2158r1643b2191],
2	Oncol	NNP	O	Oncol	_	0	SENT_370	[p17l1659t2157r1777b2191],
3	2009	CD	DATE	2009	num	2	SENT_370	[p17l1793t2157r2149b2198],
4	;	:	O	;	_	0	SENT_370	[p17l1793t2157r2149b2198],
5	11:292	CD	NUMBER	11:292	number	6	SENT_370	[p17l1793t2157r2149b2198],
6	-300	CD	NUMBER	-300	dep	2	SENT_370	[p17l1793t2157r2149b2198],
7	.	.	O	.	_	0	SENT_370	[p17l1793t2157r2149b2198],

1	Oldenburg	NNP	PERSON	Oldenburg	nn	2	SENT_371	[p17l106t2218r314b2262],
2	J	NNP	PERSON	J	_	0	SENT_371	[p17l330t2219r348b2252],
3	,	,	O	,	_	0	SENT_371	[p17l351t2247r358b2259],
4	Kraggerud	NNP	O	Kraggerud	nn	5	SENT_371	[p17l377t2218r587b2262],
5	SM	NNP	O	SM	appos	2	SENT_371	[p17l604t2218r683b2259],
6	,	,	O	,	_	0	SENT_371	[p17l604t2218r683b2259],
7	Cvancarova	NNP	O	Cvancarova	nn	8	SENT_371	[p17l702t2218r934b2252],
8	M	NNP	O	M	appos	2	SENT_371	[p17l950t2219r1003b2259],
9	,	,	O	,	_	0	SENT_371	[p17l950t2219r1003b2259],
10	et	FW	O	et	nn	11	SENT_371	[p17l1021t2223r1056b2252],
11	al.	FW	O	al.	appos	2	SENT_371	[p17l1073t2218r1116b2252],
12	.	.	O	.	_	0	SENT_371	[p17l1073t2218r1116b2252],

1	Cisplatin-induced	JJ	O	cisplatin-induced	amod	4	SENT_372	[p17l1136t2218r1486b2263],
2	long-term	JJ	O	long-term	amod	4	SENT_372	[p17l1502t2218r1696b2262],
3	hearing	NN	O	hearing	nn	4	SENT_372	[p17l1711t2218r1858b2262],
4	impairment	NN	O	impairment	nsubjpass	6	SENT_372	[p17l1876t2218r2104b2262],
5	is	VBZ	O	be	auxpass	6	SENT_372	[p17l2119t2218r2150b2252],
6	associated	VBN	O	associate	_	0	SENT_372	[p17l106t2279r308b2313],
7	with	IN	O	with	_	0	SENT_372	[p17l322t2279r408b2314],
8	speciﬁc	NN	O	speciﬁc	nn	11	SENT_372	[p17l424t2279r571b2324],
9	glutathione	NN	O	glutathione	nn	11	SENT_372	[p17l587t2279r807b2324],
10	S-transferase	NN	MISC	s-transferase	nn	11	SENT_372	[p17l823t2279r1077b2314],
11	genotypes	NNS	O	genotype	prep_with	6	SENT_372	[p17l1092t2285r1289b2324],
12	in	IN	O	in	_	0	SENT_372	[p17l1305t2279r1342b2313],
13	testicular	JJ	O	testicular	amod	15	SENT_372	[p17l1357t2279r1538b2313],
14	cancer	NN	O	cancer	nn	15	SENT_372	[p17l1551t2290r1680b2313],
15	survivors	NNS	O	survivor	prep_in	6	SENT_372	[p17l1696t2279r1885b2314],
16	.	.	O	.	_	0	SENT_372	[p17l1696t2279r1885b2314],

1	J	NNP	O	J	nn	3	SENT_373	[p17l1900t2280r1918b2314],
2	Clin	NNP	O	Clin	nn	3	SENT_373	[p17l1933t2279r2017b2314],
3	Oncol	NNP	O	Oncol	_	0	SENT_373	[p17l2032t2279r2150b2314],
4	2007	CD	DATE	2007	num	3	SENT_373	[p17l106t2341r462b2382],
5	;	:	O	;	_	0	SENT_373	[p17l106t2341r462b2382],
6	25:708	CD	NUMBER	25:708	number	7	SENT_373	[p17l106t2341r462b2382],
7	-714	CD	NUMBER	-714	dep	3	SENT_373	[p17l106t2341r462b2382],
8	.	.	O	.	_	0	SENT_373	[p17l106t2341r462b2382],

1	Peters	NNP	ORGANIZATION	Peters	nn	2	SENT_374	[p17l105t2403r223b2437],
2	U	NNP	ORGANIZATION	U	_	0	SENT_374	[p17l242t2403r287b2443],
3	,	,	O	,	_	0	SENT_374	[p17l242t2403r287b2443],
4	Preisler-Adams	NNP	O	Preisler-Adams	nn	5	SENT_374	[p17l308t2402r612b2437],
5	S	NNP	O	S	appos	2	SENT_374	[p17l632t2403r667b2443],
6	,	,	O	,	_	0	SENT_374	[p17l632t2403r667b2443],
7	Hebeisen	NNP	O	Hebeisen	nn	8	SENT_374	[p17l687t2402r870b2437],
8	A	NNP	O	A	appos	2	SENT_374	[p17l888t2403r933b2443],
9	,	,	O	,	_	0	SENT_374	[p17l888t2403r933b2443],
10	et	FW	O	et	nn	11	SENT_374	[p17l954t2408r989b2437],
11	al.	FW	O	al.	appos	2	SENT_374	[p17l1007t2403r1051b2437],
12	.	.	O	.	_	0	SENT_374	[p17l1007t2403r1051b2437],

1	Glutathione	NN	MISC	glutathione	nn	2	SENT_375	[p17l1072t2402r1303b2437],
2	S-transferase	NN	MISC	s-transferase	_	0	SENT_375	[p17l1323t2402r1578b2437],
3	genetic	JJ	O	genetic	amod	4	SENT_375	[p17l1597t2402r1737b2447],
4	polymorphisms	NNS	O	polymorphism	dep	2	SENT_375	[p17l1756t2403r2062b2447],
5	and	CC	O	and	_	0	SENT_375	[p17l2082t2403r2151b2437],
6	individual	JJ	O	individual	amod	7	SENT_375	[p17l105t2464r303b2498],
7	sensitivity	NN	O	sensitivity	dep	2	SENT_375	[p17l323t2464r522b2508],
8	to	TO	O	to	_	0	SENT_375	[p17l541t2469r577b2498],
9	the	DT	O	the	det	11	SENT_375	[p17l597t2464r656b2498],
10	ototoxic	JJ	O	ototoxic	amod	11	SENT_375	[p17l675t2464r835b2498],
11	effect	NN	O	effect	prep_to	2	SENT_375	[p17l855t2464r965b2498],
12	of	IN	O	of	_	0	SENT_375	[p17l984t2464r1027b2498],
13	cisplatin	NN	O	cisplatin	prep_of	11	SENT_375	[p17l1042t2464r1218b2508],
14	.	.	O	.	_	0	SENT_375	[p17l1042t2464r1218b2508],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_376	[p17l1239t2464r1456b2498],
2	Drugs	NNS	O	drug	_	0	SENT_376	[p17l1473t2465r1591b2508],
3	2000	CD	DATE	2000	dep	2	SENT_376	[p17l1611t2464r1967b2504],
4	;	:	O	;	_	0	SENT_376	[p17l1611t2464r1967b2504],
5	11:639	CD	NUMBER	11:639	num	6	SENT_376	[p17l1611t2464r1967b2504],
6	-643	CD	NUMBER	-643	dep	2	SENT_376	[p17l1611t2464r1967b2504],
7	.	.	O	.	_	0	SENT_376	[p17l1611t2464r1967b2504],

1	Ross	NNP	PERSON	Ross	nn	2	SENT_377	[p17l105t2527r198b2560],
2	CJ	NNP	O	CJ	_	0	SENT_377	[p17l216t2526r277b2566],
3	,	,	O	,	_	0	SENT_377	[p17l216t2526r277b2566],
4	Katzov-Eckert	NNP	PERSON	Katzov-Eckert	nn	5	SENT_377	[p17l296t2526r582b2561],
5	H	NNP	PERSON	H	appos	2	SENT_377	[p17l599t2527r643b2566],
6	,	,	O	,	_	0	SENT_377	[p17l599t2527r643b2566],
7	Dube	NNP	PERSON	Dube	nn	8	SENT_377	[p17l661t2526r766b2560],
8	MP	NNP	O	MP	appos	2	SENT_377	[p17l783t2527r859b2566],
9	,	,	O	,	_	0	SENT_377	[p17l783t2527r859b2566],
10	et	FW	O	et	nn	11	SENT_377	[p17l877t2531r912b2560],
11	al.	FW	O	al.	appos	2	SENT_377	[p17l929t2526r973b2560],
12	.	.	O	.	_	0	SENT_377	[p17l929t2526r973b2560],

1	Genetic	JJ	O	genetic	amod	2	SENT_378	[p17l993t2526r1144b2561],
2	variants	NNS	O	variant	nsubjpass	8	SENT_378	[p17l1162t2526r1314b2560],
3	in	IN	O	in	_	0	SENT_378	[p17l1332t2526r1370b2560],
4	TPMT	NN	O	tpmt	prep_in	2	SENT_378	[p17l1386t2527r1516b2560],
5	and	CC	O	and	_	0	SENT_378	[p17l1530t2526r1600b2560],
6	COMT	NN	ORGANIZATION	comt	prep_in	2	SENT_378	[p17l1616t2526r1757b2561],
7	are	VBP	O	be	auxpass	8	SENT_378	[p17l1771t2537r1828b2560],
8	associated	VBN	O	associate	_	0	SENT_378	[p17l1846t2526r2048b2560],
9	with	IN	O	with	_	0	SENT_378	[p17l2065t2526r2151b2560],
10	hearing	NN	O	hearing	nn	11	SENT_378	[p17l105t2587r252b2631],
11	loss	NN	O	loss	prep_with	8	SENT_378	[p17l270t2587r345b2621],
12	in	IN	O	in	_	0	SENT_378	[p17l365t2587r402b2621],
13	children	NNS	O	child	prep_in	8	SENT_378	[p17l421t2587r581b2621],
14	receiving	VBG	O	receive	partmod	13	SENT_378	[p17l599t2587r781b2631],
15	cisplatin	NN	O	cisplatin	nn	16	SENT_378	[p17l800t2587r966b2631],
16	chemotherapy	NN	O	chemotherapy	dobj	14	SENT_378	[p17l985t2587r1270b2631],
17	.	.	O	.	_	0	SENT_378	[p17l985t2587r1270b2631],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_379	[p17l1291t2588r1362b2621],
2	Genet	NNP	PERSON	Genet	_	0	SENT_379	[p17l1381t2587r1497b2621],
3	2009	CD	DATE	2009	num	2	SENT_379	[p17l1516t2587r1921b2627],
4	;	:	O	;	_	0	SENT_379	[p17l1516t2587r1921b2627],
5	41:1345	CD	DURATION	41:1345	number	6	SENT_379	[p17l1516t2587r1921b2627],
6	-1349	CD	DURATION	-1349	dep	2	SENT_379	[p17l1516t2587r1921b2627],
7	.	.	O	.	_	0	SENT_379	[p17l1516t2587r1921b2627],

1	Ambrosone	NNP	O	Ambrosone	nn	2	SENT_380	[p17l105t2648r334b2682],
2	CB	NNP	O	CB	_	0	SENT_380	[p17l349t2648r424b2688],
3	,	,	O	,	_	0	SENT_380	[p17l349t2648r424b2688],
4	Tian	NNP	O	Tian	nn	5	SENT_380	[p17l441t2648r529b2682],
5	C	NNP	O	C	appos	2	SENT_380	[p17l546t2648r587b2688],
6	,	,	O	,	_	0	SENT_380	[p17l546t2648r587b2688],
7	Ahn	NNP	PERSON	Ahn	nn	8	SENT_380	[p17l604t2648r688b2682],
8	J	NNP	PERSON	J	appos	2	SENT_380	[p17l703t2649r721b2682],
9	,	,	O	,	_	0	SENT_380	[p17l724t2676r732b2688],
10	et	FW	O	et	nn	11	SENT_380	[p17l749t2653r784b2682],
11	al.	FW	O	al.	appos	2	SENT_380	[p17l800t2648r844b2682],
12	.	.	O	.	_	0	SENT_380	[p17l800t2648r844b2682],

1	Genetic	JJ	O	genetic	amod	2	SENT_381	[p17l862t2648r1013b2682],
2	predictors	NNS	O	predictor	nsubj	6	SENT_381	[p17l1029t2648r1225b2692],
3	of	IN	O	of	_	0	SENT_381	[p17l1242t2648r1285b2682],
4	acute	JJ	O	acute	amod	5	SENT_381	[p17l1297t2653r1399b2682],
5	toxicities	NNS	O	toxicity	prep_of	2	SENT_381	[p17l1415t2648r1595b2682],
6	related	VBN	O	relate	_	0	SENT_381	[p17l1611t2648r1745b2682],
7	to	TO	O	to	_	0	SENT_381	[p17l1761t2653r1798b2682],
8	radiation	NN	O	radiation	nn	9	SENT_381	[p17l1813t2648r1988b2682],
9	therapy	NN	O	therapy	prep_to	6	SENT_381	[p17l2004t2648r2150b2692],
10	following	VBG	O	follow	_	0	SENT_381	[p17l105t2708r295b2752],
11	lumpectomy	NN	O	lumpectomy	prep_following	9	SENT_381	[p17l313t2708r559b2752],
12	for	IN	O	for	_	0	SENT_381	[p17l578t2708r635b2742],
13	breast	NN	O	breast	nn	14	SENT_381	[p17l652t2708r770b2742],
14	cancer	NN	O	cancer	prep_for	11	SENT_381	[p17l788t2719r926b2742],
15	:	:	O	:	_	0	SENT_381	[p17l788t2719r926b2742],
16	A	DT	O	a	det	18	SENT_381	[p17l948t2708r982b2742],
17	case-series	JJ	O	case-series	amod	18	SENT_381	[p17l1001t2708r1212b2742],
18	study	NN	O	study	dep	11	SENT_381	[p17l1233t2708r1344b2752],
19	.	.	O	.	_	0	SENT_381	[p17l1233t2708r1344b2752],

1	Breast	NN	O	breast	nn	2	SENT_382	[p17l1365t2709r1490b2742],
2	Cancer	NN	O	cancer	_	0	SENT_382	[p17l1509t2708r1648b2742],
3	Res	NNP	O	Res	dep	2	SENT_382	[p17l1666t2709r1737b2742],
4	2006	CD	DATE	2006	num	3	SENT_382	[p17l1758t2708r1999b2748],
5	;	:	O	;	_	0	SENT_382	[p17l1758t2708r1999b2748],
6	8	CD	NUMBER	8	dep	2	SENT_382	[p17l1758t2708r1999b2748],
7	:	:	O	:	_	0	SENT_382	[p17l1758t2708r1999b2748],
8	R40	NN	O	r40	dep	6	SENT_382	[p17l1758t2708r1999b2748],
9	.	.	O	.	_	0	SENT_382	[p17l1758t2708r1999b2748],

1	Edvardsen	NN	O	edvardsen	nn	2	SENT_383	[p17l105t2769r311b2803],
2	H	NN	O	h	_	0	SENT_383	[p17l325t2770r370b2810],
3	,	,	O	,	_	0	SENT_383	[p17l325t2770r370b2810],
4	Kristensen	NNP	PERSON	Kristensen	nn	5	SENT_383	[p17l387t2769r595b2803],
5	VN	NNP	O	VN	appos	2	SENT_383	[p17l610t2770r690b2810],
6	,	,	O	,	_	0	SENT_383	[p17l610t2770r690b2810],
7	Grenaker	NNP	O	Grenaker	nn	9	SENT_383	[p17l707t2769r890b2804],
8	Alnaes	NNP	O	Alnaes	nn	9	SENT_383	[p17l903t2769r1038b2803],
9	GI	NNP	O	GI	appos	2	SENT_383	[p17l1053t2769r1114b2810],
10	,	,	O	,	_	0	SENT_383	[p17l1053t2769r1114b2810],
11	et	FW	O	et	nn	12	SENT_383	[p17l1130t2774r1166b2803],
12	al.	FW	O	al.	appos	2	SENT_383	[p17l1180t2769r1224b2804],
13	.	.	O	.	_	0	SENT_383	[p17l1180t2769r1224b2804],

1	Germline	NN	O	germline	nn	4	SENT_384	[p17l1241t2769r1425b2804],
2	glutathione	NN	O	glutathione	nn	4	SENT_384	[p17l1440t2769r1661b2813],
3	S-transferase	NN	MISC	s-transferase	nn	4	SENT_384	[p17l1676t2769r1931b2804],
4	variants	NNS	O	variant	_	0	SENT_384	[p17l1945t2769r2098b2803],
5	in	IN	O	in	_	0	SENT_384	[p17l2113t2769r2150b2803],
6	breast	NN	O	breast	nn	7	SENT_384	[p17l105t2830r223b2865],
7	cancer	NN	O	cancer	prep_in	4	SENT_384	[p17l242t2841r380b2864],
8	:	:	O	:	_	0	SENT_384	[p17l242t2841r380b2864],
9	Relation	NN	O	relation	dep	4	SENT_384	[p17l405t2830r571b2864],
10	to	TO	O	to	_	0	SENT_384	[p17l591t2835r628b2864],
11	diagnosis	NN	O	diagnosis	prep_to	9	SENT_384	[p17l650t2830r833b2875],
12	and	CC	O	and	_	0	SENT_384	[p17l856t2830r925b2865],
13	cutaneous	JJ	O	cutaneous	amod	16	SENT_384	[p17l946t2836r1141b2864],
14	long-term	JJ	O	long-term	amod	16	SENT_384	[p17l1162t2830r1356b2875],
15	adverse	JJ	O	adverse	amod	16	SENT_384	[p17l1377t2830r1526b2864],
16	effects	NNS	O	effect	dep	4	SENT_384	[p17l1546t2830r1674b2864],
17	after	IN	O	after	_	0	SENT_384	[p17l1697t2830r1786b2864],
18	two	CD	NUMBER	two	num	20	SENT_384	[p17l1806t2835r1878b2865],
19	fractionation	NN	O	fractionation	nn	20	SENT_384	[p17l1899t2830r2151b2865],
20	patterns	NNS	O	pattern	prep_after	16	SENT_384	[p17l105t2896r260b2936],
21	of	IN	O	of	_	0	SENT_384	[p17l279t2891r322b2925],
22	radiotherapy	NN	O	radiotherapy	prep_of	20	SENT_384	[p17l336t2891r593b2936],
23	.	.	O	.	_	0	SENT_384	[p17l336t2891r593b2936],

1	Int	NN	O	int	nn	2	SENT_385	[p17l614t2892r668b2925],
2	J	NN	O	j	_	0	SENT_385	[p17l685t2892r703b2926],
3	Radiat	NN	O	radiat	nn	6	SENT_385	[p17l722t2891r851b2925],
4	Oncol	NN	O	oncol	nn	6	SENT_385	[p17l869t2891r988b2926],
5	Biol	NNP	O	Biol	nn	6	SENT_385	[p17l1006t2891r1090b2925],
6	Phys	NNP	O	Phys	dep	2	SENT_385	[p17l1108t2891r1202b2936],
7	2007	CD	DATE	2007	num	6	SENT_385	[p17l1222t2891r1627b2932],
8	;	:	O	;	_	0	SENT_385	[p17l1222t2891r1627b2932],
9	67:1	CD	NUMBER	67:1	num	10	SENT_385	[p17l1222t2891r1627b2932],
10	l63-1171	NN	O	l63-1171	dep	2	SENT_385	[p17l1222t2891r1627b2932],
11	.	.	O	.	_	0	SENT_385	[p17l1222t2891r1627b2932],

1	Yoon	NNP	PERSON	Yoon	nn	2	SENT_386	[p17l105t2953r208b2987],
2	HH	NNP	PERSON	HH	_	0	SENT_386	[p17l223t2953r303b2993],
3	,	,	O	,	_	0	SENT_386	[p17l223t2953r303b2993],
4	Catalano	NNP	PERSON	Catalano	nn	5	SENT_386	[p17l319t2953r493b2987],
5	P	NN	PERSON	p	appos	2	SENT_386	[p17l508t2953r539b2993],
6	,	,	O	,	_	0	SENT_386	[p17l508t2953r539b2993],
7	Gibson	NNP	PERSON	Gibson	nn	8	SENT_386	[p17l557t2952r697b2987],
8	MK	NNP	O	MK	appos	2	SENT_386	[p17l711t2953r799b2993],
9	,	,	O	,	_	0	SENT_386	[p17l711t2953r799b2993],
10	et	FW	O	et	nn	11	SENT_386	[p17l816t2958r851b2987],
11	al.	FW	O	al.	appos	2	SENT_386	[p17l865t2953r909b2987],
12	.	.	O	.	_	0	SENT_386	[p17l865t2953r909b2987],

1	Genetic	JJ	O	genetic	amod	2	SENT_387	[p17l927t2952r1078b2987],
2	variation	NN	O	variation	nsubj	8	SENT_387	[p17l1093t2952r1267b2987],
3	in	IN	O	in	_	0	SENT_387	[p17l1281t2952r1318b2986],
4	radiation	NN	O	radiation	nn	7	SENT_387	[p17l1333t2952r1508b2987],
5	and	CC	O	and	_	0	SENT_387	[p17l1523t2953r1593b2987],
6	platinum	NN	O	platinum	nn	7	SENT_387	[p17l1606t2952r1782b2997],
7	pathways	NNS	O	pathway	prep_in	2	SENT_387	[p17l1795t2953r1980b2997],
8	predicts	VBZ	O	predict	_	0	SENT_387	[p17l1995t2953r2150b2997],
9	severe	JJ	O	severe	amod	12	SENT_387	[p17l107t3024r229b3048],
10	acute	JJ	O	acute	amod	12	SENT_387	[p17l244t3019r346b3048],
11	radiation	NN	O	radiation	nn	12	SENT_387	[p17l360t3013r536b3048],
12	toxicity	NN	O	toxicity	dobj	8	SENT_387	[p17l550t3013r701b3058],
13	in	IN	O	in	_	0	SENT_387	[p17l715t3013r752b3047],
14	patients	NNS	O	patient	prep_in	12	SENT_387	[p17l766t3013r919b3058],
15	with	IN	O	with	_	0	SENT_387	[p17l935t3013r1021b3048],
16	esophageal	NN	O	esophageal	nn	17	SENT_387	[p17l1036t3014r1253b3058],
17	adenocarcinoma	NN	O	adenocarcinoma	prep_with	8	SENT_387	[p17l1269t3013r1592b3048],
18	treated	VBN	O	treat	partmod	17	SENT_387	[p17l1605t3014r1740b3048],
19	with	IN	O	with	_	0	SENT_387	[p17l1754t3014r1841b3048],
20	cisplatin-based	JJ	O	cisplatin-based	amod	22	SENT_387	[p17l1856t3013r2151b3058],
21	preoperative	JJ	O	preoperative	amod	22	SENT_387	[p17l104t3075r350b3119],
22	radiochemotherapy	NN	O	radiochemotherapy	prep_with	18	SENT_387	[p17l377t3075r769b3119],
23	:	:	O	:	_	0	SENT_387	[p17l377t3075r769b3119],
24	Results	NNS	O	result	dobj	8	SENT_387	[p17l800t3075r943b3109],
25	from	IN	O	from	_	0	SENT_387	[p17l972t3075r1068b3109],
26	the	DT	O	the	det	30	SENT_387	[p17l1095t3075r1154b3109],
27	Eastem	NNP	ORGANIZATION	Eastem	nn	30	SENT_387	[p17l1182t3076r1330b3109],
28	Cooperative	NNP	ORGANIZATION	Cooperative	nn	30	SENT_387	[p17l1359t3075r1597b3119],
29	Oncology	NNP	ORGANIZATION	Oncology	nn	30	SENT_387	[p17l1626t3075r1818b3119],
30	Group	NNP	ORGANIZATION	Group	prep_from	24	SENT_387	[p17l1847t3075r1981b3119],
31	.	.	O	.	_	0	SENT_387	[p17l1847t3075r1981b3119],

1	Cancer	NNP	O	Cancer	nn	3	SENT_388	[p17l2012t3075r2152b3109],
2	Chemother	NNP	O	Chemother	nn	3	SENT_388	[p17l106t3137r325b3172],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_388	[p17l342t3137r551b3172],
4	2011	CD	DATE	2011	num	3	SENT_388	[p17l572t3137r927b3177],
5	;	:	O	;	_	0	SENT_388	[p17l572t3137r927b3177],
6	68:863	CD	NUMBER	68:863	number	7	SENT_388	[p17l572t3137r927b3177],
7	-870	CD	NUMBER	-870	dep	3	SENT_388	[p17l572t3137r927b3177],
8	.	.	O	.	_	0	SENT_388	[p17l572t3137r927b3177],

1	Ishimoto	NNP	PERSON	Ishimoto	nn	2	SENT_389	[p17l105t3198r279b3232],
2	TM	NNP	O	TM	nsubj	15	SENT_389	[p17l300t3199r383b3238],
3	,	,	O	,	_	0	SENT_389	[p17l300t3199r383b3238],
4	Ali-Osman	NNP	PERSON	Ali-Osman	nn	7	SENT_389	[p17l405t3198r623b3232],
5	F.	NNP	PERSON	F.	nn	7	SENT_389	[p17l644t3199r676b3232],
6	Allelic	JJ	PERSON	allelic	amod	7	SENT_389	[p17l699t3198r832b3232],
7	variants	NNS	O	variant	appos	2	SENT_389	[p17l854t3198r1007b3232],
8	of	IN	O	of	_	0	SENT_389	[p17l1029t3198r1072b3232],
9	the	DT	O	the	det	14	SENT_389	[p17l1089t3198r1148b3232],
10	human	JJ	O	human	amod	14	SENT_389	[p17l1169t3198r1302b3232],
11	glutathione	NN	O	glutathione	nn	14	SENT_389	[p17l1323t3198r1544b3242],
12	S-transferase	NN	O	s-transferase	nn	14	SENT_389	[p17l1566t3198r1821b3232],
13	P1	NN	O	p1	nn	14	SENT_389	[p17l1841t3198r1887b3232],
14	gene	NN	O	gene	prep_of	7	SENT_389	[p17l1913t3209r2004b3242],
15	confer	VBP	O	confer	_	0	SENT_389	[p17l2026t3198r2151b3232],
16	differential	JJ	O	differential	amod	17	SENT_389	[p17l106t3258r322b3292],
17	cytoprotection	NN	O	cytoprotection	dobj	15	SENT_389	[p17l344t3258r628b3302],
18	against	IN	O	against	_	0	SENT_389	[p17l651t3258r789b3302],
19	anticancer	JJ	O	anticancer	amod	20	SENT_389	[p17l811t3258r1013b3292],
20	agents	NNS	O	agent	prep_against	15	SENT_389	[p17l1035t3263r1158b3302],
21	in	IN	O	in	_	0	SENT_389	[p17l1180t3258r1217b3292],
22	Escherichia	FW	LOCATION	escherichia	nn	23	SENT_389	[p17l1238t3258r1469b3292],
23	coli	FW	O	coli	prep_in	20	SENT_389	[p17l1490t3258r1573b3292],
24	.	.	O	.	_	0	SENT_389	[p17l1490t3258r1573b3292],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_390	[p17l1597t3258r1954b3302],
2	2002	CD	DATE	2002	num	1	SENT_390	[p17l1977t3258r2148b3299],
3	;	:	O	;	_	0	SENT_390	[p17l1977t3258r2148b3299],
4	12	CD	NUMBER	12	num	6	SENT_390	[p17l1977t3258r2148b3299],
5	:	:	O	:	_	0	SENT_390	[p17l1977t3258r2148b3299],
6	543-553	CD	NUMBER	543-553	dep	1	SENT_390	[p17l106t3319r286b3354],
7	.	.	O	.	_	0	SENT_390	[p17l106t3319r286b3354],

1	Peklak-Scott	JJ	O	peklak-scott	amod	2	SENT_391	[p18l105t20r357b55],
2	C	NN	O	c	_	0	SENT_391	[p18l376t21r417b61],
3	,	,	O	,	_	0	SENT_391	[p18l376t21r417b61],
4	Smitherman	NNP	PERSON	Smitherman	nn	5	SENT_391	[p18l439t20r679b55],
5	PK	NNP	O	PK	appos	2	SENT_391	[p18l697t21r770b61],
6	,	,	O	,	_	0	SENT_391	[p18l697t21r770b61],
7	Townsend	NNP	PERSON	Townsend	nn	8	SENT_391	[p18l790t20r990b54],
8	AJ	NNP	O	AJ	appos	2	SENT_391	[p18l1009t21r1072b61],
9	,	,	O	,	_	0	SENT_391	[p18l1009t21r1072b61],
10	et	FW	O	et	nn	11	SENT_391	[p18l1093t26r1128b54],
11	al.	FW	O	al.	appos	2	SENT_391	[p18l1147t20r1191b54],
12	.	.	O	.	_	0	SENT_391	[p18l1147t20r1191b54],

1	Role	NN	O	role	_	0	SENT_392	[p18l1213t20r1304b55],
2	of	IN	O	of	_	0	SENT_392	[p18l1325t20r1367b54],
3	glutathione	NN	O	glutathione	nn	5	SENT_392	[p18l1383t20r1604b65],
4	S-transferase	NN	O	s-transferase	nn	5	SENT_392	[p18l1625t20r1879b55],
5	P	NN	O	p	prep_of	1	SENT_392	[p18l1898t21r1925b54],
6	1-1	CD	NUMBER	1-1	dep	1	SENT_392	[p18l1949t21r2012b54],
7	in	IN	O	in	_	0	SENT_392	[p18l2035t20r2072b54],
8	the	DT	O	the	det	10	SENT_392	[p18l2091t20r2150b54],
9	cellular	JJ	O	cellular	amod	10	SENT_392	[p18l105t81r254b115],
10	detoxiﬁcation	NN	O	detoxiﬁcation	prep_in	6	SENT_392	[p18l271t81r542b115],
11	of	IN	O	of	_	0	SENT_392	[p18l560t81r603b115],
12	cisplatin	NN	O	cisplatin	prep_of	10	SENT_392	[p18l618t81r794b126],
13	.	.	O	.	_	0	SENT_392	[p18l618t81r794b126],

1	Mol	NNP	O	Mol	nn	3	SENT_393	[p18l815t81r896b115],
2	Cancer	NNP	O	Cancer	nn	3	SENT_393	[p18l915t82r1054b116],
3	Ther	NNP	O	Ther	_	0	SENT_393	[p18l1072t81r1165b115],
4	2008	CD	DATE	2008	num	3	SENT_393	[p18l1183t81r1564b122],
5	;	:	O	;	_	0	SENT_393	[p18l1183t81r1564b122],
6	7:3247	CD	NUMBER	7:3247	number	7	SENT_393	[p18l1183t81r1564b122],
7	—	CD	NUMBER	—	dep	3	SENT_393	[p18l1183t81r1564b122],
8	3255	CD	NUMBER	3255	dep	7	SENT_393	[p18l1183t81r1564b122],
9	.	.	O	.	_	0	SENT_393	[p18l1183t81r1564b122],

1	Bravard	NNP	MISC	Bravard	nn	2	SENT_394	[p18l105t143r262b177],
2	A	NNP	MISC	A	_	0	SENT_394	[p18l285t143r329b183],
3	,	,	O	,	_	0	SENT_394	[p18l285t143r329b183],
4	Luccioni	NNP	PERSON	Luccioni	nn	5	SENT_394	[p18l354t142r529b177],
5	C	NNP	O	C	appos	2	SENT_394	[p18l553t143r595b183],
6	,	,	O	,	_	0	SENT_394	[p18l553t143r595b183],
7	Moustacchi	NNP	O	Moustacchi	nn	8	SENT_394	[p18l620t142r849b177],
8	E	NNP	O	E	appos	2	SENT_394	[p18l872t143r911b183],
9	,	,	O	,	_	0	SENT_394	[p18l872t143r911b183],
10	et	FW	O	et	nn	11	SENT_394	[p18l937t148r972b177],
11	al.	FW	O	al.	appos	2	SENT_394	[p18l996t143r1040b177],
12	.	.	O	.	_	0	SENT_394	[p18l996t143r1040b177],

1	Contribution	NN	O	contribution	_	0	SENT_395	[p18l1066t142r1316b177],
2	of	IN	O	of	_	0	SENT_395	[p18l1340t142r1383b177],
3	antioxidant	JJ	O	antioxidant	amod	4	SENT_395	[p18l1403t142r1625b177],
4	enzymes	NNS	O	enzyme	prep_of	1	SENT_395	[p18l1648t153r1818b187],
5	to	TO	O	to	_	0	SENT_395	[p18l1842t148r1879b177],
6	the	DT	O	the	det	8	SENT_395	[p18l1903t142r1962b177],
7	adaptive	JJ	O	adaptive	amod	8	SENT_395	[p18l1987t142r2151b187],
8	response	NN	O	response	prep_to	4	SENT_395	[p18l105t214r276b248],
9	to	TO	O	to	_	0	SENT_395	[p18l294t209r331b238],
10	ionizing	VBG	O	ionize	amod	11	SENT_395	[p18l350t203r511b248],
11	radiation	NN	O	radiation	prep_to	8	SENT_395	[p18l529t203r705b238],
12	of	IN	O	of	_	0	SENT_395	[p18l724t203r766b238],
13	human	JJ	O	human	amod	14	SENT_395	[p18l781t204r915b238],
14	lymphoblasts	NNS	O	lymphoblast	prep_of	11	SENT_395	[p18l933t203r1205b248],
15	.	.	O	.	_	0	SENT_395	[p18l933t203r1205b248],

1	Int	NN	O	int	nn	4	SENT_396	[p18l1226t204r1280b238],
2	J	NN	O	j	nn	4	SENT_396	[p18l1297t204r1315b238],
3	Radiat	NNP	O	Radiat	nn	4	SENT_396	[p18l1334t203r1463b238],
4	Biol	NNP	O	Biol	_	0	SENT_396	[p18l1481t203r1564b238],
5	1999	CD	DATE	1999	num	4	SENT_396	[p18l1587t203r1939b244],
6	;	:	O	;	_	0	SENT_396	[p18l1587t203r1939b244],
7	75:639	CD	NUMBER	75:639	number	8	SENT_396	[p18l1587t203r1939b244],
8	-645	CD	NUMBER	-645	dep	4	SENT_396	[p18l1587t203r1939b244],
9	.	.	O	.	_	0	SENT_396	[p18l1587t203r1939b244],

1	Bertolini	NNP	PERSON	Bertolini	nn	2	SENT_397	[p18l105t265r276b299],
2	P	NN	O	p	_	0	SENT_397	[p18l291t266r322b305],
3	,	,	O	,	_	0	SENT_397	[p18l291t266r322b305],
4	Lassalle	NNP	PERSON	Lassalle	nn	5	SENT_397	[p18l340t265r498b299],
5	M	NNP	O	M	appos	2	SENT_397	[p18l513t266r567b305],
6	,	,	O	,	_	0	SENT_397	[p18l513t266r567b305],
7	Mercier	NNP	PERSON	Mercier	nn	8	SENT_397	[p18l583t265r737b299],
8	G	NNP	PERSON	G	appos	2	SENT_397	[p18l752t265r797b305],
9	,	,	O	,	_	0	SENT_397	[p18l752t265r797b305],
10	et	FW	O	et	nn	11	SENT_397	[p18l814t270r849b299],
11	a1	FW	O	a1	appos	2	SENT_397	[p18l865t265r907b299],
12	.	.	O	.	_	0	SENT_397	[p18l865t265r907b299],

1	Platinum	NN	O	platinum	nn	3	SENT_398	[p18l926t265r1100b299],
2	compound-related	JJ	O	compound-related	amod	3	SENT_398	[p18l1116t265r1466b309],
3	ototoxicity	NN	O	ototoxicity	nsubj	9	SENT_398	[p18l1482t265r1690b309],
4	in	IN	O	in	_	0	SENT_398	[p18l1706t265r1743b298],
5	children	NNS	O	child	prep_in	3	SENT_398	[p18l1759t265r1926b299],
6	:	:	O	:	_	0	SENT_398	[p18l1759t265r1926b299],
7	Long-term	JJ	O	long-term	amod	8	SENT_398	[p18l1945t266r2152b309],
8	follow-up	JJ	O	follow-up	amod	5	SENT_398	[p18l105t326r292b370],
9	reveals	VBZ	O	reveal	_	0	SENT_398	[p18l310t326r444b360],
10	continuous	JJ	O	continuous	amod	11	SENT_398	[p18l463t326r672b360],
11	worsening	NN	O	worsening	dobj	9	SENT_398	[p18l692t326r891b370],
12	of	IN	O	of	_	0	SENT_398	[p18l909t326r952b360],
13	hearing	NN	O	hearing	nn	14	SENT_398	[p18l966t326r1110b370],
14	loss	NN	O	loss	prep_of	11	SENT_398	[p18l1128t326r1211b360],
15	.	.	O	.	_	0	SENT_398	[p18l1128t326r1211b360],

1	J	NNP	O	J	nn	4	SENT_399	[p18l1231t327r1249b360],
2	Pediatr	NNP	O	Pediatr	nn	4	SENT_399	[p18l1267t326r1404b360],
3	Hematol	NNP	O	Hematol	nn	4	SENT_399	[p18l1421t326r1587b360],
4	Oncol	NNP	O	Oncol	_	0	SENT_399	[p18l1605t326r1722b360],
5	2004	CD	DATE	2004	num	4	SENT_399	[p18l1740t326r2088b366],
6	;	:	O	;	_	0	SENT_399	[p18l1740t326r2088b366],
7	26:649	CD	NUMBER	26:649	number	8	SENT_399	[p18l1740t326r2088b366],
8	-655	CD	NUMBER	-655	dep	4	SENT_399	[p18l1740t326r2088b366],
9	.	.	O	.	_	0	SENT_399	[p18l1740t326r2088b366],

1	Li	NNP	PERSON	Li	nn	2	SENT_400	[p18l105t387r147b421],
2	Y	NN	PERSON	y	_	0	SENT_400	[p18l166t388r205b428],
3	,	,	O	,	_	0	SENT_400	[p18l166t388r205b428],
4	Womer	NNP	PERSON	Womer	nn	5	SENT_400	[p18l224t388r369b421],
5	RB	NN	O	rb	appos	2	SENT_400	[p18l386t388r462b427],
6	,	,	O	,	_	0	SENT_400	[p18l386t388r462b427],
7	Silber	NNP	PERSON	Silber	nn	8	SENT_400	[p18l482t387r599b421],
8	JH	NNP	O	JH	appos	5	SENT_400	[p18l615t388r679b421],
9	.	.	O	.	_	0	SENT_400	[p18l615t388r679b421],

1	Predicting	VBG	O	predict	amod	3	SENT_401	[p18l699t387r901b431],
2	cisplatin	NN	O	cisplatin	nn	3	SENT_401	[p18l920t387r1086b431],
3	ototoxicity	NN	O	ototoxicity	_	0	SENT_401	[p18l1105t387r1317b431],
4	in	IN	O	in	_	0	SENT_401	[p18l1336t387r1373b421],
5	children	NNS	O	child	prep_in	3	SENT_401	[p18l1391t387r1562b421],
6	:	:	O	:	_	0	SENT_401	[p18l1391t387r1562b421],
7	the	DT	O	the	det	8	SENT_401	[p18l1584t387r1643b421],
8	inﬂuence	NN	O	inﬂuence	dep	3	SENT_401	[p18l1662t387r1841b421],
9	of	IN	O	of	_	0	SENT_401	[p18l1860t387r1903b421],
10	age	NN	O	age	prep_of	8	SENT_401	[p18l1918t398r1985b431],
11	and	CC	O	and	_	0	SENT_401	[p18l2004t387r2073b421],
12	the	DT	O	the	det	14	SENT_401	[p18l2091t387r2150b421],
13	cumulative	JJ	O	cumulative	amod	14	SENT_401	[p18l105t448r322b483],
14	dose	NN	O	dose	prep_of	8	SENT_401	[p18l342t448r440b483],
15	.	.	O	.	_	0	SENT_401	[p18l342t448r440b483],

1	Eur	NNP	O	Eur	nn	3	SENT_402	[p18l460t449r532b483],
2	J	NNP	O	J	nn	3	SENT_402	[p18l549t449r567b483],
3	Cancer	NNP	O	Cancer	_	0	SENT_402	[p18l586t448r725b483],
4	2004	CD	DATE	2004	num	3	SENT_402	[p18l744t448r1149b489],
5	;	:	O	;	_	0	SENT_402	[p18l744t448r1149b489],
6	40:2445	CD	NUMBER	40:2445	number	7	SENT_402	[p18l744t448r1149b489],
7	—	CD	NUMBER	—	dep	3	SENT_402	[p18l744t448r1149b489],
8	2451	CD	DATE	2451	dep	7	SENT_402	[p18l744t448r1149b489],
9	.	.	O	.	_	0	SENT_402	[p18l744t448r1149b489],

1	Knight	NNP	O	Knight	nn	2	SENT_403	[p18l106t509r242b553],
2	KR	NNP	O	KR	_	0	SENT_403	[p18l267t510r343b550],
3	,	,	O	,	_	0	SENT_403	[p18l267t510r343b550],
4	Kraemer	NNP	PERSON	Kraemer	nn	5	SENT_403	[p18l371t510r543b543],
5	DF	NNP	O	DF	appos	2	SENT_403	[p18l566t510r635b550],
6	,	,	O	,	_	0	SENT_403	[p18l566t510r635b550],
7	Neuwelt	NNP	PERSON	Neuwelt	nn	8	SENT_403	[p18l661t509r829b543],
8	EA	NN	O	ea	appos	5	SENT_403	[p18l852t509r927b543],
9	.	.	O	.	_	0	SENT_403	[p18l852t509r927b543],

1	Ototoxicity	NN	O	ototoxicity	nsubj	4	SENT_404	[p18l955t509r1178b553],
2	in	IN	O	in	_	0	SENT_404	[p18l1204t509r1240b543],
3	children	NNS	O	child	prep_in	1	SENT_404	[p18l1266t509r1426b543],
4	receiving	VBG	O	receive	_	0	SENT_404	[p18l1451t509r1633b553],
5	platinum	NN	O	platinum	nn	6	SENT_404	[p18l1658t509r1833b553],
6	chemotherapy	NN	O	chemotherapy	dobj	4	SENT_404	[p18l1858t509r2147b554],
7	:	:	O	:	_	0	SENT_404	[p18l1858t509r2147b554],
8	Underestimating	VBG	O	underestimate	parataxis	4	SENT_404	[p18l105t570r433b615],
9	a	DT	O	a	det	12	SENT_404	[p18l450t581r471b605],
10	commonly	RB	O	commonly	advmod	11	SENT_404	[p18l486t570r696b615],
11	occurring	VBG	O	occur	amod	12	SENT_404	[p18l712t570r899b615],
12	toxicity	NN	O	toxicity	dobj	8	SENT_404	[p18l916t570r1066b615],
13	that	WDT	O	that	nsubj	15	SENT_404	[p18l1082t570r1156b604],
14	may	MD	O	may	aux	15	SENT_404	[p18l1171t581r1255b615],
15	inﬂuence	VB	O	inﬂuence	ccomp	12	SENT_404	[p18l1272t570r1451b604],
16	academic	JJ	O	academic	amod	19	SENT_404	[p18l1468t570r1652b604],
17	and	CC	O	and	_	0	SENT_404	[p18l1670t570r1740b604],
18	social	JJ	O	social	conj_and	16	SENT_404	[p18l1757t570r1869b604],
19	development	NN	O	development	dobj	15	SENT_404	[p18l1886t570r2149b615],
20	.	.	O	.	_	0	SENT_404	[p18l1886t570r2149b615],

1	J	NNP	O	J	nn	3	SENT_405	[p18l105t633r123b667],
2	Clin	NNP	O	Clin	nn	3	SENT_405	[p18l142t632r225b667],
3	Oncol	NNP	O	Oncol	_	0	SENT_405	[p18l244t632r362b667],
4	2005	CD	DATE	2005	num	3	SENT_405	[p18l382t632r787b673],
5	;	:	O	;	_	0	SENT_405	[p18l382t632r787b673],
6	23:8588	CD	NUMBER	23:8588	number	7	SENT_405	[p18l382t632r787b673],
7	—	CD	NUMBER	—	dep	3	SENT_405	[p18l382t632r787b673],
8	8596	CD	DATE	8596	dep	7	SENT_405	[p18l382t632r787b673],
9	.	.	O	.	_	0	SENT_405	[p18l382t632r787b673],

1	Paulino	NN	PERSON	paulino	nn	2	SENT_406	[p18l105t693r253b728],
2	AC	NN	O	ac	_	0	SENT_406	[p18l280t694r356b734],
3	,	,	O	,	_	0	SENT_406	[p18l280t694r356b734],
4	Lobo	NNP	PERSON	Lobo	nn	5	SENT_406	[p18l383t694r486b728],
5	M	NNP	O	M	appos	2	SENT_406	[p18l512t694r565b734],
6	,	,	O	,	_	0	SENT_406	[p18l512t694r565b734],
7	Teh	NNP	O	Teh	nn	8	SENT_406	[p18l593t694r666b728],
8	BS	NNP	O	BS	appos	2	SENT_406	[p18l692t694r761b734],
9	,	,	O	,	_	0	SENT_406	[p18l692t694r761b734],
10	et	FW	O	et	nn	11	SENT_406	[p18l789t699r824b728],
11	al.	FW	O	al.	appos	2	SENT_406	[p18l849t694r893b728],
12	.	.	O	.	_	0	SENT_406	[p18l849t694r893b728],

1	Ototoxicity	NN	O	ototoxicity	_	0	SENT_407	[p18l922t693r1145b738],
2	after	IN	O	after	_	0	SENT_407	[p18l1172t693r1262b728],
3	intensity-modulated	JJ	O	intensity-modulated	amod	5	SENT_407	[p18l1287t693r1682b738],
4	radiation	NN	O	radiation	nn	5	SENT_407	[p18l1706t693r1882b728],
5	therapy	NN	O	therapy	prep_after	1	SENT_407	[p18l1908t694r2055b738],
6	and	CC	O	and	_	0	SENT_407	[p18l2081t694r2151b728],
7	cisplatin-based	JJ	O	cisplatin-based	amod	8	SENT_407	[p18l105t754r401b799],
8	chemotherapy	NN	O	chemotherapy	prep_after	1	SENT_407	[p18l419t754r698b799],
9	in	IN	O	in	_	0	SENT_407	[p18l717t754r754b788],
10	children	NNS	O	child	prep_in	1	SENT_407	[p18l774t754r934b789],
11	with	IN	O	with	_	0	SENT_407	[p18l953t754r1040b789],
12	medulloblastoma	NN	O	medulloblastoma	prep_with	10	SENT_407	[p18l1058t755r1408b789],
13	.	.	O	.	_	0	SENT_407	[p18l1058t755r1408b789],

1	Int	NN	O	int	nn	2	SENT_408	[p18l1429t755r1484b789],
2	J	NN	O	j	_	0	SENT_408	[p18l1501t755r1519b789],
3	Radiat	NN	O	radiat	nn	6	SENT_408	[p18l1538t754r1667b789],
4	Oncol	NN	O	oncol	nn	6	SENT_408	[p18l1686t755r1804b789],
5	Biol	NNP	O	Biol	nn	6	SENT_408	[p18l1824t755r1907b789],
6	Phys	NNP	O	Phys	dep	2	SENT_408	[p18l1926t755r2020b799],
7	2010	CD	DATE	2010	num	6	SENT_408	[p18l2040t755r2148b795],
8	;	:	O	;	_	0	SENT_408	[p18l2040t755r2148b795],
9	78:1445	CD	NUMBER	78:1445	number	10	SENT_408	[p18l105t816r399b851],
10	—	CD	NUMBER	—	dep	2	SENT_408	[p18l105t816r399b851],
11	1450	CD	DATE	1450	dep	10	SENT_408	[p18l105t816r399b851],
12	.	.	O	.	_	0	SENT_408	[p18l105t816r399b851],

1	Fouladi	NN	MISC	fouladus	nn	2	SENT_409	[p18l105t878r253b912],
2	M	NN	O	m	_	0	SENT_409	[p18l270t879r323b918],
3	,	,	O	,	_	0	SENT_409	[p18l270t879r323b918],
4	Chintagumpala	NNP	O	Chintagumpala	nn	5	SENT_409	[p18l341t878r642b922],
5	M	NNP	O	M	appos	2	SENT_409	[p18l656t879r709b918],
6	,	,	O	,	_	0	SENT_409	[p18l656t879r709b918],
7	Ashley	NNP	PERSON	Ashley	nn	8	SENT_409	[p18l727t878r865b922],
8	D	NNP	PERSON	D	appos	2	SENT_409	[p18l881t879r925b918],
9	,	,	O	,	_	0	SENT_409	[p18l881t879r925b918],
10	et	FW	O	et	nn	11	SENT_409	[p18l943t883r978b912],
11	al.	FW	O	al.	appos	2	SENT_409	[p18l994t878r1038b912],
12	.	.	O	.	_	0	SENT_409	[p18l994t878r1038b912],

1	Amifostine	NNP	O	Amifostine	nsubj	2	SENT_410	[p18l1056t878r1276b912],
2	protects	VBZ	O	protect	_	0	SENT_410	[p18l1292t883r1447b922],
3	against	IN	O	against	_	0	SENT_410	[p18l1465t878r1603b922],
4	cisplatin-induced	JJ	O	cisplatin-induced	amod	5	SENT_410	[p18l1619t878r1959b922],
5	ototoxicity	NN	O	ototoxicity	prep_against	2	SENT_410	[p18l1974t878r2150b912, p18l105t939r156b983],
6	in	IN	O	in	_	0	SENT_410	[p18l175t939r212b973],
7	children	NNS	O	child	prep_in	5	SENT_410	[p18l231t939r391b973],
8	with	IN	O	with	_	0	SENT_410	[p18l410t939r496b973],
9	average-risk	JJ	O	average-risk	amod	10	SENT_410	[p18l515t939r757b983],
10	medulloblastoma	NN	O	medulloblastoma	prep_with	7	SENT_410	[p18l775t939r1125b973],
11	.	.	O	.	_	0	SENT_410	[p18l775t939r1125b973],

1	J	NNP	O	J	nn	3	SENT_411	[p18l1145t940r1164b973],
2	Clin	NNP	O	Clin	nn	3	SENT_411	[p18l1182t939r1266b973],
3	Oncol	NNP	O	Oncol	_	0	SENT_411	[p18l1285t939r1403b973],
4	2008	CD	DATE	2008	num	3	SENT_411	[p18l1422t939r1828b979],
5	;	:	O	;	_	0	SENT_411	[p18l1422t939r1828b979],
6	26:3749	CD	NUMBER	26:3749	number	7	SENT_411	[p18l1422t939r1828b979],
7	—	CD	NUMBER	—	dep	3	SENT_411	[p18l1422t939r1828b979],
8	3755	CD	NUMBER	3755	dep	7	SENT_411	[p18l1422t939r1828b979],
9	.	.	O	.	_	0	SENT_411	[p18l1422t939r1828b979],

